(dp0
S'TAP1'
p1
(lp2
(dp3
S'source'
p4
S'http://drugbank.bio2rdf.org/sparql'
p5
sS'targetURI'
p6
Vhttp://bio2rdf.org/drugbank_target:5300
p7
sS'pharmacologicAction'
p8
NsS'drugURI'
p9
Vhttp://bio2rdf.org/drugbank:DB03431
p10
sS'targetMappingSymbol'
p11
g1
sS'targetName'
p12
S'transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)'
p13
sS'uri'
p14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_5300
p15
sS'drugGeneric'
p16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p17
sS'label'
p18
Vdrug-target interaction Adenosine-5'-Diphosphate and Antigen peptide transporter 1 [drugbank_resource:DB03431_5300]
p19
sasS'PROS1'
p20
(lp21
(dp22
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1245
p23
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00055
p24
sg11
g20
sg12
S'protein S (alpha)'
p25
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00055_1245
p26
sg16
VDrotrecogin alfa [drugbank:DB00055]
p27
sg18
Vdrug-target interaction Drotrecogin alfa and Vitamin K-dependent protein S [drugbank_resource:DB00055_1245]
p28
sa(dp29
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1245
p30
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00170
p31
sg11
g20
sg12
S'protein S (alpha)'
p32
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00170_1245
p33
sg16
VMenadione [drugbank:DB00170]
p34
sg18
Vdrug-target interaction Menadione and Vitamin K-dependent protein S [drugbank_resource:DB00170_1245]
p35
sa(dp36
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1245
p37
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00464
p38
sg11
g20
sg12
S'protein S (alpha)'
p39
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00464_1245
p40
sg16
VSodium Tetradecyl Sulfate [drugbank:DB00464]
p41
sg18
Vdrug-target interaction Sodium Tetradecyl Sulfate and Vitamin K-dependent protein S [drugbank_resource:DB00464_1245]
p42
sasS'TGM3'
p43
(lp44
(dp45
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2339
p46
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01972
p47
sg11
g43
sg12
S'transglutaminase 3'
p48
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01972_2339
p49
sg16
VGuanosine-5'-Monophosphate [drugbank:DB01972]
p50
sg18
Vdrug-target interaction Guanosine-5'-Monophosphate and Protein-glutamine gamma-glutamyltransferase E [drugbank_resource:DB01972_2339]
p51
sa(dp52
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2339
p53
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01864
p54
sg11
g43
sg12
S'transglutaminase 3'
p55
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01864_2339
p56
sg16
V5'-Guanosine-Diphosphate-Monothiophosphate [drugbank:DB01864]
p57
sg18
Vdrug-target interaction 5'-Guanosine-Diphosphate-Monothiophosphate and Protein-glutamine gamma-glutamyltransferase E [drugbank_resource:DB01864_2339]
p58
sa(dp59
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2339
p60
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03152
p61
sg11
g43
sg12
S'transglutaminase 3'
p62
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03152_2339
p63
sg16
VB-2-Octylglucoside [drugbank:DB03152]
p64
sg18
Vdrug-target interaction B-2-Octylglucoside and Protein-glutamine gamma-glutamyltransferase E [drugbank_resource:DB03152_2339]
p65
sa(dp66
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2339
p67
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04315
p68
sg11
g43
sg12
S'transglutaminase 3'
p69
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04315_2339
p70
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p71
sg18
Vdrug-target interaction Guanosine-5'-Diphosphate and Protein-glutamine gamma-glutamyltransferase E [drugbank_resource:DB04315_2339]
p72
sasS'PPP3R1'
p73
(lp74
(dp75
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:394
p76
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08231
p77
sg11
g73
sg12
S'protein phosphatase 3, regulatory subunit B, alpha'
p78
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08231_394
p79
sg16
VMYRISTIC ACID [drugbank:DB08231]
p80
sg18
Vdrug-target interaction MYRISTIC ACID and Calcineurin subunit B isoform 1 [drugbank_resource:DB08231_394]
p81
sasS'PCSK2'
p82
(lp83
(dp84
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3847
p85
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00071
p86
sg11
g82
sg12
S'proprotein convertase subtilisin/kexin type 2'
p87
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00071_3847
p88
sg16
VInsulin, porcine [drugbank:DB00071]
p89
sg18
Vdrug-target interaction Insulin, porcine and Neuroendocrine convertase 2 [drugbank_resource:DB00071_3847]
p90
sa(dp91
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3847
p92
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00030
p93
sg11
g82
sg12
S'proprotein convertase subtilisin/kexin type 2'
p94
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00030_3847
p95
sg16
VInsulin recombinant [drugbank:DB00030]
p96
sg18
Vdrug-target interaction Insulin recombinant and Neuroendocrine convertase 2 [drugbank_resource:DB00030_3847]
p97
sasS'NISCH'
p98
(lp99
(dp100
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6070
p101
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00697
p102
sg11
g98
sg12
S'nischarin'
p103
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00697_6070
p104
sg16
VTizanidine [drugbank:DB00697]
p105
sg18
Vdrug-target interaction Tizanidine and Nischarin [drugbank_resource:DB00697_6070]
p106
sasS'CLK1'
p107
(lp108
(dp109
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3318
p110
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04367
p111
sg11
g107
sg12
S'CDC-like kinase 1'
p112
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04367_3318
p113
sg16
VDebromohymenialdisine [drugbank:DB04367]
p114
sg18
Vdrug-target interaction Debromohymenialdisine and Dual specificity protein kinase CLK1 [drugbank_resource:DB04367_3318]
p115
sa(dp116
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3318
p117
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08691
p118
sg11
g107
sg12
S'CDC-like kinase 1'
p119
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08691_3318
p120
sg16
Vethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate [drugbank:DB08691]
p121
sg18
Vdrug-target interaction ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate and Dual specificity protein kinase CLK1 [drugbank_resource:DB08691_3318]
p122
sasS'NRF1'
p123
(lp124
(dp125
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6674
p126
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04147
p127
sg11
S'NFE2L1'
p128
sg12
S'nuclear factor (erythroid-derived 2)-like 1'
p129
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04147_6674
p130
sg16
VLauryl Dimethylamine-N-Oxide [drugbank:DB04147]
p131
sg18
Vdrug-target interaction Lauryl Dimethylamine-N-Oxide and Nuclear factor erythroid 2-related factor 1 [drugbank_resource:DB04147_6674]
p132
sasS'SLC6A1'
p133
(lp134
(dp135
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:276
p136
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00906
p137
sg11
g133
sg12
S'solute carrier family 6 (neurotransmitter transporter, GABA), member 1'
p138
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00906_276
p139
sg16
VTiagabine [drugbank:DB00906]
p140
sg18
Vdrug-target interaction Tiagabine and Sodium- and chloride-dependent GABA transporter 1 [drugbank_resource:DB00906_276]
p141
sasS'QDPR'
p142
(lp143
(dp144
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:597
p145
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p146
sg11
g142
sg12
S'quinoid dihydropteridine reductase'
p147
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_597
p148
sg16
VNADH [drugbank:DB00157]
p149
sg18
Vdrug-target interaction NADH and Dihydropteridine reductase [drugbank_resource:DB00157_597]
p150
sa(dp151
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:597
p152
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01907
p153
sg11
g142
sg12
S'quinoid dihydropteridine reductase'
p154
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01907_597
p155
sg16
VNicotinamide-Adenine-Dinucleotide [drugbank:DB01907]
p156
sg18
Vdrug-target interaction Nicotinamide-Adenine-Dinucleotide and Dihydropteridine reductase [drugbank_resource:DB01907_597]
p157
sa(dp158
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:597
p159
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03814
p160
sg11
g142
sg12
S'quinoid dihydropteridine reductase'
p161
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03814_597
p162
sg16
V2-(N-Morpholino)-Ethanesulfonic Acid [drugbank:DB03814]
p163
sg18
Vdrug-target interaction 2-(N-Morpholino)-Ethanesulfonic Acid and Dihydropteridine reductase [drugbank_resource:DB03814_597]
p164
sasS'IKBKB'
p165
(lp166
(dp167
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2038
p168
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00244
p169
sg11
g165
sg12
S'inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta'
p170
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00244_2038
p171
sg16
VMesalazine [drugbank:DB00244]
p172
sg18
Vdrug-target interaction Mesalazine and Inhibitor of nuclear factor kappa-B kinase subunit beta [drugbank_resource:DB00244_2038]
p173
sa(dp174
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2038
p175
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00795
p176
sg11
g165
sg12
S'inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta'
p177
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00795_2038
p178
sg16
VSulfasalazine [drugbank:DB00795]
p179
sg18
Vdrug-target interaction Sulfasalazine and Inhibitor of nuclear factor kappa-B kinase subunit beta [drugbank_resource:DB00795_2038]
p180
sa(dp181
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2038
p182
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00995
p183
sg11
g165
sg12
S'inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta'
p184
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00995_2038
p185
sg16
VAuranofin [drugbank:DB00995]
p186
sg18
Vdrug-target interaction Auranofin and Inhibitor of nuclear factor kappa-B kinase subunit beta [drugbank_resource:DB00995_2038]
p187
sa(dp188
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2038
p189
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01169
p190
sg11
g165
sg12
S'inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta'
p191
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01169_2038
p192
sg16
VArsenic trioxide [drugbank:DB01169]
p193
sg18
Vdrug-target interaction Arsenic trioxide and Inhibitor of nuclear factor kappa-B kinase subunit beta [drugbank_resource:DB01169_2038]
p194
sasS'AKT1'
p195
(lp196
(dp197
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:476
p198
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00171
p199
sg11
g195
sg12
S'v-akt murine thymoma viral oncogene homolog 1'
p200
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00171_476
p201
sg16
VAdenosine triphosphate [drugbank:DB00171]
p202
sg18
Vdrug-target interaction Adenosine triphosphate and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB00171_476]
p203
sa(dp204
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:476
p205
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01169
p206
sg11
g195
sg12
S'v-akt murine thymoma viral oncogene homolog 1'
p207
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01169_476
p208
sg16
VArsenic trioxide [drugbank:DB01169]
p209
sg18
Vdrug-target interaction Arsenic trioxide and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB01169_476]
p210
sa(dp211
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:476
p212
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01863
p213
sg11
g195
sg12
S'v-akt murine thymoma viral oncogene homolog 1'
p214
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01863_476
p215
sg16
VInositol 1,3,4,5-Tetrakisphosphate [drugbank:DB01863]
p216
sg18
Vdrug-target interaction Inositol 1,3,4,5-Tetrakisphosphate and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB01863_476]
p217
sa(dp218
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:476
p219
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07584
p220
sg11
g195
sg12
S'v-akt murine thymoma viral oncogene homolog 1'
p221
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07584_476
p222
sg16
VN-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine [drugbank:DB07584]
p223
sg18
Vdrug-target interaction N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB07584_476]
p224
sa(dp225
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:476
p226
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07585
p227
sg11
g195
sg12
S'v-akt murine thymoma viral oncogene homolog 1'
p228
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07585_476
p229
sg16
V5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine [drugbank:DB07585]
p230
sg18
Vdrug-target interaction 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB07585_476]
p231
sasS'P4HA1'
p232
(lp233
(dp234
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:67
p235
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00139
p236
sg11
g232
sg12
S'prolyl 4-hydroxylase, alpha polypeptide I'
p237
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00139_67
p238
sg16
VSuccinic acid [drugbank:DB00139]
p239
sg18
Vdrug-target interaction Succinic acid and Prolyl 4-hydroxylase subunit alpha-1 [drugbank_resource:DB00139_67]
p240
sa(dp241
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:67
p242
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00172
p243
sg11
g232
sg12
S'prolyl 4-hydroxylase, alpha polypeptide I'
p244
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00172_67
p245
sg16
VL-Proline [drugbank:DB00172]
p246
sg18
Vdrug-target interaction L-Proline and Prolyl 4-hydroxylase subunit alpha-1 [drugbank_resource:DB00172_67]
p247
sa(dp248
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:67
p249
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00126
p250
sg11
g232
sg12
S'prolyl 4-hydroxylase, alpha polypeptide I'
p251
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00126_67
p252
sg16
VVitamin C [drugbank:DB00126]
p253
sg18
Vdrug-target interaction Vitamin C and Prolyl 4-hydroxylase subunit alpha-1 [drugbank_resource:DB00126_67]
p254
sa(dp255
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:67
p256
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01275
p257
sg11
g232
sg12
S'prolyl 4-hydroxylase, alpha polypeptide I'
p258
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01275_67
p259
sg16
VHydralazine [drugbank:DB01275]
p260
sg18
Vdrug-target interaction Hydralazine and Prolyl 4-hydroxylase subunit alpha-1 [drugbank_resource:DB01275_67]
p261
sasS'RB1'
p262
(lp263
(dp264
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3846
p265
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00030
p266
sg11
g262
sg12
S'retinoblastoma 1'
p267
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00030_3846
p268
sg16
VInsulin recombinant [drugbank:DB00030]
p269
sg18
Vdrug-target interaction Insulin recombinant and Retinoblastoma-associated protein [drugbank_resource:DB00030_3846]
p270
sa(dp271
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3846
p272
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00071
p273
sg11
g262
sg12
S'retinoblastoma 1'
p274
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00071_3846
p275
sg16
VInsulin, porcine [drugbank:DB00071]
p276
sg18
Vdrug-target interaction Insulin, porcine and Retinoblastoma-associated protein [drugbank_resource:DB00071_3846]
p277
sasS'CHI3L1'
p278
(lp279
(dp280
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7113
p281
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02687
p282
sg11
g278
sg12
S'chitinase 3-like 1 (cartilage glycoprotein-39)'
p283
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02687_7113
p284
sg16
VBeta-D-Mannose [drugbank:DB02687]
p285
sg18
Vdrug-target interaction Beta-D-Mannose and Chitinase-3-like protein 1 [drugbank_resource:DB02687_7113]
p286
sa(dp287
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7113
p288
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02944
p289
sg11
g278
sg12
S'chitinase 3-like 1 (cartilage glycoprotein-39)'
p290
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02944_7113
p291
sg16
VAlpha-D-Mannose [drugbank:DB02944]
p292
sg18
Vdrug-target interaction Alpha-D-Mannose and Chitinase-3-like protein 1 [drugbank_resource:DB02944_7113]
p293
sasS'GABRB1'
p294
(lp295
(dp296
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p297
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00186
p298
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p299
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00186_4098
p300
sg16
VLorazepam [drugbank:DB00186]
p301
sg18
Vdrug-target interaction Lorazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00186_4098]
p302
sa(dp303
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p304
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00189
p305
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p306
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00189_4098
p307
sg16
VEthchlorvynol [drugbank:DB00189]
p308
sg18
Vdrug-target interaction Ethchlorvynol and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00189_4098]
p309
sa(dp310
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p311
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00231
p312
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p313
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00231_4098
p314
sg16
VTemazepam [drugbank:DB00231]
p315
sg18
Vdrug-target interaction Temazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00231_4098]
p316
sa(dp317
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p318
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00431
p319
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p320
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00431_4098
p321
sg16
VLindane [drugbank:DB00431]
p322
sg18
Vdrug-target interaction Lindane and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00431_4098]
p323
sa(dp324
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p325
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00546
p326
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p327
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00546_4098
p328
sg16
VAdinazolam [drugbank:DB00546]
p329
sg18
Vdrug-target interaction Adinazolam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00546_4098]
p330
sa(dp331
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p332
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00475
p333
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p334
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00475_4098
p335
sg16
VChlordiazepoxide [drugbank:DB00475]
p336
sg18
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00475_4098]
p337
sa(dp338
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p339
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00349
p340
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p341
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00349_4098
p342
sg16
VClobazam [drugbank:DB00349]
p343
sg18
Vdrug-target interaction Clobazam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00349_4098]
p344
sa(dp345
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p346
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00404
p347
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p348
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00404_4098
p349
sg16
VAlprazolam [drugbank:DB00404]
p350
sg18
Vdrug-target interaction Alprazolam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00404_4098]
p351
sa(dp352
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p353
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00628
p354
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p355
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00628_4098
p356
sg16
VClorazepate [drugbank:DB00628]
p357
sg18
Vdrug-target interaction Clorazepate and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00628_4098]
p358
sa(dp359
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p360
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00690
p361
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p362
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00690_4098
p363
sg16
VFlurazepam [drugbank:DB00690]
p364
sg18
Vdrug-target interaction Flurazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00690_4098]
p365
sa(dp366
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p367
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00842
p368
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p369
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00842_4098
p370
sg16
VOxazepam [drugbank:DB00842]
p371
sg18
Vdrug-target interaction Oxazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00842_4098]
p372
sa(dp373
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p374
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00683
p375
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p376
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00683_4098
p377
sg16
VMidazolam [drugbank:DB00683]
p378
sg18
Vdrug-target interaction Midazolam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00683_4098]
p379
sa(dp380
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p381
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00897
p382
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p383
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00897_4098
p384
sg16
VTriazolam [drugbank:DB00897]
p385
sg18
Vdrug-target interaction Triazolam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00897_4098]
p386
sa(dp387
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p388
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00801
p389
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p390
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00801_4098
p391
sg16
VHalazepam [drugbank:DB00801]
p392
sg18
Vdrug-target interaction Halazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00801_4098]
p393
sa(dp394
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p395
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00829
p396
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p397
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00829_4098
p398
sg16
VDiazepam [drugbank:DB00829]
p399
sg18
Vdrug-target interaction Diazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00829_4098]
p400
sa(dp401
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p402
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01068
p403
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p404
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01068_4098
p405
sg16
VClonazepam [drugbank:DB01068]
p406
sg18
Vdrug-target interaction Clonazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01068_4098]
p407
sa(dp408
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p409
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01440
p410
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p411
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01440_4098
p412
sg16
VGamma Hydroxybutyric Acid [drugbank:DB01440]
p413
sg18
Vdrug-target interaction Gamma Hydroxybutyric Acid and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01440_4098]
p414
sa(dp415
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p416
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01558
p417
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p418
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01558_4098
p419
sg16
VBromazepam [drugbank:DB01558]
p420
sg18
Vdrug-target interaction Bromazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01558_4098]
p421
sa(dp422
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p423
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01567
p424
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p425
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01567_4098
p426
sg16
VFludiazepam [drugbank:DB01567]
p427
sg18
Vdrug-target interaction Fludiazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01567_4098]
p428
sa(dp429
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p430
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01587
p431
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p432
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01587_4098
p433
sg16
VKetazolam [drugbank:DB01587]
p434
sg18
Vdrug-target interaction Ketazolam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01587_4098]
p435
sa(dp436
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p437
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01588
p438
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p439
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01588_4098
p440
sg16
VPrazepam [drugbank:DB01588]
p441
sg18
Vdrug-target interaction Prazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01588_4098]
p442
sa(dp443
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p444
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01594
p445
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p446
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01594_4098
p447
sg16
VCinolazepam [drugbank:DB01594]
p448
sg18
Vdrug-target interaction Cinolazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01594_4098]
p449
sa(dp450
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p451
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01215
p452
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p453
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01215_4098
p454
sg16
VEstazolam [drugbank:DB01215]
p455
sg18
Vdrug-target interaction Estazolam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01215_4098]
p456
sa(dp457
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p458
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01559
p459
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p460
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01559_4098
p461
sg16
VClotiazepam [drugbank:DB01559]
p462
sg18
Vdrug-target interaction Clotiazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01559_4098]
p463
sa(dp464
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p465
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01589
p466
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p467
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01589_4098
p468
sg16
VQuazepam [drugbank:DB01589]
p469
sg18
Vdrug-target interaction Quazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01589_4098]
p470
sa(dp471
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4098
p472
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01595
p473
sg11
g294
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 1'
p474
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01595_4098
p475
sg16
VNitrazepam [drugbank:DB01595]
p476
sg18
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01595_4098]
p477
sasS'TYK2'
p478
(lp479
(dp480
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6650
p481
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04716
p482
sg11
g478
sg12
S'tyrosine kinase 2'
p483
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04716_6650
p484
sg16
V2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE [drugbank:DB04716]
p485
sg18
Vdrug-target interaction 2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE and Non-receptor tyrosine-protein kinase TYK2 [drugbank_resource:DB04716_6650]
p486
sa(dp487
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6650
p488
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08183
p489
sg11
g478
sg12
S'tyrosine kinase 2'
p490
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08183_6650
p491
sg16
V3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile [drugbank:DB08183]
p492
sg18
Vdrug-target interaction 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile and Non-receptor tyrosine-protein kinase TYK2 [drugbank_resource:DB08183_6650]
p493
sasS'PAM'
p494
(lp495
(dp496
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3943
p497
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00126
p498
sg11
g494
sg12
S'peptidylglycine alpha-amidating monooxygenase'
p499
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00126_3943
p500
sg16
VVitamin C [drugbank:DB00126]
p501
sg18
Vdrug-target interaction Vitamin C and Peptidyl-glycine alpha-amidating monooxygenase [drugbank_resource:DB00126_3943]
p502
sa(dp503
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3943
p504
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02598
p505
sg11
g494
sg12
S'peptidylglycine alpha-amidating monooxygenase'
p506
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02598_3943
p507
sg16
VN-Alpha-Acetyl-3,5-Diiodotyrosylglycine [drugbank:DB02598]
p508
sg18
Vdrug-target interaction N-Alpha-Acetyl-3,5-Diiodotyrosylglycine and Peptidyl-glycine alpha-amidating monooxygenase [drugbank_resource:DB02598_3943]
p509
sa(dp510
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3943
p511
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04150
p512
sg11
g494
sg12
S'peptidylglycine alpha-amidating monooxygenase'
p513
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04150_3943
p514
sg16
VThreonine Derivative [drugbank:DB04150]
p515
sg18
Vdrug-target interaction Threonine Derivative and Peptidyl-glycine alpha-amidating monooxygenase [drugbank_resource:DB04150_3943]
p516
sasS'KIF2C'
p517
(lp518
(dp519
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7132
p520
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p521
sg11
g517
sg12
S'kinesin family member 2C'
p522
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_7132
p523
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p524
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Kinesin-like protein KIF2C [drugbank_resource:DB03431_7132]
p525
sa(dp526
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7132
p527
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p528
sg11
g517
sg12
S'kinesin family member 2C'
p529
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_7132
p530
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p531
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Kinesin-like protein KIF2C [drugbank_resource:DB04395_7132]
p532
sasS'GSN'
p533
(lp534
(dp535
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6666
p536
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02621
p537
sg11
g533
sg12
S'gelsolin'
p538
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02621_6666
p539
sg16
VLatrunculin A [drugbank:DB02621]
p540
sg18
Vdrug-target interaction Latrunculin A and Gelsolin [drugbank_resource:DB02621_6666]
p541
sasS'TAT'
p542
(lp543
(dp544
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:763
p545
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00114
p546
sg11
g542
sg12
S'tyrosine aminotransferase'
p547
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00114_763
p548
sg16
VPyridoxal Phosphate [drugbank:DB00114]
p549
sg18
Vdrug-target interaction Pyridoxal Phosphate and Tyrosine aminotransferase [drugbank_resource:DB00114_763]
p550
sa(dp551
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:763
p552
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00120
p553
sg11
g542
sg12
S'tyrosine aminotransferase'
p554
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00120_763
p555
sg16
VL-Phenylalanine [drugbank:DB00120]
p556
sg18
Vdrug-target interaction L-Phenylalanine and Tyrosine aminotransferase [drugbank_resource:DB00120_763]
p557
sa(dp558
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:763
p559
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00135
p560
sg11
g542
sg12
S'tyrosine aminotransferase'
p561
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00135_763
p562
sg16
VL-Tyrosine [drugbank:DB00135]
p563
sg18
Vdrug-target interaction L-Tyrosine and Tyrosine aminotransferase [drugbank_resource:DB00135_763]
p564
sa(dp565
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:763
p566
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p567
sg11
g542
sg12
S'tyrosine aminotransferase'
p568
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_763
p569
sg16
VL-Glutamic Acid [drugbank:DB00142]
p570
sg18
Vdrug-target interaction L-Glutamic Acid and Tyrosine aminotransferase [drugbank_resource:DB00142_763]
p571
sasS'SCNN1G'
p572
(lp573
(dp574
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:552
p575
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00594
p576
sg11
g572
sg12
S'sodium channel, non-voltage-gated 1, gamma subunit'
p577
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00594_552
p578
sg16
VAmiloride [drugbank:DB00594]
p579
sg18
Vdrug-target interaction Amiloride and Amiloride-sensitive sodium channel subunit gamma [drugbank_resource:DB00594_552]
p580
sa(dp581
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:552
p582
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00384
p583
sg11
g572
sg12
S'sodium channel, non-voltage-gated 1, gamma subunit'
p584
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00384_552
p585
sg16
VTriamterene [drugbank:DB00384]
p586
sg18
Vdrug-target interaction Triamterene and Amiloride-sensitive sodium channel subunit gamma [drugbank_resource:DB00384_552]
p587
sasS'OGDH'
p588
(lp589
(dp590
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:182
p591
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p592
sg11
g588
sg12
S'oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide)'
p593
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_182
p594
sg16
VNADH [drugbank:DB00157]
p595
sg18
Vdrug-target interaction NADH and 2-oxoglutarate dehydrogenase E1 component, mitochondrial [drugbank_resource:DB00157_182]
p596
sasS'HTR1E'
p597
(lp598
(dp599
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:528
p600
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00246
p601
sg11
g597
sg12
S'5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled'
p602
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00246_528
p603
sg16
VZiprasidone [drugbank:DB00246]
p604
sg18
Vdrug-target interaction Ziprasidone and 5-hydroxytryptamine 1E receptor [drugbank_resource:DB00246_528]
p605
sa(dp606
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:528
p607
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00216
p608
sg11
g597
sg12
S'5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled'
p609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00216_528
p610
sg16
VEletriptan [drugbank:DB00216]
p611
sg18
Vdrug-target interaction Eletriptan and 5-hydroxytryptamine 1E receptor [drugbank_resource:DB00216_528]
p612
sa(dp613
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:528
p614
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00334
p615
sg11
g597
sg12
S'5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled'
p616
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00334_528
p617
sg16
VOlanzapine [drugbank:DB00334]
p618
sg18
Vdrug-target interaction Olanzapine and 5-hydroxytryptamine 1E receptor [drugbank_resource:DB00334_528]
p619
sa(dp620
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:528
p621
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00363
p622
sg11
g597
sg12
S'5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled'
p623
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00363_528
p624
sg16
VClozapine [drugbank:DB00363]
p625
sg18
Vdrug-target interaction Clozapine and 5-hydroxytryptamine 1E receptor [drugbank_resource:DB00363_528]
p626
sa(dp627
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:528
p628
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01224
p629
sg11
g597
sg12
S'5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled'
p630
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01224_528
p631
sg16
VQuetiapine [drugbank:DB01224]
p632
sg18
Vdrug-target interaction Quetiapine and 5-hydroxytryptamine 1E receptor [drugbank_resource:DB01224_528]
p633
sa(dp634
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:528
p635
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01238
p636
sg11
g597
sg12
S'5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled'
p637
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01238_528
p638
sg16
VAripiprazole [drugbank:DB01238]
p639
sg18
Vdrug-target interaction Aripiprazole and 5-hydroxytryptamine 1E receptor [drugbank_resource:DB01238_528]
p640
sasS'NCAN'
p641
(lp642
(dp643
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7022
p644
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02379
p645
sg11
g641
sg12
S'neurocan'
p646
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02379_7022
p647
sg16
VBeta-D-Glucose [drugbank:DB02379]
p648
sg18
Vdrug-target interaction Beta-D-Glucose and Neurocan core protein [drugbank_resource:DB02379_7022]
p649
sa(dp650
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7022
p651
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04396
p652
sg11
g641
sg12
S'neurocan'
p653
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04396_7022
p654
sg16
VThiodigalactoside [drugbank:DB04396]
p655
sg18
Vdrug-target interaction Thiodigalactoside and Neurocan core protein [drugbank_resource:DB04396_7022]
p656
sasS'CABP1'
p657
(lp658
(dp659
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6586
p660
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04464
p661
sg11
S'S100G'
p662
sg12
S'S100 calcium binding protein G'
p663
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04464_6586
p664
sg16
VN-Formylmethionine [drugbank:DB04464]
p665
sg18
Vdrug-target interaction N-Formylmethionine and Protein S100-G [drugbank_resource:DB04464_6586]
p666
sasS'ABL2'
p667
(lp668
(dp669
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:484
p670
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00171
p671
sg11
g667
sg12
S'v-abl Abelson murine leukemia viral oncogene homolog 2'
p672
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00171_484
p673
sg16
VAdenosine triphosphate [drugbank:DB00171]
p674
sg18
Vdrug-target interaction Adenosine triphosphate and Tyrosine-protein kinase ABL2 [drugbank_resource:DB00171_484]
p675
sa(dp676
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:484
p677
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01254
p678
sg11
g667
sg12
S'v-abl Abelson murine leukemia viral oncogene homolog 2'
p679
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01254_484
p680
sg16
VDasatinib [drugbank:DB01254]
p681
sg18
Vdrug-target interaction Dasatinib and Tyrosine-protein kinase ABL2 [drugbank_resource:DB01254_484]
p682
sa(dp683
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:484
p684
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07664
p685
sg11
g667
sg12
S'v-abl Abelson murine leukemia viral oncogene homolog 2'
p686
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07664_484
p687
sg16
V5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE [drugbank:DB07664]
p688
sg18
Vdrug-target interaction 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE and Tyrosine-protein kinase ABL2 [drugbank_resource:DB07664_484]
p689
sasS'TSPO'
p690
(lp691
(dp692
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:811
p693
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00186
p694
sg11
g690
sg12
S'translocator protein (18kDa)'
p695
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00186_811
p696
sg16
VLorazepam [drugbank:DB00186]
p697
sg18
Vdrug-target interaction Lorazepam and Translocator protein [drugbank_resource:DB00186_811]
p698
sa(dp699
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:811
p700
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00231
p701
sg11
g690
sg12
S'translocator protein (18kDa)'
p702
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00231_811
p703
sg16
VTemazepam [drugbank:DB00231]
p704
sg18
Vdrug-target interaction Temazepam and Translocator protein [drugbank_resource:DB00231_811]
p705
sa(dp706
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:811
p707
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00404
p708
sg11
g690
sg12
S'translocator protein (18kDa)'
p709
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00404_811
p710
sg16
VAlprazolam [drugbank:DB00404]
p711
sg18
Vdrug-target interaction Alprazolam and Translocator protein [drugbank_resource:DB00404_811]
p712
sa(dp713
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:811
p714
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00402
p715
sg11
g690
sg12
S'translocator protein (18kDa)'
p716
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00402_811
p717
sg16
VEszopiclone [drugbank:DB00402]
p718
sg18
Vdrug-target interaction Eszopiclone and Translocator protein [drugbank_resource:DB00402_811]
p719
sa(dp720
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:811
p721
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00628
p722
sg11
g690
sg12
S'translocator protein (18kDa)'
p723
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00628_811
p724
sg16
VClorazepate [drugbank:DB00628]
p725
sg18
Vdrug-target interaction Clorazepate and Translocator protein [drugbank_resource:DB00628_811]
p726
sa(dp727
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:811
p728
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00829
p729
sg11
g690
sg12
S'translocator protein (18kDa)'
p730
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00829_811
p731
sg16
VDiazepam [drugbank:DB00829]
p732
sg18
Vdrug-target interaction Diazepam and Translocator protein [drugbank_resource:DB00829_811]
p733
sa(dp734
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:811
p735
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00897
p736
sg11
g690
sg12
S'translocator protein (18kDa)'
p737
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00897_811
p738
sg16
VTriazolam [drugbank:DB00897]
p739
sg18
Vdrug-target interaction Triazolam and Translocator protein [drugbank_resource:DB00897_811]
p740
sa(dp741
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:811
p742
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00962
p743
sg11
g690
sg12
S'translocator protein (18kDa)'
p744
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00962_811
p745
sg16
VZaleplon [drugbank:DB00962]
p746
sg18
Vdrug-target interaction Zaleplon and Translocator protein [drugbank_resource:DB00962_811]
p747
sa(dp748
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:811
p749
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01068
p750
sg11
g690
sg12
S'translocator protein (18kDa)'
p751
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01068_811
p752
sg16
VClonazepam [drugbank:DB01068]
p753
sg18
Vdrug-target interaction Clonazepam and Translocator protein [drugbank_resource:DB01068_811]
p754
sa(dp755
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:811
p756
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01198
p757
sg11
g690
sg12
S'translocator protein (18kDa)'
p758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01198_811
p759
sg16
VZopiclone [drugbank:DB01198]
p760
sg18
Vdrug-target interaction Zopiclone and Translocator protein [drugbank_resource:DB01198_811]
p761
sa(dp762
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:811
p763
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01587
p764
sg11
g690
sg12
S'translocator protein (18kDa)'
p765
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01587_811
p766
sg16
VKetazolam [drugbank:DB01587]
p767
sg18
Vdrug-target interaction Ketazolam and Translocator protein [drugbank_resource:DB01587_811]
p768
sa(dp769
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:811
p770
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01178
p771
sg11
g690
sg12
S'translocator protein (18kDa)'
p772
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01178_811
p773
sg16
VChlormezanone [drugbank:DB01178]
p774
sg18
Vdrug-target interaction Chlormezanone and Translocator protein [drugbank_resource:DB01178_811]
p775
sa(dp776
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:811
p777
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01544
p778
sg11
g690
sg12
S'translocator protein (18kDa)'
p779
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01544_811
p780
sg16
VFlunitrazepam [drugbank:DB01544]
p781
sg18
Vdrug-target interaction Flunitrazepam and Translocator protein [drugbank_resource:DB01544_811]
p782
sasS'PARK7'
p783
(lp784
(dp785
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1434
p786
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01769
p787
sg11
g783
sg12
S'parkinson protein 7'
p788
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01769_1434
p789
sg16
VDouble Oxidized Cysteine [drugbank:DB01769]
p790
sg18
Vdrug-target interaction Double Oxidized Cysteine and Protein DJ-1 [drugbank_resource:DB01769_1434]
p791
sasS'DNMT1'
p792
(lp793
(dp794
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1064
p795
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01035
p796
sg11
g792
sg12
S'DNA (cytosine-5-)-methyltransferase 1'
p797
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01035_1064
p798
sg16
VProcainamide [drugbank:DB01035]
p799
sg18
Vdrug-target interaction Procainamide and DNA (cytosine-5)-methyltransferase 1 [drugbank_resource:DB01035_1064]
p800
sa(dp801
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1064
p802
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00928
p803
sg11
g792
sg12
S'DNA (cytosine-5-)-methyltransferase 1'
p804
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00928_1064
p805
sg16
VAzacitidine [drugbank:DB00928]
p806
sg18
Vdrug-target interaction Azacitidine and DNA (cytosine-5)-methyltransferase 1 [drugbank_resource:DB00928_1064]
p807
sa(dp808
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1064
p809
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01099
p810
sg11
g792
sg12
S'DNA (cytosine-5-)-methyltransferase 1'
p811
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01099_1064
p812
sg16
VFlucytosine [drugbank:DB01099]
p813
sg18
Vdrug-target interaction Flucytosine and DNA (cytosine-5)-methyltransferase 1 [drugbank_resource:DB01099_1064]
p814
sa(dp815
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1064
p816
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01262
p817
sg11
g792
sg12
S'DNA (cytosine-5-)-methyltransferase 1'
p818
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01262_1064
p819
sg16
VDecitabine [drugbank:DB01262]
p820
sg18
Vdrug-target interaction Decitabine and DNA (cytosine-5)-methyltransferase 1 [drugbank_resource:DB01262_1064]
p821
sasS'NTRK2'
p822
(lp823
(dp824
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6100
p825
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00321
p826
sg11
g822
sg12
S'neurotrophic tyrosine kinase, receptor, type 2'
p827
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00321_6100
p828
sg16
VAmitriptyline [drugbank:DB00321]
p829
sg18
Vdrug-target interaction Amitriptyline and BDNF/NT-3 growth factors receptor [drugbank_resource:DB00321_6100]
p830
sasS'FGFR3'
p831
(lp832
(dp833
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3856
p834
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00039
p835
sg11
g831
sg12
S'fibroblast growth factor receptor 3'
p836
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00039_3856
p837
sg16
VPalifermin [drugbank:DB00039]
p838
sg18
Vdrug-target interaction Palifermin and Fibroblast growth factor receptor 3 [drugbank_resource:DB00039_3856]
p839
sasS'HSP90AB1'
p840
(lp841
(dp842
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3456
p843
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02754
p844
sg11
g840
sg12
S'heat shock protein 90kDa alpha (cytosolic), class B member 1'
p845
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02754_3456
p846
sg16
V9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine [drugbank:DB02754]
p847
sg18
Vdrug-target interaction 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine and Heat shock protein HSP 90-beta [drugbank_resource:DB02754_3456]
p848
sa(dp849
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3456
p850
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02424
p851
sg11
g840
sg12
S'heat shock protein 90kDa alpha (cytosolic), class B member 1'
p852
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02424_3456
p853
sg16
VGeldanamycin [drugbank:DB02424]
p854
sg18
Vdrug-target interaction Geldanamycin and Heat shock protein HSP 90-beta [drugbank_resource:DB02424_3456]
p855
sa(dp856
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3456
p857
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03758
p858
sg11
g840
sg12
S'heat shock protein 90kDa alpha (cytosolic), class B member 1'
p859
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03758_3456
p860
sg16
VRadicicol [drugbank:DB03758]
p861
sg18
Vdrug-target interaction Radicicol and Heat shock protein HSP 90-beta [drugbank_resource:DB03758_3456]
p862
sa(dp863
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3456
p864
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p865
sg11
g840
sg12
S'heat shock protein 90kDa alpha (cytosolic), class B member 1'
p866
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_3456
p867
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p868
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Heat shock protein HSP 90-beta [drugbank_resource:DB03431_3456]
p869
sa(dp870
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3456
p871
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08153
p872
sg11
g840
sg12
S'heat shock protein 90kDa alpha (cytosolic), class B member 1'
p873
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08153_3456
p874
sg16
V(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE [drugbank:DB08153]
p875
sg18
Vdrug-target interaction (5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE and Heat shock protein HSP 90-beta [drugbank_resource:DB08153_3456]
p876
sa(dp877
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3456
p878
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08464
p879
sg11
g840
sg12
S'heat shock protein 90kDa alpha (cytosolic), class B member 1'
p880
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08464_3456
p881
sg16
VMETHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE [drugbank:DB08464]
p882
sg18
Vdrug-target interaction METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE and Heat shock protein HSP 90-beta [drugbank_resource:DB08464_3456]
p883
sa(dp884
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3456
p885
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07877
p886
sg11
g840
sg12
S'heat shock protein 90kDa alpha (cytosolic), class B member 1'
p887
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07877_3456
p888
sg16
V8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE [drugbank:DB07877]
p889
sg18
Vdrug-target interaction 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE and Heat shock protein HSP 90-beta [drugbank_resource:DB07877_3456]
p890
sa(dp891
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3456
p892
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08045
p893
sg11
g840
sg12
S'heat shock protein 90kDa alpha (cytosolic), class B member 1'
p894
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08045_3456
p895
sg16
V4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL [drugbank:DB08045]
p896
sg18
Vdrug-target interaction 4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL and Heat shock protein HSP 90-beta [drugbank_resource:DB08045_3456]
p897
sa(dp898
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3456
p899
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08346
p900
sg11
g840
sg12
S'heat shock protein 90kDa alpha (cytosolic), class B member 1'
p901
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08346_3456
p902
sg16
V(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE [drugbank:DB08346]
p903
sg18
Vdrug-target interaction (5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE and Heat shock protein HSP 90-beta [drugbank_resource:DB08346_3456]
p904
sa(dp905
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3456
p906
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07594
p907
sg11
g840
sg12
S'heat shock protein 90kDa alpha (cytosolic), class B member 1'
p908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07594_3456
p909
sg16
V4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL [drugbank:DB07594]
p910
sg18
Vdrug-target interaction 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL and Heat shock protein HSP 90-beta [drugbank_resource:DB07594_3456]
p911
sa(dp912
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3456
p913
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08292
p914
sg11
g840
sg12
S'heat shock protein 90kDa alpha (cytosolic), class B member 1'
p915
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08292_3456
p916
sg16
V(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE [drugbank:DB08292]
p917
sg18
Vdrug-target interaction (5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE and Heat shock protein HSP 90-beta [drugbank_resource:DB08292_3456]
p918
sa(dp919
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3456
p920
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08293
p921
sg11
g840
sg12
S'heat shock protein 90kDa alpha (cytosolic), class B member 1'
p922
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08293_3456
p923
sg16
V(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE [drugbank:DB08293]
p924
sg18
Vdrug-target interaction (5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE and Heat shock protein HSP 90-beta [drugbank_resource:DB08293_3456]
p925
sa(dp926
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3456
p927
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08465
p928
sg11
g840
sg12
S'heat shock protein 90kDa alpha (cytosolic), class B member 1'
p929
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08465_3456
p930
sg16
V2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE [drugbank:DB08465]
p931
sg18
Vdrug-target interaction 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE and Heat shock protein HSP 90-beta [drugbank_resource:DB08465_3456]
p932
sasS'PLK1'
p933
(lp934
(dp935
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6246
p936
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06897
p937
sg11
g933
sg12
S'polo-like kinase 1'
p938
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06897_6246
p939
sg16
V3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol [drugbank:DB06897]
p940
sg18
Vdrug-target interaction 3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB06897_6246]
p941
sa(dp942
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6246
p943
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06963
p944
sg11
g933
sg12
S'polo-like kinase 1'
p945
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06963_6246
p946
sg16
V3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide [drugbank:DB06963]
p947
sg18
Vdrug-target interaction 3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB06963_6246]
p948
sa(dp949
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6246
p950
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07186
p951
sg11
g933
sg12
S'polo-like kinase 1'
p952
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07186_6246
p953
sg16
V4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE [drugbank:DB07186]
p954
sg18
Vdrug-target interaction 4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB07186_6246]
p955
sa(dp956
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6246
p957
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07789
p958
sg11
g933
sg12
S'polo-like kinase 1'
p959
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07789_6246
p960
sg16
V1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea [drugbank:DB07789]
p961
sg18
Vdrug-target interaction 1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB07789_6246]
p962
sa(dp963
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6246
p964
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08059
p965
sg11
g933
sg12
S'polo-like kinase 1'
p966
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08059_6246
p967
sg16
V(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE [drugbank:DB08059]
p968
sg18
Vdrug-target interaction (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB08059_6246]
p969
sasS'CDK5R1'
p970
(lp971
(dp972
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6321
p973
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02052
p974
sg11
g970
sg12
S'cyclin-dependent kinase 5, regulatory subunit 1 (p35)'
p975
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02052_6321
p976
sg16
VIndirubin-3'-Monoxime [drugbank:DB02052]
p977
sg18
Vdrug-target interaction Indirubin-3'-Monoxime and Cyclin-dependent kinase 5 activator 1 [drugbank_resource:DB02052_6321]
p978
sa(dp979
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6321
p980
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07364
p981
sg11
g970
sg12
S'cyclin-dependent kinase 5, regulatory subunit 1 (p35)'
p982
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07364_6321
p983
sg16
V6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE [drugbank:DB07364]
p984
sg18
Vdrug-target interaction 6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE and Cyclin-dependent kinase 5 activator 1 [drugbank_resource:DB07364_6321]
p985
sasS'GRIN1'
p986
(lp987
(dp988
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:401
p989
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p990
sg11
g986
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 1'
p991
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_401
p992
sg16
VL-Glutamic Acid [drugbank:DB00142]
p993
sg18
Vdrug-target interaction L-Glutamic Acid and Glutamate [NMDA] receptor subunit zeta-1 [drugbank_resource:DB00142_401]
p994
sa(dp995
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:401
p996
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00454
p997
sg11
g986
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 1'
p998
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00454_401
p999
sg16
VMeperidine [drugbank:DB00454]
p1000
sg18
Vdrug-target interaction Meperidine and Glutamate [NMDA] receptor subunit zeta-1 [drugbank_resource:DB00454_401]
p1001
sa(dp1002
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:401
p1003
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01173
p1004
sg11
g986
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 1'
p1005
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01173_401
p1006
sg16
VOrphenadrine [drugbank:DB01173]
p1007
sg18
Vdrug-target interaction Orphenadrine and Glutamate [NMDA] receptor subunit zeta-1 [drugbank_resource:DB01173_401]
p1008
sa(dp1009
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:401
p1010
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01931
p1011
sg11
g986
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 1'
p1012
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01931_401
p1013
sg16
VDcka, 5,7-Dichlorokynurenic Acid [drugbank:DB01931]
p1014
sg18
Vdrug-target interaction Dcka, 5,7-Dichlorokynurenic Acid and Glutamate [NMDA] receptor subunit zeta-1 [drugbank_resource:DB01931_401]
p1015
sa(dp1016
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:401
p1017
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03929
p1018
sg11
g986
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 1'
p1019
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03929_401
p1020
sg16
VD-Serine [drugbank:DB03929]
p1021
sg18
Vdrug-target interaction D-Serine and Glutamate [NMDA] receptor subunit zeta-1 [drugbank_resource:DB03929_401]
p1022
sa(dp1023
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:401
p1024
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04620
p1025
sg11
g986
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 1'
p1026
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04620_401
p1027
sg16
VCycloleucine [drugbank:DB04620]
p1028
sg18
Vdrug-target interaction Cycloleucine and Glutamate [NMDA] receptor subunit zeta-1 [drugbank_resource:DB04620_401]
p1029
sasS'GOT1'
p1030
(lp1031
(dp1032
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:586
p1033
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00114
p1034
sg11
g1030
sg12
S'glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)'
p1035
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00114_586
p1036
sg16
VPyridoxal Phosphate [drugbank:DB00114]
p1037
sg18
Vdrug-target interaction Pyridoxal Phosphate and Aspartate aminotransferase, cytoplasmic [drugbank_resource:DB00114_586]
p1038
sa(dp1039
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:586
p1040
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00151
p1041
sg11
g1030
sg12
S'glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)'
p1042
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00151_586
p1043
sg16
VL-Cysteine [drugbank:DB00151]
p1044
sg18
Vdrug-target interaction L-Cysteine and Aspartate aminotransferase, cytoplasmic [drugbank_resource:DB00151_586]
p1045
sa(dp1046
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:586
p1047
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00128
p1048
sg11
g1030
sg12
S'glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)'
p1049
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00128_586
p1050
sg16
VL-Aspartic Acid [drugbank:DB00128]
p1051
sg18
Vdrug-target interaction L-Aspartic Acid and Aspartate aminotransferase, cytoplasmic [drugbank_resource:DB00128_586]
p1052
sa(dp1053
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:586
p1054
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p1055
sg11
g1030
sg12
S'glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)'
p1056
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_586
p1057
sg16
VL-Glutamic Acid [drugbank:DB00142]
p1058
sg18
Vdrug-target interaction L-Glutamic Acid and Aspartate aminotransferase, cytoplasmic [drugbank_resource:DB00142_586]
p1059
sa(dp1060
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:586
p1061
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04299
p1062
sg11
g1030
sg12
S'glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)'
p1063
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04299_586
p1064
sg16
VMaleic Acid [drugbank:DB04299]
p1065
sg18
Vdrug-target interaction Maleic Acid and Aspartate aminotransferase, cytoplasmic [drugbank_resource:DB04299_586]
p1066
sasS'PYGL'
p1067
(lp1068
(dp1069
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:10
p1070
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00131
p1071
sg11
g1067
sg12
S'phosphorylase, glycogen, liver'
p1072
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00131_10
p1073
sg16
VAdenosine monophosphate [drugbank:DB00131]
p1074
sg18
Vdrug-target interaction Adenosine monophosphate and Glycogen phosphorylase, liver form [drugbank_resource:DB00131_10]
p1075
sa(dp1076
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:10
p1077
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00114
p1078
sg11
g1067
sg12
S'phosphorylase, glycogen, liver'
p1079
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00114_10
p1080
sg16
VPyridoxal Phosphate [drugbank:DB00114]
p1081
sg18
Vdrug-target interaction Pyridoxal Phosphate and Glycogen phosphorylase, liver form [drugbank_resource:DB00114_10]
p1082
sa(dp1083
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:10
p1084
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02089
p1085
sg11
g1067
sg12
S'phosphorylase, glycogen, liver'
p1086
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02089_10
p1087
sg16
VCP-526423 [drugbank:DB02089]
p1088
sg18
Vdrug-target interaction CP-526423 and Glycogen phosphorylase, liver form [drugbank_resource:DB02089_10]
p1089
sa(dp1090
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:10
p1091
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01696
p1092
sg11
g1067
sg12
S'phosphorylase, glycogen, liver'
p1093
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01696_10
p1094
sg16
V7,9-Dihydro-1h-Purine-2,6,8(3h)-Trione [drugbank:DB01696]
p1095
sg18
Vdrug-target interaction 7,9-Dihydro-1h-Purine-2,6,8(3h)-Trione and Glycogen phosphorylase, liver form [drugbank_resource:DB01696_10]
p1096
sa(dp1097
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:10
p1098
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02379
p1099
sg11
g1067
sg12
S'phosphorylase, glycogen, liver'
p1100
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02379_10
p1101
sg16
VBeta-D-Glucose [drugbank:DB02379]
p1102
sg18
Vdrug-target interaction Beta-D-Glucose and Glycogen phosphorylase, liver form [drugbank_resource:DB02379_10]
p1103
sa(dp1104
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:10
p1105
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02320
p1106
sg11
g1067
sg12
S'phosphorylase, glycogen, liver'
p1107
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02320_10
p1108
sg16
V1-N-Acetyl-Beta-D-Glucosamine [drugbank:DB02320]
p1109
sg18
Vdrug-target interaction 1-N-Acetyl-Beta-D-Glucosamine and Glycogen phosphorylase, liver form [drugbank_resource:DB02320_10]
p1110
sa(dp1111
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:10
p1112
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03288
p1113
sg11
g1067
sg12
S'phosphorylase, glycogen, liver'
p1114
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03288_10
p1115
sg16
V5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide [drugbank:DB03288]
p1116
sg18
Vdrug-target interaction 5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide and Glycogen phosphorylase, liver form [drugbank_resource:DB03288_10]
p1117
sa(dp1118
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:10
p1119
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03744
p1120
sg11
g1067
sg12
S'phosphorylase, glycogen, liver'
p1121
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03744_10
p1122
sg16
VCp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate [drugbank:DB03744]
p1123
sg18
Vdrug-target interaction Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate and Glycogen phosphorylase, liver form [drugbank_resource:DB03744_10]
p1124
sa(dp1125
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:10
p1126
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04522
p1127
sg11
g1067
sg12
S'phosphorylase, glycogen, liver'
p1128
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04522_10
p1129
sg16
VPhosphonoserine [drugbank:DB04522]
p1130
sg18
Vdrug-target interaction Phosphonoserine and Glycogen phosphorylase, liver form [drugbank_resource:DB04522_10]
p1131
sa(dp1132
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:10
p1133
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07395
p1134
sg11
g1067
sg12
S'phosphorylase, glycogen, liver'
p1135
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07395_10
p1136
sg16
V4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid [drugbank:DB07395]
p1137
sg18
Vdrug-target interaction 4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid and Glycogen phosphorylase, liver form [drugbank_resource:DB07395_10]
p1138
sa(dp1139
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:10
p1140
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07315
p1141
sg11
g1067
sg12
S'phosphorylase, glycogen, liver'
p1142
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07315_10
p1143
sg16
V5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide [drugbank:DB07315]
p1144
sg18
Vdrug-target interaction 5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide and Glycogen phosphorylase, liver form [drugbank_resource:DB07315_10]
p1145
sa(dp1146
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:10
p1147
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07396
p1148
sg11
g1067
sg12
S'phosphorylase, glycogen, liver'
p1149
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07396_10
p1150
sg16
V1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid [drugbank:DB07396]
p1151
sg18
Vdrug-target interaction 1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid and Glycogen phosphorylase, liver form [drugbank_resource:DB07396_10]
p1152
sa(dp1153
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:10
p1154
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07968
p1155
sg11
g1067
sg12
S'phosphorylase, glycogen, liver'
p1156
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07968_10
p1157
sg16
VN-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA [drugbank:DB07968]
p1158
sg18
Vdrug-target interaction N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA and Glycogen phosphorylase, liver form [drugbank_resource:DB07968_10]
p1159
sasS'PYGM'
p1160
(lp1161
(dp1162
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1163
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00114
p1164
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1165
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00114_1152
p1166
sg16
VPyridoxal Phosphate [drugbank:DB00114]
p1167
sg18
Vdrug-target interaction Pyridoxal Phosphate and Glycogen phosphorylase, muscle form [drugbank_resource:DB00114_1152]
p1168
sa(dp1169
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1170
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01823
p1171
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1172
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01823_1152
p1173
sg16
VBeta-D-Glucopyranose Spirohydantoin [drugbank:DB01823]
p1174
sg18
Vdrug-target interaction Beta-D-Glucopyranose Spirohydantoin and Glycogen phosphorylase, muscle form [drugbank_resource:DB01823_1152]
p1175
sa(dp1176
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1177
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01843
p1178
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1179
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01843_1152
p1180
sg16
V3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione [drugbank:DB01843]
p1181
sg18
Vdrug-target interaction 3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione and Glycogen phosphorylase, muscle form [drugbank_resource:DB01843_1152]
p1182
sa(dp1183
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1184
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02007
p1185
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1186
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02007_1152
p1187
sg16
VAlpha-D-Glucose-6-Phosphate [drugbank:DB02007]
p1188
sg18
Vdrug-target interaction Alpha-D-Glucose-6-Phosphate and Glycogen phosphorylase, muscle form [drugbank_resource:DB02007_1152]
p1189
sa(dp1190
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1191
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02719
p1192
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1193
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02719_1152
p1194
sg16
VC-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide [drugbank:DB02719]
p1195
sg18
Vdrug-target interaction C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide and Glycogen phosphorylase, muscle form [drugbank_resource:DB02719_1152]
p1196
sa(dp1197
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1198
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02447
p1199
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1200
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02447_1152
p1201
sg16
V3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione [drugbank:DB02447]
p1202
sg18
Vdrug-target interaction 3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione and Glycogen phosphorylase, muscle form [drugbank_resource:DB02447_1152]
p1203
sa(dp1204
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1205
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02519
p1206
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1207
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02519_1152
p1208
sg16
VIndirubin-5-Sulphonate [drugbank:DB02519]
p1209
sg18
Vdrug-target interaction Indirubin-5-Sulphonate and Glycogen phosphorylase, muscle form [drugbank_resource:DB02519_1152]
p1210
sa(dp1211
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1212
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02604
p1213
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1214
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02604_1152
p1215
sg16
V2-Deoxy-Glucose-6-Phosphate [drugbank:DB02604]
p1216
sg18
Vdrug-target interaction 2-Deoxy-Glucose-6-Phosphate and Glycogen phosphorylase, muscle form [drugbank_resource:DB02604_1152]
p1217
sa(dp1218
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1219
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02720
p1220
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1221
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02720_1152
p1222
sg16
VAlpha-D-Glucopyranosyl-2-Carboxylic Acid Amide [drugbank:DB02720]
p1223
sg18
Vdrug-target interaction Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide and Glycogen phosphorylase, muscle form [drugbank_resource:DB02720_1152]
p1224
sa(dp1225
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1226
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03067
p1227
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1228
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03067_1152
p1229
sg16
V4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid [drugbank:DB03067]
p1230
sg18
Vdrug-target interaction 4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid and Glycogen phosphorylase, muscle form [drugbank_resource:DB03067_1152]
p1231
sa(dp1232
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1233
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02320
p1234
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1235
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02320_1152
p1236
sg16
V1-N-Acetyl-Beta-D-Glucosamine [drugbank:DB02320]
p1237
sg18
Vdrug-target interaction 1-N-Acetyl-Beta-D-Glucosamine and Glycogen phosphorylase, muscle form [drugbank_resource:DB02320_1152]
p1238
sa(dp1239
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1240
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02348
p1241
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1242
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02348_1152
p1243
sg16
VFluoro-Phosphite Ion [drugbank:DB02348]
p1244
sg18
Vdrug-target interaction Fluoro-Phosphite Ion and Glycogen phosphorylase, muscle form [drugbank_resource:DB02348_1152]
p1245
sa(dp1246
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1247
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02379
p1248
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1249
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02379_1152
p1250
sg16
VBeta-D-Glucose [drugbank:DB02379]
p1251
sg18
Vdrug-target interaction Beta-D-Glucose and Glycogen phosphorylase, muscle form [drugbank_resource:DB02379_1152]
p1252
sa(dp1253
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1254
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02471
p1255
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1256
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02471_1152
p1257
sg16
VNojirimycine Tetrazole [drugbank:DB02471]
p1258
sg18
Vdrug-target interaction Nojirimycine Tetrazole and Glycogen phosphorylase, muscle form [drugbank_resource:DB02471_1152]
p1259
sa(dp1260
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1261
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03218
p1262
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03218_1152
p1264
sg16
VN-Acetyl-N'-Beta-D-Glucopyranosyl Urea [drugbank:DB03218]
p1265
sg18
Vdrug-target interaction N-Acetyl-N'-Beta-D-Glucopyranosyl Urea and Glycogen phosphorylase, muscle form [drugbank_resource:DB03218_1152]
p1266
sa(dp1267
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1268
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03250
p1269
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03250_1152
p1271
sg16
V2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole [drugbank:DB03250]
p1272
sg18
Vdrug-target interaction 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole and Glycogen phosphorylase, muscle form [drugbank_resource:DB03250_1152]
p1273
sa(dp1274
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1275
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03286
p1276
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1277
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03286_1152
p1278
sg16
VC-(1-Azido-Alpha-D-Glucopyranosyl) Formamide [drugbank:DB03286]
p1279
sg18
Vdrug-target interaction C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide and Glycogen phosphorylase, muscle form [drugbank_resource:DB03286_1152]
p1280
sa(dp1281
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1282
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02843
p1283
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1284
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02843_1152
p1285
sg16
VAlpha-D-Glucose-1-Phosphate [drugbank:DB02843]
p1286
sg18
Vdrug-target interaction Alpha-D-Glucose-1-Phosphate and Glycogen phosphorylase, muscle form [drugbank_resource:DB02843_1152]
p1287
sa(dp1288
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1289
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02964
p1290
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1291
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02964_1152
p1292
sg16
V8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One [drugbank:DB02964]
p1293
sg18
Vdrug-target interaction 8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One and Glycogen phosphorylase, muscle form [drugbank_resource:DB02964_1152]
p1294
sa(dp1295
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1296
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03133
p1297
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1298
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03133_1152
p1299
sg16
V2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole [drugbank:DB03133]
p1300
sg18
Vdrug-target interaction 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole and Glycogen phosphorylase, muscle form [drugbank_resource:DB03133_1152]
p1301
sa(dp1302
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1303
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p1304
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1305
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_1152
p1306
sg16
VFlavopiridol [drugbank:DB03496]
p1307
sg18
Vdrug-target interaction Flavopiridol and Glycogen phosphorylase, muscle form [drugbank_resource:DB03496_1152]
p1308
sa(dp1309
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1310
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03354
p1311
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1312
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03354_1152
p1313
sg16
V2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole [drugbank:DB03354]
p1314
sg18
Vdrug-target interaction 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole and Glycogen phosphorylase, muscle form [drugbank_resource:DB03354_1152]
p1315
sa(dp1316
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1317
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03383
p1318
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1319
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03383_1152
p1320
sg16
V5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide [drugbank:DB03383]
p1321
sg18
Vdrug-target interaction 5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide and Glycogen phosphorylase, muscle form [drugbank_resource:DB03383_1152]
p1322
sa(dp1323
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1324
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03392
p1325
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1326
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03392_1152
p1327
sg16
V(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester [drugbank:DB03392]
p1328
sg18
Vdrug-target interaction (3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester and Glycogen phosphorylase, muscle form [drugbank_resource:DB03392_1152]
p1329
sa(dp1330
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1331
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04055
p1332
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04055_1152
p1334
sg16
V2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium [drugbank:DB04055]
p1335
sg18
Vdrug-target interaction 2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium and Glycogen phosphorylase, muscle form [drugbank_resource:DB04055_1152]
p1336
sa(dp1337
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1338
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04195
p1339
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1340
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04195_1152
p1341
sg16
VHeptulose-2-Phosphate [drugbank:DB04195]
p1342
sg18
Vdrug-target interaction Heptulose-2-Phosphate and Glycogen phosphorylase, muscle form [drugbank_resource:DB04195_1152]
p1343
sa(dp1344
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1345
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03479
p1346
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1347
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03479_1152
p1348
sg16
V8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione [drugbank:DB03479]
p1349
sg18
Vdrug-target interaction 8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione and Glycogen phosphorylase, muscle form [drugbank_resource:DB03479_1152]
p1350
sa(dp1351
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1352
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03657
p1353
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1354
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03657_1152
p1355
sg16
V1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose [drugbank:DB03657]
p1356
sg18
Vdrug-target interaction 1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose and Glycogen phosphorylase, muscle form [drugbank_resource:DB03657_1152]
p1357
sa(dp1358
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1359
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03835
p1360
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1361
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03835_1152
p1362
sg16
VN-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide [drugbank:DB03835]
p1363
sg18
Vdrug-target interaction N-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide and Glycogen phosphorylase, muscle form [drugbank_resource:DB03835_1152]
p1364
sa(dp1365
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1366
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04013
p1367
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1368
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04013_1152
p1369
sg16
V1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide [drugbank:DB04013]
p1370
sg18
Vdrug-target interaction 1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide and Glycogen phosphorylase, muscle form [drugbank_resource:DB04013_1152]
p1371
sa(dp1372
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1373
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04083
p1374
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1375
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04083_1152
p1376
sg16
VN'-Pyridoxyl-Lysine-5'-Monophosphate [drugbank:DB04083]
p1377
sg18
Vdrug-target interaction N'-Pyridoxyl-Lysine-5'-Monophosphate and Glycogen phosphorylase, muscle form [drugbank_resource:DB04083_1152]
p1378
sa(dp1379
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1380
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04295
p1381
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1382
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04295_1152
p1383
sg16
VN-Benzoyl-N'-Beta-D-Glucopyranosyl Urea [drugbank:DB04295]
p1384
sg18
Vdrug-target interaction N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea and Glycogen phosphorylase, muscle form [drugbank_resource:DB04295_1152]
p1385
sa(dp1386
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1387
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04044
p1388
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04044_1152
p1390
sg16
V4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid [drugbank:DB04044]
p1391
sg18
Vdrug-target interaction 4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid and Glycogen phosphorylase, muscle form [drugbank_resource:DB04044_1152]
p1392
sa(dp1393
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1394
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04544
p1395
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1396
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04544_1152
p1397
sg16
V1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide [drugbank:DB04544]
p1398
sg18
Vdrug-target interaction 1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide and Glycogen phosphorylase, muscle form [drugbank_resource:DB04544_1152]
p1399
sa(dp1400
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1401
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04643
p1402
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1403
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04643_1152
p1404
sg16
V4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID [drugbank:DB04643]
p1405
sg18
Vdrug-target interaction 4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID and Glycogen phosphorylase, muscle form [drugbank_resource:DB04643_1152]
p1406
sa(dp1407
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1408
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04522
p1409
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04522_1152
p1411
sg16
VPhosphonoserine [drugbank:DB04522]
p1412
sg18
Vdrug-target interaction Phosphonoserine and Glycogen phosphorylase, muscle form [drugbank_resource:DB04522_1152]
p1413
sa(dp1414
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1415
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04566
p1416
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1417
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04566_1152
p1418
sg16
VInosinic Acid [drugbank:DB04566]
p1419
sg18
Vdrug-target interaction Inosinic Acid and Glycogen phosphorylase, muscle form [drugbank_resource:DB04566_1152]
p1420
sa(dp1421
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1422
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04645
p1423
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1424
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04645_1152
p1425
sg16
V5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID [drugbank:DB04645]
p1426
sg18
Vdrug-target interaction 5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID and Glycogen phosphorylase, muscle form [drugbank_resource:DB04645_1152]
p1427
sa(dp1428
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1429
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04642
p1430
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1431
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04642_1152
p1432
sg16
V7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID [drugbank:DB04642]
p1433
sg18
Vdrug-target interaction 7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID and Glycogen phosphorylase, muscle form [drugbank_resource:DB04642_1152]
p1434
sa(dp1435
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1436
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04644
p1437
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1438
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04644_1152
p1439
sg16
V4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID [drugbank:DB04644]
p1440
sg18
Vdrug-target interaction 4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID and Glycogen phosphorylase, muscle form [drugbank_resource:DB04644_1152]
p1441
sa(dp1442
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1443
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06986
p1444
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1445
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06986_1152
p1446
sg16
V2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE [drugbank:DB06986]
p1447
sg18
Vdrug-target interaction 2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE and Glycogen phosphorylase, muscle form [drugbank_resource:DB06986_1152]
p1448
sa(dp1449
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1450
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07066
p1451
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1452
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07066_1152
p1453
sg16
V2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE [drugbank:DB07066]
p1454
sg18
Vdrug-target interaction 2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE and Glycogen phosphorylase, muscle form [drugbank_resource:DB07066_1152]
p1455
sa(dp1456
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1457
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07792
p1458
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1459
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07792_1152
p1460
sg16
V(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE [drugbank:DB07792]
p1461
sg18
Vdrug-target interaction (S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE and Glycogen phosphorylase, muscle form [drugbank_resource:DB07792_1152]
p1462
sa(dp1463
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1464
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08151
p1465
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1466
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08151_1152
p1467
sg16
V(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol [drugbank:DB08151]
p1468
sg18
Vdrug-target interaction (5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol and Glycogen phosphorylase, muscle form [drugbank_resource:DB08151_1152]
p1469
sa(dp1470
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1471
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08503
p1472
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1473
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08503_1152
p1474
sg16
V(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol [drugbank:DB08503]
p1475
sg18
Vdrug-target interaction (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol and Glycogen phosphorylase, muscle form [drugbank_resource:DB08503_1152]
p1476
sa(dp1477
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1478
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07807
p1479
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1480
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07807_1152
p1481
sg16
V(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL [drugbank:DB07807]
p1482
sg18
Vdrug-target interaction (3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL and Glycogen phosphorylase, muscle form [drugbank_resource:DB07807_1152]
p1483
sa(dp1484
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1485
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07949
p1486
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1487
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07949_1152
p1488
sg16
V({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID [drugbank:DB07949]
p1489
sg18
Vdrug-target interaction ({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID and Glycogen phosphorylase, muscle form [drugbank_resource:DB07949_1152]
p1490
sa(dp1491
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1492
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07793
p1493
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1494
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07793_1152
p1495
sg16
V(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE [drugbank:DB07793]
p1496
sg18
Vdrug-target interaction (2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE and Glycogen phosphorylase, muscle form [drugbank_resource:DB07793_1152]
p1497
sa(dp1498
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1499
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08322
p1500
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1501
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08322_1152
p1502
sg16
V2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID [drugbank:DB08322]
p1503
sg18
Vdrug-target interaction 2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID and Glycogen phosphorylase, muscle form [drugbank_resource:DB08322_1152]
p1504
sa(dp1505
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1152
p1506
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08500
p1507
sg11
g1160
sg12
S'phosphorylase, glycogen, muscle'
p1508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08500_1152
p1509
sg16
V(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol [drugbank:DB08500]
p1510
sg18
Vdrug-target interaction (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol and Glycogen phosphorylase, muscle form [drugbank_resource:DB08500_1152]
p1511
sasS'PFAS'
p1512
(lp1513
(dp1514
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3982
p1515
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p1516
sg11
g1512
sg12
S'phosphoribosylformylglycinamidine synthase'
p1517
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_3982
p1518
sg16
VL-Glutamic Acid [drugbank:DB00142]
p1519
sg18
Vdrug-target interaction L-Glutamic Acid and Phosphoribosylformylglycinamidine synthase [drugbank_resource:DB00142_3982]
p1520
sasS'AURKA'
p1521
(lp1522
(dp1523
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p1524
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02482
p1525
sg11
g1521
sg12
S'aurora kinase A'
p1526
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02482_1422
p1527
sg16
VPhosphonothreonine [drugbank:DB02482]
p1528
sg18
Vdrug-target interaction Phosphonothreonine and Serine/threonine-protein kinase 6 [drugbank_resource:DB02482_1422]
p1529
sa(dp1530
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p1531
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p1532
sg11
g1521
sg12
S'aurora kinase A'
p1533
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_1422
p1534
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p1535
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Serine/threonine-protein kinase 6 [drugbank_resource:DB03431_1422]
p1536
sa(dp1537
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p1538
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07186
p1539
sg11
g1521
sg12
S'aurora kinase A'
p1540
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07186_1422
p1541
sg16
V4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE [drugbank:DB07186]
p1542
sg18
Vdrug-target interaction 4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE and Serine/threonine-protein kinase 6 [drugbank_resource:DB07186_1422]
p1543
sa(dp1544
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p1545
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07266
p1546
sg11
g1521
sg12
S'aurora kinase A'
p1547
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07266_1422
p1548
sg16
V8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one [drugbank:DB07266]
p1549
sg18
Vdrug-target interaction 8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one and Serine/threonine-protein kinase 6 [drugbank_resource:DB07266_1422]
p1550
sa(dp1551
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p1552
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07361
p1553
sg11
g1521
sg12
S'aurora kinase A'
p1554
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07361_1422
p1555
sg16
V1-(3-chlorophenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}urea [drugbank:DB07361]
p1556
sg18
Vdrug-target interaction 1-(3-chlorophenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}urea and Serine/threonine-protein kinase 6 [drugbank_resource:DB07361_1422]
p1557
sa(dp1558
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p1559
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07360
p1560
sg11
g1521
sg12
S'aurora kinase A'
p1561
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07360_1422
p1562
sg16
V1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea [drugbank:DB07360]
p1563
sg18
Vdrug-target interaction 1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea and Serine/threonine-protein kinase 6 [drugbank_resource:DB07360_1422]
p1564
sa(dp1565
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p1566
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07362
p1567
sg11
g1521
sg12
S'aurora kinase A'
p1568
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07362_1422
p1569
sg16
V1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea [drugbank:DB07362]
p1570
sg18
Vdrug-target interaction 1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea and Serine/threonine-protein kinase 6 [drugbank_resource:DB07362_1422]
p1571
sa(dp1572
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p1573
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07545
p1574
sg11
g1521
sg12
S'aurora kinase A'
p1575
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07545_1422
p1576
sg16
VN-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE [drugbank:DB07545]
p1577
sg18
Vdrug-target interaction N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE and Serine/threonine-protein kinase 6 [drugbank_resource:DB07545_1422]
p1578
sa(dp1579
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p1580
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08066
p1581
sg11
g1521
sg12
S'aurora kinase A'
p1582
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08066_1422
p1583
sg16
VN-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE [drugbank:DB08066]
p1584
sg18
Vdrug-target interaction N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE and Serine/threonine-protein kinase 6 [drugbank_resource:DB08066_1422]
p1585
sa(dp1586
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p1587
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07801
p1588
sg11
g1521
sg12
S'aurora kinase A'
p1589
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07801_1422
p1590
sg16
VN-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide [drugbank:DB07801]
p1591
sg18
Vdrug-target interaction N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide and Serine/threonine-protein kinase 6 [drugbank_resource:DB07801_1422]
p1592
sa(dp1593
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1422
p1594
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08065
p1595
sg11
g1521
sg12
S'aurora kinase A'
p1596
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08065_1422
p1597
sg16
V2-(1H-pyrazol-3-yl)-1H-benzimidazole [drugbank:DB08065]
p1598
sg18
Vdrug-target interaction 2-(1H-pyrazol-3-yl)-1H-benzimidazole and Serine/threonine-protein kinase 6 [drugbank_resource:DB08065_1422]
p1599
sasS'ERBB2'
p1600
(lp1601
(dp1602
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:567
p1603
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00072
p1604
sg11
g1600
sg12
S'v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)'
p1605
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00072_567
p1606
sg16
VTrastuzumab [drugbank:DB00072]
p1607
sg18
Vdrug-target interaction Trastuzumab and Receptor tyrosine-protein kinase erbB-2 [drugbank_resource:DB00072_567]
p1608
sa(dp1609
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:567
p1610
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01259
p1611
sg11
g1600
sg12
S'v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)'
p1612
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01259_567
p1613
sg16
VLapatinib [drugbank:DB01259]
p1614
sg18
Vdrug-target interaction Lapatinib and Receptor tyrosine-protein kinase erbB-2 [drugbank_resource:DB01259_567]
p1615
sasS'LRP2'
p1616
(lp1617
(dp1618
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1244
p1619
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00013
p1620
sg11
g1616
sg12
S'low density lipoprotein receptor-related protein 2'
p1621
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00013_1244
p1622
sg16
VUrokinase [drugbank:DB00013]
p1623
sg18
Vdrug-target interaction Urokinase and Low-density lipoprotein receptor-related protein 2 [drugbank_resource:DB00013_1244]
p1624
sa(dp1625
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1244
p1626
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00030
p1627
sg11
g1616
sg12
S'low density lipoprotein receptor-related protein 2'
p1628
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00030_1244
p1629
sg16
VInsulin recombinant [drugbank:DB00030]
p1630
sg18
Vdrug-target interaction Insulin recombinant and Low-density lipoprotein receptor-related protein 2 [drugbank_resource:DB00030_1244]
p1631
sa(dp1632
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1244
p1633
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00071
p1634
sg11
g1616
sg12
S'low density lipoprotein receptor-related protein 2'
p1635
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00071_1244
p1636
sg16
VInsulin, porcine [drugbank:DB00071]
p1637
sg18
Vdrug-target interaction Insulin, porcine and Low-density lipoprotein receptor-related protein 2 [drugbank_resource:DB00071_1244]
p1638
sa(dp1639
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1244
p1640
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00798
p1641
sg11
g1616
sg12
S'low density lipoprotein receptor-related protein 2'
p1642
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00798_1244
p1643
sg16
VGentamicin [drugbank:DB00798]
p1644
sg18
Vdrug-target interaction Gentamicin and Low-density lipoprotein receptor-related protein 2 [drugbank_resource:DB00798_1244]
p1645
sasS'IGF1R'
p1646
(lp1647
(dp1648
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:958
p1649
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00030
p1650
sg11
g1646
sg12
S'insulin-like growth factor 1 receptor'
p1651
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00030_958
p1652
sg16
VInsulin recombinant [drugbank:DB00030]
p1653
sg18
Vdrug-target interaction Insulin recombinant and Insulin-like growth factor 1 receptor [drugbank_resource:DB00030_958]
p1654
sa(dp1655
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:958
p1656
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00046
p1657
sg11
g1646
sg12
S'insulin-like growth factor 1 receptor'
p1658
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00046_958
p1659
sg16
VInsulin Lispro [drugbank:DB00046]
p1660
sg18
Vdrug-target interaction Insulin Lispro and Insulin-like growth factor 1 receptor [drugbank_resource:DB00046_958]
p1661
sa(dp1662
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:958
p1663
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00071
p1664
sg11
g1646
sg12
S'insulin-like growth factor 1 receptor'
p1665
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00071_958
p1666
sg16
VInsulin, porcine [drugbank:DB00071]
p1667
sg18
Vdrug-target interaction Insulin, porcine and Insulin-like growth factor 1 receptor [drugbank_resource:DB00071_958]
p1668
sa(dp1669
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:958
p1670
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00047
p1671
sg11
g1646
sg12
S'insulin-like growth factor 1 receptor'
p1672
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00047_958
p1673
sg16
VInsulin Glargine [drugbank:DB00047]
p1674
sg18
Vdrug-target interaction Insulin Glargine and Insulin-like growth factor 1 receptor [drugbank_resource:DB00047_958]
p1675
sa(dp1676
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:958
p1677
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01277
p1678
sg11
g1646
sg12
S'insulin-like growth factor 1 receptor'
p1679
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01277_958
p1680
sg16
VMecasermin [drugbank:DB01277]
p1681
sg18
Vdrug-target interaction Mecasermin and Insulin-like growth factor 1 receptor [drugbank_resource:DB01277_958]
p1682
sa(dp1683
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:958
p1684
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02944
p1685
sg11
g1646
sg12
S'insulin-like growth factor 1 receptor'
p1686
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02944_958
p1687
sg16
VAlpha-D-Mannose [drugbank:DB02944]
p1688
sg18
Vdrug-target interaction Alpha-D-Mannose and Insulin-like growth factor 1 receptor [drugbank_resource:DB02944_958]
p1689
sa(dp1690
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:958
p1691
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p1692
sg11
g1646
sg12
S'insulin-like growth factor 1 receptor'
p1693
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_958
p1694
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p1695
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Insulin-like growth factor 1 receptor [drugbank_resource:DB04395_958]
p1696
sa(dp1697
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:958
p1698
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07156
p1699
sg11
g1646
sg12
S'insulin-like growth factor 1 receptor'
p1700
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07156_958
p1701
sg16
V(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione [drugbank:DB07156]
p1702
sg18
Vdrug-target interaction (4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione and Insulin-like growth factor 1 receptor [drugbank_resource:DB07156_958]
p1703
sa(dp1704
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:958
p1705
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07474
p1706
sg11
g1646
sg12
S'insulin-like growth factor 1 receptor'
p1707
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07474_958
p1708
sg16
V3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE [drugbank:DB07474]
p1709
sg18
Vdrug-target interaction 3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE and Insulin-like growth factor 1 receptor [drugbank_resource:DB07474_958]
p1710
sasS'LYN'
p1711
(lp1712
(dp1713
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6824
p1714
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03023
p1715
sg11
g1711
sg12
S'v-yes-1 Yamaguchi sarcoma viral related oncogene homolog'
p1716
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03023_6824
p1717
sg16
V1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine [drugbank:DB03023]
p1718
sg18
Vdrug-target interaction 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine and Tyrosine-protein kinase Lyn [drugbank_resource:DB03023_6824]
p1719
sasS'SOD2'
p1720
(lp1721
(dp1722
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6963
p1723
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03297
p1724
sg11
g1720
sg12
S'superoxide dismutase 2, mitochondrial'
p1725
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03297_6963
p1726
sg16
VBenzylsulfinic Acid [drugbank:DB03297]
p1727
sg18
Vdrug-target interaction Benzylsulfinic Acid and Superoxide dismutase [Mn], mitochondrial [drugbank_resource:DB03297_6963]
p1728
sa(dp1729
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6963
p1730
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04436
p1731
sg11
g1720
sg12
S'superoxide dismutase 2, mitochondrial'
p1732
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04436_6963
p1733
sg16
V3-Fluorotyrosine [drugbank:DB04436]
p1734
sg18
Vdrug-target interaction 3-Fluorotyrosine and Superoxide dismutase [Mn], mitochondrial [drugbank_resource:DB04436_6963]
p1735
sasS'OXCT1'
p1736
(lp1737
(dp1738
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4003
p1739
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00139
p1740
sg11
g1736
sg12
S'3-oxoacid CoA transferase 1'
p1741
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00139_4003
p1742
sg16
VSuccinic acid [drugbank:DB00139]
p1743
sg18
Vdrug-target interaction Succinic acid and Succinyl-CoA:3-ketoacid-coenzyme A transferase 1, mitochondrial [drugbank_resource:DB00139_4003]
p1744
sa(dp1745
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4003
p1746
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02731
p1747
sg11
g1736
sg12
S'3-oxoacid CoA transferase 1'
p1748
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02731_4003
p1749
sg16
VThimerosal [drugbank:DB02731]
p1750
sg18
Vdrug-target interaction Thimerosal and Succinyl-CoA:3-ketoacid-coenzyme A transferase 1, mitochondrial [drugbank_resource:DB02731_4003]
p1751
sasS'AQP1'
p1752
(lp1753
(dp1754
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1025
p1755
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00819
p1756
sg11
g1752
sg12
S'aquaporin 1 (Colton blood group)'
p1757
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00819_1025
p1758
sg16
VAcetazolamide [drugbank:DB00819]
p1759
sg18
Vdrug-target interaction Acetazolamide and Aquaporin-1 [drugbank_resource:DB00819_1025]
p1760
sasS'CACNA2D2'
p1761
(lp1762
(dp1763
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4160
p1764
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00270
p1765
sg11
g1761
sg12
S'calcium channel, voltage-dependent, alpha 2/delta subunit 2'
p1766
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00270_4160
p1767
sg16
VIsradipine [drugbank:DB00270]
p1768
sg18
Vdrug-target interaction Isradipine and Voltage-dependent calcium channel subunit alpha-2/delta-2 [drugbank_resource:DB00270_4160]
p1769
sa(dp1770
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4160
p1771
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00996
p1772
sg11
g1761
sg12
S'calcium channel, voltage-dependent, alpha 2/delta subunit 2'
p1773
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00996_4160
p1774
sg16
VGabapentin [drugbank:DB00996]
p1775
sg18
Vdrug-target interaction Gabapentin and Voltage-dependent calcium channel subunit alpha-2/delta-2 [drugbank_resource:DB00996_4160]
p1776
sa(dp1777
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4160
p1778
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01054
p1779
sg11
g1761
sg12
S'calcium channel, voltage-dependent, alpha 2/delta subunit 2'
p1780
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01054_4160
p1781
sg16
VNitrendipine [drugbank:DB01054]
p1782
sg18
Vdrug-target interaction Nitrendipine and Voltage-dependent calcium channel subunit alpha-2/delta-2 [drugbank_resource:DB01054_4160]
p1783
sa(dp1784
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4160
p1785
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01023
p1786
sg11
g1761
sg12
S'calcium channel, voltage-dependent, alpha 2/delta subunit 2'
p1787
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01023_4160
p1788
sg16
VFelodipine [drugbank:DB01023]
p1789
sg18
Vdrug-target interaction Felodipine and Voltage-dependent calcium channel subunit alpha-2/delta-2 [drugbank_resource:DB01023_4160]
p1790
sa(dp1791
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4160
p1792
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01118
p1793
sg11
g1761
sg12
S'calcium channel, voltage-dependent, alpha 2/delta subunit 2'
p1794
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01118_4160
p1795
sg16
VAmiodarone [drugbank:DB01118]
p1796
sg18
Vdrug-target interaction Amiodarone and Voltage-dependent calcium channel subunit alpha-2/delta-2 [drugbank_resource:DB01118_4160]
p1797
sa(dp1798
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4160
p1799
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01244
p1800
sg11
g1761
sg12
S'calcium channel, voltage-dependent, alpha 2/delta subunit 2'
p1801
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01244_4160
p1802
sg16
VBepridil [drugbank:DB01244]
p1803
sg18
Vdrug-target interaction Bepridil and Voltage-dependent calcium channel subunit alpha-2/delta-2 [drugbank_resource:DB01244_4160]
p1804
sasS'P4HB'
p1805
(lp1806
(dp1807
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4240
p1808
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03615
p1809
sg11
g1805
sg12
S'prolyl 4-hydroxylase, beta polypeptide'
p1810
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03615_4240
p1811
sg16
VRibostamycin [drugbank:DB03615]
p1812
sg18
Vdrug-target interaction Ribostamycin and Protein disulfide-isomerase [drugbank_resource:DB03615_4240]
p1813
sasS'CAMK2G'
p1814
(lp1815
(dp1816
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6893
p1817
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08699
p1818
sg11
g1814
sg12
S'calcium/calmodulin-dependent protein kinase II gamma'
p1819
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08699_6893
p1820
sg16
V1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine [drugbank:DB08699]
p1821
sg18
Vdrug-target interaction 1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine and Calcium/calmodulin-dependent protein kinase type II gamma chain [drugbank_resource:DB08699_6893]
p1822
sasS'PPP2R2A'
p1823
(lp1824
(dp1825
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6313
p1826
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02506
p1827
sg11
g1823
sg12
S'protein phosphatase 2, regulatory subunit B, alpha'
p1828
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02506_6313
p1829
sg16
V2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid [drugbank:DB02506]
p1830
sg18
Vdrug-target interaction 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid and Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform [drugbank_resource:DB02506_6313]
p1831
sasS'CAMK2A'
p1832
(lp1833
(dp1834
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6579
p1835
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04447
p1836
sg11
g1832
sg12
S'calcium/calmodulin-dependent protein kinase II alpha'
p1837
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04447_6579
p1838
sg16
V1,4-Dithiothreitol [drugbank:DB04447]
p1839
sg18
Vdrug-target interaction 1,4-Dithiothreitol and Calcium/calmodulin-dependent protein kinase type II alpha chain [drugbank_resource:DB04447_6579]
p1840
sa(dp1841
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6579
p1842
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04119
p1843
sg11
g1832
sg12
S'calcium/calmodulin-dependent protein kinase II alpha'
p1844
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04119_6579
p1845
sg16
VHexatantalum Dodecabromide [drugbank:DB04119]
p1846
sg18
Vdrug-target interaction Hexatantalum Dodecabromide and Calcium/calmodulin-dependent protein kinase type II alpha chain [drugbank_resource:DB04119_6579]
p1847
sa(dp1848
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6579
p1849
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07766
p1850
sg11
g1832
sg12
S'calcium/calmodulin-dependent protein kinase II alpha'
p1851
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07766_6579
p1852
sg16
V(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME} [drugbank:DB07766]
p1853
sg18
Vdrug-target interaction (2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME} and Calcium/calmodulin-dependent protein kinase type II alpha chain [drugbank_resource:DB07766_6579]
p1854
sasS'CAMK2B'
p1855
(lp1856
(dp1857
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6294
p1858
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07168
p1859
sg11
g1855
sg12
S'calcium/calmodulin-dependent protein kinase II beta'
p1860
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07168_6294
p1861
sg16
V[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile [drugbank:DB07168]
p1862
sg18
Vdrug-target interaction [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile and Calcium/calmodulin-dependent protein kinase type II beta chain [drugbank_resource:DB07168_6294]
p1863
sasS'RBP1'
p1864
(lp1865
(dp1866
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:331
p1867
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00162
p1868
sg11
g1864
sg12
S'retinol binding protein 1, cellular'
p1869
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00162_331
p1870
sg16
VVitamin A [drugbank:DB00162]
p1871
sg18
Vdrug-target interaction Vitamin A and Retinol-binding protein I, cellular [drugbank_resource:DB00162_331]
p1872
sa(dp1873
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:331
p1874
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00459
p1875
sg11
g1864
sg12
S'retinol binding protein 1, cellular'
p1876
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00459_331
p1877
sg16
VAcitretin [drugbank:DB00459]
p1878
sg18
Vdrug-target interaction Acitretin and Retinol-binding protein I, cellular [drugbank_resource:DB00459_331]
p1879
sasS'LPL'
p1880
(lp1881
(dp1882
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:266
p1883
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06439
p1884
sg11
g1880
sg12
S'lipoprotein lipase'
p1885
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06439_266
p1886
sg16
VTyloxapol [drugbank:DB06439]
p1887
sg18
Vdrug-target interaction Tyloxapol and Lipoprotein lipase [drugbank_resource:DB06439_266]
p1888
sasS'CCND1'
p1889
(lp1890
(dp1891
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1569
p1892
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01169
p1893
sg11
g1889
sg12
S'cyclin D1'
p1894
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01169_1569
p1895
sg16
VArsenic trioxide [drugbank:DB01169]
p1896
sg18
Vdrug-target interaction Arsenic trioxide and G1/S-specific cyclin-D1 [drugbank_resource:DB01169_1569]
p1897
sasS'RET'
p1898
(lp1899
(dp1900
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1864
p1901
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00619
p1902
sg11
g1898
sg12
S'ret proto-oncogene'
p1903
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00619_1864
p1904
sg16
VImatinib [drugbank:DB00619]
p1905
sg18
Vdrug-target interaction Imatinib and RET proto-oncogene [drugbank_resource:DB00619_1864]
p1906
sa(dp1907
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4177
p1908
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01809
p1909
sg11
g1898
sg12
S'ret proto-oncogene'
p1910
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01809_4177
p1911
sg16
V1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine [drugbank:DB01809]
p1912
sg18
Vdrug-target interaction 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine and Proto-oncogene tyrosine-protein kinase receptor ret [drugbank_resource:DB01809_4177]
p1913
sa(dp1914
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4177
p1915
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08764
p1916
sg11
g1898
sg12
S'ret proto-oncogene'
p1917
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08764_4177
p1918
sg16
V4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE [drugbank:DB08764]
p1919
sg18
Vdrug-target interaction 4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE and Proto-oncogene tyrosine-protein kinase receptor ret [drugbank_resource:DB08764_4177]
p1920
sasS'KLK6'
p1921
(lp1922
(dp1923
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2889
p1924
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03127
p1925
sg11
g1921
sg12
S'kallikrein-related peptidase 6'
p1926
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03127_2889
p1927
sg16
VBenzamidine [drugbank:DB03127]
p1928
sg18
Vdrug-target interaction Benzamidine and Kallikrein-6 [drugbank_resource:DB03127_2889]
p1929
sasS'OAS1'
p1930
(lp1931
(dp1932
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7095
p1933
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02987
p1934
sg11
g1930
sg12
S"2'-5'-oligoadenylate synthetase 1, 40/46kDa"
p1935
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02987_7095
p1936
sg16
VCysteine-S-Acetamide [drugbank:DB02987]
p1937
sg18
Vdrug-target interaction Cysteine-S-Acetamide and 2'-5'-oligoadenylate synthase 1 [drugbank_resource:DB02987_7095]
p1938
sasS'LY96'
p1939
(lp1940
(dp1941
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6527
p1942
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02767
p1943
sg11
g1939
sg12
S'lymphocyte antigen 96'
p1944
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02767_6527
p1945
sg16
V3-Hydroxy-Myristic Acid [drugbank:DB02767]
p1946
sg18
Vdrug-target interaction 3-Hydroxy-Myristic Acid and Lymphocyte antigen 96 [drugbank_resource:DB02767_6527]
p1947
sa(dp1948
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6527
p1949
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08231
p1950
sg11
g1939
sg12
S'lymphocyte antigen 96'
p1951
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08231_6527
p1952
sg16
VMYRISTIC ACID [drugbank:DB08231]
p1953
sg18
Vdrug-target interaction MYRISTIC ACID and Lymphocyte antigen 96 [drugbank_resource:DB08231_6527]
p1954
sasS'CXCL10'
p1955
(lp1956
(dp1957
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1209
p1958
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04487
p1959
sg11
g1955
sg12
S'chemokine (C-X-C motif) ligand 10'
p1960
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04487_1209
p1961
sg16
VN-Methylleucine [drugbank:DB04487]
p1962
sg18
Vdrug-target interaction N-Methylleucine and Small inducible cytokine B10 [drugbank_resource:DB04487_1209]
p1963
sasS'MDM2'
p1964
(lp1965
(dp1966
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1485
p1967
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02872
p1968
sg11
g1964
sg12
S'MDM2 oncogene, E3 ubiquitin protein ligase'
p1969
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02872_1485
p1970
sg16
VCis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone [drugbank:DB02872]
p1971
sg18
Vdrug-target interaction Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone and Ubiquitin-protein ligase E3 Mdm2 [drugbank_resource:DB02872_1485]
p1972
sa(dp1973
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1485
p1974
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04144
p1975
sg11
g1964
sg12
S'MDM2 oncogene, E3 ubiquitin protein ligase'
p1976
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04144_1485
p1977
sg16
VCis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone [drugbank:DB04144]
p1978
sg18
Vdrug-target interaction Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone and Ubiquitin-protein ligase E3 Mdm2 [drugbank_resource:DB04144_1485]
p1979
sasS'PIK3C3'
p1980
(lp1981
(dp1982
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6229
p1983
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06836
p1984
sg11
g1980
sg12
S'phosphatidylinositol 3-kinase, catalytic subunit type 3'
p1985
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06836_6229
p1986
sg16
VN-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE [drugbank:DB06836]
p1987
sg18
Vdrug-target interaction N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE and Phosphatidylinositol 3-kinase catalytic subunit type 3 [drugbank_resource:DB06836_6229]
p1988
sasS'FGFR2'
p1989
(lp1990
(dp1991
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:823
p1992
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00039
p1993
sg11
g1989
sg12
S'fibroblast growth factor receptor 2'
p1994
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00039_823
p1995
sg16
VPalifermin [drugbank:DB00039]
p1996
sg18
Vdrug-target interaction Palifermin and Fibroblast growth factor receptor 2 [drugbank_resource:DB00039_823]
p1997
sa(dp1998
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:823
p1999
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01041
p2000
sg11
g1989
sg12
S'fibroblast growth factor receptor 2'
p2001
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01041_823
p2002
sg16
VThalidomide [drugbank:DB01041]
p2003
sg18
Vdrug-target interaction Thalidomide and Fibroblast growth factor receptor 2 [drugbank_resource:DB01041_823]
p2004
sa(dp2005
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:823
p2006
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02058
p2007
sg11
g1989
sg12
S'fibroblast growth factor receptor 2'
p2008
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02058_823
p2009
sg16
VSU4984 [drugbank:DB02058]
p2010
sg18
Vdrug-target interaction SU4984 and Fibroblast growth factor receptor 2 [drugbank_resource:DB02058_823]
p2011
sa(dp2012
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:823
p2013
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02491
p2014
sg11
g1989
sg12
S'fibroblast growth factor receptor 2'
p2015
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02491_823
p2016
sg16
V4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine [drugbank:DB02491]
p2017
sg18
Vdrug-target interaction 4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine and Fibroblast growth factor receptor 2 [drugbank_resource:DB02491_823]
p2018
sasS'EPRS'
p2019
(lp2020
(dp2021
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:210
p2022
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p2023
sg11
g2019
sg12
S'glutamyl-prolyl-tRNA synthetase'
p2024
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_210
p2025
sg16
VL-Glutamic Acid [drugbank:DB00142]
p2026
sg18
Vdrug-target interaction L-Glutamic Acid and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB00142_210]
p2027
sa(dp2028
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:210
p2029
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00172
p2030
sg11
g2019
sg12
S'glutamyl-prolyl-tRNA synthetase'
p2031
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00172_210
p2032
sg16
VL-Proline [drugbank:DB00172]
p2033
sg18
Vdrug-target interaction L-Proline and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB00172_210]
p2034
sa(dp2035
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:210
p2036
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02510
p2037
sg11
g2019
sg12
S'glutamyl-prolyl-tRNA synthetase'
p2038
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02510_210
p2039
sg16
V'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine [drugbank:DB02510]
p2040
sg18
Vdrug-target interaction '5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB02510_210]
p2041
sa(dp2042
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:210
p2043
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02684
p2044
sg11
g2019
sg12
S'glutamyl-prolyl-tRNA synthetase'
p2045
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02684_210
p2046
sg16
V5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine [drugbank:DB02684]
p2047
sg18
Vdrug-target interaction 5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB02684_210]
p2048
sa(dp2049
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:210
p2050
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03376
p2051
sg11
g2019
sg12
S'glutamyl-prolyl-tRNA synthetase'
p2052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03376_210
p2053
sg16
V'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine [drugbank:DB03376]
p2054
sg18
Vdrug-target interaction '5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB03376_210]
p2055
sasS'CSNK2A1'
p2056
(lp2057
(dp2058
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2059
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01765
p2060
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2061
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01765_2236
p2062
sg16
V(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid [drugbank:DB01765]
p2063
sg18
Vdrug-target interaction (5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid and Casein kinase II subunit alpha [drugbank_resource:DB01765_2236]
p2064
sa(dp2065
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2066
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02709
p2067
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2068
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02709_2236
p2069
sg16
VResveratrol [drugbank:DB02709]
p2070
sg18
Vdrug-target interaction Resveratrol and Casein kinase II subunit alpha [drugbank_resource:DB02709_2236]
p2071
sa(dp2072
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2073
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02170
p2074
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2075
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02170_2236
p2076
sg16
V1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One [drugbank:DB02170]
p2077
sg18
Vdrug-target interaction 1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One and Casein kinase II subunit alpha [drugbank_resource:DB02170_2236]
p2078
sa(dp2079
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2080
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03035
p2081
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2082
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03035_2236
p2083
sg16
V1,8-Di-Hydroxy-4-Nitro-Anthraquinone [drugbank:DB03035]
p2084
sg18
Vdrug-target interaction 1,8-Di-Hydroxy-4-Nitro-Anthraquinone and Casein kinase II subunit alpha [drugbank_resource:DB03035_2236]
p2085
sa(dp2086
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2087
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03127
p2088
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2089
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03127_2236
p2090
sg16
VBenzamidine [drugbank:DB03127]
p2091
sg18
Vdrug-target interaction Benzamidine and Casein kinase II subunit alpha [drugbank_resource:DB03127_2236]
p2092
sa(dp2093
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2094
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03924
p2095
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2096
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03924_2236
p2097
sg16
V5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone [drugbank:DB03924]
p2098
sg18
Vdrug-target interaction 5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone and Casein kinase II subunit alpha [drugbank_resource:DB03924_2236]
p2099
sa(dp2100
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2101
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p2102
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2103
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_2236
p2104
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p2105
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Casein kinase II subunit alpha [drugbank_resource:DB04395_2236]
p2106
sa(dp2107
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2108
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04462
p2109
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2110
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04462_2236
p2111
sg16
VTetrabromo-2-Benzotriazole [drugbank:DB04462]
p2112
sg18
Vdrug-target interaction Tetrabromo-2-Benzotriazole and Casein kinase II subunit alpha [drugbank_resource:DB04462_2236]
p2113
sa(dp2114
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2115
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04719
p2116
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2117
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04719_2236
p2118
sg16
VDIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE [drugbank:DB04719]
p2119
sg18
Vdrug-target interaction DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE and Casein kinase II subunit alpha [drugbank_resource:DB04719_2236]
p2120
sa(dp2121
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2122
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04721
p2123
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2124
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04721_2236
p2125
sg16
VN1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE [drugbank:DB04721]
p2126
sg18
Vdrug-target interaction N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE and Casein kinase II subunit alpha [drugbank_resource:DB04721_2236]
p2127
sa(dp2128
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2129
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04720
p2130
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2131
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04720_2236
p2132
sg16
VS-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE [drugbank:DB04720]
p2133
sg18
Vdrug-target interaction S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE and Casein kinase II subunit alpha [drugbank_resource:DB04720_2236]
p2134
sa(dp2135
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2136
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07802
p2137
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2138
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07802_2236
p2139
sg16
V3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE [drugbank:DB07802]
p2140
sg18
Vdrug-target interaction 3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE and Casein kinase II subunit alpha [drugbank_resource:DB07802_2236]
p2141
sa(dp2142
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2143
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08354
p2144
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2145
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08354_2236
p2146
sg16
V2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE [drugbank:DB08354]
p2147
sg18
Vdrug-target interaction 2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE and Casein kinase II subunit alpha [drugbank_resource:DB08354_2236]
p2148
sa(dp2149
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2150
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08360
p2151
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08360_2236
p2153
sg16
V2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE [drugbank:DB08360]
p2154
sg18
Vdrug-target interaction 2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE and Casein kinase II subunit alpha [drugbank_resource:DB08360_2236]
p2155
sa(dp2156
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2157
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08362
p2158
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2159
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08362_2236
p2160
sg16
VN-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE [drugbank:DB08362]
p2161
sg18
Vdrug-target interaction N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE and Casein kinase II subunit alpha [drugbank_resource:DB08362_2236]
p2162
sa(dp2163
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2164
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07715
p2165
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2166
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07715_2236
p2167
sg16
V3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE [drugbank:DB07715]
p2168
sg18
Vdrug-target interaction 3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE and Casein kinase II subunit alpha [drugbank_resource:DB07715_2236]
p2169
sa(dp2170
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2171
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08340
p2172
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2173
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08340_2236
p2174
sg16
VN,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE [drugbank:DB08340]
p2175
sg18
Vdrug-target interaction N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE and Casein kinase II subunit alpha [drugbank_resource:DB08340_2236]
p2176
sa(dp2177
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2178
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08345
p2179
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2180
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08345_2236
p2181
sg16
V4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE [drugbank:DB08345]
p2182
sg18
Vdrug-target interaction 4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE and Casein kinase II subunit alpha [drugbank_resource:DB08345_2236]
p2183
sa(dp2184
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2185
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08468
p2186
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2187
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08468_2236
p2188
sg16
V2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione [drugbank:DB08468]
p2189
sg18
Vdrug-target interaction 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione and Casein kinase II subunit alpha [drugbank_resource:DB08468_2236]
p2190
sa(dp2191
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2192
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08473
p2193
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2194
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08473_2236
p2195
sg16
V5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole [drugbank:DB08473]
p2196
sg18
Vdrug-target interaction 5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole and Casein kinase II subunit alpha [drugbank_resource:DB08473_2236]
p2197
sa(dp2198
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2199
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08660
p2200
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2201
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08660_2236
p2202
sg16
V1,2,5,8-tetrahydroxyanthracene-9,10-dione [drugbank:DB08660]
p2203
sg18
Vdrug-target interaction 1,2,5,8-tetrahydroxyanthracene-9,10-dione and Casein kinase II subunit alpha [drugbank_resource:DB08660_2236]
p2204
sa(dp2205
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2206
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08338
p2207
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08338_2236
p2209
sg16
V19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one [drugbank:DB08338]
p2210
sg18
Vdrug-target interaction 19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one and Casein kinase II subunit alpha [drugbank_resource:DB08338_2236]
p2211
sa(dp2212
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2236
p2213
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08353
p2214
sg11
g2056
sg12
S'casein kinase 2, alpha 1 polypeptide'
p2215
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08353_2236
p2216
sg16
V2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE [drugbank:DB08353]
p2217
sg18
Vdrug-target interaction 2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE and Casein kinase II subunit alpha [drugbank_resource:DB08353_2236]
p2218
sasS'KCNJ6'
p2219
(lp2220
(dp2221
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1581
p2222
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01159
p2223
sg11
g2219
sg12
S'potassium inwardly-rectifying channel, subfamily J, member 6'
p2224
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01159_1581
p2225
sg16
VHalothane [drugbank:DB01159]
p2226
sg18
Vdrug-target interaction Halothane and G protein-activated inward rectifier potassium channel 2 [drugbank_resource:DB01159_1581]
p2227
sasS'ACCN1'
p2228
(lp2229
(dp2230
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:749
p2231
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00594
p2232
sg11
g2228
sg12
S''
p2233
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00594_749
p2234
sg16
VAmiloride [drugbank:DB00594]
p2235
sg18
Vdrug-target interaction Amiloride and Amiloride-sensitive cation channel 1, neuronal [drugbank_resource:DB00594_749]
p2236
sasS'AR'
p2237
(lp2238
(dp2239
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2240
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00421
p2241
sg11
g2237
sg12
S'androgen receptor'
p2242
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00421_146
p2243
sg16
VSpironolactone [drugbank:DB00421]
p2244
sg18
Vdrug-target interaction Spironolactone and Androgen receptor [drugbank_resource:DB00421_146]
p2245
sa(dp2246
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2247
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00621
p2248
sg11
g2237
sg12
S'androgen receptor'
p2249
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00621_146
p2250
sg16
VOxandrolone [drugbank:DB00621]
p2251
sg18
Vdrug-target interaction Oxandrolone and Androgen receptor [drugbank_resource:DB00621_146]
p2252
sa(dp2253
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2254
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00367
p2255
sg11
g2237
sg12
S'androgen receptor'
p2256
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00367_146
p2257
sg16
VLevonorgestrel [drugbank:DB00367]
p2258
sg18
Vdrug-target interaction Levonorgestrel and Androgen receptor [drugbank_resource:DB00367_146]
p2259
sa(dp2260
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2261
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00499
p2262
sg11
g2237
sg12
S'androgen receptor'
p2263
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00499_146
p2264
sg16
VFlutamide [drugbank:DB00499]
p2265
sg18
Vdrug-target interaction Flutamide and Androgen receptor [drugbank_resource:DB00499_146]
p2266
sa(dp2267
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2268
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00624
p2269
sg11
g2237
sg12
S'androgen receptor'
p2270
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00624_146
p2271
sg16
VTestosterone [drugbank:DB00624]
p2272
sg18
Vdrug-target interaction Testosterone and Androgen receptor [drugbank_resource:DB00624_146]
p2273
sa(dp2274
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2275
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00687
p2276
sg11
g2237
sg12
S'androgen receptor'
p2277
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00687_146
p2278
sg16
VFludrocortisone [drugbank:DB00687]
p2279
sg18
Vdrug-target interaction Fludrocortisone and Androgen receptor [drugbank_resource:DB00687_146]
p2280
sa(dp2281
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2282
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00984
p2283
sg11
g2237
sg12
S'androgen receptor'
p2284
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00984_146
p2285
sg16
VNandrolone phenpropionate [drugbank:DB00984]
p2286
sg18
Vdrug-target interaction Nandrolone phenpropionate and Androgen receptor [drugbank_resource:DB00984_146]
p2287
sa(dp2288
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2289
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00665
p2290
sg11
g2237
sg12
S'androgen receptor'
p2291
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00665_146
p2292
sg16
VNilutamide [drugbank:DB00665]
p2293
sg18
Vdrug-target interaction Nilutamide and Androgen receptor [drugbank_resource:DB00665_146]
p2294
sa(dp2295
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2296
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01128
p2297
sg11
g2237
sg12
S'androgen receptor'
p2298
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01128_146
p2299
sg16
VBicalutamide [drugbank:DB01128]
p2300
sg18
Vdrug-target interaction Bicalutamide and Androgen receptor [drugbank_resource:DB01128_146]
p2301
sa(dp2302
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2303
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00858
p2304
sg11
g2237
sg12
S'androgen receptor'
p2305
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00858_146
p2306
sg16
VDrostanolone [drugbank:DB00858]
p2307
sg18
Vdrug-target interaction Drostanolone and Androgen receptor [drugbank_resource:DB00858_146]
p2308
sa(dp2309
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2310
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01406
p2311
sg11
g2237
sg12
S'androgen receptor'
p2312
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01406_146
p2313
sg16
VDanazol [drugbank:DB01406]
p2314
sg18
Vdrug-target interaction Danazol and Androgen receptor [drugbank_resource:DB01406_146]
p2315
sa(dp2316
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2317
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01185
p2318
sg11
g2237
sg12
S'androgen receptor'
p2319
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01185_146
p2320
sg16
VFluoxymesterone [drugbank:DB01185]
p2321
sg18
Vdrug-target interaction Fluoxymesterone and Androgen receptor [drugbank_resource:DB01185_146]
p2322
sa(dp2323
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2324
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01420
p2325
sg11
g2237
sg12
S'androgen receptor'
p2326
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01420_146
p2327
sg16
VTestosterone Propionate [drugbank:DB01420]
p2328
sg18
Vdrug-target interaction Testosterone Propionate and Androgen receptor [drugbank_resource:DB01420_146]
p2329
sa(dp2330
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2331
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01481
p2332
sg11
g2237
sg12
S'androgen receptor'
p2333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01481_146
p2334
sg16
VDelta1-dihydrotestosterone [drugbank:DB01481]
p2335
sg18
Vdrug-target interaction Delta1-dihydrotestosterone and Androgen receptor [drugbank_resource:DB01481_146]
p2336
sa(dp2337
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2338
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01395
p2339
sg11
g2237
sg12
S'androgen receptor'
p2340
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01395_146
p2341
sg16
VDrospirenone [drugbank:DB01395]
p2342
sg18
Vdrug-target interaction Drospirenone and Androgen receptor [drugbank_resource:DB01395_146]
p2343
sa(dp2344
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2345
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01541
p2346
sg11
g2237
sg12
S'androgen receptor'
p2347
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01541_146
p2348
sg16
VBoldenone [drugbank:DB01541]
p2349
sg18
Vdrug-target interaction Boldenone and Androgen receptor [drugbank_resource:DB01541_146]
p2350
sa(dp2351
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2352
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01564
p2353
sg11
g2237
sg12
S'androgen receptor'
p2354
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01564_146
p2355
sg16
VCalusterone [drugbank:DB01564]
p2356
sg18
Vdrug-target interaction Calusterone and Androgen receptor [drugbank_resource:DB01564_146]
p2357
sa(dp2358
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2359
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02266
p2360
sg11
g2237
sg12
S'androgen receptor'
p2361
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02266_146
p2362
sg16
VFlufenamic Acid [drugbank:DB02266]
p2363
sg18
Vdrug-target interaction Flufenamic Acid and Androgen receptor [drugbank_resource:DB02266_146]
p2364
sa(dp2365
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2366
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02932
p2367
sg11
g2237
sg12
S'androgen receptor'
p2368
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02932_146
p2369
sg16
V(2r)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-3-[(4-Fluorophenyl)Sulfonyl]-2-Hydroxy-2-Methylpropanamide [drugbank:DB02932]
p2370
sg18
Vdrug-target interaction (2r)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-3-[(4-Fluorophenyl)Sulfonyl]-2-Hydroxy-2-Methylpropanamide and Androgen receptor [drugbank_resource:DB02932_146]
p2371
sa(dp2372
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2373
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02998
p2374
sg11
g2237
sg12
S'androgen receptor'
p2375
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02998_146
p2376
sg16
VMethyltrienolone [drugbank:DB02998]
p2377
sg18
Vdrug-target interaction Methyltrienolone and Androgen receptor [drugbank_resource:DB02998_146]
p2378
sa(dp2379
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2380
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02901
p2381
sg11
g2237
sg12
S'androgen receptor'
p2382
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02901_146
p2383
sg16
VDihydrotestosterone [drugbank:DB02901]
p2384
sg18
Vdrug-target interaction Dihydrotestosterone and Androgen receptor [drugbank_resource:DB02901_146]
p2385
sa(dp2386
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2387
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07286
p2388
sg11
g2237
sg12
S'androgen receptor'
p2389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07286_146
p2390
sg16
V2-CHLORO-4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-3-METHYLBENZONITRILE [drugbank:DB07286]
p2391
sg18
Vdrug-target interaction 2-CHLORO-4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-3-METHYLBENZONITRILE and Androgen receptor [drugbank_resource:DB07286_146]
p2392
sa(dp2393
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2394
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06710
p2395
sg11
g2237
sg12
S'androgen receptor'
p2396
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06710_146
p2397
sg16
VMethyltestosterone [drugbank:DB06710]
p2398
sg18
Vdrug-target interaction Methyltestosterone and Androgen receptor [drugbank_resource:DB06710_146]
p2399
sa(dp2400
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2401
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07419
p2402
sg11
g2237
sg12
S'androgen receptor'
p2403
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07419_146
p2404
sg16
V(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide [drugbank:DB07419]
p2405
sg18
Vdrug-target interaction (2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide and Androgen receptor [drugbank_resource:DB07419_146]
p2406
sa(dp2407
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2408
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04709
p2409
sg11
g2237
sg12
S'androgen receptor'
p2410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04709_146
p2411
sg16
V(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE [drugbank:DB04709]
p2412
sg18
Vdrug-target interaction (3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE and Androgen receptor [drugbank_resource:DB04709_146]
p2413
sa(dp2414
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2415
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04839
p2416
sg11
g2237
sg12
S'androgen receptor'
p2417
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04839_146
p2418
sg16
VCyproterone [drugbank:DB04839]
p2419
sg18
Vdrug-target interaction Cyproterone and Androgen receptor [drugbank_resource:DB04839_146]
p2420
sa(dp2421
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2422
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06870
p2423
sg11
g2237
sg12
S'androgen receptor'
p2424
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06870_146
p2425
sg16
V17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE [drugbank:DB06870]
p2426
sg18
Vdrug-target interaction 17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE and Androgen receptor [drugbank_resource:DB06870_146]
p2427
sa(dp2428
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2429
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07039
p2430
sg11
g2237
sg12
S'androgen receptor'
p2431
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07039_146
p2432
sg16
V(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide [drugbank:DB07039]
p2433
sg18
Vdrug-target interaction (2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and Androgen receptor [drugbank_resource:DB07039_146]
p2434
sa(dp2435
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2436
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07422
p2437
sg11
g2237
sg12
S'androgen receptor'
p2438
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07422_146
p2439
sg16
V(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide [drugbank:DB07422]
p2440
sg18
Vdrug-target interaction (2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide and Androgen receptor [drugbank_resource:DB07422_146]
p2441
sa(dp2442
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2443
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07454
p2444
sg11
g2237
sg12
S'androgen receptor'
p2445
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07454_146
p2446
sg16
V(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE [drugbank:DB07454]
p2447
sg18
Vdrug-target interaction (R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE and Androgen receptor [drugbank_resource:DB07454_146]
p2448
sa(dp2449
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2450
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07421
p2451
sg11
g2237
sg12
S'androgen receptor'
p2452
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07421_146
p2453
sg16
V4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile [drugbank:DB07421]
p2454
sg18
Vdrug-target interaction 4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile and Androgen receptor [drugbank_resource:DB07421_146]
p2455
sa(dp2456
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2457
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07423
p2458
sg11
g2237
sg12
S'androgen receptor'
p2459
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07423_146
p2460
sg16
V(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide [drugbank:DB07423]
p2461
sg18
Vdrug-target interaction (2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide and Androgen receptor [drugbank_resource:DB07423_146]
p2462
sa(dp2463
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2464
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07769
p2465
sg11
g2237
sg12
S'androgen receptor'
p2466
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07769_146
p2467
sg16
VS-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE [drugbank:DB07769]
p2468
sg18
Vdrug-target interaction S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE and Androgen receptor [drugbank_resource:DB07769_146]
p2469
sa(dp2470
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2471
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08035
p2472
sg11
g2237
sg12
S'androgen receptor'
p2473
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08035_146
p2474
sg16
V1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE [drugbank:DB08035]
p2475
sg18
Vdrug-target interaction 1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE and Androgen receptor [drugbank_resource:DB08035_146]
p2476
sa(dp2477
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2478
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08089
p2479
sg11
g2237
sg12
S'androgen receptor'
p2480
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08089_146
p2481
sg16
V6-[BIS(2,2,2-TRIFLUOROETHYL)AMINO]-4-(TRIFLUOROMETHYL)QUINOLIN-2(1H)-ONE [drugbank:DB08089]
p2482
sg18
Vdrug-target interaction 6-[BIS(2,2,2-TRIFLUOROETHYL)AMINO]-4-(TRIFLUOROMETHYL)QUINOLIN-2(1H)-ONE and Androgen receptor [drugbank_resource:DB08089_146]
p2483
sa(dp2484
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2485
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07717
p2486
sg11
g2237
sg12
S'androgen receptor'
p2487
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07717_146
p2488
sg16
V(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE [drugbank:DB07717]
p2489
sg18
Vdrug-target interaction (5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE and Androgen receptor [drugbank_resource:DB07717_146]
p2490
sa(dp2491
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2492
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08087
p2493
sg11
g2237
sg12
S'androgen receptor'
p2494
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08087_146
p2495
sg16
V4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE [drugbank:DB08087]
p2496
sg18
Vdrug-target interaction 4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE and Androgen receptor [drugbank_resource:DB08087_146]
p2497
sa(dp2498
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2499
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08088
p2500
sg11
g2237
sg12
S'androgen receptor'
p2501
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08088_146
p2502
sg16
V2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile [drugbank:DB08088]
p2503
sg18
Vdrug-target interaction 2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile and Androgen receptor [drugbank_resource:DB08088_146]
p2504
sa(dp2505
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2506
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08461
p2507
sg11
g2237
sg12
S'androgen receptor'
p2508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08461_146
p2509
sg16
V3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL [drugbank:DB08461]
p2510
sg18
Vdrug-target interaction 3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL and Androgen receptor [drugbank_resource:DB08461_146]
p2511
sa(dp2512
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:146
p2513
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08804
p2514
sg11
g2237
sg12
S'androgen receptor'
p2515
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08804_146
p2516
sg16
VNandrolone decanoate [drugbank:DB08804]
p2517
sg18
Vdrug-target interaction Nandrolone decanoate and Androgen receptor [drugbank_resource:DB08804_146]
p2518
sasS'KCNMB4'
p2519
(lp2520
(dp2521
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6933
p2522
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01110
p2523
sg11
g2519
sg12
S'potassium large conductance calcium-activated channel, subfamily M, beta member 4'
p2524
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01110_6933
p2525
sg16
VMiconazole [drugbank:DB01110]
p2526
sg18
Vdrug-target interaction Miconazole and Calcium-activated potassium channel subunit beta-4 [drugbank_resource:DB01110_6933]
p2527
sasS'PLD2'
p2528
(lp2529
(dp2530
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3922
p2531
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00122
p2532
sg11
g2528
sg12
S'phospholipase D2'
p2533
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00122_3922
p2534
sg16
VCholine [drugbank:DB00122]
p2535
sg18
Vdrug-target interaction Choline and Phospholipase D2 [drugbank_resource:DB00122_3922]
p2536
sasS'PPP2CA'
p2537
(lp2538
(dp2539
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4078
p2540
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00163
p2541
sg11
g2537
sg12
S'protein phosphatase 2, catalytic subunit, alpha isozyme'
p2542
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00163_4078
p2543
sg16
VVitamin E [drugbank:DB00163]
p2544
sg18
Vdrug-target interaction Vitamin E and Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform [drugbank_resource:DB00163_4078]
p2545
sa(dp2546
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4078
p2547
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02506
p2548
sg11
g2537
sg12
S'protein phosphatase 2, catalytic subunit, alpha isozyme'
p2549
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02506_4078
p2550
sg16
V2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid [drugbank:DB02506]
p2551
sg18
Vdrug-target interaction 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid and Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform [drugbank_resource:DB02506_4078]
p2552
sa(dp2553
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4078
p2554
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06905
p2555
sg11
g2537
sg12
S'protein phosphatase 2, catalytic subunit, alpha isozyme'
p2556
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06905_4078
p2557
sg16
V(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid [drugbank:DB06905]
p2558
sg18
Vdrug-target interaction (2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid and Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform [drugbank_resource:DB06905_4078]
p2559
sasS'APP'
p2560
(lp2561
(dp2562
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5800
p2563
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02235
p2564
sg11
g2560
sg12
S'amyloid beta (A4) precursor protein'
p2565
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02235_5800
p2566
sg16
VMethionine Sulfoxide [drugbank:DB02235]
p2567
sg18
Vdrug-target interaction Methionine Sulfoxide and Amyloid beta A4 protein [drugbank_resource:DB02235_5800]
p2568
sasS'ITPKA'
p2569
(lp2570
(dp2571
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2950
p2572
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01863
p2573
sg11
g2569
sg12
S'inositol-trisphosphate 3-kinase A'
p2574
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01863_2950
p2575
sg16
VInositol 1,3,4,5-Tetrakisphosphate [drugbank:DB01863]
p2576
sg18
Vdrug-target interaction Inositol 1,3,4,5-Tetrakisphosphate and Inositol-trisphosphate 3-kinase A [drugbank_resource:DB01863_2950]
p2577
sa(dp2578
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2950
p2579
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03401
p2580
sg11
g2569
sg12
S'inositol-trisphosphate 3-kinase A'
p2581
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03401_2950
p2582
sg16
VD-Myo-Inositol-1,4,5-Triphosphate [drugbank:DB03401]
p2583
sg18
Vdrug-target interaction D-Myo-Inositol-1,4,5-Triphosphate and Inositol-trisphosphate 3-kinase A [drugbank_resource:DB03401_2950]
p2584
sa(dp2585
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2950
p2586
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p2587
sg11
g2569
sg12
S'inositol-trisphosphate 3-kinase A'
p2588
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_2950
p2589
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p2590
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Inositol-trisphosphate 3-kinase A [drugbank_resource:DB04395_2950]
p2591
sa(dp2592
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2950
p2593
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p2594
sg11
g2569
sg12
S'inositol-trisphosphate 3-kinase A'
p2595
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_2950
p2596
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p2597
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Inositol-trisphosphate 3-kinase A [drugbank_resource:DB03431_2950]
p2598
sasS'KAT5'
p2599
(lp2600
(dp2601
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7088
p2602
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02039
p2603
sg11
g2599
sg12
S'K(lysine) acetyltransferase 5'
p2604
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02039_7088
p2605
sg16
VS-Acetyl-Cysteine [drugbank:DB02039]
p2606
sg18
Vdrug-target interaction S-Acetyl-Cysteine and Histone acetyltransferase KAT5 [drugbank_resource:DB02039_7088]
p2607
sa(dp2608
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7088
p2609
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01992
p2610
sg11
g2599
sg12
S'K(lysine) acetyltransferase 5'
p2611
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01992_7088
p2612
sg16
VCoenzyme A [drugbank:DB01992]
p2613
sg18
Vdrug-target interaction Coenzyme A and Histone acetyltransferase KAT5 [drugbank_resource:DB01992_7088]
p2614
sasS'GSK3B'
p2615
(lp2616
(dp2617
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2618
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01356
p2619
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2620
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01356_1721
p2621
sg16
VLithium [drugbank:DB01356]
p2622
sg18
Vdrug-target interaction Lithium and Glycogen synthase kinase-3 beta [drugbank_resource:DB01356_1721]
p2623
sa(dp2624
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2625
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01950
p2626
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2627
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01950_1721
p2628
sg16
VN-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea [drugbank:DB01950]
p2629
sg18
Vdrug-target interaction N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea and Glycogen synthase kinase-3 beta [drugbank_resource:DB01950_1721]
p2630
sa(dp2631
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2632
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01793
p2633
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2634
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01793_1721
p2635
sg16
VI-5 [drugbank:DB01793]
p2636
sg18
Vdrug-target interaction I-5 and Glycogen synthase kinase-3 beta [drugbank_resource:DB01793_1721]
p2637
sa(dp2638
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2639
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02010
p2640
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2641
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02010_1721
p2642
sg16
VStaurosporine [drugbank:DB02010]
p2643
sg18
Vdrug-target interaction Staurosporine and Glycogen synthase kinase-3 beta [drugbank_resource:DB02010_1721]
p2644
sa(dp2645
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2646
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01772
p2647
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2648
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01772_1721
p2649
sg16
V3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione [drugbank:DB01772]
p2650
sg18
Vdrug-target interaction 3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione and Glycogen synthase kinase-3 beta [drugbank_resource:DB01772_1721]
p2651
sa(dp2652
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2653
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02052
p2654
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2655
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02052_1721
p2656
sg16
VIndirubin-3'-Monoxime [drugbank:DB02052]
p2657
sg18
Vdrug-target interaction Indirubin-3'-Monoxime and Glycogen synthase kinase-3 beta [drugbank_resource:DB02052_1721]
p2658
sa(dp2659
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2660
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03444
p2661
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2662
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03444_1721
p2663
sg16
V(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime [drugbank:DB03444]
p2664
sg18
Vdrug-target interaction (3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime and Glycogen synthase kinase-3 beta [drugbank_resource:DB03444_1721]
p2665
sa(dp2666
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2667
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p2668
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2669
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_1721
p2670
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p2671
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Glycogen synthase kinase-3 beta [drugbank_resource:DB03431_1721]
p2672
sa(dp2673
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2674
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04014
p2675
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2676
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04014_1721
p2677
sg16
VAlsterpaullone [drugbank:DB04014]
p2678
sg18
Vdrug-target interaction Alsterpaullone and Glycogen synthase kinase-3 beta [drugbank_resource:DB04014_1721]
p2679
sa(dp2680
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2681
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p2682
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2683
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_1721
p2684
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p2685
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Glycogen synthase kinase-3 beta [drugbank_resource:DB04395_1721]
p2686
sa(dp2687
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2688
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07149
p2689
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2690
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07149_1721
p2691
sg16
V(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one [drugbank:DB07149]
p2692
sg18
Vdrug-target interaction (7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one and Glycogen synthase kinase-3 beta [drugbank_resource:DB07149_1721]
p2693
sa(dp2694
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2695
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07058
p2696
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2697
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07058_1721
p2698
sg16
V5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione [drugbank:DB07058]
p2699
sg18
Vdrug-target interaction 5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione and Glycogen synthase kinase-3 beta [drugbank_resource:DB07058_1721]
p2700
sa(dp2701
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2702
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07014
p2703
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2704
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07014_1721
p2705
sg16
V2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole [drugbank:DB07014]
p2706
sg18
Vdrug-target interaction 2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole and Glycogen synthase kinase-3 beta [drugbank_resource:DB07014_1721]
p2707
sa(dp2708
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2709
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07584
p2710
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2711
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07584_1721
p2712
sg16
VN-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine [drugbank:DB07584]
p2713
sg18
Vdrug-target interaction N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine and Glycogen synthase kinase-3 beta [drugbank_resource:DB07584_1721]
p2714
sa(dp2715
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2716
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07585
p2717
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2718
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07585_1721
p2719
sg16
V5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine [drugbank:DB07585]
p2720
sg18
Vdrug-target interaction 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and Glycogen synthase kinase-3 beta [drugbank_resource:DB07585_1721]
p2721
sa(dp2722
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2723
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08073
p2724
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2725
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08073_1721
p2726
sg16
V(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE [drugbank:DB08073]
p2727
sg18
Vdrug-target interaction (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE and Glycogen synthase kinase-3 beta [drugbank_resource:DB08073_1721]
p2728
sa(dp2729
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2730
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07859
p2731
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2732
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07859_1721
p2733
sg16
V4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE [drugbank:DB07859]
p2734
sg18
Vdrug-target interaction 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE and Glycogen synthase kinase-3 beta [drugbank_resource:DB07859_1721]
p2735
sa(dp2736
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2737
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07676
p2738
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2739
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07676_1721
p2740
sg16
V3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one [drugbank:DB07676]
p2741
sg18
Vdrug-target interaction 3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one and Glycogen synthase kinase-3 beta [drugbank_resource:DB07676_1721]
p2742
sa(dp2743
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2744
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07812
p2745
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2746
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07812_1721
p2747
sg16
VN-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide [drugbank:DB07812]
p2748
sg18
Vdrug-target interaction N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide and Glycogen synthase kinase-3 beta [drugbank_resource:DB07812_1721]
p2749
sa(dp2750
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1721
p2751
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07947
p2752
sg11
g2615
sg12
S'glycogen synthase kinase 3 beta'
p2753
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07947_1721
p2754
sg16
VISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE [drugbank:DB07947]
p2755
sg18
Vdrug-target interaction ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE and Glycogen synthase kinase-3 beta [drugbank_resource:DB07947_1721]
p2756
sasS'TLR2'
p2757
(lp2758
(dp2759
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2090
p2760
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00045
p2761
sg11
g2757
sg12
S'toll-like receptor 2'
p2762
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00045_2090
p2763
sg16
VOspA lipoprotein [drugbank:DB00045]
p2764
sg18
Vdrug-target interaction OspA lipoprotein and Toll-like receptor 2 [drugbank_resource:DB00045_2090]
p2765
sa(dp2766
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2090
p2767
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03963
p2768
sg11
g2757
sg12
S'toll-like receptor 2'
p2769
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03963_2090
p2770
sg16
VS-(Dimethylarsenic)Cysteine [drugbank:DB03963]
p2771
sg18
Vdrug-target interaction S-(Dimethylarsenic)Cysteine and Toll-like receptor 2 [drugbank_resource:DB03963_2090]
p2772
sasS'F2R'
p2773
(lp2774
(dp2775
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1193
p2776
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00086
p2777
sg11
g2773
sg12
S'coagulation factor II (thrombin) receptor'
p2778
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00086_1193
p2779
sg16
VStreptokinase [drugbank:DB00086]
p2780
sg18
Vdrug-target interaction Streptokinase and Proteinase-activated receptor 1 [drugbank_resource:DB00086_1193]
p2781
sasS'GRB2'
p2782
(lp2783
(dp2784
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1157
p2785
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00061
p2786
sg11
g2782
sg12
S'growth factor receptor-bound protein 2'
p2787
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00061_1157
p2788
sg16
VPegademase bovine [drugbank:DB00061]
p2789
sg18
Vdrug-target interaction Pegademase bovine and Growth factor receptor-bound protein 2 [drugbank_resource:DB00061_1157]
p2790
sa(dp2791
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1157
p2792
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03276
p2793
sg11
g2782
sg12
S'growth factor receptor-bound protein 2'
p2794
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03276_1157
p2795
sg16
V4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid [drugbank:DB03276]
p2796
sg18
Vdrug-target interaction 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid and Growth factor receptor-bound protein 2 [drugbank_resource:DB03276_1157]
p2797
sasS'NPY'
p2798
(lp2799
(dp2800
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5925
p2801
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02952
p2802
sg11
g2798
sg12
S'neuropeptide Y'
p2803
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02952_5925
p2804
sg16
VAlpha-Aminoisobutyric Acid [drugbank:DB02952]
p2805
sg18
Vdrug-target interaction Alpha-Aminoisobutyric Acid and Neuropeptide Y [drugbank_resource:DB02952_5925]
p2806
sa(dp2807
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5925
p2808
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03380
p2809
sg11
g2798
sg12
S'neuropeptide Y'
p2810
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03380_5925
p2811
sg16
VL-Tyrosinamide [drugbank:DB03380]
p2812
sg18
Vdrug-target interaction L-Tyrosinamide and Neuropeptide Y [drugbank_resource:DB03380_5925]
p2813
sasS'PLEKHA1'
p2814
(lp2815
(dp2816
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5586
p2817
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04272
p2818
sg11
g2814
sg12
S'pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1'
p2819
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04272_5586
p2820
sg16
VCitric Acid [drugbank:DB04272]
p2821
sg18
Vdrug-target interaction Citric Acid and Pleckstrin homology domain-containing family A member 1 [drugbank_resource:DB04272_5586]
p2822
sasS'UBC'
p2823
(lp2824
(dp2825
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6590
p2826
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04464
p2827
sg11
g2823
sg12
S'ubiquitin C'
p2828
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04464_6590
p2829
sg16
VN-Formylmethionine [drugbank:DB04464]
p2830
sg18
Vdrug-target interaction N-Formylmethionine and Polyubiquitin-C [drugbank_resource:DB04464_6590]
p2831
sasS'GRM3'
p2832
(lp2833
(dp2834
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4096
p2835
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00659
p2836
sg11
g2832
sg12
S'glutamate receptor, metabotropic 3'
p2837
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00659_4096
p2838
sg16
VAcamprosate [drugbank:DB00659]
p2839
sg18
Vdrug-target interaction Acamprosate and Metabotropic glutamate receptor 3 [drugbank_resource:DB00659_4096]
p2840
sasS'SCN3A'
p2841
(lp2842
(dp2843
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3803
p2844
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00909
p2845
sg11
g2841
sg12
S'sodium channel, voltage-gated, type III, alpha subunit'
p2846
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00909_3803
p2847
sg16
VZonisamide [drugbank:DB00909]
p2848
sg18
Vdrug-target interaction Zonisamide and Sodium channel protein type 3 subunit alpha [drugbank_resource:DB00909_3803]
p2849
sasS'SCN3B'
p2850
(lp2851
(dp2852
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6134
p2853
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00909
p2854
sg11
g2850
sg12
S'sodium channel, voltage-gated, type III, beta subunit'
p2855
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00909_6134
p2856
sg16
VZonisamide [drugbank:DB00909]
p2857
sg18
Vdrug-target interaction Zonisamide and Sodium channel subunit beta-3 [drugbank_resource:DB00909_6134]
p2858
sasS'CCR5'
p2859
(lp2860
(dp2861
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1129
p2862
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04835
p2863
sg11
g2859
sg12
S'chemokine (C-C motif) receptor 5 (gene/pseudogene)'
p2864
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04835_1129
p2865
sg16
VMaraviroc [drugbank:DB04835]
p2866
sg18
Vdrug-target interaction Maraviroc and C-C chemokine receptor type 5 [drugbank_resource:DB04835_1129]
p2867
sasS'CCL2'
p2868
(lp2869
(dp2870
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1649
p2871
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01055
p2872
sg11
g2868
sg12
S'chemokine (C-C motif) ligand 2'
p2873
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01055_1649
p2874
sg16
VMimosine [drugbank:DB01055]
p2875
sg18
Vdrug-target interaction Mimosine and Small inducible cytokine A2 [drugbank_resource:DB01055_1649]
p2876
sa(dp2877
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1649
p2878
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01406
p2879
sg11
g2868
sg12
S'chemokine (C-C motif) ligand 2'
p2880
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01406_1649
p2881
sg16
VDanazol [drugbank:DB01406]
p2882
sg18
Vdrug-target interaction Danazol and Small inducible cytokine A2 [drugbank_resource:DB01406_1649]
p2883
sasS'ITGB1'
p2884
(lp2885
(dp2886
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6065
p2887
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00098
p2888
sg11
g2884
sg12
S'integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)'
p2889
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00098_6065
p2890
sg16
VAntithymocyte globulin [drugbank:DB00098]
p2891
sg18
Vdrug-target interaction Antithymocyte globulin and Integrin beta-1 [drugbank_resource:DB00098_6065]
p2892
sasS'GABBR1'
p2893
(lp2894
(dp2895
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:240
p2896
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00181
p2897
sg11
g2893
sg12
S'gamma-aminobutyric acid (GABA) B receptor, 1'
p2898
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00181_240
p2899
sg16
VBaclofen [drugbank:DB00181]
p2900
sg18
Vdrug-target interaction Baclofen and Gamma-aminobutyric acid type B receptor, subunit 1 [drugbank_resource:DB00181_240]
p2901
sa(dp2902
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:240
p2903
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01080
p2904
sg11
g2893
sg12
S'gamma-aminobutyric acid (GABA) B receptor, 1'
p2905
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01080_240
p2906
sg16
VVigabatrin [drugbank:DB01080]
p2907
sg18
Vdrug-target interaction Vigabatrin and Gamma-aminobutyric acid type B receptor, subunit 1 [drugbank_resource:DB01080_240]
p2908
sa(dp2909
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:240
p2910
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00837
p2911
sg11
g2893
sg12
S'gamma-aminobutyric acid (GABA) B receptor, 1'
p2912
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00837_240
p2913
sg16
VProgabide [drugbank:DB00837]
p2914
sg18
Vdrug-target interaction Progabide and Gamma-aminobutyric acid type B receptor, subunit 1 [drugbank_resource:DB00837_240]
p2915
sasS'ACTA1'
p2916
(lp2917
(dp2918
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p2919
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02621
p2920
sg11
g2916
sg12
S'actin, alpha 1, skeletal muscle'
p2921
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02621_3822
p2922
sg16
VLatrunculin A [drugbank:DB02621]
p2923
sg18
Vdrug-target interaction Latrunculin A and Actin, alpha skeletal muscle [drugbank_resource:DB02621_3822]
p2924
sa(dp2925
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p2926
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02772
p2927
sg11
g2916
sg12
S'actin, alpha 1, skeletal muscle'
p2928
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02772_3822
p2929
sg16
VSucrose [drugbank:DB02772]
p2930
sg18
Vdrug-target interaction Sucrose and Actin, alpha skeletal muscle [drugbank_resource:DB02772_3822]
p2931
sa(dp2932
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p2933
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03021
p2934
sg11
g2916
sg12
S'actin, alpha 1, skeletal muscle'
p2935
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03021_3822
p2936
sg16
VUlapualide A [drugbank:DB03021]
p2937
sg18
Vdrug-target interaction Ulapualide A and Actin, alpha skeletal muscle [drugbank_resource:DB03021_3822]
p2938
sa(dp2939
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p2940
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03850
p2941
sg11
g2916
sg12
S'actin, alpha 1, skeletal muscle'
p2942
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03850_3822
p2943
sg16
VJaspisamide A [drugbank:DB03850]
p2944
sg18
Vdrug-target interaction Jaspisamide A and Actin, alpha skeletal muscle [drugbank_resource:DB03850_3822]
p2945
sa(dp2946
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p2947
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03616
p2948
sg11
g2916
sg12
S'actin, alpha 1, skeletal muscle'
p2949
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03616_3822
p2950
sg16
VKabiramide C [drugbank:DB03616]
p2951
sg18
Vdrug-target interaction Kabiramide C and Actin, alpha skeletal muscle [drugbank_resource:DB03616_3822]
p2952
sa(dp2953
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p2954
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p2955
sg11
g2916
sg12
S'actin, alpha 1, skeletal muscle'
p2956
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_3822
p2957
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p2958
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Actin, alpha skeletal muscle [drugbank_resource:DB03431_3822]
p2959
sa(dp2960
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p2961
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03903
p2962
sg11
g2916
sg12
S'actin, alpha 1, skeletal muscle'
p2963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03903_3822
p2964
sg16
VTmr [drugbank:DB03903]
p2965
sg18
Vdrug-target interaction Tmr and Actin, alpha skeletal muscle [drugbank_resource:DB03903_3822]
p2966
sa(dp2967
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p2968
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04151
p2969
sg11
g2916
sg12
S'actin, alpha 1, skeletal muscle'
p2970
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04151_3822
p2971
sg16
V4-Methyl-Histidine [drugbank:DB04151]
p2972
sg18
Vdrug-target interaction 4-Methyl-Histidine and Actin, alpha skeletal muscle [drugbank_resource:DB04151_3822]
p2973
sa(dp2974
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p2975
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p2976
sg11
g2916
sg12
S'actin, alpha 1, skeletal muscle'
p2977
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_3822
p2978
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p2979
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Actin, alpha skeletal muscle [drugbank_resource:DB04395_3822]
p2980
sa(dp2981
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p2982
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04629
p2983
sg11
g2916
sg12
S'actin, alpha 1, skeletal muscle'
p2984
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04629_3822
p2985
sg16
VAplyronine A [drugbank:DB04629]
p2986
sg18
Vdrug-target interaction Aplyronine A and Actin, alpha skeletal muscle [drugbank_resource:DB04629_3822]
p2987
sa(dp2988
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p2989
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04774
p2990
sg11
g2916
sg12
S'actin, alpha 1, skeletal muscle'
p2991
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04774_3822
p2992
sg16
VReidispongiolide A [drugbank:DB04774]
p2993
sg18
Vdrug-target interaction Reidispongiolide A and Actin, alpha skeletal muscle [drugbank_resource:DB04774_3822]
p2994
sa(dp2995
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p2996
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04775
p2997
sg11
g2916
sg12
S'actin, alpha 1, skeletal muscle'
p2998
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04775_3822
p2999
sg16
VReidispongiolide C [drugbank:DB04775]
p3000
sg18
Vdrug-target interaction Reidispongiolide C and Actin, alpha skeletal muscle [drugbank_resource:DB04775_3822]
p3001
sa(dp3002
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3003
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04783
p3004
sg11
g2916
sg12
S'actin, alpha 1, skeletal muscle'
p3005
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04783_3822
p3006
sg16
VSphinxolide B [drugbank:DB04783]
p3007
sg18
Vdrug-target interaction Sphinxolide B and Actin, alpha skeletal muscle [drugbank_resource:DB04783_3822]
p3008
sa(dp3009
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3822
p3010
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08080
p3011
sg11
g2916
sg12
S'actin, alpha 1, skeletal muscle'
p3012
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08080_3822
p3013
sg16
VLATRUNCULIN B [drugbank:DB08080]
p3014
sg18
Vdrug-target interaction LATRUNCULIN B and Actin, alpha skeletal muscle [drugbank_resource:DB08080_3822]
p3015
sasS'ATP6V1A'
p3016
(lp3017
(dp3018
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6057
p3019
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00630
p3020
sg11
g3016
sg12
S'ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A'
p3021
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00630_6057
p3022
sg16
VAlendronate [drugbank:DB00630]
p3023
sg18
Vdrug-target interaction Alendronate and V-type proton ATPase catalytic subunit A [drugbank_resource:DB00630_6057]
p3024
sa(dp3025
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6057
p3026
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01077
p3027
sg11
g3016
sg12
S'ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A'
p3028
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01077_6057
p3029
sg16
VEtidronic acid [drugbank:DB01077]
p3030
sg18
Vdrug-target interaction Etidronic acid and V-type proton ATPase catalytic subunit A [drugbank_resource:DB01077_6057]
p3031
sa(dp3032
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6057
p3033
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01133
p3034
sg11
g3016
sg12
S'ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A'
p3035
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01133_6057
p3036
sg16
VTiludronate [drugbank:DB01133]
p3037
sg18
Vdrug-target interaction Tiludronate and V-type proton ATPase catalytic subunit A [drugbank_resource:DB01133_6057]
p3038
sa(dp3039
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6057
p3040
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06733
p3041
sg11
g3016
sg12
S'ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A'
p3042
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06733_6057
p3043
sg16
VBafilomycin A1 [drugbank:DB06733]
p3044
sg18
Vdrug-target interaction Bafilomycin A1 and V-type proton ATPase catalytic subunit A [drugbank_resource:DB06733_6057]
p3045
sa(dp3046
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6057
p3047
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06734
p3048
sg11
g3016
sg12
S'ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A'
p3049
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06734_6057
p3050
sg16
VBafilomycin B1 [drugbank:DB06734]
p3051
sg18
Vdrug-target interaction Bafilomycin B1 and V-type proton ATPase catalytic subunit A [drugbank_resource:DB06734_6057]
p3052
sasS'GABRG2'
p3053
(lp3054
(dp3055
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3056
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00186
p3057
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3058
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00186_6086
p3059
sg16
VLorazepam [drugbank:DB00186]
p3060
sg18
Vdrug-target interaction Lorazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00186_6086]
p3061
sa(dp3062
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3063
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00231
p3064
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3065
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00231_6086
p3066
sg16
VTemazepam [drugbank:DB00231]
p3067
sg18
Vdrug-target interaction Temazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00231_6086]
p3068
sa(dp3069
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3070
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00475
p3071
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3072
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00475_6086
p3073
sg16
VChlordiazepoxide [drugbank:DB00475]
p3074
sg18
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00475_6086]
p3075
sa(dp3076
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3077
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00349
p3078
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3079
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00349_6086
p3080
sg16
VClobazam [drugbank:DB00349]
p3081
sg18
Vdrug-target interaction Clobazam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00349_6086]
p3082
sa(dp3083
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3084
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00404
p3085
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3086
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00404_6086
p3087
sg16
VAlprazolam [drugbank:DB00404]
p3088
sg18
Vdrug-target interaction Alprazolam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00404_6086]
p3089
sa(dp3090
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3091
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00546
p3092
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3093
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00546_6086
p3094
sg16
VAdinazolam [drugbank:DB00546]
p3095
sg18
Vdrug-target interaction Adinazolam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00546_6086]
p3096
sa(dp3097
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3098
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00628
p3099
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3100
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00628_6086
p3101
sg16
VClorazepate [drugbank:DB00628]
p3102
sg18
Vdrug-target interaction Clorazepate and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00628_6086]
p3103
sa(dp3104
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3105
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00690
p3106
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3107
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00690_6086
p3108
sg16
VFlurazepam [drugbank:DB00690]
p3109
sg18
Vdrug-target interaction Flurazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00690_6086]
p3110
sa(dp3111
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3112
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00829
p3113
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3114
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00829_6086
p3115
sg16
VDiazepam [drugbank:DB00829]
p3116
sg18
Vdrug-target interaction Diazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00829_6086]
p3117
sa(dp3118
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3119
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00842
p3120
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3121
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00842_6086
p3122
sg16
VOxazepam [drugbank:DB00842]
p3123
sg18
Vdrug-target interaction Oxazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00842_6086]
p3124
sa(dp3125
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3126
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00683
p3127
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3128
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00683_6086
p3129
sg16
VMidazolam [drugbank:DB00683]
p3130
sg18
Vdrug-target interaction Midazolam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00683_6086]
p3131
sa(dp3132
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3133
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00801
p3134
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3135
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00801_6086
p3136
sg16
VHalazepam [drugbank:DB00801]
p3137
sg18
Vdrug-target interaction Halazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00801_6086]
p3138
sa(dp3139
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3140
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00897
p3141
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3142
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00897_6086
p3143
sg16
VTriazolam [drugbank:DB00897]
p3144
sg18
Vdrug-target interaction Triazolam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00897_6086]
p3145
sa(dp3146
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3147
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01068
p3148
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3149
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01068_6086
p3150
sg16
VClonazepam [drugbank:DB01068]
p3151
sg18
Vdrug-target interaction Clonazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01068_6086]
p3152
sa(dp3153
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3154
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01381
p3155
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3156
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01381_6086
p3157
sg16
VGinkgo biloba [drugbank:DB01381]
p3158
sg18
Vdrug-target interaction Ginkgo biloba and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01381_6086]
p3159
sa(dp3160
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3161
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01567
p3162
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3163
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01567_6086
p3164
sg16
VFludiazepam [drugbank:DB01567]
p3165
sg18
Vdrug-target interaction Fludiazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01567_6086]
p3166
sa(dp3167
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3168
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01588
p3169
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3170
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01588_6086
p3171
sg16
VPrazepam [drugbank:DB01588]
p3172
sg18
Vdrug-target interaction Prazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01588_6086]
p3173
sa(dp3174
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3175
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01215
p3176
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3177
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01215_6086
p3178
sg16
VEstazolam [drugbank:DB01215]
p3179
sg18
Vdrug-target interaction Estazolam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01215_6086]
p3180
sa(dp3181
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3182
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01558
p3183
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3184
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01558_6086
p3185
sg16
VBromazepam [drugbank:DB01558]
p3186
sg18
Vdrug-target interaction Bromazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01558_6086]
p3187
sa(dp3188
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3189
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01559
p3190
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3191
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01559_6086
p3192
sg16
VClotiazepam [drugbank:DB01559]
p3193
sg18
Vdrug-target interaction Clotiazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01559_6086]
p3194
sa(dp3195
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3196
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01589
p3197
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3198
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01589_6086
p3199
sg16
VQuazepam [drugbank:DB01589]
p3200
sg18
Vdrug-target interaction Quazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01589_6086]
p3201
sa(dp3202
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3203
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01594
p3204
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3205
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01594_6086
p3206
sg16
VCinolazepam [drugbank:DB01594]
p3207
sg18
Vdrug-target interaction Cinolazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01594_6086]
p3208
sa(dp3209
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6086
p3210
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01595
p3211
sg11
g3053
sg12
S'gamma-aminobutyric acid (GABA) A receptor, gamma 2'
p3212
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01595_6086
p3213
sg16
VNitrazepam [drugbank:DB01595]
p3214
sg18
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01595_6086]
p3215
sasS'HLA-A'
p3216
(lp3217
(dp3218
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5948
p3219
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02740
p3220
sg11
g3216
sg12
S'major histocompatibility complex, class I, A'
p3221
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02740_5948
p3222
sg16
V3-Indolebutyric Acid [drugbank:DB02740]
p3223
sg18
Vdrug-target interaction 3-Indolebutyric Acid and HLA class I histocompatibility antigen, A-2 alpha chain [drugbank_resource:DB02740_5948]
p3224
sasS'HSPG2'
p3225
(lp3226
(dp3227
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1585
p3228
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00039
p3229
sg11
g3225
sg12
S'heparan sulfate proteoglycan 2'
p3230
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00039_1585
p3231
sg16
VPalifermin [drugbank:DB00039]
p3232
sg18
Vdrug-target interaction Palifermin and Basement membrane-specific heparan sulfate proteoglycan core protein [drugbank_resource:DB00039_1585]
p3233
sasS'ITGA4'
p3234
(lp3235
(dp3236
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:647
p3237
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00108
p3238
sg11
g3234
sg12
S'integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)'
p3239
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00108_647
p3240
sg16
VNatalizumab [drugbank:DB00108]
p3241
sg18
Vdrug-target interaction Natalizumab and Integrin alpha-4 [drugbank_resource:DB00108_647]
p3242
sa(dp3243
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:647
p3244
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06822
p3245
sg11
g3234
sg12
S'integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)'
p3246
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06822_647
p3247
sg16
VTinzaparin [drugbank:DB06822]
p3248
sg18
Vdrug-target interaction Tinzaparin and Integrin alpha-4 [drugbank_resource:DB06822_647]
p3249
sasS'GAPDH'
p3250
(lp3251
(dp3252
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:599
p3253
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p3254
sg11
g3250
sg12
S'glyceraldehyde-3-phosphate dehydrogenase'
p3255
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_599
p3256
sg16
VNADH [drugbank:DB00157]
p3257
sg18
Vdrug-target interaction NADH and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB00157_599]
p3258
sa(dp3259
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:599
p3260
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02059
p3261
sg11
g3250
sg12
S'glyceraldehyde-3-phosphate dehydrogenase'
p3262
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02059_599
p3263
sg16
VAdenosine-5-Diphosphoribose [drugbank:DB02059]
p3264
sg18
Vdrug-target interaction Adenosine-5-Diphosphoribose and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB02059_599]
p3265
sa(dp3266
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:599
p3267
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01907
p3268
sg11
g3250
sg12
S'glyceraldehyde-3-phosphate dehydrogenase'
p3269
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01907_599
p3270
sg16
VNicotinamide-Adenine-Dinucleotide [drugbank:DB01907]
p3271
sg18
Vdrug-target interaction Nicotinamide-Adenine-Dinucleotide and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB01907_599]
p3272
sa(dp3273
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:599
p3274
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03893
p3275
sg11
g3250
sg12
S'glyceraldehyde-3-phosphate dehydrogenase'
p3276
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03893_599
p3277
sg16
VThionicotinamide-Adenine-Dinucleotide [drugbank:DB03893]
p3278
sg18
Vdrug-target interaction Thionicotinamide-Adenine-Dinucleotide and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB03893_599]
p3279
sa(dp3280
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:599
p3281
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07347
p3282
sg11
g3250
sg12
S'glyceraldehyde-3-phosphate dehydrogenase'
p3283
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07347_599
p3284
sg16
V4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE [drugbank:DB07347]
p3285
sg18
Vdrug-target interaction 4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB07347_599]
p3286
sasS'KAT2A'
p3287
(lp3288
(dp3289
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7093
p3290
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01992
p3291
sg11
g3287
sg12
S'K(lysine) acetyltransferase 2A'
p3292
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01992_7093
p3293
sg16
VCoenzyme A [drugbank:DB01992]
p3294
sg18
Vdrug-target interaction Coenzyme A and Histone acetyltransferase KAT2A [drugbank_resource:DB01992_7093]
p3295
sasS'C1QB'
p3296
(lp3297
(dp3298
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3299
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00056
p3300
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3301
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00056_3816
p3302
sg16
VGemtuzumab ozogamicin [drugbank:DB00056]
p3303
sg18
Vdrug-target interaction Gemtuzumab ozogamicin and Complement C1q subcomponent subunit B [drugbank_resource:DB00056_3816]
p3304
sa(dp3305
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3306
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00074
p3307
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3308
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00074_3816
p3309
sg16
VBasiliximab [drugbank:DB00074]
p3310
sg18
Vdrug-target interaction Basiliximab and Complement C1q subcomponent subunit B [drugbank_resource:DB00074_3816]
p3311
sa(dp3312
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3313
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00081
p3314
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3315
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00081_3816
p3316
sg16
VTositumomab [drugbank:DB00081]
p3317
sg18
Vdrug-target interaction Tositumomab and Complement C1q subcomponent subunit B [drugbank_resource:DB00081_3816]
p3318
sa(dp3319
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3320
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00095
p3321
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3322
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00095_3816
p3323
sg16
VEfalizumab [drugbank:DB00095]
p3324
sg18
Vdrug-target interaction Efalizumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00095_3816]
p3325
sa(dp3326
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3327
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00108
p3328
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3329
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00108_3816
p3330
sg16
VNatalizumab [drugbank:DB00108]
p3331
sg18
Vdrug-target interaction Natalizumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00108_3816]
p3332
sa(dp3333
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3334
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00112
p3335
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3336
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00112_3816
p3337
sg16
VBevacizumab [drugbank:DB00112]
p3338
sg18
Vdrug-target interaction Bevacizumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00112_3816]
p3339
sa(dp3340
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3341
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00002
p3342
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3343
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00002_3816
p3344
sg16
VCetuximab [drugbank:DB00002]
p3345
sg18
Vdrug-target interaction Cetuximab and Complement C1q subcomponent subunit B [drugbank_resource:DB00002_3816]
p3346
sa(dp3347
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3348
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00092
p3349
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3350
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00092_3816
p3351
sg16
VAlefacept [drugbank:DB00092]
p3352
sg18
Vdrug-target interaction Alefacept and Complement C1q subcomponent subunit B [drugbank_resource:DB00092_3816]
p3353
sa(dp3354
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3355
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00110
p3356
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3357
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00110_3816
p3358
sg16
VPalivizumab [drugbank:DB00110]
p3359
sg18
Vdrug-target interaction Palivizumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00110_3816]
p3360
sa(dp3361
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3362
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00005
p3363
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3364
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00005_3816
p3365
sg16
VEtanercept [drugbank:DB00005]
p3366
sg18
Vdrug-target interaction Etanercept and Complement C1q subcomponent subunit B [drugbank_resource:DB00005_3816]
p3367
sa(dp3368
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3369
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00051
p3370
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3371
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00051_3816
p3372
sg16
VAdalimumab [drugbank:DB00051]
p3373
sg18
Vdrug-target interaction Adalimumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00051_3816]
p3374
sa(dp3375
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3376
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00054
p3377
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3378
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00054_3816
p3379
sg16
VAbciximab [drugbank:DB00054]
p3380
sg18
Vdrug-target interaction Abciximab and Complement C1q subcomponent subunit B [drugbank_resource:DB00054_3816]
p3381
sa(dp3382
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3383
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00072
p3384
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3385
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00072_3816
p3386
sg16
VTrastuzumab [drugbank:DB00072]
p3387
sg18
Vdrug-target interaction Trastuzumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00072_3816]
p3388
sa(dp3389
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3390
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00073
p3391
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3392
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00073_3816
p3393
sg16
VRituximab [drugbank:DB00073]
p3394
sg18
Vdrug-target interaction Rituximab and Complement C1q subcomponent subunit B [drugbank_resource:DB00073_3816]
p3395
sa(dp3396
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3397
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00075
p3398
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3399
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00075_3816
p3400
sg16
VMuromonab [drugbank:DB00075]
p3401
sg18
Vdrug-target interaction Muromonab and Complement C1q subcomponent subunit B [drugbank_resource:DB00075_3816]
p3402
sa(dp3403
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3404
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00078
p3405
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3406
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00078_3816
p3407
sg16
VIbritumomab [drugbank:DB00078]
p3408
sg18
Vdrug-target interaction Ibritumomab and Complement C1q subcomponent subunit B [drugbank_resource:DB00078_3816]
p3409
sa(dp3410
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3411
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00087
p3412
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3413
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00087_3816
p3414
sg16
VAlemtuzumab [drugbank:DB00087]
p3415
sg18
Vdrug-target interaction Alemtuzumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00087_3816]
p3416
sa(dp3417
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3816
p3418
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00111
p3419
sg11
g3296
sg12
S'complement component 1, q subcomponent, B chain'
p3420
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00111_3816
p3421
sg16
VDaclizumab [drugbank:DB00111]
p3422
sg18
Vdrug-target interaction Daclizumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00111_3816]
p3423
sasS'ABL1'
p3424
(lp3425
(dp3426
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p3427
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00171
p3428
sg11
g3424
sg12
S'c-abl oncogene 1, non-receptor tyrosine kinase'
p3429
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00171_17
p3430
sg16
VAdenosine triphosphate [drugbank:DB00171]
p3431
sg18
Vdrug-target interaction Adenosine triphosphate and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB00171_17]
p3432
sa(dp3433
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p3434
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00619
p3435
sg11
g3424
sg12
S'c-abl oncogene 1, non-receptor tyrosine kinase'
p3436
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00619_17
p3437
sg16
VImatinib [drugbank:DB00619]
p3438
sg18
Vdrug-target interaction Imatinib and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB00619_17]
p3439
sa(dp3440
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p3441
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01254
p3442
sg11
g3424
sg12
S'c-abl oncogene 1, non-receptor tyrosine kinase'
p3443
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01254_17
p3444
sg16
VDasatinib [drugbank:DB01254]
p3445
sg18
Vdrug-target interaction Dasatinib and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB01254_17]
p3446
sa(dp3447
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p3448
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03878
p3449
sg11
g3424
sg12
S'c-abl oncogene 1, non-receptor tyrosine kinase'
p3450
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03878_17
p3451
sg16
VN-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide [drugbank:DB03878]
p3452
sg18
Vdrug-target interaction N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB03878_17]
p3453
sa(dp3454
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p3455
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04868
p3456
sg11
g3424
sg12
S'c-abl oncogene 1, non-receptor tyrosine kinase'
p3457
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04868_17
p3458
sg16
VNilotinib [drugbank:DB04868]
p3459
sg18
Vdrug-target interaction Nilotinib and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB04868_17]
p3460
sa(dp3461
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p3462
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07831
p3463
sg11
g3424
sg12
S'c-abl oncogene 1, non-receptor tyrosine kinase'
p3464
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07831_17
p3465
sg16
V2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE [drugbank:DB07831]
p3466
sg18
Vdrug-target interaction 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB07831_17]
p3467
sa(dp3468
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p3469
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08043
p3470
sg11
g3424
sg12
S'c-abl oncogene 1, non-receptor tyrosine kinase'
p3471
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08043_17
p3472
sg16
V1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA [drugbank:DB08043]
p3473
sg18
Vdrug-target interaction 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08043_17]
p3474
sa(dp3475
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p3476
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08339
p3477
sg11
g3424
sg12
S'c-abl oncogene 1, non-receptor tyrosine kinase'
p3478
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08339_17
p3479
sg16
V6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE [drugbank:DB08339]
p3480
sg18
Vdrug-target interaction 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08339_17]
p3481
sa(dp3482
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p3483
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08350
p3484
sg11
g3424
sg12
S'c-abl oncogene 1, non-receptor tyrosine kinase'
p3485
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08350_17
p3486
sg16
V5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE [drugbank:DB08350]
p3487
sg18
Vdrug-target interaction 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08350_17]
p3488
sa(dp3489
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p3490
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08583
p3491
sg11
g3424
sg12
S'c-abl oncogene 1, non-receptor tyrosine kinase'
p3492
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08583_17
p3493
sg16
V2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide [drugbank:DB08583]
p3494
sg18
Vdrug-target interaction 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08583_17]
p3495
sa(dp3496
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:17
p3497
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08231
p3498
sg11
g3424
sg12
S'c-abl oncogene 1, non-receptor tyrosine kinase'
p3499
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08231_17
p3500
sg16
VMYRISTIC ACID [drugbank:DB08231]
p3501
sg18
Vdrug-target interaction MYRISTIC ACID and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08231_17]
p3502
sasS'ITGB2'
p3503
(lp3504
(dp3505
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1630
p3506
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00641
p3507
sg11
g3503
sg12
S'integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)'
p3508
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00641_1630
p3509
sg16
VSimvastatin [drugbank:DB00641]
p3510
sg18
Vdrug-target interaction Simvastatin and Integrin beta-2 [drugbank_resource:DB00641_1630]
p3511
sasS'EDNRA'
p3512
(lp3513
(dp3514
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:578
p3515
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00559
p3516
sg11
g3512
sg12
S'endothelin receptor type A'
p3517
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00559_578
p3518
sg16
VBosentan [drugbank:DB00559]
p3519
sg18
Vdrug-target interaction Bosentan and Endothelin-1 receptor [drugbank_resource:DB00559_578]
p3520
sa(dp3521
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:578
p3522
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04674
p3523
sg11
g3512
sg12
S'endothelin receptor type A'
p3524
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04674_578
p3525
sg16
V2-HYDROXY-3,5-DIIODOBENZOIC ACID [drugbank:DB04674]
p3526
sg18
Vdrug-target interaction 2-HYDROXY-3,5-DIIODOBENZOIC ACID and Endothelin-1 receptor [drugbank_resource:DB04674_578]
p3527
sa(dp3528
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:578
p3529
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06268
p3530
sg11
g3512
sg12
S'endothelin receptor type A'
p3531
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06268_578
p3532
sg16
VSitaxentan [drugbank:DB06268]
p3533
sg18
Vdrug-target interaction Sitaxentan and Endothelin-1 receptor [drugbank_resource:DB06268_578]
p3534
sasS'GABBR2'
p3535
(lp3536
(dp3537
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4094
p3538
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00181
p3539
sg11
g3535
sg12
S'gamma-aminobutyric acid (GABA) B receptor, 2'
p3540
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00181_4094
p3541
sg16
VBaclofen [drugbank:DB00181]
p3542
sg18
Vdrug-target interaction Baclofen and Gamma-aminobutyric acid type B receptor, subunit 2 [drugbank_resource:DB00181_4094]
p3543
sasS'KIT'
p3544
(lp3545
(dp3546
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:504
p3547
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00398
p3548
sg11
g3544
sg12
S'v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog'
p3549
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00398_504
p3550
sg16
VSorafenib [drugbank:DB00398]
p3551
sg18
Vdrug-target interaction Sorafenib and Mast/stem cell growth factor receptor [drugbank_resource:DB00398_504]
p3552
sa(dp3553
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:504
p3554
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00619
p3555
sg11
g3544
sg12
S'v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog'
p3556
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00619_504
p3557
sg16
VImatinib [drugbank:DB00619]
p3558
sg18
Vdrug-target interaction Imatinib and Mast/stem cell growth factor receptor [drugbank_resource:DB00619_504]
p3559
sa(dp3560
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:504
p3561
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01254
p3562
sg11
g3544
sg12
S'v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog'
p3563
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01254_504
p3564
sg16
VDasatinib [drugbank:DB01254]
p3565
sg18
Vdrug-target interaction Dasatinib and Mast/stem cell growth factor receptor [drugbank_resource:DB01254_504]
p3566
sa(dp3567
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:504
p3568
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01268
p3569
sg11
g3544
sg12
S'v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog'
p3570
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01268_504
p3571
sg16
VSunitinib [drugbank:DB01268]
p3572
sg18
Vdrug-target interaction Sunitinib and Mast/stem cell growth factor receptor [drugbank_resource:DB01268_504]
p3573
sa(dp3574
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:504
p3575
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01962
p3576
sg11
g3544
sg12
S'v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog'
p3577
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01962_504
p3578
sg16
VPhosphonotyrosine [drugbank:DB01962]
p3579
sg18
Vdrug-target interaction Phosphonotyrosine and Mast/stem cell growth factor receptor [drugbank_resource:DB01962_504]
p3580
sa(dp3581
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:504
p3582
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p3583
sg11
g3544
sg12
S'v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog'
p3584
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_504
p3585
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p3586
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Mast/stem cell growth factor receptor [drugbank_resource:DB03431_504]
p3587
sa(dp3588
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:504
p3589
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04868
p3590
sg11
g3544
sg12
S'v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog'
p3591
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04868_504
p3592
sg16
VNilotinib [drugbank:DB04868]
p3593
sg18
Vdrug-target interaction Nilotinib and Mast/stem cell growth factor receptor [drugbank_resource:DB04868_504]
p3594
sasS'SERPINE1'
p3595
(lp3596
(dp3597
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:267
p3598
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00009
p3599
sg11
g3595
sg12
S'serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1'
p3600
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00009_267
p3601
sg16
VAlteplase [drugbank:DB00009]
p3602
sg18
Vdrug-target interaction Alteplase and Plasminogen activator inhibitor 1 [drugbank_resource:DB00009_267]
p3603
sa(dp3604
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:267
p3605
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00015
p3606
sg11
g3595
sg12
S'serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1'
p3607
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00015_267
p3608
sg16
VReteplase [drugbank:DB00015]
p3609
sg18
Vdrug-target interaction Reteplase and Plasminogen activator inhibitor 1 [drugbank_resource:DB00015_267]
p3610
sa(dp3611
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:267
p3612
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00197
p3613
sg11
g3595
sg12
S'serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1'
p3614
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00197_267
p3615
sg16
VTroglitazone [drugbank:DB00197]
p3616
sg18
Vdrug-target interaction Troglitazone and Plasminogen activator inhibitor 1 [drugbank_resource:DB00197_267]
p3617
sa(dp3618
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:267
p3619
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00029
p3620
sg11
g3595
sg12
S'serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1'
p3621
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00029_267
p3622
sg16
VAnistreplase [drugbank:DB00029]
p3623
sg18
Vdrug-target interaction Anistreplase and Plasminogen activator inhibitor 1 [drugbank_resource:DB00029_267]
p3624
sa(dp3625
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:267
p3626
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00013
p3627
sg11
g3595
sg12
S'serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1'
p3628
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00013_267
p3629
sg16
VUrokinase [drugbank:DB00013]
p3630
sg18
Vdrug-target interaction Urokinase and Plasminogen activator inhibitor 1 [drugbank_resource:DB00013_267]
p3631
sa(dp3632
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:267
p3633
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00031
p3634
sg11
g3595
sg12
S'serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1'
p3635
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00031_267
p3636
sg16
VTenecteplase [drugbank:DB00031]
p3637
sg18
Vdrug-target interaction Tenecteplase and Plasminogen activator inhibitor 1 [drugbank_resource:DB00031_267]
p3638
sa(dp3639
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:267
p3640
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00055
p3641
sg11
g3595
sg12
S'serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1'
p3642
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00055_267
p3643
sg16
VDrotrecogin alfa [drugbank:DB00055]
p3644
sg18
Vdrug-target interaction Drotrecogin alfa and Plasminogen activator inhibitor 1 [drugbank_resource:DB00055_267]
p3645
sasS'CHD1'
p3646
(lp3647
(dp3648
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:588
p3649
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00445
p3650
sg11
g3646
sg12
S'chromodomain helicase DNA binding protein 1'
p3651
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00445_588
p3652
sg16
VEpirubicin [drugbank:DB00445]
p3653
sg18
Vdrug-target interaction Epirubicin and Chromodomain-helicase-DNA-binding protein 1 [drugbank_resource:DB00445_588]
p3654
sasS'AHR'
p3655
(lp3656
(dp3657
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6220
p3658
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00393
p3659
sg11
g3655
sg12
S'aryl hydrocarbon receptor'
p3660
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00393_6220
p3661
sg16
VNimodipine [drugbank:DB00393]
p3662
sg18
Vdrug-target interaction Nimodipine and Aryl hydrocarbon receptor [drugbank_resource:DB00393_6220]
p3663
sa(dp3664
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6220
p3665
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00379
p3666
sg11
g3655
sg12
S'aryl hydrocarbon receptor'
p3667
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00379_6220
p3668
sg16
VMexiletine [drugbank:DB00379]
p3669
sg18
Vdrug-target interaction Mexiletine and Aryl hydrocarbon receptor [drugbank_resource:DB00379_6220]
p3670
sa(dp3671
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6220
p3672
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00499
p3673
sg11
g3655
sg12
S'aryl hydrocarbon receptor'
p3674
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00499_6220
p3675
sg16
VFlutamide [drugbank:DB00499]
p3676
sg18
Vdrug-target interaction Flutamide and Aryl hydrocarbon receptor [drugbank_resource:DB00499_6220]
p3677
sa(dp3678
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6220
p3679
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01076
p3680
sg11
g3655
sg12
S'aryl hydrocarbon receptor'
p3681
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01076_6220
p3682
sg16
VAtorvastatin [drugbank:DB01076]
p3683
sg18
Vdrug-target interaction Atorvastatin and Aryl hydrocarbon receptor [drugbank_resource:DB01076_6220]
p3684
sa(dp3685
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6220
p3686
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01097
p3687
sg11
g3655
sg12
S'aryl hydrocarbon receptor'
p3688
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01097_6220
p3689
sg16
VLeflunomide [drugbank:DB01097]
p3690
sg18
Vdrug-target interaction Leflunomide and Aryl hydrocarbon receptor [drugbank_resource:DB01097_6220]
p3691
sa(dp3692
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6220
p3693
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01404
p3694
sg11
g3655
sg12
S'aryl hydrocarbon receptor'
p3695
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01404_6220
p3696
sg16
VGinseng [drugbank:DB01404]
p3697
sg18
Vdrug-target interaction Ginseng and Aryl hydrocarbon receptor [drugbank_resource:DB01404_6220]
p3698
sasS'KRT8'
p3699
(lp3700
(dp3701
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3826
p3702
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00031
p3703
sg11
g3699
sg12
S'keratin 8'
p3704
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00031_3826
p3705
sg16
VTenecteplase [drugbank:DB00031]
p3706
sg18
Vdrug-target interaction Tenecteplase and Keratin, type II cytoskeletal 8 [drugbank_resource:DB00031_3826]
p3707
sasS'NEK2'
p3708
(lp3709
(dp3710
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6298
p3711
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07180
p3712
sg11
g3708
sg12
S'NIMA-related kinase 2'
p3713
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07180_6298
p3714
sg16
V5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE [drugbank:DB07180]
p3715
sg18
Vdrug-target interaction 5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE and Serine/threonine-protein kinase Nek2 [drugbank_resource:DB07180_6298]
p3716
sasS'HMOX1'
p3717
(lp3718
(dp3719
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:810
p3720
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00157
p3721
sg11
g3717
sg12
S'heme oxygenase (decycling) 1'
p3722
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00157_810
p3723
sg16
VNADH [drugbank:DB00157]
p3724
sg18
Vdrug-target interaction NADH and Heme oxygenase 1 [drugbank_resource:DB00157_810]
p3725
sa(dp3726
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:810
p3727
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02073
p3728
sg11
g3717
sg12
S'heme oxygenase (decycling) 1'
p3729
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02073_810
p3730
sg16
VBiliverdine Ix Alpha [drugbank:DB02073]
p3731
sg18
Vdrug-target interaction Biliverdine Ix Alpha and Heme oxygenase 1 [drugbank_resource:DB02073_810]
p3732
sa(dp3733
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:810
p3734
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01942
p3735
sg11
g3717
sg12
S'heme oxygenase (decycling) 1'
p3736
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01942_810
p3737
sg16
VFormic Acid [drugbank:DB01942]
p3738
sg18
Vdrug-target interaction Formic Acid and Heme oxygenase 1 [drugbank_resource:DB01942_810]
p3739
sa(dp3740
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:810
p3741
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02468
p3742
sg11
g3717
sg12
S'heme oxygenase (decycling) 1'
p3743
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02468_810
p3744
sg16
V12-Phenylheme [drugbank:DB02468]
p3745
sg18
Vdrug-target interaction 12-Phenylheme and Heme oxygenase 1 [drugbank_resource:DB02468_810]
p3746
sa(dp3747
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:810
p3748
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03014
p3749
sg11
g3717
sg12
S'heme oxygenase (decycling) 1'
p3750
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03014_810
p3751
sg16
VHeme [drugbank:DB03014]
p3752
sg18
Vdrug-target interaction Heme and Heme oxygenase 1 [drugbank_resource:DB03014_810]
p3753
sa(dp3754
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:810
p3755
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03906
p3756
sg11
g3717
sg12
S'heme oxygenase (decycling) 1'
p3757
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03906_810
p3758
sg16
V2-Phenylheme [drugbank:DB03906]
p3759
sg18
Vdrug-target interaction 2-Phenylheme and Heme oxygenase 1 [drugbank_resource:DB03906_810]
p3760
sa(dp3761
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:810
p3762
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04803
p3763
sg11
g3717
sg12
S'heme oxygenase (decycling) 1'
p3764
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04803_810
p3765
sg16
VVerdoheme [drugbank:DB04803]
p3766
sg18
Vdrug-target interaction Verdoheme and Heme oxygenase 1 [drugbank_resource:DB04803_810]
p3767
sa(dp3768
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:810
p3769
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06914
p3770
sg11
g3717
sg12
S'heme oxygenase (decycling) 1'
p3771
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06914_810
p3772
sg16
V1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE [drugbank:DB06914]
p3773
sg18
Vdrug-target interaction 1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE and Heme oxygenase 1 [drugbank_resource:DB06914_810]
p3774
sa(dp3775
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:810
p3776
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07342
p3777
sg11
g3717
sg12
S'heme oxygenase (decycling) 1'
p3778
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07342_810
p3779
sg16
V1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone [drugbank:DB07342]
p3780
sg18
Vdrug-target interaction 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone and Heme oxygenase 1 [drugbank_resource:DB07342_810]
p3781
sasS'JUN'
p3782
(lp3783
(dp3784
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1629
p3785
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00570
p3786
sg11
g3782
sg12
S'jun proto-oncogene'
p3787
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00570_1629
p3788
sg16
VVinblastine [drugbank:DB00570]
p3789
sg18
Vdrug-target interaction Vinblastine and Transcription factor AP-1 [drugbank_resource:DB00570_1629]
p3790
sa(dp3791
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1629
p3792
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01029
p3793
sg11
g3782
sg12
S'jun proto-oncogene'
p3794
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01029_1629
p3795
sg16
VIrbesartan [drugbank:DB01029]
p3796
sg18
Vdrug-target interaction Irbesartan and Transcription factor AP-1 [drugbank_resource:DB01029_1629]
p3797
sa(dp3798
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1629
p3799
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01169
p3800
sg11
g3782
sg12
S'jun proto-oncogene'
p3801
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01169_1629
p3802
sg16
VArsenic trioxide [drugbank:DB01169]
p3803
sg18
Vdrug-target interaction Arsenic trioxide and Transcription factor AP-1 [drugbank_resource:DB01169_1629]
p3804
sasS'KCNMA1'
p3805
(lp3806
(dp3807
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:610
p3808
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00228
p3809
sg11
g3805
sg12
S'potassium large conductance calcium-activated channel, subfamily M, alpha member 1'
p3810
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00228_610
p3811
sg16
VEnflurane [drugbank:DB00228]
p3812
sg18
Vdrug-target interaction Enflurane and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB00228_610]
p3813
sa(dp3814
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:610
p3815
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00436
p3816
sg11
g3805
sg12
S'potassium large conductance calcium-activated channel, subfamily M, alpha member 1'
p3817
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00436_610
p3818
sg16
VBendroflumethiazide [drugbank:DB00436]
p3819
sg18
Vdrug-target interaction Bendroflumethiazide and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB00436_610]
p3820
sa(dp3821
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:610
p3822
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00356
p3823
sg11
g3805
sg12
S'potassium large conductance calcium-activated channel, subfamily M, alpha member 1'
p3824
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00356_610
p3825
sg16
VChlorzoxazone [drugbank:DB00356]
p3826
sg18
Vdrug-target interaction Chlorzoxazone and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB00356_610]
p3827
sa(dp3828
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:610
p3829
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00999
p3830
sg11
g3805
sg12
S'potassium large conductance calcium-activated channel, subfamily M, alpha member 1'
p3831
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00999_610
p3832
sg16
VHydrochlorothiazide [drugbank:DB00999]
p3833
sg18
Vdrug-target interaction Hydrochlorothiazide and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB00999_610]
p3834
sa(dp3835
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:610
p3836
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01003
p3837
sg11
g3805
sg12
S'potassium large conductance calcium-activated channel, subfamily M, alpha member 1'
p3838
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01003_610
p3839
sg16
VCromoglicic acid [drugbank:DB01003]
p3840
sg18
Vdrug-target interaction Cromoglicic acid and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB01003_610]
p3841
sa(dp3842
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:610
p3843
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01110
p3844
sg11
g3805
sg12
S'potassium large conductance calcium-activated channel, subfamily M, alpha member 1'
p3845
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01110_610
p3846
sg16
VMiconazole [drugbank:DB01110]
p3847
sg18
Vdrug-target interaction Miconazole and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB01110_610]
p3848
sa(dp3849
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:610
p3850
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01159
p3851
sg11
g3805
sg12
S'potassium large conductance calcium-activated channel, subfamily M, alpha member 1'
p3852
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01159_610
p3853
sg16
VHalothane [drugbank:DB01159]
p3854
sg18
Vdrug-target interaction Halothane and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB01159_610]
p3855
sa(dp3856
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:610
p3857
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00774
p3858
sg11
g3805
sg12
S'potassium large conductance calcium-activated channel, subfamily M, alpha member 1'
p3859
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00774_610
p3860
sg16
VHydroflumethiazide [drugbank:DB00774]
p3861
sg18
Vdrug-target interaction Hydroflumethiazide and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB00774_610]
p3862
sa(dp3863
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:610
p3864
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01119
p3865
sg11
g3805
sg12
S'potassium large conductance calcium-activated channel, subfamily M, alpha member 1'
p3866
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01119_610
p3867
sg16
VDiazoxide [drugbank:DB01119]
p3868
sg18
Vdrug-target interaction Diazoxide and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB01119_610]
p3869
sasS'TTK'
p3870
(lp3871
(dp3872
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6293
p3873
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01782
p3874
sg11
g3870
sg12
S'TTK protein kinase'
p3875
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01782_6293
p3876
sg16
V2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One [drugbank:DB01782]
p3877
sg18
Vdrug-target interaction 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One and Dual specificity protein kinase TTK [drugbank_resource:DB01782_6293]
p3878
sasS'NID1'
p3879
(lp3880
(dp3881
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3834
p3882
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00013
p3883
sg11
g3879
sg12
S'nidogen 1'
p3884
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00013_3834
p3885
sg16
VUrokinase [drugbank:DB00013]
p3886
sg18
Vdrug-target interaction Urokinase and Nidogen-1 [drugbank_resource:DB00013_3834]
p3887
sasS'HLA-DQB1'
p3888
(lp3889
(dp3890
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6976
p3891
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00071
p3892
sg11
g3888
sg12
S'major histocompatibility complex, class II, DQ beta 1'
p3893
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00071_6976
p3894
sg16
VInsulin, porcine [drugbank:DB00071]
p3895
sg18
Vdrug-target interaction Insulin, porcine and HLA class II histocompatibility antigen, DQ beta 1 chain [drugbank_resource:DB00071_6976]
p3896
sasS'FECH'
p3897
(lp3898
(dp3899
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1591
p3900
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02659
p3901
sg11
g3897
sg12
S'ferrochelatase'
p3902
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02659_1591
p3903
sg16
VCholic Acid [drugbank:DB02659]
p3904
sg18
Vdrug-target interaction Cholic Acid and Ferrochelatase, mitochondrial [drugbank_resource:DB02659_1591]
p3905
sasS'HTR2C'
p3906
(lp3907
(dp3908
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p3909
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00246
p3910
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p3911
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00246_590
p3912
sg16
VZiprasidone [drugbank:DB00246]
p3913
sg18
Vdrug-target interaction Ziprasidone and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00246_590]
p3914
sa(dp3915
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p3916
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00247
p3917
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p3918
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00247_590
p3919
sg16
VMethysergide [drugbank:DB00247]
p3920
sg18
Vdrug-target interaction Methysergide and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00247_590]
p3921
sa(dp3922
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p3923
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00248
p3924
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p3925
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00248_590
p3926
sg16
VCabergoline [drugbank:DB00248]
p3927
sg18
Vdrug-target interaction Cabergoline and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00248_590]
p3928
sa(dp3929
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p3930
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00268
p3931
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p3932
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00268_590
p3933
sg16
VRopinirole [drugbank:DB00268]
p3934
sg18
Vdrug-target interaction Ropinirole and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00268_590]
p3935
sa(dp3936
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p3937
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00193
p3938
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p3939
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00193_590
p3940
sg16
VTramadol [drugbank:DB00193]
p3941
sg18
Vdrug-target interaction Tramadol and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00193_590]
p3942
sa(dp3943
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p3944
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00413
p3945
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p3946
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00413_590
p3947
sg16
VPramipexole [drugbank:DB00413]
p3948
sg18
Vdrug-target interaction Pramipexole and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00413_590]
p3949
sa(dp3950
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p3951
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00589
p3952
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p3953
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00589_590
p3954
sg16
VLisuride [drugbank:DB00589]
p3955
sg18
Vdrug-target interaction Lisuride and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00589_590]
p3956
sa(dp3957
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p3958
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00334
p3959
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p3960
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00334_590
p3961
sg16
VOlanzapine [drugbank:DB00334]
p3962
sg18
Vdrug-target interaction Olanzapine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00334_590]
p3963
sa(dp3964
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p3965
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00363
p3966
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p3967
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00363_590
p3968
sg16
VClozapine [drugbank:DB00363]
p3969
sg18
Vdrug-target interaction Clozapine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00363_590]
p3970
sa(dp3971
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p3972
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00408
p3973
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p3974
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00408_590
p3975
sg16
VLoxapine [drugbank:DB00408]
p3976
sg18
Vdrug-target interaction Loxapine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00408_590]
p3977
sa(dp3978
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p3979
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00574
p3980
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p3981
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00574_590
p3982
sg16
VFenfluramine [drugbank:DB00574]
p3983
sg18
Vdrug-target interaction Fenfluramine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00574_590]
p3984
sa(dp3985
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p3986
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00370
p3987
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p3988
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00370_590
p3989
sg16
VMirtazapine [drugbank:DB00370]
p3990
sg18
Vdrug-target interaction Mirtazapine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00370_590]
p3991
sa(dp3992
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p3993
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00420
p3994
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p3995
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00420_590
p3996
sg16
VPromazine [drugbank:DB00420]
p3997
sg18
Vdrug-target interaction Promazine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00420_590]
p3998
sa(dp3999
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4000
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00434
p4001
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4002
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00434_590
p4003
sg16
VCyproheptadine [drugbank:DB00434]
p4004
sg18
Vdrug-target interaction Cyproheptadine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00434_590]
p4005
sa(dp4006
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4007
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00656
p4008
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4009
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00656_590
p4010
sg16
VTrazodone [drugbank:DB00656]
p4011
sg18
Vdrug-target interaction Trazodone and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00656_590]
p4012
sa(dp4013
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4014
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00714
p4015
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4016
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00714_590
p4017
sg16
VApomorphine [drugbank:DB00714]
p4018
sg18
Vdrug-target interaction Apomorphine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00714_590]
p4019
sa(dp4020
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4021
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00734
p4022
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4023
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00734_590
p4024
sg16
VRisperidone [drugbank:DB00734]
p4025
sg18
Vdrug-target interaction Risperidone and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00734_590]
p4026
sa(dp4027
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4028
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00777
p4029
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00777_590
p4031
sg16
VPropiomazine [drugbank:DB00777]
p4032
sg18
Vdrug-target interaction Propiomazine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00777_590]
p4033
sa(dp4034
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4035
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01079
p4036
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4037
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01079_590
p4038
sg16
VTegaserod [drugbank:DB01079]
p4039
sg18
Vdrug-target interaction Tegaserod and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01079_590]
p4040
sa(dp4041
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4042
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00805
p4043
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4044
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00805_590
p4045
sg16
VMinaprine [drugbank:DB00805]
p4046
sg18
Vdrug-target interaction Minaprine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00805_590]
p4047
sa(dp4048
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4049
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01142
p4050
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4051
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01142_590
p4052
sg16
VDoxepin [drugbank:DB01142]
p4053
sg18
Vdrug-target interaction Doxepin and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01142_590]
p4054
sa(dp4055
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4056
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01149
p4057
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4058
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01149_590
p4059
sg16
VNefazodone [drugbank:DB01149]
p4060
sg18
Vdrug-target interaction Nefazodone and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01149_590]
p4061
sa(dp4062
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4063
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01224
p4064
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4065
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01224_590
p4066
sg16
VQuetiapine [drugbank:DB01224]
p4067
sg18
Vdrug-target interaction Quetiapine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01224_590]
p4068
sa(dp4069
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4070
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01238
p4071
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4072
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01238_590
p4073
sg16
VAripiprazole [drugbank:DB01238]
p4074
sg18
Vdrug-target interaction Aripiprazole and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01238_590]
p4075
sa(dp4076
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4077
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01239
p4078
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4079
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01239_590
p4080
sg16
VChlorprothixene [drugbank:DB01239]
p4081
sg18
Vdrug-target interaction Chlorprothixene and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01239_590]
p4082
sa(dp4083
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4084
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01267
p4085
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4086
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01267_590
p4087
sg16
VPaliperidone [drugbank:DB01267]
p4088
sg18
Vdrug-target interaction Paliperidone and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01267_590]
p4089
sa(dp4090
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4091
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01454
p4092
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4093
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01454_590
p4094
sg16
V3,4-Methylenedioxymethamphetamine [drugbank:DB01454]
p4095
sg18
Vdrug-target interaction 3,4-Methylenedioxymethamphetamine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01454_590]
p4096
sa(dp4097
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4098
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01191
p4099
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4100
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01191_590
p4101
sg16
VDexfenfluramine [drugbank:DB01191]
p4102
sg18
Vdrug-target interaction Dexfenfluramine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01191_590]
p4103
sa(dp4104
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4105
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01242
p4106
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4107
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01242_590
p4108
sg16
VClomipramine [drugbank:DB01242]
p4109
sg18
Vdrug-target interaction Clomipramine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01242_590]
p4110
sa(dp4111
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4112
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01392
p4113
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4114
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01392_590
p4115
sg16
VYohimbine [drugbank:DB01392]
p4116
sg18
Vdrug-target interaction Yohimbine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01392_590]
p4117
sa(dp4118
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4119
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01186
p4120
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4121
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01186_590
p4122
sg16
VPergolide [drugbank:DB01186]
p4123
sg18
Vdrug-target interaction Pergolide and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01186_590]
p4124
sa(dp4125
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4126
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01200
p4127
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4128
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01200_590
p4129
sg16
VBromocriptine [drugbank:DB01200]
p4130
sg18
Vdrug-target interaction Bromocriptine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01200_590]
p4131
sa(dp4132
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4133
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01403
p4134
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4135
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01403_590
p4136
sg16
VMethotrimeprazine [drugbank:DB01403]
p4137
sg18
Vdrug-target interaction Methotrimeprazine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01403_590]
p4138
sa(dp4139
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4140
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06148
p4141
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4142
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06148_590
p4143
sg16
VMianserin [drugbank:DB06148]
p4144
sg18
Vdrug-target interaction Mianserin and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB06148_590]
p4145
sa(dp4146
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4147
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06594
p4148
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4149
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06594_590
p4150
sg16
VAgomelatine [drugbank:DB06594]
p4151
sg18
Vdrug-target interaction Agomelatine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB06594_590]
p4152
sa(dp4153
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:590
p4154
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06144
p4155
sg11
g3906
sg12
S'5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled'
p4156
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06144_590
p4157
sg16
VSertindole [drugbank:DB06144]
p4158
sg18
Vdrug-target interaction Sertindole and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB06144_590]
p4159
sasS'JAK1'
p4160
(lp4161
(dp4162
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6649
p4163
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04716
p4164
sg11
g4160
sg12
S'Janus kinase 1'
p4165
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04716_6649
p4166
sg16
V2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE [drugbank:DB04716]
p4167
sg18
Vdrug-target interaction 2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE and Tyrosine-protein kinase JAK1 [drugbank_resource:DB04716_6649]
p4168
sa(dp4169
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6649
p4170
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08183
p4171
sg11
g4160
sg12
S'Janus kinase 1'
p4172
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08183_6649
p4173
sg16
V3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile [drugbank:DB08183]
p4174
sg18
Vdrug-target interaction 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile and Tyrosine-protein kinase JAK1 [drugbank_resource:DB08183_6649]
p4175
sasS'NR1H4'
p4176
(lp4177
(dp4178
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3233
p4179
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02545
p4180
sg11
g4176
sg12
S'nuclear receptor subfamily 1, group H, member 4'
p4181
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02545_3233
p4182
sg16
VFexaramine [drugbank:DB02545]
p4183
sg18
Vdrug-target interaction Fexaramine and Bile acid receptor [drugbank_resource:DB02545_3233]
p4184
sa(dp4185
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3233
p4186
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06777
p4187
sg11
g4176
sg12
S'nuclear receptor subfamily 1, group H, member 4'
p4188
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06777_3233
p4189
sg16
VChenodeoxycholic acid [drugbank:DB06777]
p4190
sg18
Vdrug-target interaction Chenodeoxycholic acid and Bile acid receptor [drugbank_resource:DB06777_3233]
p4191
sa(dp4192
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3233
p4193
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08220
p4194
sg11
g4176
sg12
S'nuclear receptor subfamily 1, group H, member 4'
p4195
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08220_3233
p4196
sg16
V(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid [drugbank:DB08220]
p4197
sg18
Vdrug-target interaction (8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid and Bile acid receptor [drugbank_resource:DB08220_3233]
p4198
sasS'COL1A2'
p4199
(lp4200
(dp4201
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3864
p4202
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00048
p4203
sg11
g4199
sg12
S'collagen, type I, alpha 2'
p4204
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00048_3864
p4205
sg16
VCollagenase [drugbank:DB00048]
p4206
sg18
Vdrug-target interaction Collagenase and Collagen alpha-2(I) chain [drugbank_resource:DB00048_3864]
p4207
sasS'NLK'
p4208
(lp4209
(dp4210
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2206
p4211
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02007
p4212
sg11
S'GPI'
p4213
sg12
S'glucose-6-phosphate isomerase'
p4214
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02007_2206
p4215
sg16
VAlpha-D-Glucose-6-Phosphate [drugbank:DB02007]
p4216
sg18
Vdrug-target interaction Alpha-D-Glucose-6-Phosphate and Glucose-6-phosphate isomerase [drugbank_resource:DB02007_2206]
p4217
sa(dp4218
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2206
p4219
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02076
p4220
sg11
g4213
sg12
g4214
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02076_2206
p4221
sg16
V6-Phosphogluconic Acid [drugbank:DB02076]
p4222
sg18
Vdrug-target interaction 6-Phosphogluconic Acid and Glucose-6-phosphate isomerase [drugbank_resource:DB02076_2206]
p4223
sa(dp4224
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2206
p4225
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02093
p4226
sg11
g4213
sg12
g4214
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02093_2206
p4227
sg16
V5-Phospho-D-Arabinohydroxamic Acid [drugbank:DB02093]
p4228
sg18
Vdrug-target interaction 5-Phospho-D-Arabinohydroxamic Acid and Glucose-6-phosphate isomerase [drugbank_resource:DB02093_2206]
p4229
sa(dp4230
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2206
p4231
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02548
p4232
sg11
g4213
sg12
g4214
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02548_2206
p4233
sg16
VSorbitol 6-phosphate [drugbank:DB02548]
p4234
sg18
Vdrug-target interaction Sorbitol 6-phosphate and Glucose-6-phosphate isomerase [drugbank_resource:DB02548_2206]
p4235
sa(dp4236
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2206
p4237
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03042
p4238
sg11
g4213
sg12
g4214
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03042_2206
p4239
sg16
V5-Phosphoarabinonic Acid [drugbank:DB03042]
p4240
sg18
Vdrug-target interaction 5-Phosphoarabinonic Acid and Glucose-6-phosphate isomerase [drugbank_resource:DB03042_2206]
p4241
sa(dp4242
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2206
p4243
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03581
p4244
sg11
g4213
sg12
g4214
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03581_2206
p4245
sg16
VGlucose-6-Phosphate [drugbank:DB03581]
p4246
sg18
Vdrug-target interaction Glucose-6-Phosphate and Glucose-6-phosphate isomerase [drugbank_resource:DB03581_2206]
p4247
sa(dp4248
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2206
p4249
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03937
p4250
sg11
g4213
sg12
g4214
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03937_2206
p4251
sg16
VErythose-4-Phosphate [drugbank:DB03937]
p4252
sg18
Vdrug-target interaction Erythose-4-Phosphate and Glucose-6-phosphate isomerase [drugbank_resource:DB03937_2206]
p4253
sa(dp4254
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2206
p4255
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04493
p4256
sg11
g4213
sg12
g4214
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04493_2206
p4257
sg16
VFructose-6-Phosphate [drugbank:DB04493]
p4258
sg18
Vdrug-target interaction Fructose-6-Phosphate and Glucose-6-phosphate isomerase [drugbank_resource:DB04493_2206]
p4259
sasS'GRM7'
p4260
(lp4261
(dp4262
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:926
p4263
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p4264
sg11
g4260
sg12
S'glutamate receptor, metabotropic 7'
p4265
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_926
p4266
sg16
VL-Glutamic Acid [drugbank:DB00142]
p4267
sg18
Vdrug-target interaction L-Glutamic Acid and Metabotropic glutamate receptor 7 [drugbank_resource:DB00142_926]
p4268
sasS'NR1H2'
p4269
(lp4270
(dp4271
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2907
p4272
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03791
p4273
sg11
g4269
sg12
S'nuclear receptor subfamily 1, group H, member 2'
p4274
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03791_2907
p4275
sg16
V(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid [drugbank:DB03791]
p4276
sg18
Vdrug-target interaction (3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid and Oxysterols receptor LXR-beta [drugbank_resource:DB03791_2907]
p4277
sa(dp4278
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2907
p4279
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03848
p4280
sg11
g4269
sg12
S'nuclear receptor subfamily 1, group H, member 2'
p4281
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03848_2907
p4282
sg16
VBenzenesulfonyl [drugbank:DB03848]
p4283
sg18
Vdrug-target interaction Benzenesulfonyl and Oxysterols receptor LXR-beta [drugbank_resource:DB03848_2907]
p4284
sa(dp4285
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2907
p4286
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07080
p4287
sg11
g4269
sg12
S'nuclear receptor subfamily 1, group H, member 2'
p4288
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07080_2907
p4289
sg16
VN-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE [drugbank:DB07080]
p4290
sg18
Vdrug-target interaction N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE and Oxysterols receptor LXR-beta [drugbank_resource:DB07080_2907]
p4291
sa(dp4292
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2907
p4293
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07082
p4294
sg11
g4269
sg12
S'nuclear receptor subfamily 1, group H, member 2'
p4295
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07082_2907
p4296
sg16
V1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL [drugbank:DB07082]
p4297
sg18
Vdrug-target interaction 1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL and Oxysterols receptor LXR-beta [drugbank_resource:DB07082_2907]
p4298
sasS'CHEK1'
p4299
(lp4300
(dp4301
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4302
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06876
p4303
sg11
g4299
sg12
S'checkpoint kinase 1'
p4304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06876_5790
p4305
sg16
VN-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE [drugbank:DB06876]
p4306
sg18
Vdrug-target interaction N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB06876_5790]
p4307
sa(dp4308
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4309
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07037
p4310
sg11
g4299
sg12
S'checkpoint kinase 1'
p4311
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07037_5790
p4312
sg16
V(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL [drugbank:DB07037]
p4313
sg18
Vdrug-target interaction (2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07037_5790]
p4314
sa(dp4315
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4316
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07038
p4317
sg11
g4299
sg12
S'checkpoint kinase 1'
p4318
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07038_5790
p4319
sg16
V2-(cyclohexylamino)benzoic acid [drugbank:DB07038]
p4320
sg18
Vdrug-target interaction 2-(cyclohexylamino)benzoic acid and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07038_5790]
p4321
sa(dp4322
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4323
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07228
p4324
sg11
g4299
sg12
S'checkpoint kinase 1'
p4325
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07228_5790
p4326
sg16
V1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA [drugbank:DB07228]
p4327
sg18
Vdrug-target interaction 1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07228_5790]
p4328
sa(dp4329
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4330
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07025
p4331
sg11
g4299
sg12
S'checkpoint kinase 1'
p4332
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07025_5790
p4333
sg16
V3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE [drugbank:DB07025]
p4334
sg18
Vdrug-target interaction 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07025_5790]
p4335
sa(dp4336
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4337
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07213
p4338
sg11
g4299
sg12
S'checkpoint kinase 1'
p4339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07213_5790
p4340
sg16
V(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL [drugbank:DB07213]
p4341
sg18
Vdrug-target interaction (5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07213_5790]
p4342
sa(dp4343
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4344
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07243
p4345
sg11
g4299
sg12
S'checkpoint kinase 1'
p4346
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07243_5790
p4347
sg16
V(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE [drugbank:DB07243]
p4348
sg18
Vdrug-target interaction (3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07243_5790]
p4349
sa(dp4350
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4351
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07314
p4352
sg11
g4299
sg12
S'checkpoint kinase 1'
p4353
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07314_5790
p4354
sg16
V1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA [drugbank:DB07314]
p4355
sg18
Vdrug-target interaction 1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07314_5790]
p4356
sa(dp4357
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4358
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06852
p4359
sg11
g4299
sg12
S'checkpoint kinase 1'
p4360
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06852_5790
p4361
sg16
V4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE [drugbank:DB06852]
p4362
sg18
Vdrug-target interaction 4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB06852_5790]
p4363
sa(dp4364
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4365
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07034
p4366
sg11
g4299
sg12
S'checkpoint kinase 1'
p4367
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07034_5790
p4368
sg16
V2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID [drugbank:DB07034]
p4369
sg18
Vdrug-target interaction 2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07034_5790]
p4370
sa(dp4371
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4372
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07075
p4373
sg11
g4299
sg12
S'checkpoint kinase 1'
p4374
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07075_5790
p4375
sg16
V3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE [drugbank:DB07075]
p4376
sg18
Vdrug-target interaction 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07075_5790]
p4377
sa(dp4378
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4379
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07078
p4380
sg11
g4299
sg12
S'checkpoint kinase 1'
p4381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07078_5790
p4382
sg16
V(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE [drugbank:DB07078]
p4383
sg18
Vdrug-target interaction (3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07078_5790]
p4384
sa(dp4385
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4386
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07158
p4387
sg11
g4299
sg12
S'checkpoint kinase 1'
p4388
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07158_5790
p4389
sg16
V5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE [drugbank:DB07158]
p4390
sg18
Vdrug-target interaction 5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07158_5790]
p4391
sa(dp4392
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4393
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07311
p4394
sg11
g4299
sg12
S'checkpoint kinase 1'
p4395
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07311_5790
p4396
sg16
V18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE [drugbank:DB07311]
p4397
sg18
Vdrug-target interaction 18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07311_5790]
p4398
sa(dp4399
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4400
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07320
p4401
sg11
g4299
sg12
S'checkpoint kinase 1'
p4402
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07320_5790
p4403
sg16
V4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID [drugbank:DB07320]
p4404
sg18
Vdrug-target interaction 4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07320_5790]
p4405
sa(dp4406
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4407
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07336
p4408
sg11
g4299
sg12
S'checkpoint kinase 1'
p4409
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07336_5790
p4410
sg16
V4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL [drugbank:DB07336]
p4411
sg18
Vdrug-target interaction 4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07336_5790]
p4412
sa(dp4413
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4414
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07653
p4415
sg11
g4299
sg12
S'checkpoint kinase 1'
p4416
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07653_5790
p4417
sg16
VN-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE [drugbank:DB07653]
p4418
sg18
Vdrug-target interaction N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07653_5790]
p4419
sa(dp4420
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4421
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08392
p4422
sg11
g4299
sg12
S'checkpoint kinase 1'
p4423
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08392_5790
p4424
sg16
V2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL [drugbank:DB08392]
p4425
sg18
Vdrug-target interaction 2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08392_5790]
p4426
sa(dp4427
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4428
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08393
p4429
sg11
g4299
sg12
S'checkpoint kinase 1'
p4430
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08393_5790
p4431
sg16
V2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL [drugbank:DB08393]
p4432
sg18
Vdrug-target interaction 2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08393_5790]
p4433
sa(dp4434
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4435
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07647
p4436
sg11
g4299
sg12
S'checkpoint kinase 1'
p4437
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07647_5790
p4438
sg16
V(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL [drugbank:DB07647]
p4439
sg18
Vdrug-target interaction (2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07647_5790]
p4440
sa(dp4441
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4442
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07648
p4443
sg11
g4299
sg12
S'checkpoint kinase 1'
p4444
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07648_5790
p4445
sg16
V(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL [drugbank:DB07648]
p4446
sg18
Vdrug-target interaction (2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07648_5790]
p4447
sa(dp4448
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4449
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07654
p4450
sg11
g4299
sg12
S'checkpoint kinase 1'
p4451
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07654_5790
p4452
sg16
V(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC [drugbank:DB07654]
p4453
sg18
Vdrug-target interaction (5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07654_5790]
p4454
sa(dp4455
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4456
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08774
p4457
sg11
g4299
sg12
S'checkpoint kinase 1'
p4458
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08774_5790
p4459
sg16
V1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine [drugbank:DB08774]
p4460
sg18
Vdrug-target interaction 1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08774_5790]
p4461
sa(dp4462
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4463
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07655
p4464
sg11
g4299
sg12
S'checkpoint kinase 1'
p4465
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07655_5790
p4466
sg16
V3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE [drugbank:DB07655]
p4467
sg18
Vdrug-target interaction 3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07655_5790]
p4468
sa(dp4469
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4470
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07959
p4471
sg11
g4299
sg12
S'checkpoint kinase 1'
p4472
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07959_5790
p4473
sg16
V3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE [drugbank:DB07959]
p4474
sg18
Vdrug-target interaction 3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07959_5790]
p4475
sa(dp4476
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4477
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08683
p4478
sg11
g4299
sg12
S'checkpoint kinase 1'
p4479
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08683_5790
p4480
sg16
VREL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE [drugbank:DB08683]
p4481
sg18
Vdrug-target interaction REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08683_5790]
p4482
sa(dp4483
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4484
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08776
p4485
sg11
g4299
sg12
S'checkpoint kinase 1'
p4486
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08776_5790
p4487
sg16
VN-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE [drugbank:DB08776]
p4488
sg18
Vdrug-target interaction N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08776_5790]
p4489
sa(dp4490
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4491
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08777
p4492
sg11
g4299
sg12
S'checkpoint kinase 1'
p4493
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08777_5790
p4494
sg16
V5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE [drugbank:DB08777]
p4495
sg18
Vdrug-target interaction 5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08777_5790]
p4496
sa(dp4497
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4498
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08780
p4499
sg11
g4299
sg12
S'checkpoint kinase 1'
p4500
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08780_5790
p4501
sg16
V6-MORPHOLIN-4-YL-9H-PURINE [drugbank:DB08780]
p4502
sg18
Vdrug-target interaction 6-MORPHOLIN-4-YL-9H-PURINE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08780_5790]
p4503
sa(dp4504
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4505
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08778
p4506
sg11
g4299
sg12
S'checkpoint kinase 1'
p4507
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08778_5790
p4508
sg16
V[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone [drugbank:DB08778]
p4509
sg18
Vdrug-target interaction [4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08778_5790]
p4510
sa(dp4511
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4512
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08779
p4513
sg11
g4299
sg12
S'checkpoint kinase 1'
p4514
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08779_5790
p4515
sg16
V2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol [drugbank:DB08779]
p4516
sg18
Vdrug-target interaction 2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08779_5790]
p4517
sa(dp4518
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5790
p4519
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08781
p4520
sg11
g4299
sg12
S'checkpoint kinase 1'
p4521
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08781_5790
p4522
sg16
V1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE [drugbank:DB08781]
p4523
sg18
Vdrug-target interaction 1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08781_5790]
p4524
sasS'SLC12A5'
p4525
(lp4526
(dp4527
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:53
p4528
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00761
p4529
sg11
g4525
sg12
S'solute carrier family 12 (potassium/chloride transporter), member 5'
p4530
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00761_53
p4531
sg16
VPotassium Chloride [drugbank:DB00761]
p4532
sg18
Vdrug-target interaction Potassium Chloride and Solute carrier family 12 member 5 [drugbank_resource:DB00761_53]
p4533
sa(dp4534
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:53
p4535
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00887
p4536
sg11
g4525
sg12
S'solute carrier family 12 (potassium/chloride transporter), member 5'
p4537
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00887_53
p4538
sg16
VBumetanide [drugbank:DB00887]
p4539
sg18
Vdrug-target interaction Bumetanide and Solute carrier family 12 member 5 [drugbank_resource:DB00887_53]
p4540
sasS'FOS'
p4541
(lp4542
(dp4543
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1953
p4544
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08813
p4545
sg11
g4541
sg12
S'FBJ murine osteosarcoma viral oncogene homolog'
p4546
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08813_1953
p4547
sg16
VNadroparin [drugbank:DB08813]
p4548
sg18
Vdrug-target interaction Nadroparin and Proto-oncogene protein c-fos [drugbank_resource:DB08813_1953]
p4549
sasS'CDC25B'
p4550
(lp4551
(dp4552
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3105
p4553
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01769
p4554
sg11
g4550
sg12
S'cell division cycle 25B'
p4555
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01769_3105
p4556
sg16
VDouble Oxidized Cysteine [drugbank:DB01769]
p4557
sg18
Vdrug-target interaction Double Oxidized Cysteine and M-phase inducer phosphatase 2 [drugbank_resource:DB01769_3105]
p4558
sa(dp4559
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3105
p4560
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03661
p4561
sg11
g4550
sg12
S'cell division cycle 25B'
p4562
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03661_3105
p4563
sg16
VCysteinesulfonic Acid [drugbank:DB03661]
p4564
sg18
Vdrug-target interaction Cysteinesulfonic Acid and M-phase inducer phosphatase 2 [drugbank_resource:DB03661_3105]
p4565
sa(dp4566
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3105
p4567
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03674
p4568
sg11
g4550
sg12
S'cell division cycle 25B'
p4569
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03674_3105
p4570
sg16
VMethyl Mercury Ion [drugbank:DB03674]
p4571
sg18
Vdrug-target interaction Methyl Mercury Ion and M-phase inducer phosphatase 2 [drugbank_resource:DB03674_3105]
p4572
sasS'CDK7'
p4573
(lp4574
(dp4575
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3482
p4576
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02482
p4577
sg11
g4573
sg12
S'cyclin-dependent kinase 7'
p4578
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02482_3482
p4579
sg16
VPhosphonothreonine [drugbank:DB02482]
p4580
sg18
Vdrug-target interaction Phosphonothreonine and Cell division protein kinase 7 [drugbank_resource:DB02482_3482]
p4581
sa(dp4582
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3482
p4583
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p4584
sg11
g4573
sg12
S'cyclin-dependent kinase 7'
p4585
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_3482
p4586
sg16
VFlavopiridol [drugbank:DB03496]
p4587
sg18
Vdrug-target interaction Flavopiridol and Cell division protein kinase 7 [drugbank_resource:DB03496_3482]
p4588
sasS'PARP1'
p4589
(lp4590
(dp4591
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p4592
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02690
p4593
sg11
g4589
sg12
S'poly (ADP-ribose) polymerase 1'
p4594
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02690_3126
p4595
sg16
VNU1025 [drugbank:DB02690]
p4596
sg18
Vdrug-target interaction NU1025 and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB02690_3126]
p4597
sa(dp4598
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p4599
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02498
p4600
sg11
g4589
sg12
S'poly (ADP-ribose) polymerase 1'
p4601
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02498_3126
p4602
sg16
VCarba-Nicotinamide-Adenine-Dinucleotide [drugbank:DB02498]
p4603
sg18
Vdrug-target interaction Carba-Nicotinamide-Adenine-Dinucleotide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB02498_3126]
p4604
sa(dp4605
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p4606
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02701
p4607
sg11
g4589
sg12
S'poly (ADP-ribose) polymerase 1'
p4608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02701_3126
p4609
sg16
VNicotinamide [drugbank:DB02701]
p4610
sg18
Vdrug-target interaction Nicotinamide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB02701_3126]
p4611
sa(dp4612
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p4613
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03072
p4614
sg11
g4589
sg12
S'poly (ADP-ribose) polymerase 1'
p4615
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03072_3126
p4616
sg16
V2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone [drugbank:DB03072]
p4617
sg18
Vdrug-target interaction 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB03072_3126]
p4618
sa(dp4619
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p4620
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03073
p4621
sg11
g4589
sg12
S'poly (ADP-ribose) polymerase 1'
p4622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03073_3126
p4623
sg16
V3-Methoxybenzamide [drugbank:DB03073]
p4624
sg18
Vdrug-target interaction 3-Methoxybenzamide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB03073_3126]
p4625
sa(dp4626
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p4627
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03722
p4628
sg11
g4589
sg12
S'poly (ADP-ribose) polymerase 1'
p4629
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03722_3126
p4630
sg16
V3,4-Dihydro-5-Methyl-Isoquinolinone [drugbank:DB03722]
p4631
sg18
Vdrug-target interaction 3,4-Dihydro-5-Methyl-Isoquinolinone and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB03722_3126]
p4632
sa(dp4633
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p4634
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03509
p4635
sg11
g4589
sg12
S'poly (ADP-ribose) polymerase 1'
p4636
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03509_3126
p4637
sg16
V2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide [drugbank:DB03509]
p4638
sg18
Vdrug-target interaction 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB03509_3126]
p4639
sa(dp4640
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p4641
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04010
p4642
sg11
g4589
sg12
S'poly (ADP-ribose) polymerase 1'
p4643
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04010_3126
p4644
sg16
V2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide [drugbank:DB04010]
p4645
sg18
Vdrug-target interaction 2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB04010_3126]
p4646
sa(dp4647
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p4648
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07096
p4649
sg11
g4589
sg12
S'poly (ADP-ribose) polymerase 1'
p4650
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07096_3126
p4651
sg16
V6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE [drugbank:DB07096]
p4652
sg18
Vdrug-target interaction 6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB07096_3126]
p4653
sa(dp4654
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p4655
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07232
p4656
sg11
g4589
sg12
S'poly (ADP-ribose) polymerase 1'
p4657
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07232_3126
p4658
sg16
V(2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium [drugbank:DB07232]
p4659
sg18
Vdrug-target interaction (2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB07232_3126]
p4660
sa(dp4661
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p4662
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07330
p4663
sg11
g4589
sg12
S'poly (ADP-ribose) polymerase 1'
p4664
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07330_3126
p4665
sg16
Vtrans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium [drugbank:DB07330]
p4666
sg18
Vdrug-target interaction trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB07330_3126]
p4667
sa(dp4668
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3126
p4669
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07787
p4670
sg11
g4589
sg12
S'poly (ADP-ribose) polymerase 1'
p4671
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07787_3126
p4672
sg16
V5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE [drugbank:DB07787]
p4673
sg18
Vdrug-target interaction 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB07787_3126]
p4674
sasS'HIF1A'
p4675
(lp4676
(dp4677
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4130
p4678
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08687
p4679
sg11
g4675
sg12
S'hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)'
p4680
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08687_4130
p4681
sg16
VN-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE [drugbank:DB08687]
p4682
sg18
Vdrug-target interaction N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE and Hypoxia-inducible factor 1 alpha [drugbank_resource:DB08687_4130]
p4683
sasS'GLRB'
p4684
(lp4685
(dp4686
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:62
p4687
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00145
p4688
sg11
g4684
sg12
S'glycine receptor, beta'
p4689
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00145_62
p4690
sg16
VGlycine [drugbank:DB00145]
p4691
sg18
Vdrug-target interaction Glycine and Glycine receptor subunit beta [drugbank_resource:DB00145_62]
p4692
sa(dp4693
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:62
p4694
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00431
p4695
sg11
g4684
sg12
S'glycine receptor, beta'
p4696
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00431_62
p4697
sg16
VLindane [drugbank:DB00431]
p4698
sg18
Vdrug-target interaction Lindane and Glycine receptor subunit beta [drugbank_resource:DB00431_62]
p4699
sasS'IGFBP3'
p4700
(lp4701
(dp4702
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1350
p4703
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01277
p4704
sg11
g4700
sg12
S'insulin-like growth factor binding protein 3'
p4705
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01277_1350
p4706
sg16
VMecasermin [drugbank:DB01277]
p4707
sg18
Vdrug-target interaction Mecasermin and Insulin-like growth factor-binding protein 3 [drugbank_resource:DB01277_1350]
p4708
sasS'VEGFA'
p4709
(lp4710
(dp4711
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:183
p4712
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00112
p4713
sg11
g4709
sg12
S'vascular endothelial growth factor A'
p4714
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00112_183
p4715
sg16
VBevacizumab [drugbank:DB00112]
p4716
sg18
Vdrug-target interaction Bevacizumab and Vascular endothelial growth factor A [drugbank_resource:DB00112_183]
p4717
sa(dp4718
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:183
p4719
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01017
p4720
sg11
g4709
sg12
S'vascular endothelial growth factor A'
p4721
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01017_183
p4722
sg16
VMinocycline [drugbank:DB01017]
p4723
sg18
Vdrug-target interaction Minocycline and Vascular endothelial growth factor A [drugbank_resource:DB01017_183]
p4724
sa(dp4725
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:183
p4726
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01120
p4727
sg11
g4709
sg12
S'vascular endothelial growth factor A'
p4728
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01120_183
p4729
sg16
VGliclazide [drugbank:DB01120]
p4730
sg18
Vdrug-target interaction Gliclazide and Vascular endothelial growth factor A [drugbank_resource:DB01120_183]
p4731
sa(dp4732
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:183
p4733
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01136
p4734
sg11
g4709
sg12
S'vascular endothelial growth factor A'
p4735
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01136_183
p4736
sg16
VCarvedilol [drugbank:DB01136]
p4737
sg18
Vdrug-target interaction Carvedilol and Vascular endothelial growth factor A [drugbank_resource:DB01136_183]
p4738
sa(dp4739
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:183
p4740
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01270
p4741
sg11
g4709
sg12
S'vascular endothelial growth factor A'
p4742
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01270_183
p4743
sg16
VRanibizumab [drugbank:DB01270]
p4744
sg18
Vdrug-target interaction Ranibizumab and Vascular endothelial growth factor A [drugbank_resource:DB01270_183]
p4745
sa(dp4746
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:183
p4747
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03088
p4748
sg11
g4709
sg12
S'vascular endothelial growth factor A'
p4749
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03088_183
p4750
sg16
VPyroglutamic Acid [drugbank:DB03088]
p4751
sg18
Vdrug-target interaction Pyroglutamic Acid and Vascular endothelial growth factor A [drugbank_resource:DB03088_183]
p4752
sa(dp4753
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:183
p4754
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03754
p4755
sg11
g4709
sg12
S'vascular endothelial growth factor A'
p4756
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03754_183
p4757
sg16
VTris(Hydroxymethyl)Aminomethane [drugbank:DB03754]
p4758
sg18
Vdrug-target interaction Tris(Hydroxymethyl)Aminomethane and Vascular endothelial growth factor A [drugbank_resource:DB03754_183]
p4759
sa(dp4760
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:183
p4761
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06779
p4762
sg11
g4709
sg12
S'vascular endothelial growth factor A'
p4763
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06779_183
p4764
sg16
VDalteparin [drugbank:DB06779]
p4765
sg18
Vdrug-target interaction Dalteparin and Vascular endothelial growth factor A [drugbank_resource:DB06779_183]
p4766
sasS'PLAU'
p4767
(lp4768
(dp4769
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4770
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00013
p4771
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4772
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00013_1074
p4773
sg16
VUrokinase [drugbank:DB00013]
p4774
sg18
Vdrug-target interaction Urokinase and Urokinase-type plasminogen activator [drugbank_resource:DB00013_1074]
p4775
sa(dp4776
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4777
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00594
p4778
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4779
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00594_1074
p4780
sg16
VAmiloride [drugbank:DB00594]
p4781
sg18
Vdrug-target interaction Amiloride and Urokinase-type plasminogen activator [drugbank_resource:DB00594_1074]
p4782
sa(dp4783
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4784
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01905
p4785
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4786
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01905_1074
p4787
sg16
V2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine [drugbank:DB01905]
p4788
sg18
Vdrug-target interaction 2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB01905_1074]
p4789
sa(dp4790
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4791
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01977
p4792
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4793
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01977_1074
p4794
sg16
V6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine [drugbank:DB01977]
p4795
sg18
Vdrug-target interaction 6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB01977_1074]
p4796
sa(dp4797
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4798
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02526
p4799
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4800
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02526_1074
p4801
sg16
VCRA_10655 [drugbank:DB02526]
p4802
sg18
Vdrug-target interaction CRA_10655 and Urokinase-type plasminogen activator [drugbank_resource:DB02526_1074]
p4803
sa(dp4804
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4805
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02551
p4806
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4807
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02551_1074
p4808
sg16
V6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine [drugbank:DB02551]
p4809
sg18
Vdrug-target interaction 6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02551_1074]
p4810
sa(dp4811
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4812
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02193
p4813
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4814
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02193_1074
p4815
sg16
V2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine [drugbank:DB02193]
p4816
sg18
Vdrug-target interaction 2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02193_1074]
p4817
sa(dp4818
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4819
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02705
p4820
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4821
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02705_1074
p4822
sg16
V6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine [drugbank:DB02705]
p4823
sg18
Vdrug-target interaction 6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02705_1074]
p4824
sa(dp4825
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4826
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03046
p4827
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4828
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03046_1074
p4829
sg16
V7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide [drugbank:DB03046]
p4830
sg18
Vdrug-target interaction 7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide and Urokinase-type plasminogen activator [drugbank_resource:DB03046_1074]
p4831
sa(dp4832
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4833
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03127
p4834
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4835
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03127_1074
p4836
sg16
VBenzamidine [drugbank:DB03127]
p4837
sg18
Vdrug-target interaction Benzamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03127_1074]
p4838
sa(dp4839
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4840
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03136
p4841
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4842
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03136_1074
p4843
sg16
V4-Iodobenzo[B]Thiophene-2-Carboxamidine [drugbank:DB03136]
p4844
sg18
Vdrug-target interaction 4-Iodobenzo[B]Thiophene-2-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03136_1074]
p4845
sa(dp4846
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4847
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03159
p4848
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4849
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03159_1074
p4850
sg16
VCRA_8696 [drugbank:DB03159]
p4851
sg18
Vdrug-target interaction CRA_8696 and Urokinase-type plasminogen activator [drugbank_resource:DB03159_1074]
p4852
sa(dp4853
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4854
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02398
p4855
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4856
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02398_1074
p4857
sg16
V6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine [drugbank:DB02398]
p4858
sg18
Vdrug-target interaction 6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02398_1074]
p4859
sa(dp4860
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4861
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02473
p4862
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4863
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02473_1074
p4864
sg16
V6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine [drugbank:DB02473]
p4865
sg18
Vdrug-target interaction 6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02473_1074]
p4866
sa(dp4867
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4868
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03082
p4869
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4870
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03082_1074
p4871
sg16
V6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide [drugbank:DB03082]
p4872
sg18
Vdrug-target interaction 6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide and Urokinase-type plasminogen activator [drugbank_resource:DB03082_1074]
p4873
sa(dp4874
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4875
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03476
p4876
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4877
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03476_1074
p4878
sg16
VTrans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine [drugbank:DB03476]
p4879
sg18
Vdrug-target interaction Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03476_1074]
p4880
sa(dp4881
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4882
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03782
p4883
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4884
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03782_1074
p4885
sg16
VN-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea [drugbank:DB03782]
p4886
sg18
Vdrug-target interaction N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea and Urokinase-type plasminogen activator [drugbank_resource:DB03782_1074]
p4887
sa(dp4888
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4889
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03876
p4890
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4891
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03876_1074
p4892
sg16
VThieno[2,3-B]Pyridine-2-Carboxamidine [drugbank:DB03876]
p4893
sg18
Vdrug-target interaction Thieno[2,3-B]Pyridine-2-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03876_1074]
p4894
sa(dp4895
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4896
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03865
p4897
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4898
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03865_1074
p4899
sg16
V6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine [drugbank:DB03865]
p4900
sg18
Vdrug-target interaction 6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03865_1074]
p4901
sa(dp4902
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4903
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04059
p4904
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4905
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04059_1074
p4906
sg16
V8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide [drugbank:DB04059]
p4907
sg18
Vdrug-target interaction 8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide and Urokinase-type plasminogen activator [drugbank_resource:DB04059_1074]
p4908
sa(dp4909
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4910
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03729
p4911
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4912
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03729_1074
p4913
sg16
V2-Amino-5-Hydroxy-Benzimidazole [drugbank:DB03729]
p4914
sg18
Vdrug-target interaction 2-Amino-5-Hydroxy-Benzimidazole and Urokinase-type plasminogen activator [drugbank_resource:DB03729_1074]
p4915
sa(dp4916
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4917
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04172
p4918
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4919
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04172_1074
p4920
sg16
V[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine [drugbank:DB04172]
p4921
sg18
Vdrug-target interaction [2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine and Urokinase-type plasminogen activator [drugbank_resource:DB04172_1074]
p4922
sa(dp4923
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4924
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06857
p4925
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4926
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06857_1074
p4927
sg16
VN-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE [drugbank:DB06857]
p4928
sg18
Vdrug-target interaction N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE and Urokinase-type plasminogen activator [drugbank_resource:DB06857_1074]
p4929
sa(dp4930
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4931
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07122
p4932
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4933
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07122_1074
p4934
sg16
V1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine [drugbank:DB07122]
p4935
sg18
Vdrug-target interaction 1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine and Urokinase-type plasminogen activator [drugbank_resource:DB07122_1074]
p4936
sa(dp4937
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4938
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06855
p4939
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4940
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06855_1074
p4941
sg16
V6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE [drugbank:DB06855]
p4942
sg18
Vdrug-target interaction 6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE and Urokinase-type plasminogen activator [drugbank_resource:DB06855_1074]
p4943
sa(dp4944
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4945
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06856
p4946
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4947
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06856_1074
p4948
sg16
V6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE [drugbank:DB06856]
p4949
sg18
Vdrug-target interaction 6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE and Urokinase-type plasminogen activator [drugbank_resource:DB06856_1074]
p4950
sa(dp4951
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4952
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07076
p4953
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4954
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07076_1074
p4955
sg16
V6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE [drugbank:DB07076]
p4956
sg18
Vdrug-target interaction 6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE and Urokinase-type plasminogen activator [drugbank_resource:DB07076_1074]
p4957
sa(dp4958
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4959
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06854
p4960
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4961
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06854_1074
p4962
sg16
V2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE [drugbank:DB06854]
p4963
sg18
Vdrug-target interaction 2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE and Urokinase-type plasminogen activator [drugbank_resource:DB06854_1074]
p4964
sa(dp4965
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4966
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07129
p4967
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4968
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07129_1074
p4969
sg16
V(2R)-1-(2,6-dimethylphenoxy)propan-2-amine [drugbank:DB07129]
p4970
sg18
Vdrug-target interaction (2R)-1-(2,6-dimethylphenoxy)propan-2-amine and Urokinase-type plasminogen activator [drugbank_resource:DB07129_1074]
p4971
sa(dp4972
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4973
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07625
p4974
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4975
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07625_1074
p4976
sg16
V4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide [drugbank:DB07625]
p4977
sg18
Vdrug-target interaction 4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide and Urokinase-type plasminogen activator [drugbank_resource:DB07625_1074]
p4978
sa(dp4979
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4980
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07626
p4981
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4982
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07626_1074
p4983
sg16
V4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide [drugbank:DB07626]
p4984
sg18
Vdrug-target interaction 4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide and Urokinase-type plasminogen activator [drugbank_resource:DB07626_1074]
p4985
sa(dp4986
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4987
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08072
p4988
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4989
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08072_1074
p4990
sg16
V4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE [drugbank:DB08072]
p4991
sg18
Vdrug-target interaction 4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE and Urokinase-type plasminogen activator [drugbank_resource:DB08072_1074]
p4992
sa(dp4993
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1074
p4994
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08697
p4995
sg11
g4767
sg12
S'plasminogen activator, urokinase'
p4996
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08697_1074
p4997
sg16
V4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide [drugbank:DB08697]
p4998
sg18
Vdrug-target interaction 4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide and Urokinase-type plasminogen activator [drugbank_resource:DB08697_1074]
p4999
sasS'PPARA'
p5000
(lp5001
(dp5002
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:80
p5003
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00636
p5004
sg11
g5000
sg12
S'peroxisome proliferator-activated receptor alpha'
p5005
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00636_80
p5006
sg16
VClofibrate [drugbank:DB00636]
p5007
sg18
Vdrug-target interaction Clofibrate and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB00636_80]
p5008
sa(dp5009
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:80
p5010
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01039
p5011
sg11
g5000
sg12
S'peroxisome proliferator-activated receptor alpha'
p5012
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01039_80
p5013
sg16
VFenofibrate [drugbank:DB01039]
p5014
sg18
Vdrug-target interaction Fenofibrate and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB01039_80]
p5015
sa(dp5016
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:80
p5017
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01241
p5018
sg11
g5000
sg12
S'peroxisome proliferator-activated receptor alpha'
p5019
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01241_80
p5020
sg16
VGemfibrozil [drugbank:DB01241]
p5021
sg18
Vdrug-target interaction Gemfibrozil and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB01241_80]
p5022
sa(dp5023
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:80
p5024
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01393
p5025
sg11
g5000
sg12
S'peroxisome proliferator-activated receptor alpha'
p5026
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01393_80
p5027
sg16
VBezafibrate [drugbank:DB01393]
p5028
sg18
Vdrug-target interaction Bezafibrate and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB01393_80]
p5029
sa(dp5030
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:80
p5031
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01890
p5032
sg11
g5000
sg12
S'peroxisome proliferator-activated receptor alpha'
p5033
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01890_80
p5034
sg16
VDeoxy-Bigchap [drugbank:DB01890]
p5035
sg18
Vdrug-target interaction Deoxy-Bigchap and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB01890_80]
p5036
sa(dp5037
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:80
p5038
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07215
p5039
sg11
g5000
sg12
S'peroxisome proliferator-activated receptor alpha'
p5040
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07215_80
p5041
sg16
V2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID [drugbank:DB07215]
p5042
sg18
Vdrug-target interaction 2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB07215_80]
p5043
sa(dp5044
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:80
p5045
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07724
p5046
sg11
g5000
sg12
S'peroxisome proliferator-activated receptor alpha'
p5047
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07724_80
p5048
sg16
V3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid [drugbank:DB07724]
p5049
sg18
Vdrug-target interaction 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB07724_80]
p5050
sa(dp5051
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:80
p5052
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08483
p5053
sg11
g5000
sg12
S'peroxisome proliferator-activated receptor alpha'
p5054
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08483_80
p5055
sg16
V(2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid [drugbank:DB08483]
p5056
sg18
Vdrug-target interaction (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB08483_80]
p5057
sasS'HCK'
p5058
(lp5059
(dp5060
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2599
p5061
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01809
p5062
sg11
g5058
sg12
S'hemopoietic cell kinase'
p5063
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01809_2599
p5064
sg16
V1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine [drugbank:DB01809]
p5065
sg18
Vdrug-target interaction 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine and Tyrosine-protein kinase HCK [drugbank_resource:DB01809_2599]
p5066
sa(dp5067
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2599
p5068
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01962
p5069
sg11
g5058
sg12
S'hemopoietic cell kinase'
p5070
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01962_2599
p5071
sg16
VPhosphonotyrosine [drugbank:DB01962]
p5072
sg18
Vdrug-target interaction Phosphonotyrosine and Tyrosine-protein kinase HCK [drugbank_resource:DB01962_2599]
p5073
sa(dp5074
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2599
p5075
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04216
p5076
sg11
g5058
sg12
S'hemopoietic cell kinase'
p5077
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04216_2599
p5078
sg16
VQuercetin [drugbank:DB04216]
p5079
sg18
Vdrug-target interaction Quercetin and Tyrosine-protein kinase HCK [drugbank_resource:DB04216_2599]
p5080
sasS'RHOA'
p5081
(lp5082
(dp5083
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2170
p5084
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04315
p5085
sg11
g5081
sg12
S'ras homolog family member A'
p5086
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04315_2170
p5087
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p5088
sg18
Vdrug-target interaction Guanosine-5'-Diphosphate and Transforming protein RhoA [drugbank_resource:DB04315_2170]
p5089
sasS'ITPR1'
p5090
(lp5091
(dp5092
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7032
p5093
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03401
p5094
sg11
g5090
sg12
S'inositol 1,4,5-trisphosphate receptor, type 1'
p5095
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03401_7032
p5096
sg16
VD-Myo-Inositol-1,4,5-Triphosphate [drugbank:DB03401]
p5097
sg18
Vdrug-target interaction D-Myo-Inositol-1,4,5-Triphosphate and Inositol 1,4,5-trisphosphate receptor type 1 [drugbank_resource:DB03401_7032]
p5098
sa(dp5099
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7032
p5100
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04077
p5101
sg11
g5090
sg12
S'inositol 1,4,5-trisphosphate receptor, type 1'
p5102
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04077_7032
p5103
sg16
VGlycerol [drugbank:DB04077]
p5104
sg18
Vdrug-target interaction Glycerol and Inositol 1,4,5-trisphosphate receptor type 1 [drugbank_resource:DB04077_7032]
p5105
sasS'NR3C1'
p5106
(lp5107
(dp5108
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5109
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00180
p5110
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5111
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00180_871
p5112
sg16
VFlunisolide [drugbank:DB00180]
p5113
sg18
Vdrug-target interaction Flunisolide and Glucocorticoid receptor [drugbank_resource:DB00180_871]
p5114
sa(dp5115
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5116
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00288
p5117
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00288_871
p5119
sg16
VAmcinonide [drugbank:DB00288]
p5120
sg18
Vdrug-target interaction Amcinonide and Glucocorticoid receptor [drugbank_resource:DB00288_871]
p5121
sa(dp5122
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5123
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00223
p5124
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5125
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00223_871
p5126
sg16
VDiflorasone [drugbank:DB00223]
p5127
sg18
Vdrug-target interaction Diflorasone and Glucocorticoid receptor [drugbank_resource:DB00223_871]
p5128
sa(dp5129
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5130
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00240
p5131
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5132
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00240_871
p5133
sg16
VAlclometasone [drugbank:DB00240]
p5134
sg18
Vdrug-target interaction Alclometasone and Glucocorticoid receptor [drugbank_resource:DB00240_871]
p5135
sa(dp5136
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5137
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00253
p5138
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00253_871
p5140
sg16
VMedrysone [drugbank:DB00253]
p5141
sg18
Vdrug-target interaction Medrysone and Glucocorticoid receptor [drugbank_resource:DB00253_871]
p5142
sa(dp5143
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5144
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00591
p5145
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5146
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00591_871
p5147
sg16
VFluocinolone Acetonide [drugbank:DB00591]
p5148
sg18
Vdrug-target interaction Fluocinolone Acetonide and Glucocorticoid receptor [drugbank_resource:DB00591_871]
p5149
sa(dp5150
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5151
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00351
p5152
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5153
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00351_871
p5154
sg16
VMegestrol [drugbank:DB00351]
p5155
sg18
Vdrug-target interaction Megestrol and Glucocorticoid receptor [drugbank_resource:DB00351_871]
p5156
sa(dp5157
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5158
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00394
p5159
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5160
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00394_871
p5161
sg16
VBeclometasone dipropionate [drugbank:DB00394]
p5162
sg18
Vdrug-target interaction Beclometasone dipropionate and Glucocorticoid receptor [drugbank_resource:DB00394_871]
p5163
sa(dp5164
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5165
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00443
p5166
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5167
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00443_871
p5168
sg16
VBetamethasone [drugbank:DB00443]
p5169
sg18
Vdrug-target interaction Betamethasone and Glucocorticoid receptor [drugbank_resource:DB00443_871]
p5170
sa(dp5171
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5172
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00588
p5173
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5174
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00588_871
p5175
sg16
VFluticasone Propionate [drugbank:DB00588]
p5176
sg18
Vdrug-target interaction Fluticasone Propionate and Glucocorticoid receptor [drugbank_resource:DB00588_871]
p5177
sa(dp5178
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5179
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00620
p5180
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5181
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00620_871
p5182
sg16
VTriamcinolone [drugbank:DB00620]
p5183
sg18
Vdrug-target interaction Triamcinolone and Glucocorticoid receptor [drugbank_resource:DB00620_871]
p5184
sa(dp5185
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5186
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00635
p5187
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5188
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00635_871
p5189
sg16
VPrednisone [drugbank:DB00635]
p5190
sg18
Vdrug-target interaction Prednisone and Glucocorticoid receptor [drugbank_resource:DB00635_871]
p5191
sa(dp5192
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5193
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00324
p5194
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5195
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00324_871
p5196
sg16
VFluorometholone [drugbank:DB00324]
p5197
sg18
Vdrug-target interaction Fluorometholone and Glucocorticoid receptor [drugbank_resource:DB00324_871]
p5198
sa(dp5199
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5200
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00547
p5201
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5202
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00547_871
p5203
sg16
VDesoximetasone [drugbank:DB00547]
p5204
sg18
Vdrug-target interaction Desoximetasone and Glucocorticoid receptor [drugbank_resource:DB00547_871]
p5205
sa(dp5206
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5207
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00596
p5208
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5209
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00596_871
p5210
sg16
VHalobetasol Propionate [drugbank:DB00596]
p5211
sg18
Vdrug-target interaction Halobetasol Propionate and Glucocorticoid receptor [drugbank_resource:DB00596_871]
p5212
sa(dp5213
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5214
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00663
p5215
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5216
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00663_871
p5217
sg16
VFlumethasone Pivalate [drugbank:DB00663]
p5218
sg18
Vdrug-target interaction Flumethasone Pivalate and Glucocorticoid receptor [drugbank_resource:DB00663_871]
p5219
sa(dp5220
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5221
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00687
p5222
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5223
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00687_871
p5224
sg16
VFludrocortisone [drugbank:DB00687]
p5225
sg18
Vdrug-target interaction Fludrocortisone and Glucocorticoid receptor [drugbank_resource:DB00687_871]
p5226
sa(dp5227
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5228
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00741
p5229
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5230
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00741_871
p5231
sg16
VHydrocortisone [drugbank:DB00741]
p5232
sg18
Vdrug-target interaction Hydrocortisone and Glucocorticoid receptor [drugbank_resource:DB00741_871]
p5233
sa(dp5234
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5235
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00764
p5236
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5237
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00764_871
p5238
sg16
VMometasone [drugbank:DB00764]
p5239
sg18
Vdrug-target interaction Mometasone and Glucocorticoid receptor [drugbank_resource:DB00764_871]
p5240
sa(dp5241
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5242
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00834
p5243
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5244
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00834_871
p5245
sg16
VMifepristone [drugbank:DB00834]
p5246
sg18
Vdrug-target interaction Mifepristone and Glucocorticoid receptor [drugbank_resource:DB00834_871]
p5247
sa(dp5248
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5249
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00838
p5250
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5251
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00838_871
p5252
sg16
VClocortolone [drugbank:DB00838]
p5253
sg18
Vdrug-target interaction Clocortolone and Glucocorticoid receptor [drugbank_resource:DB00838_871]
p5254
sa(dp5255
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5256
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00860
p5257
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5258
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00860_871
p5259
sg16
VPrednisolone [drugbank:DB00860]
p5260
sg18
Vdrug-target interaction Prednisolone and Glucocorticoid receptor [drugbank_resource:DB00860_871]
p5261
sa(dp5262
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5263
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00873
p5264
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5265
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00873_871
p5266
sg16
VLoteprednol [drugbank:DB00873]
p5267
sg18
Vdrug-target interaction Loteprednol and Glucocorticoid receptor [drugbank_resource:DB00873_871]
p5268
sa(dp5269
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5270
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00769
p5271
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5272
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00769_871
p5273
sg16
VHydrocortamate [drugbank:DB00769]
p5274
sg18
Vdrug-target interaction Hydrocortamate and Glucocorticoid receptor [drugbank_resource:DB00769_871]
p5275
sa(dp5276
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5277
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00846
p5278
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5279
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00846_871
p5280
sg16
VFlurandrenolide [drugbank:DB00846]
p5281
sg18
Vdrug-target interaction Flurandrenolide and Glucocorticoid receptor [drugbank_resource:DB00846_871]
p5282
sa(dp5283
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5284
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00896
p5285
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5286
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00896_871
p5287
sg16
VRimexolone [drugbank:DB00896]
p5288
sg18
Vdrug-target interaction Rimexolone and Glucocorticoid receptor [drugbank_resource:DB00896_871]
p5289
sa(dp5290
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5291
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00959
p5292
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5293
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00959_871
p5294
sg16
VMethylprednisolone [drugbank:DB00959]
p5295
sg18
Vdrug-target interaction Methylprednisolone and Glucocorticoid receptor [drugbank_resource:DB00959_871]
p5296
sa(dp5297
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5298
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01013
p5299
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5300
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01013_871
p5301
sg16
VClobetasol [drugbank:DB01013]
p5302
sg18
Vdrug-target interaction Clobetasol and Glucocorticoid receptor [drugbank_resource:DB01013_871]
p5303
sa(dp5304
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5305
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01130
p5306
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5307
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01130_871
p5308
sg16
VPrednicarbate [drugbank:DB01130]
p5309
sg18
Vdrug-target interaction Prednicarbate and Glucocorticoid receptor [drugbank_resource:DB01130_871]
p5310
sa(dp5311
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5312
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01047
p5313
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5314
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01047_871
p5315
sg16
VFluocinonide [drugbank:DB01047]
p5316
sg18
Vdrug-target interaction Fluocinonide and Glucocorticoid receptor [drugbank_resource:DB01047_871]
p5317
sa(dp5318
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5319
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01260
p5320
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5321
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01260_871
p5322
sg16
VDesonide [drugbank:DB01260]
p5323
sg18
Vdrug-target interaction Desonide and Glucocorticoid receptor [drugbank_resource:DB01260_871]
p5324
sa(dp5325
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5326
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01222
p5327
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5328
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01222_871
p5329
sg16
VBudesonide [drugbank:DB01222]
p5330
sg18
Vdrug-target interaction Budesonide and Glucocorticoid receptor [drugbank_resource:DB01222_871]
p5331
sa(dp5332
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5333
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01234
p5334
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5335
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01234_871
p5336
sg16
VDexamethasone [drugbank:DB01234]
p5337
sg18
Vdrug-target interaction Dexamethasone and Glucocorticoid receptor [drugbank_resource:DB01234_871]
p5338
sa(dp5339
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5340
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01380
p5341
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5342
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01380_871
p5343
sg16
VCortisone acetate [drugbank:DB01380]
p5344
sg18
Vdrug-target interaction Cortisone acetate and Glucocorticoid receptor [drugbank_resource:DB01380_871]
p5345
sa(dp5346
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5347
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01384
p5348
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5349
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01384_871
p5350
sg16
VParamethasone [drugbank:DB01384]
p5351
sg18
Vdrug-target interaction Paramethasone and Glucocorticoid receptor [drugbank_resource:DB01384_871]
p5352
sa(dp5353
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5354
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01410
p5355
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5356
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01410_871
p5357
sg16
VCiclesonide [drugbank:DB01410]
p5358
sg18
Vdrug-target interaction Ciclesonide and Glucocorticoid receptor [drugbank_resource:DB01410_871]
p5359
sa(dp5360
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5361
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01185
p5362
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5363
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01185_871
p5364
sg16
VFluoxymesterone [drugbank:DB01185]
p5365
sg18
Vdrug-target interaction Fluoxymesterone and Glucocorticoid receptor [drugbank_resource:DB01185_871]
p5366
sa(dp5367
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5368
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02210
p5369
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5370
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02210_871
p5371
sg16
VHexane-1,6-Diol [drugbank:DB02210]
p5372
sg18
Vdrug-target interaction Hexane-1,6-Diol and Glucocorticoid receptor [drugbank_resource:DB02210_871]
p5373
sa(dp5374
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:871
p5375
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06781
p5376
sg11
g5106
sg12
S'nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)'
p5377
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06781_871
p5378
sg16
VDifluprednate [drugbank:DB06781]
p5379
sg18
Vdrug-target interaction Difluprednate and Glucocorticoid receptor [drugbank_resource:DB06781_871]
p5380
sasS'ANG'
p5381
(lp5382
(dp5383
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2149
p5384
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02212
p5385
sg11
g5381
sg12
S'angiogenin, ribonuclease, RNase A family, 5'
p5386
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02212_2149
p5387
sg16
VPyrophosphate 2- [drugbank:DB02212]
p5388
sg18
Vdrug-target interaction Pyrophosphate 2- and Angiogenin [drugbank_resource:DB02212_2149]
p5389
sa(dp5390
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2149
p5391
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03088
p5392
sg11
g5381
sg12
S'angiogenin, ribonuclease, RNase A family, 5'
p5393
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03088_2149
p5394
sg16
VPyroglutamic Acid [drugbank:DB03088]
p5395
sg18
Vdrug-target interaction Pyroglutamic Acid and Angiogenin [drugbank_resource:DB03088_2149]
p5396
sa(dp5397
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2149
p5398
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04272
p5399
sg11
g5381
sg12
S'angiogenin, ribonuclease, RNase A family, 5'
p5400
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04272_2149
p5401
sg16
VCitric Acid [drugbank:DB04272]
p5402
sg18
Vdrug-target interaction Citric Acid and Angiogenin [drugbank_resource:DB04272_2149]
p5403
sasS'TP53'
p5404
(lp5405
(dp5406
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5788
p5407
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08363
p5408
sg11
g5404
sg12
S'tumor protein p53'
p5409
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08363_5788
p5410
sg16
V1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine [drugbank:DB08363]
p5411
sg18
Vdrug-target interaction 1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine and Cellular tumor antigen p53 [drugbank_resource:DB08363_5788]
p5412
sasS'PPARG'
p5413
(lp5414
(dp5415
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5416
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00244
p5417
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5418
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00244_238
p5419
sg16
VMesalazine [drugbank:DB00244]
p5420
sg18
Vdrug-target interaction Mesalazine and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00244_238]
p5421
sa(dp5422
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5423
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00159
p5424
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5425
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00159_238
p5426
sg16
VIcosapent [drugbank:DB00159]
p5427
sg18
Vdrug-target interaction Icosapent and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00159_238]
p5428
sa(dp5429
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5430
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00197
p5431
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5432
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00197_238
p5433
sg16
VTroglitazone [drugbank:DB00197]
p5434
sg18
Vdrug-target interaction Troglitazone and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00197_238]
p5435
sa(dp5436
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5437
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00328
p5438
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5439
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00328_238
p5440
sg16
VIndomethacin [drugbank:DB00328]
p5441
sg18
Vdrug-target interaction Indomethacin and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00328_238]
p5442
sa(dp5443
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5444
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00412
p5445
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5446
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00412_238
p5447
sg16
VRosiglitazone [drugbank:DB00412]
p5448
sg18
Vdrug-target interaction Rosiglitazone and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00412_238]
p5449
sa(dp5450
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5451
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00795
p5452
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5453
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00795_238
p5454
sg16
VSulfasalazine [drugbank:DB00795]
p5455
sg18
Vdrug-target interaction Sulfasalazine and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00795_238]
p5456
sa(dp5457
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5458
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00912
p5459
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5460
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00912_238
p5461
sg16
VRepaglinide [drugbank:DB00912]
p5462
sg18
Vdrug-target interaction Repaglinide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00912_238]
p5463
sa(dp5464
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5465
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00731
p5466
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5467
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00731_238
p5468
sg16
VNateglinide [drugbank:DB00731]
p5469
sg18
Vdrug-target interaction Nateglinide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00731_238]
p5470
sa(dp5471
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5472
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01014
p5473
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5474
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01014_238
p5475
sg16
VBalsalazide [drugbank:DB01014]
p5476
sg18
Vdrug-target interaction Balsalazide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01014_238]
p5477
sa(dp5478
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5479
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00966
p5480
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5481
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00966_238
p5482
sg16
VTelmisartan [drugbank:DB00966]
p5483
sg18
Vdrug-target interaction Telmisartan and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00966_238]
p5484
sa(dp5485
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5486
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01067
p5487
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5488
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01067_238
p5489
sg16
VGlipizide [drugbank:DB01067]
p5490
sg18
Vdrug-target interaction Glipizide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01067_238]
p5491
sa(dp5492
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5493
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01132
p5494
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5495
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01132_238
p5496
sg16
VPioglitazone [drugbank:DB01132]
p5497
sg18
Vdrug-target interaction Pioglitazone and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01132_238]
p5498
sa(dp5499
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5500
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01252
p5501
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5502
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01252_238
p5503
sg16
VMitiglinide [drugbank:DB01252]
p5504
sg18
Vdrug-target interaction Mitiglinide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01252_238]
p5505
sa(dp5506
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5507
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01393
p5508
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5509
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01393_238
p5510
sg16
VBezafibrate [drugbank:DB01393]
p5511
sg18
Vdrug-target interaction Bezafibrate and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01393_238]
p5512
sa(dp5513
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5514
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04270
p5515
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5516
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04270_238
p5517
sg16
V(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid [drugbank:DB04270]
p5518
sg18
Vdrug-target interaction (S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB04270_238]
p5519
sa(dp5520
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5521
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06926
p5522
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5523
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06926_238
p5524
sg16
V(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid [drugbank:DB06926]
p5525
sg18
Vdrug-target interaction (9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB06926_238]
p5526
sa(dp5527
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5528
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07111
p5529
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5530
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07111_238
p5531
sg16
V(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid [drugbank:DB07111]
p5532
sg18
Vdrug-target interaction (4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07111_238]
p5533
sa(dp5534
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5535
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07172
p5536
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5537
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07172_238
p5538
sg16
V(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid [drugbank:DB07172]
p5539
sg18
Vdrug-target interaction (5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07172_238]
p5540
sa(dp5541
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5542
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07208
p5543
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5544
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07208_238
p5545
sg16
V(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid [drugbank:DB07208]
p5546
sg18
Vdrug-target interaction (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07208_238]
p5547
sa(dp5548
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5549
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07209
p5550
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5551
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07209_238
p5552
sg16
V(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid [drugbank:DB07209]
p5553
sg18
Vdrug-target interaction (8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07209_238]
p5554
sa(dp5555
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5556
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06908
p5557
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5558
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06908_238
p5559
sg16
V(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID [drugbank:DB06908]
p5560
sg18
Vdrug-target interaction (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB06908_238]
p5561
sa(dp5562
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5563
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04689
p5564
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5565
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04689_238
p5566
sg16
V2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID [drugbank:DB04689]
p5567
sg18
Vdrug-target interaction 2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB04689_238]
p5568
sa(dp5569
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5570
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07053
p5571
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5572
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07053_238
p5573
sg16
V2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID [drugbank:DB07053]
p5574
sg18
Vdrug-target interaction 2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07053_238]
p5575
sa(dp5576
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5577
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07302
p5578
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5579
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07302_238
p5580
sg16
V(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid [drugbank:DB07302]
p5581
sg18
Vdrug-target interaction (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07302_238]
p5582
sa(dp5583
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5584
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07509
p5585
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07509_238
p5587
sg16
Vdifluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron [drugbank:DB07509]
p5588
sg18
Vdrug-target interaction difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07509_238]
p5589
sa(dp5590
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5591
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07723
p5592
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5593
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07723_238
p5594
sg16
V3-(5-methoxy-1H-indol-3-yl)propanoic acid [drugbank:DB07723]
p5595
sg18
Vdrug-target interaction 3-(5-methoxy-1H-indol-3-yl)propanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07723_238]
p5596
sa(dp5597
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5598
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07724
p5599
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5600
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07724_238
p5601
sg16
V3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid [drugbank:DB07724]
p5602
sg18
Vdrug-target interaction 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07724_238]
p5603
sa(dp5604
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5605
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08302
p5606
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5607
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08302_238
p5608
sg16
V3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid [drugbank:DB08302]
p5609
sg18
Vdrug-target interaction 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08302_238]
p5610
sa(dp5611
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5612
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07842
p5613
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5614
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07842_238
p5615
sg16
V(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid [drugbank:DB07842]
p5616
sg18
Vdrug-target interaction (2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07842_238]
p5617
sa(dp5618
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5619
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07863
p5620
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5621
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07863_238
p5622
sg16
V2-chloro-5-nitro-N-phenylbenzamide [drugbank:DB07863]
p5623
sg18
Vdrug-target interaction 2-chloro-5-nitro-N-phenylbenzamide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07863_238]
p5624
sa(dp5625
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5626
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08402
p5627
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5628
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08402_238
p5629
sg16
V2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID [drugbank:DB08402]
p5630
sg18
Vdrug-target interaction 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08402_238]
p5631
sa(dp5632
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5633
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08435
p5634
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5635
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08435_238
p5636
sg16
V(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid [drugbank:DB08435]
p5637
sg18
Vdrug-target interaction (5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08435_238]
p5638
sa(dp5639
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5640
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08560
p5641
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5642
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08560_238
p5643
sg16
V3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE [drugbank:DB08560]
p5644
sg18
Vdrug-target interaction 3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08560_238]
p5645
sa(dp5646
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5647
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08760
p5648
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5649
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08760_238
p5650
sg16
V(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid [drugbank:DB08760]
p5651
sg18
Vdrug-target interaction (2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08760_238]
p5652
sa(dp5653
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5654
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07675
p5655
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5656
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07675_238
p5657
sg16
V(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID [drugbank:DB07675]
p5658
sg18
Vdrug-target interaction (2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07675_238]
p5659
sa(dp5660
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5661
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08121
p5662
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5663
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08121_238
p5664
sg16
V(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid [drugbank:DB08121]
p5665
sg18
Vdrug-target interaction (2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08121_238]
p5666
sa(dp5667
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:238
p5668
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08483
p5669
sg11
g5413
sg12
S'peroxisome proliferator-activated receptor gamma'
p5670
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08483_238
p5671
sg16
V(2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid [drugbank:DB08483]
p5672
sg18
Vdrug-target interaction (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08483_238]
p5673
sasS'ABCA1'
p5674
(lp5675
(dp5676
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:132
p5677
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00171
p5678
sg11
g5674
sg12
S'ATP-binding cassette, sub-family A (ABC1), member 1'
p5679
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00171_132
p5680
sg16
VAdenosine triphosphate [drugbank:DB00171]
p5681
sg18
Vdrug-target interaction Adenosine triphosphate and ATP-binding cassette sub-family A member 1 [drugbank_resource:DB00171_132]
p5682
sa(dp5683
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:132
p5684
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01016
p5685
sg11
g5674
sg12
S'ATP-binding cassette, sub-family A (ABC1), member 1'
p5686
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01016_132
p5687
sg16
VGlyburide [drugbank:DB01016]
p5688
sg18
Vdrug-target interaction Glyburide and ATP-binding cassette sub-family A member 1 [drugbank_resource:DB01016_132]
p5689
sa(dp5690
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:132
p5691
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01599
p5692
sg11
g5674
sg12
S'ATP-binding cassette, sub-family A (ABC1), member 1'
p5693
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01599_132
p5694
sg16
VProbucol [drugbank:DB01599]
p5695
sg18
Vdrug-target interaction Probucol and ATP-binding cassette sub-family A member 1 [drugbank_resource:DB01599_132]
p5696
sasS'SST'
p5697
(lp5698
(dp5699
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1736
p5700
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00847
p5701
sg11
g5697
sg12
S'somatostatin'
p5702
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00847_1736
p5703
sg16
VCysteamine [drugbank:DB00847]
p5704
sg18
Vdrug-target interaction Cysteamine and Somatostatin [drugbank_resource:DB00847_1736]
p5705
sasS'DDR1'
p5706
(lp5707
(dp5708
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1950
p5709
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00619
p5710
sg11
g5706
sg12
S'discoidin domain receptor tyrosine kinase 1'
p5711
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00619_1950
p5712
sg16
VImatinib [drugbank:DB00619]
p5713
sg18
Vdrug-target interaction Imatinib and Epithelial discoidin domain-containing receptor 1 [drugbank_resource:DB00619_1950]
p5714
sasS'HNF4A'
p5715
(lp5716
(dp5717
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6522
p5718
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08231
p5719
sg11
g5715
sg12
S'hepatocyte nuclear factor 4, alpha'
p5720
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08231_6522
p5721
sg16
VMYRISTIC ACID [drugbank:DB08231]
p5722
sg18
Vdrug-target interaction MYRISTIC ACID and Hepatocyte nuclear factor 4-alpha [drugbank_resource:DB08231_6522]
p5723
sasS'ITGAV'
p5724
(lp5725
(dp5726
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6066
p5727
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00098
p5728
sg11
g5724
sg12
S'integrin, alpha V'
p5729
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00098_6066
p5730
sg16
VAntithymocyte globulin [drugbank:DB00098]
p5731
sg18
Vdrug-target interaction Antithymocyte globulin and Integrin alpha-V [drugbank_resource:DB00098_6066]
p5732
sasS'MAL'
p5733
(lp5734
(dp5735
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6661
p5736
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08080
p5737
sg11
S'MKL1'
p5738
sg12
S'megakaryoblastic leukemia (translocation) 1'
p5739
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08080_6661
p5740
sg16
VLATRUNCULIN B [drugbank:DB08080]
p5741
sg18
Vdrug-target interaction LATRUNCULIN B and MKL/myocardin-like protein 1 [drugbank_resource:DB08080_6661]
p5742
sasS'PRODH'
p5743
(lp5744
(dp5745
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4082
p5746
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00172
p5747
sg11
g5743
sg12
S'proline dehydrogenase (oxidase) 1'
p5748
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00172_4082
p5749
sg16
VL-Proline [drugbank:DB00172]
p5750
sg18
Vdrug-target interaction L-Proline and Proline oxidase, mitochondrial [drugbank_resource:DB00172_4082]
p5751
sa(dp5752
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4082
p5753
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00172
p5754
sg11
g5743
sg12
S'proline dehydrogenase (oxidase) 1'
p5755
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00172_4082
p5756
sg16
VL-Proline [drugbank:DB00172]
p5757
sg18
Vdrug-enzyme interaction L-Proline and Proline oxidase, mitochondrial [drugbank_resource:DB00172_4082]
p5758
sasS'NNMT'
p5759
(lp5760
(dp5761
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:860
p5762
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00627
p5763
sg11
g5759
sg12
S'nicotinamide N-methyltransferase'
p5764
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00627_860
p5765
sg16
VNiacin [drugbank:DB00627]
p5766
sg18
Vdrug-target interaction Niacin and Nicotinamide N-methyltransferase [drugbank_resource:DB00627_860]
p5767
sasS'DTYMK'
p5768
(lp5769
(dp5770
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2254
p5771
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01643
p5772
sg11
g5768
sg12
S'deoxythymidylate kinase (thymidylate kinase)'
p5773
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01643_2254
p5774
sg16
VThymidine-5'-Phosphate [drugbank:DB01643]
p5775
sg18
Vdrug-target interaction Thymidine-5'-Phosphate and Thymidylate kinase [drugbank_resource:DB01643_2254]
p5776
sa(dp5777
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2254
p5778
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03195
p5779
sg11
g5768
sg12
S'deoxythymidylate kinase (thymidylate kinase)'
p5780
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03195_2254
p5781
sg16
VPhosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester [drugbank:DB03195]
p5782
sg18
Vdrug-target interaction Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester and Thymidylate kinase [drugbank_resource:DB03195_2254]
p5783
sa(dp5784
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2254
p5785
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03280
p5786
sg11
g5768
sg12
S'deoxythymidylate kinase (thymidylate kinase)'
p5787
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03280_2254
p5788
sg16
VP1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate [drugbank:DB03280]
p5789
sg18
Vdrug-target interaction P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate and Thymidylate kinase [drugbank_resource:DB03280_2254]
p5790
sa(dp5791
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2254
p5792
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03150
p5793
sg11
g5768
sg12
S'deoxythymidylate kinase (thymidylate kinase)'
p5794
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03150_2254
p5795
sg16
V2',3'-Dideoxythymidine-5'-Monophosphate [drugbank:DB03150]
p5796
sg18
Vdrug-target interaction 2',3'-Dideoxythymidine-5'-Monophosphate and Thymidylate kinase [drugbank_resource:DB03150_2254]
p5797
sa(dp5798
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2254
p5799
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03233
p5800
sg11
g5768
sg12
S'deoxythymidylate kinase (thymidylate kinase)'
p5801
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03233_2254
p5802
sg16
VPhosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester [drugbank:DB03233]
p5803
sg18
Vdrug-target interaction Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester and Thymidylate kinase [drugbank_resource:DB03233_2254]
p5804
sa(dp5805
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2254
p5806
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p5807
sg11
g5768
sg12
S'deoxythymidylate kinase (thymidylate kinase)'
p5808
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_2254
p5809
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p5810
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Thymidylate kinase [drugbank_resource:DB03431_2254]
p5811
sa(dp5812
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2254
p5813
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03666
p5814
sg11
g5768
sg12
S'deoxythymidylate kinase (thymidylate kinase)'
p5815
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03666_2254
p5816
sg16
V3'-Azido-3'-Deoxythymidine-5'-Monophosphate [drugbank:DB03666]
p5817
sg18
Vdrug-target interaction 3'-Azido-3'-Deoxythymidine-5'-Monophosphate and Thymidylate kinase [drugbank_resource:DB03666_2254]
p5818
sa(dp5819
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2254
p5820
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03845
p5821
sg11
g5768
sg12
S'deoxythymidylate kinase (thymidylate kinase)'
p5822
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03845_2254
p5823
sg16
VP1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate [drugbank:DB03845]
p5824
sg18
Vdrug-target interaction P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate and Thymidylate kinase [drugbank_resource:DB03845_2254]
p5825
sa(dp5826
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2254
p5827
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p5828
sg11
g5768
sg12
S'deoxythymidylate kinase (thymidylate kinase)'
p5829
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_2254
p5830
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p5831
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Thymidylate kinase [drugbank_resource:DB04395_2254]
p5832
sasS'POLE2'
p5833
(lp5834
(dp5835
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6110
p5836
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00242
p5837
sg11
g5833
sg12
S'polymerase (DNA directed), epsilon 2, accessory subunit'
p5838
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00242_6110
p5839
sg16
VCladribine [drugbank:DB00242]
p5840
sg18
Vdrug-target interaction Cladribine and DNA polymerase epsilon subunit 2 [drugbank_resource:DB00242_6110]
p5841
sasS'CDK4'
p5842
(lp5843
(dp5844
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3959
p5845
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02733
p5846
sg11
g5842
sg12
S'cyclin-dependent kinase 4'
p5847
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02733_3959
p5848
sg16
VPurvalanol [drugbank:DB02733]
p5849
sg18
Vdrug-target interaction Purvalanol and Cell division protein kinase 4 [drugbank_resource:DB02733_3959]
p5850
sa(dp5851
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3959
p5852
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p5853
sg11
g5842
sg12
S'cyclin-dependent kinase 4'
p5854
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_3959
p5855
sg16
VFlavopiridol [drugbank:DB03496]
p5856
sg18
Vdrug-target interaction Flavopiridol and Cell division protein kinase 4 [drugbank_resource:DB03496_3959]
p5857
sasS'VWF'
p5858
(lp5859
(dp5860
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1635
p5861
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00025
p5862
sg11
g5858
sg12
S'von Willebrand factor'
p5863
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00025_1635
p5864
sg16
VAntihemophilic Factor [drugbank:DB00025]
p5865
sg18
Vdrug-target interaction Antihemophilic Factor and von Willebrand factor [drugbank_resource:DB00025_1635]
p5866
sasS'AIFM1'
p5867
(lp5868
(dp5869
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1329
p5870
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03147
p5871
sg11
g5867
sg12
S'apoptosis-inducing factor, mitochondrion-associated, 1'
p5872
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03147_1329
p5873
sg16
VFlavin-Adenine Dinucleotide [drugbank:DB03147]
p5874
sg18
Vdrug-target interaction Flavin-Adenine Dinucleotide and Apoptosis-inducing factor 1, mitochondrial [drugbank_resource:DB03147_1329]
p5875
sasS'AMY1A'
p5876
(lp5877
(dp5878
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3030
p5879
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02379
p5880
sg11
g5876
sg12
S'amylase, alpha 1A (salivary)'
p5881
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02379_3030
p5882
sg16
VBeta-D-Glucose [drugbank:DB02379]
p5883
sg18
Vdrug-target interaction Beta-D-Glucose and Salivary alpha-amylase [drugbank_resource:DB02379_3030]
p5884
sa(dp5885
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3030
p5886
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03088
p5887
sg11
g5876
sg12
S'amylase, alpha 1A (salivary)'
p5888
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03088_3030
p5889
sg16
VPyroglutamic Acid [drugbank:DB03088]
p5890
sg18
Vdrug-target interaction Pyroglutamic Acid and Salivary alpha-amylase [drugbank_resource:DB03088_3030]
p5891
sa(dp5892
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3030
p5893
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03092
p5894
sg11
g5876
sg12
S'amylase, alpha 1A (salivary)'
p5895
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03092_3030
p5896
sg16
V5-Hydroxymethyl-Chonduritol [drugbank:DB03092]
p5897
sg18
Vdrug-target interaction 5-Hydroxymethyl-Chonduritol and Salivary alpha-amylase [drugbank_resource:DB03092_3030]
p5898
sa(dp5899
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3030
p5900
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03439
p5901
sg11
g5876
sg12
S'amylase, alpha 1A (salivary)'
p5902
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03439_3030
p5903
sg16
V4,6-Dideoxy-4-Amino-Alpha-D-Glucose [drugbank:DB03439]
p5904
sg18
Vdrug-target interaction 4,6-Dideoxy-4-Amino-Alpha-D-Glucose and Salivary alpha-amylase [drugbank_resource:DB03439_3030]
p5905
sa(dp5906
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3030
p5907
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04237
p5908
sg11
g5876
sg12
S'amylase, alpha 1A (salivary)'
p5909
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04237_3030
p5910
sg16
VTris(Hydroxyethyl)Aminomethane [drugbank:DB04237]
p5911
sg18
Vdrug-target interaction Tris(Hydroxyethyl)Aminomethane and Salivary alpha-amylase [drugbank_resource:DB04237_3030]
p5912
sasS'LCK'
p5913
(lp5914
(dp5915
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p5916
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01254
p5917
sg11
g5913
sg12
S'lymphocyte-specific protein tyrosine kinase'
p5918
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01254_937
p5919
sg16
VDasatinib [drugbank:DB01254]
p5920
sg18
Vdrug-target interaction Dasatinib and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB01254_937]
p5921
sa(dp5922
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p5923
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01830
p5924
sg11
g5913
sg12
S'lymphocyte-specific protein tyrosine kinase'
p5925
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01830_937
p5926
sg16
V{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid [drugbank:DB01830]
p5927
sg18
Vdrug-target interaction {4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB01830_937]
p5928
sa(dp5929
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p5930
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02010
p5931
sg11
g5913
sg12
S'lymphocyte-specific protein tyrosine kinase'
p5932
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02010_937
p5933
sg16
VStaurosporine [drugbank:DB02010]
p5934
sg18
Vdrug-target interaction Staurosporine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB02010_937]
p5935
sa(dp5936
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p5937
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03023
p5938
sg11
g5913
sg12
S'lymphocyte-specific protein tyrosine kinase'
p5939
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03023_937
p5940
sg16
V1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine [drugbank:DB03023]
p5941
sg18
Vdrug-target interaction 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB03023_937]
p5942
sa(dp5943
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p5944
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p5945
sg11
g5913
sg12
S'lymphocyte-specific protein tyrosine kinase'
p5946
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_937
p5947
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p5948
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB04395_937]
p5949
sa(dp5950
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p5951
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04003
p5952
sg11
g5913
sg12
S'lymphocyte-specific protein tyrosine kinase'
p5953
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04003_937
p5954
sg16
V(4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid [drugbank:DB04003]
p5955
sg18
Vdrug-target interaction (4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB04003_937]
p5956
sa(dp5957
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p5958
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07146
p5959
sg11
g5913
sg12
S'lymphocyte-specific protein tyrosine kinase'
p5960
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07146_937
p5961
sg16
V2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE [drugbank:DB07146]
p5962
sg18
Vdrug-target interaction 2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB07146_937]
p5963
sa(dp5964
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p5965
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06925
p5966
sg11
g5913
sg12
S'lymphocyte-specific protein tyrosine kinase'
p5967
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06925_937
p5968
sg16
V3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE [drugbank:DB06925]
p5969
sg18
Vdrug-target interaction 3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB06925_937]
p5970
sa(dp5971
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p5972
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07297
p5973
sg11
g5913
sg12
S'lymphocyte-specific protein tyrosine kinase'
p5974
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07297_937
p5975
sg16
V5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE [drugbank:DB07297]
p5976
sg18
Vdrug-target interaction 5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB07297_937]
p5977
sa(dp5978
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p5979
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08055
p5980
sg11
g5913
sg12
S'lymphocyte-specific protein tyrosine kinase'
p5981
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08055_937
p5982
sg16
VN-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine [drugbank:DB08055]
p5983
sg18
Vdrug-target interaction N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB08055_937]
p5984
sa(dp5985
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p5986
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08056
p5987
sg11
g5913
sg12
S'lymphocyte-specific protein tyrosine kinase'
p5988
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08056_937
p5989
sg16
VN-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine [drugbank:DB08056]
p5990
sg18
Vdrug-target interaction N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB08056_937]
p5991
sa(dp5992
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:937
p5993
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08057
p5994
sg11
g5913
sg12
S'lymphocyte-specific protein tyrosine kinase'
p5995
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08057_937
p5996
sg16
VN-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine [drugbank:DB08057]
p5997
sg18
Vdrug-target interaction N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB08057_937]
p5998
sasS'BTK'
p5999
(lp6000
(dp6001
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2355
p6002
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01863
p6003
sg11
g5999
sg12
S'Bruton agammaglobulinemia tyrosine kinase'
p6004
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01863_2355
p6005
sg16
VInositol 1,3,4,5-Tetrakisphosphate [drugbank:DB01863]
p6006
sg18
Vdrug-target interaction Inositol 1,3,4,5-Tetrakisphosphate and Tyrosine-protein kinase BTK [drugbank_resource:DB01863_2355]
p6007
sasS'FAS'
p6008
(lp6009
(dp6010
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1295
p6011
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01034
p6012
sg11
S'FASN'
p6013
sg12
S'fatty acid synthase'
p6014
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01034_1295
p6015
sg16
VCerulenin [drugbank:DB01034]
p6016
sg18
Vdrug-target interaction Cerulenin and Fatty acid synthase [drugbank_resource:DB01034_1295]
p6017
sa(dp6018
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1295
p6019
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01083
p6020
sg11
g6013
sg12
g6014
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01083_1295
p6021
sg16
VOrlistat [drugbank:DB01083]
p6022
sg18
Vdrug-target interaction Orlistat and Fatty acid synthase [drugbank_resource:DB01083_1295]
p6023
sasS'HDAC1'
p6024
(lp6025
(dp6026
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4121
p6027
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02546
p6028
sg11
g6024
sg12
S'histone deacetylase 1'
p6029
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02546_4121
p6030
sg16
VVorinostat [drugbank:DB02546]
p6031
sg18
Vdrug-target interaction Vorinostat and Histone deacetylase 1 [drugbank_resource:DB02546_4121]
p6032
sasS'PDGFRA'
p6033
(lp6034
(dp6035
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:950
p6036
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00102
p6037
sg11
g6033
sg12
S'platelet-derived growth factor receptor, alpha polypeptide'
p6038
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00102_950
p6039
sg16
VBecaplermin [drugbank:DB00102]
p6040
sg18
Vdrug-target interaction Becaplermin and Alpha platelet-derived growth factor receptor [drugbank_resource:DB00102_950]
p6041
sa(dp6042
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:950
p6043
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00619
p6044
sg11
g6033
sg12
S'platelet-derived growth factor receptor, alpha polypeptide'
p6045
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00619_950
p6046
sg16
VImatinib [drugbank:DB00619]
p6047
sg18
Vdrug-target interaction Imatinib and Alpha platelet-derived growth factor receptor [drugbank_resource:DB00619_950]
p6048
sa(dp6049
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:950
p6050
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01268
p6051
sg11
g6033
sg12
S'platelet-derived growth factor receptor, alpha polypeptide'
p6052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01268_950
p6053
sg16
VSunitinib [drugbank:DB01268]
p6054
sg18
Vdrug-target interaction Sunitinib and Alpha platelet-derived growth factor receptor [drugbank_resource:DB01268_950]
p6055
sasS'HDAC2'
p6056
(lp6057
(dp6058
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4122
p6059
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00227
p6060
sg11
g6056
sg12
S'histone deacetylase 2'
p6061
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00227_4122
p6062
sg16
VLovastatin [drugbank:DB00227]
p6063
sg18
Vdrug-target interaction Lovastatin and Histone deacetylase 2 [drugbank_resource:DB00227_4122]
p6064
sa(dp6065
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4122
p6066
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02546
p6067
sg11
g6056
sg12
S'histone deacetylase 2'
p6068
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02546_4122
p6069
sg16
VVorinostat [drugbank:DB02546]
p6070
sg18
Vdrug-target interaction Vorinostat and Histone deacetylase 2 [drugbank_resource:DB02546_4122]
p6071
sasS'HDAC4'
p6072
(lp6073
(dp6074
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6003
p6075
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07879
p6076
sg11
g6072
sg12
S'histone deacetylase 4'
p6077
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07879_6003
p6078
sg16
VN-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide [drugbank:DB07879]
p6079
sg18
Vdrug-target interaction N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide and Histone deacetylase 4 [drugbank_resource:DB07879_6003]
p6080
sa(dp6081
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6003
p6082
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08613
p6083
sg11
g6072
sg12
S'histone deacetylase 4'
p6084
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08613_6003
p6085
sg16
V2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL [drugbank:DB08613]
p6086
sg18
Vdrug-target interaction 2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL and Histone deacetylase 4 [drugbank_resource:DB08613_6003]
p6087
sasS'MAP2K1'
p6088
(lp6089
(dp6090
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:990
p6091
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02152
p6092
sg11
g6088
sg12
S'mitogen-activated protein kinase kinase 1'
p6093
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02152_990
p6094
sg16
VK-252a [drugbank:DB02152]
p6095
sg18
Vdrug-target interaction K-252a and Dual specificity mitogen-activated protein kinase kinase 1 [drugbank_resource:DB02152_990]
p6096
sa(dp6097
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:990
p6098
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03115
p6099
sg11
g6088
sg12
S'mitogen-activated protein kinase kinase 1'
p6100
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03115_990
p6101
sg16
V5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide [drugbank:DB03115]
p6102
sg18
Vdrug-target interaction 5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide and Dual specificity mitogen-activated protein kinase kinase 1 [drugbank_resource:DB03115_990]
p6103
sa(dp6104
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:990
p6105
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07046
p6106
sg11
g6088
sg12
S'mitogen-activated protein kinase kinase 1'
p6107
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07046_990
p6108
sg16
V2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide [drugbank:DB07046]
p6109
sg18
Vdrug-target interaction 2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide and Dual specificity mitogen-activated protein kinase kinase 1 [drugbank_resource:DB07046_990]
p6110
sa(dp6111
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:990
p6112
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07101
p6113
sg11
g6088
sg12
S'mitogen-activated protein kinase kinase 1'
p6114
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07101_990
p6115
sg16
VN-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide [drugbank:DB07101]
p6116
sg18
Vdrug-target interaction N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide and Dual specificity mitogen-activated protein kinase kinase 1 [drugbank_resource:DB07101_990]
p6117
sa(dp6118
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:990
p6119
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06892
p6120
sg11
g6088
sg12
S'mitogen-activated protein kinase kinase 1'
p6121
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06892_990
p6122
sg16
V(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide [drugbank:DB06892]
p6123
sg18
Vdrug-target interaction (5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide and Dual specificity mitogen-activated protein kinase kinase 1 [drugbank_resource:DB06892_990]
p6124
sa(dp6125
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:990
p6126
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08130
p6127
sg11
g6088
sg12
S'mitogen-activated protein kinase kinase 1'
p6128
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08130_990
p6129
sg16
VN-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine [drugbank:DB08130]
p6130
sg18
Vdrug-target interaction N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine and Dual specificity mitogen-activated protein kinase kinase 1 [drugbank_resource:DB08130_990]
p6131
sa(dp6132
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:990
p6133
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08208
p6134
sg11
g6088
sg12
S'mitogen-activated protein kinase kinase 1'
p6135
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08208_990
p6136
sg16
V2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE [drugbank:DB08208]
p6137
sg18
Vdrug-target interaction 2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE and Dual specificity mitogen-activated protein kinase kinase 1 [drugbank_resource:DB08208_990]
p6138
sasS'HDAC6'
p6139
(lp6140
(dp6141
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4124
p6142
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02546
p6143
sg11
g6139
sg12
S'histone deacetylase 6'
p6144
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02546_4124
p6145
sg16
VVorinostat [drugbank:DB02546]
p6146
sg18
Vdrug-target interaction Vorinostat and Histone deacetylase 6 [drugbank_resource:DB02546_4124]
p6147
sasS'HDAC9'
p6148
(lp6149
(dp6150
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1039
p6151
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00313
p6152
sg11
g6148
sg12
S'histone deacetylase 9'
p6153
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00313_1039
p6154
sg16
VValproic Acid [drugbank:DB00313]
p6155
sg18
Vdrug-target interaction Valproic Acid and Histone deacetylase 9 [drugbank_resource:DB00313_1039]
p6156
sasS'MYO1D'
p6157
(lp6158
(dp6159
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7085
p6160
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p6161
sg11
g6157
sg12
S'myosin ID'
p6162
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_7085
p6163
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p6164
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Myosin-Id [drugbank_resource:DB03431_7085]
p6165
sasS'SMAD1'
p6166
(lp6167
(dp6168
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1466
p6169
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00145
p6170
sg11
S'GARS'
p6171
sg12
S'glycyl-tRNA synthetase'
p6172
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00145_1466
p6173
sg16
VGlycine [drugbank:DB00145]
p6174
sg18
Vdrug-target interaction Glycine and Glycyl-tRNA synthetase [drugbank_resource:DB00145_1466]
p6175
sasS'SMAD2'
p6176
(lp6177
(dp6178
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6955
p6179
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04522
p6180
sg11
g6176
sg12
S'SMAD family member 2'
p6181
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04522_6955
p6182
sg16
VPhosphonoserine [drugbank:DB04522]
p6183
sg18
Vdrug-target interaction Phosphonoserine and Mothers against decapentaplegic homolog 2 [drugbank_resource:DB04522_6955]
p6184
sasS'PIK3R3'
p6185
(lp6186
(dp6187
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4146
p6188
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01064
p6189
sg11
g6185
sg12
S'phosphoinositide-3-kinase, regulatory subunit 3 (gamma)'
p6190
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01064_4146
p6191
sg16
VIsoproterenol [drugbank:DB01064]
p6192
sg18
Vdrug-target interaction Isoproterenol and Phosphatidylinositol 3-kinase regulatory subunit gamma [drugbank_resource:DB01064_4146]
p6193
sasS'MAPK14'
p6194
(lp6195
(dp6196
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6197
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01807
p6198
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6199
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01807_1540
p6200
sg16
VN-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea [drugbank:DB01807]
p6201
sg18
Vdrug-target interaction N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea and Mitogen-activated protein kinase 14 [drugbank_resource:DB01807_1540]
p6202
sa(dp6203
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6204
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01761
p6205
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6206
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01761_1540
p6207
sg16
V4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine [drugbank:DB01761]
p6208
sg18
Vdrug-target interaction 4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine and Mitogen-activated protein kinase 14 [drugbank_resource:DB01761_1540]
p6209
sa(dp6210
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6211
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01948
p6212
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6213
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01948_1540
p6214
sg16
V1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One [drugbank:DB01948]
p6215
sg18
Vdrug-target interaction 1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One and Mitogen-activated protein kinase 14 [drugbank_resource:DB01948_1540]
p6216
sa(dp6217
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6218
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01988
p6219
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6220
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01988_1540
p6221
sg16
V6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine [drugbank:DB01988]
p6222
sg18
Vdrug-target interaction 6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine and Mitogen-activated protein kinase 14 [drugbank_resource:DB01988_1540]
p6223
sa(dp6224
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6225
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02195
p6226
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6227
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02195_1540
p6228
sg16
V3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine [drugbank:DB02195]
p6229
sg18
Vdrug-target interaction 3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine and Mitogen-activated protein kinase 14 [drugbank_resource:DB02195_1540]
p6230
sa(dp6231
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6232
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01953
p6233
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6234
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01953_1540
p6235
sg16
VInhibitor of P38 Kinase [drugbank:DB01953]
p6236
sg18
Vdrug-target interaction Inhibitor of P38 Kinase and Mitogen-activated protein kinase 14 [drugbank_resource:DB01953_1540]
p6237
sa(dp6238
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6239
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02352
p6240
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6241
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02352_1540
p6242
sg16
V3-(Benzyloxy)Pyridin-2-Amine [drugbank:DB02352]
p6243
sg18
Vdrug-target interaction 3-(Benzyloxy)Pyridin-2-Amine and Mitogen-activated protein kinase 14 [drugbank_resource:DB02352_1540]
p6244
sa(dp6245
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6246
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02277
p6247
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6248
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02277_1540
p6249
sg16
V1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea [drugbank:DB02277]
p6250
sg18
Vdrug-target interaction 1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea and Mitogen-activated protein kinase 14 [drugbank_resource:DB02277_1540]
p6251
sa(dp6252
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6253
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02873
p6254
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6255
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02873_1540
p6256
sg16
V1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One [drugbank:DB02873]
p6257
sg18
Vdrug-target interaction 1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One and Mitogen-activated protein kinase 14 [drugbank_resource:DB02873_1540]
p6258
sa(dp6259
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6260
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03044
p6261
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6262
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03044_1540
p6263
sg16
V1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea [drugbank:DB03044]
p6264
sg18
Vdrug-target interaction 1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea and Mitogen-activated protein kinase 14 [drugbank_resource:DB03044_1540]
p6265
sa(dp6266
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6267
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02984
p6268
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6269
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02984_1540
p6270
sg16
V4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline [drugbank:DB02984]
p6271
sg18
Vdrug-target interaction 4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline and Mitogen-activated protein kinase 14 [drugbank_resource:DB02984_1540]
p6272
sa(dp6273
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6274
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03110
p6275
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6276
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03110_1540
p6277
sg16
V2-Chlorophenol [drugbank:DB03110]
p6278
sg18
Vdrug-target interaction 2-Chlorophenol and Mitogen-activated protein kinase 14 [drugbank_resource:DB03110_1540]
p6279
sa(dp6280
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6281
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03980
p6282
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6283
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03980_1540
p6284
sg16
V4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole [drugbank:DB03980]
p6285
sg18
Vdrug-target interaction 4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole and Mitogen-activated protein kinase 14 [drugbank_resource:DB03980_1540]
p6286
sa(dp6287
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6288
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04338
p6289
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6290
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04338_1540
p6291
sg16
VSB220025 [drugbank:DB04338]
p6292
sg18
Vdrug-target interaction SB220025 and Mitogen-activated protein kinase 14 [drugbank_resource:DB04338_1540]
p6293
sa(dp6294
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6295
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04797
p6296
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6297
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04797_1540
p6298
sg16
VTriazolopyridine [drugbank:DB04797]
p6299
sg18
Vdrug-target interaction Triazolopyridine and Mitogen-activated protein kinase 14 [drugbank_resource:DB04797_1540]
p6300
sa(dp6301
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6302
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06940
p6303
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06940_1540
p6305
sg16
VN-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide [drugbank:DB06940]
p6306
sg18
Vdrug-target interaction N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB06940_1540]
p6307
sa(dp6308
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6309
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04632
p6310
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6311
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04632_1540
p6312
sg16
V4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE [drugbank:DB04632]
p6313
sg18
Vdrug-target interaction 4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE and Mitogen-activated protein kinase 14 [drugbank_resource:DB04632_1540]
p6314
sa(dp6315
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6316
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06882
p6317
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6318
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06882_1540
p6319
sg16
V1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea [drugbank:DB06882]
p6320
sg18
Vdrug-target interaction 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea and Mitogen-activated protein kinase 14 [drugbank_resource:DB06882_1540]
p6321
sa(dp6322
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6323
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06991
p6324
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6325
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06991_1540
p6326
sg16
VN-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide [drugbank:DB06991]
p6327
sg18
Vdrug-target interaction N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB06991_1540]
p6328
sa(dp6329
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6330
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07138
p6331
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6332
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07138_1540
p6333
sg16
V5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-b]pyridazin-6-one [drugbank:DB07138]
p6334
sg18
Vdrug-target interaction 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-b]pyridazin-6-one and Mitogen-activated protein kinase 14 [drugbank_resource:DB07138_1540]
p6335
sa(dp6336
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6337
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07307
p6338
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07307_1540
p6340
sg16
VN-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide [drugbank:DB07307]
p6341
sg18
Vdrug-target interaction N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB07307_1540]
p6342
sa(dp6343
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6344
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07459
p6345
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6346
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07459_1540
p6347
sg16
V4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE [drugbank:DB07459]
p6348
sg18
Vdrug-target interaction 4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE and Mitogen-activated protein kinase 14 [drugbank_resource:DB07459_1540]
p6349
sa(dp6350
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6351
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07607
p6352
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6353
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07607_1540
p6354
sg16
V4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE [drugbank:DB07607]
p6355
sg18
Vdrug-target interaction 4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE and Mitogen-activated protein kinase 14 [drugbank_resource:DB07607_1540]
p6356
sa(dp6357
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6358
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07811
p6359
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6360
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07811_1540
p6361
sg16
VN-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide [drugbank:DB07811]
p6362
sg18
Vdrug-target interaction N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB07811_1540]
p6363
sa(dp6364
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6365
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07829
p6366
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6367
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07829_1540
p6368
sg16
V4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE [drugbank:DB07829]
p6369
sg18
Vdrug-target interaction 4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE and Mitogen-activated protein kinase 14 [drugbank_resource:DB07829_1540]
p6370
sa(dp6371
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6372
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07832
p6373
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6374
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07832_1540
p6375
sg16
V4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde [drugbank:DB07832]
p6376
sg18
Vdrug-target interaction 4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde and Mitogen-activated protein kinase 14 [drugbank_resource:DB07832_1540]
p6377
sa(dp6378
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6379
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07833
p6380
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07833_1540
p6382
sg16
VN-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide [drugbank:DB07833]
p6383
sg18
Vdrug-target interaction N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB07833_1540]
p6384
sa(dp6385
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6386
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07834
p6387
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6388
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07834_1540
p6389
sg16
VN-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide [drugbank:DB07834]
p6390
sg18
Vdrug-target interaction N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB07834_1540]
p6391
sa(dp6392
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6393
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08092
p6394
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6395
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08092_1540
p6396
sg16
V3-FLUORO-N-1H-INDOL-5-YL-5-MORPHOLIN-4-YLBENZAMIDE [drugbank:DB08092]
p6397
sg18
Vdrug-target interaction 3-FLUORO-N-1H-INDOL-5-YL-5-MORPHOLIN-4-YLBENZAMIDE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08092_1540]
p6398
sa(dp6399
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6400
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08093
p6401
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6402
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08093_1540
p6403
sg16
V3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE [drugbank:DB08093]
p6404
sg18
Vdrug-target interaction 3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08093_1540]
p6405
sa(dp6406
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6407
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08097
p6408
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6409
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08097_1540
p6410
sg16
V2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE [drugbank:DB08097]
p6411
sg18
Vdrug-target interaction 2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08097_1540]
p6412
sa(dp6413
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6414
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08351
p6415
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6416
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08351_1540
p6417
sg16
VN-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide [drugbank:DB08351]
p6418
sg18
Vdrug-target interaction N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB08351_1540]
p6419
sa(dp6420
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6421
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08424
p6422
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6423
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08424_1540
p6424
sg16
V[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE [drugbank:DB08424]
p6425
sg18
Vdrug-target interaction [5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08424_1540]
p6426
sa(dp6427
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6428
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08730
p6429
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6430
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08730_1540
p6431
sg16
V3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE [drugbank:DB08730]
p6432
sg18
Vdrug-target interaction 3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08730_1540]
p6433
sa(dp6434
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6435
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07835
p6436
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6437
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07835_1540
p6438
sg16
VN~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide [drugbank:DB07835]
p6439
sg18
Vdrug-target interaction N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB07835_1540]
p6440
sa(dp6441
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6442
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08091
p6443
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6444
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08091_1540
p6445
sg16
V3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE [drugbank:DB08091]
p6446
sg18
Vdrug-target interaction 3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08091_1540]
p6447
sa(dp6448
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6449
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08096
p6450
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6451
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08096_1540
p6452
sg16
V8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM [drugbank:DB08096]
p6453
sg18
Vdrug-target interaction 8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM and Mitogen-activated protein kinase 14 [drugbank_resource:DB08096_1540]
p6454
sa(dp6455
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6456
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08242
p6457
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6458
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08242_1540
p6459
sg16
VN,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide [drugbank:DB08242]
p6460
sg18
Vdrug-target interaction N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB08242_1540]
p6461
sa(dp6462
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6463
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08352
p6464
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6465
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08352_1540
p6466
sg16
V6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine [drugbank:DB08352]
p6467
sg18
Vdrug-target interaction 6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine and Mitogen-activated protein kinase 14 [drugbank_resource:DB08352_1540]
p6468
sa(dp6469
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6470
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08522
p6471
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6472
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08522_1540
p6473
sg16
V4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE [drugbank:DB08522]
p6474
sg18
Vdrug-target interaction 4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08522_1540]
p6475
sa(dp6476
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6477
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07941
p6478
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6479
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07941_1540
p6480
sg16
V3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide [drugbank:DB07941]
p6481
sg18
Vdrug-target interaction 3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB07941_1540]
p6482
sa(dp6483
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6484
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07942
p6485
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6486
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07942_1540
p6487
sg16
V2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine [drugbank:DB07942]
p6488
sg18
Vdrug-target interaction 2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine and Mitogen-activated protein kinase 14 [drugbank_resource:DB07942_1540]
p6489
sa(dp6490
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6491
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07943
p6492
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6493
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07943_1540
p6494
sg16
V2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol [drugbank:DB07943]
p6495
sg18
Vdrug-target interaction 2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol and Mitogen-activated protein kinase 14 [drugbank_resource:DB07943_1540]
p6496
sa(dp6497
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6498
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08064
p6499
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6500
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08064_1540
p6501
sg16
VN-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA [drugbank:DB08064]
p6502
sg18
Vdrug-target interaction N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA and Mitogen-activated protein kinase 14 [drugbank_resource:DB08064_1540]
p6503
sa(dp6504
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6505
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08068
p6506
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6507
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08068_1540
p6508
sg16
VN-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO- [drugbank:DB08068]
p6509
sg18
Vdrug-target interaction N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO- and Mitogen-activated protein kinase 14 [drugbank_resource:DB08068_1540]
p6510
sa(dp6511
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6512
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08095
p6513
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6514
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08095_1540
p6515
sg16
V3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA [drugbank:DB08095]
p6516
sg18
Vdrug-target interaction 3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA and Mitogen-activated protein kinase 14 [drugbank_resource:DB08095_1540]
p6517
sa(dp6518
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6519
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08349
p6520
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6521
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08349_1540
p6522
sg16
VN-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide [drugbank:DB08349]
p6523
sg18
Vdrug-target interaction N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB08349_1540]
p6524
sa(dp6525
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6526
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08395
p6527
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6528
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08395_1540
p6529
sg16
V2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE [drugbank:DB08395]
p6530
sg18
Vdrug-target interaction 2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08395_1540]
p6531
sa(dp6532
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6533
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08423
p6534
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6535
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08423_1540
p6536
sg16
V[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE [drugbank:DB08423]
p6537
sg18
Vdrug-target interaction [5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08423_1540]
p6538
sa(dp6539
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1540
p6540
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08521
p6541
sg11
g6194
sg12
S'mitogen-activated protein kinase 14'
p6542
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08521_1540
p6543
sg16
V4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE [drugbank:DB08521]
p6544
sg18
Vdrug-target interaction 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08521_1540]
p6545
sasS'ISG20'
p6546
(lp6547
(dp6548
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3529
p6549
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03685
p6550
sg11
g6546
sg12
S'interferon stimulated exonuclease gene 20kDa'
p6551
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03685_3529
p6552
sg16
VUridine-5'-Monophosphate [drugbank:DB03685]
p6553
sg18
Vdrug-target interaction Uridine-5'-Monophosphate and Interferon-stimulated gene 20 kDa protein [drugbank_resource:DB03685_3529]
p6554
sasS'SNAP25'
p6555
(lp6556
(dp6557
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:433
p6558
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00083
p6559
sg11
g6555
sg12
S'synaptosomal-associated protein, 25kDa'
p6560
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00083_433
p6561
sg16
VBotulinum Toxin Type A [drugbank:DB00083]
p6562
sg18
Vdrug-target interaction Botulinum Toxin Type A and Synaptosomal-associated protein 25 [drugbank_resource:DB00083_433]
p6563
sasS'PRKAR2B'
p6564
(lp6565
(dp6566
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7007
p6567
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02527
p6568
sg11
g6564
sg12
S'protein kinase, cAMP-dependent, regulatory, type II, beta'
p6569
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02527_7007
p6570
sg16
VCyclic Adenosine Monophosphate [drugbank:DB02527]
p6571
sg18
Vdrug-target interaction Cyclic Adenosine Monophosphate and cAMP-dependent protein kinase type II-beta regulatory subunit [drugbank_resource:DB02527_7007]
p6572
sasS'KIF11'
p6573
(lp6574
(dp6575
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p6576
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p6577
sg11
g6573
sg12
S'kinesin family member 11'
p6578
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_3379
p6579
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p6580
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Kinesin-like protein KIF11 [drugbank_resource:DB03431_3379]
p6581
sa(dp6582
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p6583
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04331
p6584
sg11
g6573
sg12
S'kinesin family member 11'
p6585
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04331_3379
p6586
sg16
VMonastrol [drugbank:DB04331]
p6587
sg18
Vdrug-target interaction Monastrol and Kinesin-like protein KIF11 [drugbank_resource:DB04331_3379]
p6588
sa(dp6589
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p6590
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03996
p6591
sg11
g6573
sg12
S'kinesin family member 11'
p6592
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03996_3379
p6593
sg16
V3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol [drugbank:DB03996]
p6594
sg18
Vdrug-target interaction 3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol and Kinesin-like protein KIF11 [drugbank_resource:DB03996_3379]
p6595
sa(dp6596
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p6597
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07064
p6598
sg11
g6573
sg12
S'kinesin family member 11'
p6599
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07064_3379
p6600
sg16
V(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE [drugbank:DB07064]
p6601
sg18
Vdrug-target interaction (4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB07064_3379]
p6602
sa(dp6603
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p6604
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08033
p6605
sg11
g6573
sg12
S'kinesin family member 11'
p6606
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08033_3379
p6607
sg16
V(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE [drugbank:DB08033]
p6608
sg18
Vdrug-target interaction (5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08033_3379]
p6609
sa(dp6610
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p6611
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08037
p6612
sg11
g6573
sg12
S'kinesin family member 11'
p6613
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08037_3379
p6614
sg16
V(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide [drugbank:DB08037]
p6615
sg18
Vdrug-target interaction (2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide and Kinesin-like protein KIF11 [drugbank_resource:DB08037_3379]
p6616
sa(dp6617
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p6618
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08246
p6619
sg11
g6573
sg12
S'kinesin family member 11'
p6620
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08246_3379
p6621
sg16
V(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE [drugbank:DB08246]
p6622
sg18
Vdrug-target interaction (2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08246_3379]
p6623
sa(dp6624
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p6625
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08032
p6626
sg11
g6573
sg12
S'kinesin family member 11'
p6627
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08032_3379
p6628
sg16
VN,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE [drugbank:DB08032]
p6629
sg18
Vdrug-target interaction N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08032_3379]
p6630
sa(dp6631
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p6632
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08198
p6633
sg11
g6573
sg12
S'kinesin family member 11'
p6634
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08198_3379
p6635
sg16
V[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE [drugbank:DB08198]
p6636
sg18
Vdrug-target interaction [(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE and Kinesin-like protein KIF11 [drugbank_resource:DB08198_3379]
p6637
sa(dp6638
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p6639
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08244
p6640
sg11
g6573
sg12
S'kinesin family member 11'
p6641
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08244_3379
p6642
sg16
V(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE [drugbank:DB08244]
p6643
sg18
Vdrug-target interaction (1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE and Kinesin-like protein KIF11 [drugbank_resource:DB08244_3379]
p6644
sa(dp6645
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p6646
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08239
p6647
sg11
g6573
sg12
S'kinesin family member 11'
p6648
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08239_3379
p6649
sg16
V(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE [drugbank:DB08239]
p6650
sg18
Vdrug-target interaction (2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08239_3379]
p6651
sa(dp6652
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3379
p6653
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08250
p6654
sg11
g6573
sg12
S'kinesin family member 11'
p6655
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08250_3379
p6656
sg16
V(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE [drugbank:DB08250]
p6657
sg18
Vdrug-target interaction (5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08250_3379]
p6658
sasS'CD2'
p6659
(lp6660
(dp6661
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:793
p6662
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00092
p6663
sg11
g6659
sg12
S'CD2 molecule'
p6664
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00092_793
p6665
sg16
VAlefacept [drugbank:DB00092]
p6666
sg18
Vdrug-target interaction Alefacept and T-cell surface antigen CD2 [drugbank_resource:DB00092_793]
p6667
sa(dp6668
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:793
p6669
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02944
p6670
sg11
g6659
sg12
S'CD2 molecule'
p6671
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02944_793
p6672
sg16
VAlpha-D-Mannose [drugbank:DB02944]
p6673
sg18
Vdrug-target interaction Alpha-D-Mannose and T-cell surface antigen CD2 [drugbank_resource:DB02944_793]
p6674
sasS'GABRA5'
p6675
(lp6676
(dp6677
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6678
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00237
p6679
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6680
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00237_523
p6681
sg16
VButabarbital [drugbank:DB00237]
p6682
sg18
Vdrug-target interaction Butabarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00237_523]
p6683
sa(dp6684
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6685
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00241
p6686
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6687
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00241_523
p6688
sg16
VButalbital [drugbank:DB00241]
p6689
sg18
Vdrug-target interaction Butalbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00241_523]
p6690
sa(dp6691
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6692
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00186
p6693
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6694
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00186_523
p6695
sg16
VLorazepam [drugbank:DB00186]
p6696
sg18
Vdrug-target interaction Lorazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00186_523]
p6697
sa(dp6698
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6699
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00189
p6700
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6701
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00189_523
p6702
sg16
VEthchlorvynol [drugbank:DB00189]
p6703
sg18
Vdrug-target interaction Ethchlorvynol and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00189_523]
p6704
sa(dp6705
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6706
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00231
p6707
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6708
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00231_523
p6709
sg16
VTemazepam [drugbank:DB00231]
p6710
sg18
Vdrug-target interaction Temazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00231_523]
p6711
sa(dp6712
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6713
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00312
p6714
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6715
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00312_523
p6716
sg16
VPentobarbital [drugbank:DB00312]
p6717
sg18
Vdrug-target interaction Pentobarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00312_523]
p6718
sa(dp6719
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6720
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00418
p6721
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6722
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00418_523
p6723
sg16
VSecobarbital [drugbank:DB00418]
p6724
sg18
Vdrug-target interaction Secobarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00418_523]
p6725
sa(dp6726
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6727
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00463
p6728
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6729
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00463_523
p6730
sg16
VMetharbital [drugbank:DB00463]
p6731
sg18
Vdrug-target interaction Metharbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00463_523]
p6732
sa(dp6733
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6734
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00475
p6735
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6736
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00475_523
p6737
sg16
VChlordiazepoxide [drugbank:DB00475]
p6738
sg18
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00475_523]
p6739
sa(dp6740
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6741
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00546
p6742
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6743
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00546_523
p6744
sg16
VAdinazolam [drugbank:DB00546]
p6745
sg18
Vdrug-target interaction Adinazolam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00546_523]
p6746
sa(dp6747
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6748
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00628
p6749
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6750
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00628_523
p6751
sg16
VClorazepate [drugbank:DB00628]
p6752
sg18
Vdrug-target interaction Clorazepate and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00628_523]
p6753
sa(dp6754
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6755
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00306
p6756
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6757
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00306_523
p6758
sg16
VTalbutal [drugbank:DB00306]
p6759
sg18
Vdrug-target interaction Talbutal and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00306_523]
p6760
sa(dp6761
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6762
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00349
p6763
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6764
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00349_523
p6765
sg16
VClobazam [drugbank:DB00349]
p6766
sg18
Vdrug-target interaction Clobazam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00349_523]
p6767
sa(dp6768
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6769
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00371
p6770
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6771
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00371_523
p6772
sg16
VMeprobamate [drugbank:DB00371]
p6773
sg18
Vdrug-target interaction Meprobamate and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00371_523]
p6774
sa(dp6775
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6776
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00402
p6777
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6778
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00402_523
p6779
sg16
VEszopiclone [drugbank:DB00402]
p6780
sg18
Vdrug-target interaction Eszopiclone and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00402_523]
p6781
sa(dp6782
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6783
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00404
p6784
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6785
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00404_523
p6786
sg16
VAlprazolam [drugbank:DB00404]
p6787
sg18
Vdrug-target interaction Alprazolam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00404_523]
p6788
sa(dp6789
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6790
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00599
p6791
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6792
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00599_523
p6793
sg16
VThiopental [drugbank:DB00599]
p6794
sg18
Vdrug-target interaction Thiopental and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00599_523]
p6795
sa(dp6796
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6797
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00683
p6798
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6799
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00683_523
p6800
sg16
VMidazolam [drugbank:DB00683]
p6801
sg18
Vdrug-target interaction Midazolam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00683_523]
p6802
sa(dp6803
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6804
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00690
p6805
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6806
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00690_523
p6807
sg16
VFlurazepam [drugbank:DB00690]
p6808
sg18
Vdrug-target interaction Flurazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00690_523]
p6809
sa(dp6810
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6811
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00794
p6812
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6813
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00794_523
p6814
sg16
VPrimidone [drugbank:DB00794]
p6815
sg18
Vdrug-target interaction Primidone and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00794_523]
p6816
sa(dp6817
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6818
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00829
p6819
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6820
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00829_523
p6821
sg16
VDiazepam [drugbank:DB00829]
p6822
sg18
Vdrug-target interaction Diazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00829_523]
p6823
sa(dp6824
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6825
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00842
p6826
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6827
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00842_523
p6828
sg16
VOxazepam [drugbank:DB00842]
p6829
sg18
Vdrug-target interaction Oxazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00842_523]
p6830
sa(dp6831
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6832
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00801
p6833
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6834
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00801_523
p6835
sg16
VHalazepam [drugbank:DB00801]
p6836
sg18
Vdrug-target interaction Halazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00801_523]
p6837
sa(dp6838
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6839
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00849
p6840
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6841
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00849_523
p6842
sg16
VMethylphenobarbital [drugbank:DB00849]
p6843
sg18
Vdrug-target interaction Methylphenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00849_523]
p6844
sa(dp6845
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6846
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01068
p6847
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6848
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01068_523
p6849
sg16
VClonazepam [drugbank:DB01068]
p6850
sg18
Vdrug-target interaction Clonazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01068_523]
p6851
sa(dp6852
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6853
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00897
p6854
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6855
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00897_523
p6856
sg16
VTriazolam [drugbank:DB00897]
p6857
sg18
Vdrug-target interaction Triazolam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00897_523]
p6858
sa(dp6859
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6860
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01215
p6861
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6862
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01215_523
p6863
sg16
VEstazolam [drugbank:DB01215]
p6864
sg18
Vdrug-target interaction Estazolam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01215_523]
p6865
sa(dp6866
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6867
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01354
p6868
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6869
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01354_523
p6870
sg16
VHeptabarbital [drugbank:DB01354]
p6871
sg18
Vdrug-target interaction Heptabarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01354_523]
p6872
sa(dp6873
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6874
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01558
p6875
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6876
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01558_523
p6877
sg16
VBromazepam [drugbank:DB01558]
p6878
sg18
Vdrug-target interaction Bromazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01558_523]
p6879
sa(dp6880
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6881
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01588
p6882
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6883
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01588_523
p6884
sg16
VPrazepam [drugbank:DB01588]
p6885
sg18
Vdrug-target interaction Prazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01588_523]
p6886
sa(dp6887
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6888
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01589
p6889
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6890
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01589_523
p6891
sg16
VQuazepam [drugbank:DB01589]
p6892
sg18
Vdrug-target interaction Quazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01589_523]
p6893
sa(dp6894
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6895
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01174
p6896
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6897
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01174_523
p6898
sg16
VPhenobarbital [drugbank:DB01174]
p6899
sg18
Vdrug-target interaction Phenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01174_523]
p6900
sa(dp6901
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6902
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01198
p6903
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6904
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01198_523
p6905
sg16
VZopiclone [drugbank:DB01198]
p6906
sg18
Vdrug-target interaction Zopiclone and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01198_523]
p6907
sa(dp6908
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6909
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01352
p6910
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6911
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01352_523
p6912
sg16
VAprobarbital [drugbank:DB01352]
p6913
sg18
Vdrug-target interaction Aprobarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01352_523]
p6914
sa(dp6915
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6916
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01355
p6917
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6918
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01355_523
p6919
sg16
VHexobarbital [drugbank:DB01355]
p6920
sg18
Vdrug-target interaction Hexobarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01355_523]
p6921
sa(dp6922
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6923
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01544
p6924
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6925
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01544_523
p6926
sg16
VFlunitrazepam [drugbank:DB01544]
p6927
sg18
Vdrug-target interaction Flunitrazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01544_523]
p6928
sa(dp6929
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6930
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01559
p6931
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6932
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01559_523
p6933
sg16
VClotiazepam [drugbank:DB01559]
p6934
sg18
Vdrug-target interaction Clotiazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01559_523]
p6935
sa(dp6936
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6937
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01567
p6938
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6939
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01567_523
p6940
sg16
VFludiazepam [drugbank:DB01567]
p6941
sg18
Vdrug-target interaction Fludiazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01567_523]
p6942
sa(dp6943
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6944
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01205
p6945
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6946
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01205_523
p6947
sg16
VFlumazenil [drugbank:DB01205]
p6948
sg18
Vdrug-target interaction Flumazenil and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01205_523]
p6949
sa(dp6950
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6951
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01351
p6952
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6953
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01351_523
p6954
sg16
VAmobarbital [drugbank:DB01351]
p6955
sg18
Vdrug-target interaction Amobarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01351_523]
p6956
sa(dp6957
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6958
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01353
p6959
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6960
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01353_523
p6961
sg16
VButethal [drugbank:DB01353]
p6962
sg18
Vdrug-target interaction Butethal and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01353_523]
p6963
sa(dp6964
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6965
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01483
p6966
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6967
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01483_523
p6968
sg16
VBarbital [drugbank:DB01483]
p6969
sg18
Vdrug-target interaction Barbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01483_523]
p6970
sa(dp6971
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6972
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01496
p6973
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6974
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01496_523
p6975
sg16
VBarbituric acid derivative [drugbank:DB01496]
p6976
sg18
Vdrug-target interaction Barbituric acid derivative and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01496_523]
p6977
sa(dp6978
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6979
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01594
p6980
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6981
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01594_523
p6982
sg16
VCinolazepam [drugbank:DB01594]
p6983
sg18
Vdrug-target interaction Cinolazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01594_523]
p6984
sa(dp6985
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:523
p6986
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01595
p6987
sg11
g6675
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 5'
p6988
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01595_523
p6989
sg16
VNitrazepam [drugbank:DB01595]
p6990
sg18
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01595_523]
p6991
sasS'GABRA4'
p6992
(lp6993
(dp6994
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p6995
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00186
p6996
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p6997
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00186_530
p6998
sg16
VLorazepam [drugbank:DB00186]
p6999
sg18
Vdrug-target interaction Lorazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00186_530]
p7000
sa(dp7001
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7002
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00189
p7003
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7004
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00189_530
p7005
sg16
VEthchlorvynol [drugbank:DB00189]
p7006
sg18
Vdrug-target interaction Ethchlorvynol and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00189_530]
p7007
sa(dp7008
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7009
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00231
p7010
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7011
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00231_530
p7012
sg16
VTemazepam [drugbank:DB00231]
p7013
sg18
Vdrug-target interaction Temazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00231_530]
p7014
sa(dp7015
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7016
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00237
p7017
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00237_530
p7019
sg16
VButabarbital [drugbank:DB00237]
p7020
sg18
Vdrug-target interaction Butabarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00237_530]
p7021
sa(dp7022
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7023
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00241
p7024
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7025
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00241_530
p7026
sg16
VButalbital [drugbank:DB00241]
p7027
sg18
Vdrug-target interaction Butalbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00241_530]
p7028
sa(dp7029
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7030
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00306
p7031
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7032
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00306_530
p7033
sg16
VTalbutal [drugbank:DB00306]
p7034
sg18
Vdrug-target interaction Talbutal and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00306_530]
p7035
sa(dp7036
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7037
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00349
p7038
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7039
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00349_530
p7040
sg16
VClobazam [drugbank:DB00349]
p7041
sg18
Vdrug-target interaction Clobazam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00349_530]
p7042
sa(dp7043
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7044
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00371
p7045
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7046
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00371_530
p7047
sg16
VMeprobamate [drugbank:DB00371]
p7048
sg18
Vdrug-target interaction Meprobamate and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00371_530]
p7049
sa(dp7050
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7051
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00418
p7052
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7053
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00418_530
p7054
sg16
VSecobarbital [drugbank:DB00418]
p7055
sg18
Vdrug-target interaction Secobarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00418_530]
p7056
sa(dp7057
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7058
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00312
p7059
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7060
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00312_530
p7061
sg16
VPentobarbital [drugbank:DB00312]
p7062
sg18
Vdrug-target interaction Pentobarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00312_530]
p7063
sa(dp7064
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7065
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00404
p7066
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7067
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00404_530
p7068
sg16
VAlprazolam [drugbank:DB00404]
p7069
sg18
Vdrug-target interaction Alprazolam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00404_530]
p7070
sa(dp7071
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7072
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00463
p7073
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7074
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00463_530
p7075
sg16
VMetharbital [drugbank:DB00463]
p7076
sg18
Vdrug-target interaction Metharbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00463_530]
p7077
sa(dp7078
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7079
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00475
p7080
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7081
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00475_530
p7082
sg16
VChlordiazepoxide [drugbank:DB00475]
p7083
sg18
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00475_530]
p7084
sa(dp7085
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7086
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00599
p7087
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7088
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00599_530
p7089
sg16
VThiopental [drugbank:DB00599]
p7090
sg18
Vdrug-target interaction Thiopental and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00599_530]
p7091
sa(dp7092
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7093
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00628
p7094
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7095
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00628_530
p7096
sg16
VClorazepate [drugbank:DB00628]
p7097
sg18
Vdrug-target interaction Clorazepate and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00628_530]
p7098
sa(dp7099
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7100
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00683
p7101
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7102
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00683_530
p7103
sg16
VMidazolam [drugbank:DB00683]
p7104
sg18
Vdrug-target interaction Midazolam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00683_530]
p7105
sa(dp7106
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7107
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00690
p7108
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7109
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00690_530
p7110
sg16
VFlurazepam [drugbank:DB00690]
p7111
sg18
Vdrug-target interaction Flurazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00690_530]
p7112
sa(dp7113
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7114
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00794
p7115
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7116
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00794_530
p7117
sg16
VPrimidone [drugbank:DB00794]
p7118
sg18
Vdrug-target interaction Primidone and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00794_530]
p7119
sa(dp7120
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7121
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00897
p7122
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7123
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00897_530
p7124
sg16
VTriazolam [drugbank:DB00897]
p7125
sg18
Vdrug-target interaction Triazolam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00897_530]
p7126
sa(dp7127
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7128
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00842
p7129
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7130
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00842_530
p7131
sg16
VOxazepam [drugbank:DB00842]
p7132
sg18
Vdrug-target interaction Oxazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00842_530]
p7133
sa(dp7134
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7135
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00849
p7136
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7137
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00849_530
p7138
sg16
VMethylphenobarbital [drugbank:DB00849]
p7139
sg18
Vdrug-target interaction Methylphenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00849_530]
p7140
sa(dp7141
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7142
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01068
p7143
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7144
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01068_530
p7145
sg16
VClonazepam [drugbank:DB01068]
p7146
sg18
Vdrug-target interaction Clonazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01068_530]
p7147
sa(dp7148
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7149
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01352
p7150
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7151
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01352_530
p7152
sg16
VAprobarbital [drugbank:DB01352]
p7153
sg18
Vdrug-target interaction Aprobarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01352_530]
p7154
sa(dp7155
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7156
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01355
p7157
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7158
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01355_530
p7159
sg16
VHexobarbital [drugbank:DB01355]
p7160
sg18
Vdrug-target interaction Hexobarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01355_530]
p7161
sa(dp7162
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7163
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01544
p7164
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7165
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01544_530
p7166
sg16
VFlunitrazepam [drugbank:DB01544]
p7167
sg18
Vdrug-target interaction Flunitrazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01544_530]
p7168
sa(dp7169
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7170
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01558
p7171
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7172
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01558_530
p7173
sg16
VBromazepam [drugbank:DB01558]
p7174
sg18
Vdrug-target interaction Bromazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01558_530]
p7175
sa(dp7176
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7177
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01595
p7178
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7179
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01595_530
p7180
sg16
VNitrazepam [drugbank:DB01595]
p7181
sg18
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01595_530]
p7182
sa(dp7183
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7184
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01174
p7185
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7186
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01174_530
p7187
sg16
VPhenobarbital [drugbank:DB01174]
p7188
sg18
Vdrug-target interaction Phenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01174_530]
p7189
sa(dp7190
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7191
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01351
p7192
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7193
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01351_530
p7194
sg16
VAmobarbital [drugbank:DB01351]
p7195
sg18
Vdrug-target interaction Amobarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01351_530]
p7196
sa(dp7197
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7198
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01353
p7199
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7200
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01353_530
p7201
sg16
VButethal [drugbank:DB01353]
p7202
sg18
Vdrug-target interaction Butethal and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01353_530]
p7203
sa(dp7204
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7205
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01354
p7206
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7207
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01354_530
p7208
sg16
VHeptabarbital [drugbank:DB01354]
p7209
sg18
Vdrug-target interaction Heptabarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01354_530]
p7210
sa(dp7211
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7212
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01483
p7213
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7214
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01483_530
p7215
sg16
VBarbital [drugbank:DB01483]
p7216
sg18
Vdrug-target interaction Barbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01483_530]
p7217
sa(dp7218
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:530
p7219
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01496
p7220
sg11
g6992
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 4'
p7221
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01496_530
p7222
sg16
VBarbituric acid derivative [drugbank:DB01496]
p7223
sg18
Vdrug-target interaction Barbituric acid derivative and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01496_530]
p7224
sasS'GLS'
p7225
(lp7226
(dp7227
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:917
p7228
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p7229
sg11
g7225
sg12
S'glutaminase'
p7230
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_917
p7231
sg16
VL-Glutamic Acid [drugbank:DB00142]
p7232
sg18
Vdrug-target interaction L-Glutamic Acid and Glutaminase kidney isoform, mitochondrial [drugbank_resource:DB00142_917]
p7233
sasS'GABRA1'
p7234
(lp7235
(dp7236
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7237
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00186
p7238
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7239
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00186_872
p7240
sg16
VLorazepam [drugbank:DB00186]
p7241
sg18
Vdrug-target interaction Lorazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00186_872]
p7242
sa(dp7243
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7244
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00189
p7245
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7246
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00189_872
p7247
sg16
VEthchlorvynol [drugbank:DB00189]
p7248
sg18
Vdrug-target interaction Ethchlorvynol and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00189_872]
p7249
sa(dp7250
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7251
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00228
p7252
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7253
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00228_872
p7254
sg16
VEnflurane [drugbank:DB00228]
p7255
sg18
Vdrug-target interaction Enflurane and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00228_872]
p7256
sa(dp7257
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7258
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00237
p7259
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7260
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00237_872
p7261
sg16
VButabarbital [drugbank:DB00237]
p7262
sg18
Vdrug-target interaction Butabarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00237_872]
p7263
sa(dp7264
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7265
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00312
p7266
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7267
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00312_872
p7268
sg16
VPentobarbital [drugbank:DB00312]
p7269
sg18
Vdrug-target interaction Pentobarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00312_872]
p7270
sa(dp7271
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7272
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00231
p7273
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7274
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00231_872
p7275
sg16
VTemazepam [drugbank:DB00231]
p7276
sg18
Vdrug-target interaction Temazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00231_872]
p7277
sa(dp7278
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7279
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00241
p7280
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7281
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00241_872
p7282
sg16
VButalbital [drugbank:DB00241]
p7283
sg18
Vdrug-target interaction Butalbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00241_872]
p7284
sa(dp7285
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7286
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00273
p7287
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7288
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00273_872
p7289
sg16
VTopiramate [drugbank:DB00273]
p7290
sg18
Vdrug-target interaction Topiramate and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00273_872]
p7291
sa(dp7292
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7293
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00292
p7294
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7295
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00292_872
p7296
sg16
VEtomidate [drugbank:DB00292]
p7297
sg18
Vdrug-target interaction Etomidate and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00292_872]
p7298
sa(dp7299
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7300
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00306
p7301
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7302
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00306_872
p7303
sg16
VTalbutal [drugbank:DB00306]
p7304
sg18
Vdrug-target interaction Talbutal and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00306_872]
p7305
sa(dp7306
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7307
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00371
p7308
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7309
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00371_872
p7310
sg16
VMeprobamate [drugbank:DB00371]
p7311
sg18
Vdrug-target interaction Meprobamate and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00371_872]
p7312
sa(dp7313
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7314
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00402
p7315
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7316
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00402_872
p7317
sg16
VEszopiclone [drugbank:DB00402]
p7318
sg18
Vdrug-target interaction Eszopiclone and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00402_872]
p7319
sa(dp7320
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7321
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00404
p7322
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7323
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00404_872
p7324
sg16
VAlprazolam [drugbank:DB00404]
p7325
sg18
Vdrug-target interaction Alprazolam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00404_872]
p7326
sa(dp7327
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7328
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00418
p7329
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7330
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00418_872
p7331
sg16
VSecobarbital [drugbank:DB00418]
p7332
sg18
Vdrug-target interaction Secobarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00418_872]
p7333
sa(dp7334
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7335
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00599
p7336
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7337
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00599_872
p7338
sg16
VThiopental [drugbank:DB00599]
p7339
sg18
Vdrug-target interaction Thiopental and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00599_872]
p7340
sa(dp7341
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7342
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00425
p7343
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7344
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00425_872
p7345
sg16
VZolpidem [drugbank:DB00425]
p7346
sg18
Vdrug-target interaction Zolpidem and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00425_872]
p7347
sa(dp7348
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7349
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00475
p7350
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7351
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00475_872
p7352
sg16
VChlordiazepoxide [drugbank:DB00475]
p7353
sg18
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00475_872]
p7354
sa(dp7355
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7356
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00543
p7357
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7358
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00543_872
p7359
sg16
VAmoxapine [drugbank:DB00543]
p7360
sg18
Vdrug-target interaction Amoxapine and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00543_872]
p7361
sa(dp7362
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7363
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00546
p7364
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7365
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00546_872
p7366
sg16
VAdinazolam [drugbank:DB00546]
p7367
sg18
Vdrug-target interaction Adinazolam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00546_872]
p7368
sa(dp7369
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7370
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00349
p7371
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7372
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00349_872
p7373
sg16
VClobazam [drugbank:DB00349]
p7374
sg18
Vdrug-target interaction Clobazam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00349_872]
p7375
sa(dp7376
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7377
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00463
p7378
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7379
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00463_872
p7380
sg16
VMetharbital [drugbank:DB00463]
p7381
sg18
Vdrug-target interaction Metharbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00463_872]
p7382
sa(dp7383
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7384
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00466
p7385
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7386
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00466_872
p7387
sg16
VPicrotoxin [drugbank:DB00466]
p7388
sg18
Vdrug-target interaction Picrotoxin and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00466_872]
p7389
sa(dp7390
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7391
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00474
p7392
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7393
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00474_872
p7394
sg16
VMethohexital [drugbank:DB00474]
p7395
sg18
Vdrug-target interaction Methohexital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00474_872]
p7396
sa(dp7397
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7398
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00628
p7399
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7400
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00628_872
p7401
sg16
VClorazepate [drugbank:DB00628]
p7402
sg18
Vdrug-target interaction Clorazepate and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00628_872]
p7403
sa(dp7404
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7405
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00829
p7406
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7407
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00829_872
p7408
sg16
VDiazepam [drugbank:DB00829]
p7409
sg18
Vdrug-target interaction Diazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00829_872]
p7410
sa(dp7411
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7412
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00837
p7413
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7414
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00837_872
p7415
sg16
VProgabide [drugbank:DB00837]
p7416
sg18
Vdrug-target interaction Progabide and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00837_872]
p7417
sa(dp7418
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7419
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00962
p7420
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7421
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00962_872
p7422
sg16
VZaleplon [drugbank:DB00962]
p7423
sg18
Vdrug-target interaction Zaleplon and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00962_872]
p7424
sa(dp7425
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7426
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00683
p7427
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7428
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00683_872
p7429
sg16
VMidazolam [drugbank:DB00683]
p7430
sg18
Vdrug-target interaction Midazolam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00683_872]
p7431
sa(dp7432
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7433
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00690
p7434
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7435
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00690_872
p7436
sg16
VFlurazepam [drugbank:DB00690]
p7437
sg18
Vdrug-target interaction Flurazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00690_872]
p7438
sa(dp7439
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7440
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00794
p7441
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7442
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00794_872
p7443
sg16
VPrimidone [drugbank:DB00794]
p7444
sg18
Vdrug-target interaction Primidone and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00794_872]
p7445
sa(dp7446
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7447
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00849
p7448
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7449
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00849_872
p7450
sg16
VMethylphenobarbital [drugbank:DB00849]
p7451
sg18
Vdrug-target interaction Methylphenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00849_872]
p7452
sa(dp7453
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7454
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00897
p7455
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7456
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00897_872
p7457
sg16
VTriazolam [drugbank:DB00897]
p7458
sg18
Vdrug-target interaction Triazolam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00897_872]
p7459
sa(dp7460
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7461
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01028
p7462
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7463
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01028_872
p7464
sg16
VMethoxyflurane [drugbank:DB01028]
p7465
sg18
Vdrug-target interaction Methoxyflurane and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01028_872]
p7466
sa(dp7467
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7468
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00753
p7469
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7470
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00753_872
p7471
sg16
VIsoflurane [drugbank:DB00753]
p7472
sg18
Vdrug-target interaction Isoflurane and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00753_872]
p7473
sa(dp7474
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7475
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00801
p7476
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7477
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00801_872
p7478
sg16
VHalazepam [drugbank:DB00801]
p7479
sg18
Vdrug-target interaction Halazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00801_872]
p7480
sa(dp7481
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7482
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00842
p7483
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7484
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00842_872
p7485
sg16
VOxazepam [drugbank:DB00842]
p7486
sg18
Vdrug-target interaction Oxazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00842_872]
p7487
sa(dp7488
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7489
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00898
p7490
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7491
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00898_872
p7492
sg16
VEthanol [drugbank:DB00898]
p7493
sg18
Vdrug-target interaction Ethanol and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00898_872]
p7494
sa(dp7495
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7496
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01068
p7497
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7498
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01068_872
p7499
sg16
VClonazepam [drugbank:DB01068]
p7500
sg18
Vdrug-target interaction Clonazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01068_872]
p7501
sa(dp7502
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7503
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01107
p7504
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7505
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01107_872
p7506
sg16
VMethyprylon [drugbank:DB01107]
p7507
sg18
Vdrug-target interaction Methyprylon and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01107_872]
p7508
sa(dp7509
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7510
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01154
p7511
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7512
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01154_872
p7513
sg16
VThiamylal [drugbank:DB01154]
p7514
sg18
Vdrug-target interaction Thiamylal and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01154_872]
p7515
sa(dp7516
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7517
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01174
p7518
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7519
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01174_872
p7520
sg16
VPhenobarbital [drugbank:DB01174]
p7521
sg18
Vdrug-target interaction Phenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01174_872]
p7522
sa(dp7523
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7524
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01205
p7525
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7526
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01205_872
p7527
sg16
VFlumazenil [drugbank:DB01205]
p7528
sg18
Vdrug-target interaction Flumazenil and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01205_872]
p7529
sa(dp7530
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7531
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01341
p7532
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7533
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01341_872
p7534
sg16
VDihydroquinidine barbiturate [drugbank:DB01341]
p7535
sg18
Vdrug-target interaction Dihydroquinidine barbiturate and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01341_872]
p7536
sa(dp7537
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7538
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01352
p7539
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7540
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01352_872
p7541
sg16
VAprobarbital [drugbank:DB01352]
p7542
sg18
Vdrug-target interaction Aprobarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01352_872]
p7543
sa(dp7544
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7545
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01353
p7546
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7547
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01353_872
p7548
sg16
VButethal [drugbank:DB01353]
p7549
sg18
Vdrug-target interaction Butethal and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01353_872]
p7550
sa(dp7551
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7552
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01354
p7553
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7554
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01354_872
p7555
sg16
VHeptabarbital [drugbank:DB01354]
p7556
sg18
Vdrug-target interaction Heptabarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01354_872]
p7557
sa(dp7558
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7559
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01355
p7560
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7561
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01355_872
p7562
sg16
VHexobarbital [drugbank:DB01355]
p7563
sg18
Vdrug-target interaction Hexobarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01355_872]
p7564
sa(dp7565
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7566
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01483
p7567
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7568
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01483_872
p7569
sg16
VBarbital [drugbank:DB01483]
p7570
sg18
Vdrug-target interaction Barbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01483_872]
p7571
sa(dp7572
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7573
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01558
p7574
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7575
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01558_872
p7576
sg16
VBromazepam [drugbank:DB01558]
p7577
sg18
Vdrug-target interaction Bromazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01558_872]
p7578
sa(dp7579
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7580
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01559
p7581
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7582
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01559_872
p7583
sg16
VClotiazepam [drugbank:DB01559]
p7584
sg18
Vdrug-target interaction Clotiazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01559_872]
p7585
sa(dp7586
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7587
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01589
p7588
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7589
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01589_872
p7590
sg16
VQuazepam [drugbank:DB01589]
p7591
sg18
Vdrug-target interaction Quazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01589_872]
p7592
sa(dp7593
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7594
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01594
p7595
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7596
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01594_872
p7597
sg16
VCinolazepam [drugbank:DB01594]
p7598
sg18
Vdrug-target interaction Cinolazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01594_872]
p7599
sa(dp7600
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7601
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01159
p7602
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7603
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01159_872
p7604
sg16
VHalothane [drugbank:DB01159]
p7605
sg18
Vdrug-target interaction Halothane and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01159_872]
p7606
sa(dp7607
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7608
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01198
p7609
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7610
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01198_872
p7611
sg16
VZopiclone [drugbank:DB01198]
p7612
sg18
Vdrug-target interaction Zopiclone and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01198_872]
p7613
sa(dp7614
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7615
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01287
p7616
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7617
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01287_872
p7618
sg16
VDihydroergotoxine [drugbank:DB01287]
p7619
sg18
Vdrug-target interaction Dihydroergotoxine and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01287_872]
p7620
sa(dp7621
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7622
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01346
p7623
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01346_872
p7625
sg16
VQuinidine barbiturate [drugbank:DB01346]
p7626
sg18
Vdrug-target interaction Quinidine barbiturate and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01346_872]
p7627
sa(dp7628
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7629
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01496
p7630
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7631
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01496_872
p7632
sg16
VBarbituric acid derivative [drugbank:DB01496]
p7633
sg18
Vdrug-target interaction Barbituric acid derivative and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01496_872]
p7634
sa(dp7635
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7636
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01567
p7637
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7638
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01567_872
p7639
sg16
VFludiazepam [drugbank:DB01567]
p7640
sg18
Vdrug-target interaction Fludiazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01567_872]
p7641
sa(dp7642
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7643
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01588
p7644
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7645
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01588_872
p7646
sg16
VPrazepam [drugbank:DB01588]
p7647
sg18
Vdrug-target interaction Prazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01588_872]
p7648
sa(dp7649
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7650
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01595
p7651
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7652
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01595_872
p7653
sg16
VNitrazepam [drugbank:DB01595]
p7654
sg18
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01595_872]
p7655
sa(dp7656
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7657
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01189
p7658
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7659
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01189_872
p7660
sg16
VDesflurane [drugbank:DB01189]
p7661
sg18
Vdrug-target interaction Desflurane and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01189_872]
p7662
sa(dp7663
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7664
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01215
p7665
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7666
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01215_872
p7667
sg16
VEstazolam [drugbank:DB01215]
p7668
sg18
Vdrug-target interaction Estazolam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01215_872]
p7669
sa(dp7670
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7671
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01236
p7672
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7673
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01236_872
p7674
sg16
VSevoflurane [drugbank:DB01236]
p7675
sg18
Vdrug-target interaction Sevoflurane and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01236_872]
p7676
sa(dp7677
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7678
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01351
p7679
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7680
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01351_872
p7681
sg16
VAmobarbital [drugbank:DB01351]
p7682
sg18
Vdrug-target interaction Amobarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01351_872]
p7683
sa(dp7684
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7685
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01381
p7686
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7687
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01381_872
p7688
sg16
VGinkgo biloba [drugbank:DB01381]
p7689
sg18
Vdrug-target interaction Ginkgo biloba and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01381_872]
p7690
sa(dp7691
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7692
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01437
p7693
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7694
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01437_872
p7695
sg16
VGlutethimide [drugbank:DB01437]
p7696
sg18
Vdrug-target interaction Glutethimide and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01437_872]
p7697
sa(dp7698
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:872
p7699
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01587
p7700
sg11
g7234
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 1'
p7701
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01587_872
p7702
sg16
VKetazolam [drugbank:DB01587]
p7703
sg18
Vdrug-target interaction Ketazolam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01587_872]
p7704
sasS'GAD2'
p7705
(lp7706
(dp7707
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3890
p7708
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00114
p7709
sg11
g7705
sg12
S'glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)'
p7710
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00114_3890
p7711
sg16
VPyridoxal Phosphate [drugbank:DB00114]
p7712
sg18
Vdrug-target interaction Pyridoxal Phosphate and Glutamate decarboxylase 2 [drugbank_resource:DB00114_3890]
p7713
sa(dp7714
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:664
p7715
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p7716
sg11
g7705
sg12
S'glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)'
p7717
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_664
p7718
sg16
VL-Glutamic Acid [drugbank:DB00142]
p7719
sg18
Vdrug-target interaction L-Glutamic Acid and Glutamate decarboxylase 2 [drugbank_resource:DB00142_664]
p7720
sasS'GABRA2'
p7721
(lp7722
(dp7723
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7724
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00186
p7725
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7726
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00186_423
p7727
sg16
VLorazepam [drugbank:DB00186]
p7728
sg18
Vdrug-target interaction Lorazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00186_423]
p7729
sa(dp7730
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7731
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00189
p7732
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7733
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00189_423
p7734
sg16
VEthchlorvynol [drugbank:DB00189]
p7735
sg18
Vdrug-target interaction Ethchlorvynol and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00189_423]
p7736
sa(dp7737
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7738
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00231
p7739
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7740
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00231_423
p7741
sg16
VTemazepam [drugbank:DB00231]
p7742
sg18
Vdrug-target interaction Temazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00231_423]
p7743
sa(dp7744
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7745
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00237
p7746
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7747
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00237_423
p7748
sg16
VButabarbital [drugbank:DB00237]
p7749
sg18
Vdrug-target interaction Butabarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00237_423]
p7750
sa(dp7751
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7752
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00241
p7753
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7754
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00241_423
p7755
sg16
VButalbital [drugbank:DB00241]
p7756
sg18
Vdrug-target interaction Butalbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00241_423]
p7757
sa(dp7758
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7759
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00402
p7760
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7761
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00402_423
p7762
sg16
VEszopiclone [drugbank:DB00402]
p7763
sg18
Vdrug-target interaction Eszopiclone and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00402_423]
p7764
sa(dp7765
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7766
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00418
p7767
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7768
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00418_423
p7769
sg16
VSecobarbital [drugbank:DB00418]
p7770
sg18
Vdrug-target interaction Secobarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00418_423]
p7771
sa(dp7772
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7773
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00425
p7774
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7775
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00425_423
p7776
sg16
VZolpidem [drugbank:DB00425]
p7777
sg18
Vdrug-target interaction Zolpidem and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00425_423]
p7778
sa(dp7779
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7780
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00463
p7781
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7782
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00463_423
p7783
sg16
VMetharbital [drugbank:DB00463]
p7784
sg18
Vdrug-target interaction Metharbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00463_423]
p7785
sa(dp7786
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7787
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00546
p7788
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7789
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00546_423
p7790
sg16
VAdinazolam [drugbank:DB00546]
p7791
sg18
Vdrug-target interaction Adinazolam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00546_423]
p7792
sa(dp7793
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7794
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00599
p7795
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00599_423
p7797
sg16
VThiopental [drugbank:DB00599]
p7798
sg18
Vdrug-target interaction Thiopental and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00599_423]
p7799
sa(dp7800
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7801
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00628
p7802
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7803
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00628_423
p7804
sg16
VClorazepate [drugbank:DB00628]
p7805
sg18
Vdrug-target interaction Clorazepate and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00628_423]
p7806
sa(dp7807
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7808
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00306
p7809
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7810
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00306_423
p7811
sg16
VTalbutal [drugbank:DB00306]
p7812
sg18
Vdrug-target interaction Talbutal and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00306_423]
p7813
sa(dp7814
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7815
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00312
p7816
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7817
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00312_423
p7818
sg16
VPentobarbital [drugbank:DB00312]
p7819
sg18
Vdrug-target interaction Pentobarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00312_423]
p7820
sa(dp7821
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7822
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00371
p7823
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7824
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00371_423
p7825
sg16
VMeprobamate [drugbank:DB00371]
p7826
sg18
Vdrug-target interaction Meprobamate and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00371_423]
p7827
sa(dp7828
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7829
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00404
p7830
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7831
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00404_423
p7832
sg16
VAlprazolam [drugbank:DB00404]
p7833
sg18
Vdrug-target interaction Alprazolam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00404_423]
p7834
sa(dp7835
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7836
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00475
p7837
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7838
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00475_423
p7839
sg16
VChlordiazepoxide [drugbank:DB00475]
p7840
sg18
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00475_423]
p7841
sa(dp7842
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7843
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00349
p7844
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7845
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00349_423
p7846
sg16
VClobazam [drugbank:DB00349]
p7847
sg18
Vdrug-target interaction Clobazam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00349_423]
p7848
sa(dp7849
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7850
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00683
p7851
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7852
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00683_423
p7853
sg16
VMidazolam [drugbank:DB00683]
p7854
sg18
Vdrug-target interaction Midazolam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00683_423]
p7855
sa(dp7856
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7857
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00801
p7858
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7859
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00801_423
p7860
sg16
VHalazepam [drugbank:DB00801]
p7861
sg18
Vdrug-target interaction Halazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00801_423]
p7862
sa(dp7863
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7864
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00842
p7865
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7866
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00842_423
p7867
sg16
VOxazepam [drugbank:DB00842]
p7868
sg18
Vdrug-target interaction Oxazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00842_423]
p7869
sa(dp7870
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7871
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00690
p7872
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7873
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00690_423
p7874
sg16
VFlurazepam [drugbank:DB00690]
p7875
sg18
Vdrug-target interaction Flurazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00690_423]
p7876
sa(dp7877
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7878
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00829
p7879
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7880
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00829_423
p7881
sg16
VDiazepam [drugbank:DB00829]
p7882
sg18
Vdrug-target interaction Diazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00829_423]
p7883
sa(dp7884
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7885
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00849
p7886
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7887
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00849_423
p7888
sg16
VMethylphenobarbital [drugbank:DB00849]
p7889
sg18
Vdrug-target interaction Methylphenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00849_423]
p7890
sa(dp7891
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7892
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00794
p7893
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7894
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00794_423
p7895
sg16
VPrimidone [drugbank:DB00794]
p7896
sg18
Vdrug-target interaction Primidone and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00794_423]
p7897
sa(dp7898
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7899
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00897
p7900
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7901
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00897_423
p7902
sg16
VTriazolam [drugbank:DB00897]
p7903
sg18
Vdrug-target interaction Triazolam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00897_423]
p7904
sa(dp7905
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7906
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01068
p7907
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01068_423
p7909
sg16
VClonazepam [drugbank:DB01068]
p7910
sg18
Vdrug-target interaction Clonazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01068_423]
p7911
sa(dp7912
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7913
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01174
p7914
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7915
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01174_423
p7916
sg16
VPhenobarbital [drugbank:DB01174]
p7917
sg18
Vdrug-target interaction Phenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01174_423]
p7918
sa(dp7919
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7920
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01346
p7921
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7922
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01346_423
p7923
sg16
VQuinidine barbiturate [drugbank:DB01346]
p7924
sg18
Vdrug-target interaction Quinidine barbiturate and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01346_423]
p7925
sa(dp7926
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7927
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01352
p7928
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7929
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01352_423
p7930
sg16
VAprobarbital [drugbank:DB01352]
p7931
sg18
Vdrug-target interaction Aprobarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01352_423]
p7932
sa(dp7933
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7934
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01483
p7935
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7936
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01483_423
p7937
sg16
VBarbital [drugbank:DB01483]
p7938
sg18
Vdrug-target interaction Barbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01483_423]
p7939
sa(dp7940
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7941
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01544
p7942
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7943
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01544_423
p7944
sg16
VFlunitrazepam [drugbank:DB01544]
p7945
sg18
Vdrug-target interaction Flunitrazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01544_423]
p7946
sa(dp7947
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7948
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01558
p7949
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7950
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01558_423
p7951
sg16
VBromazepam [drugbank:DB01558]
p7952
sg18
Vdrug-target interaction Bromazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01558_423]
p7953
sa(dp7954
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7955
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01567
p7956
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7957
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01567_423
p7958
sg16
VFludiazepam [drugbank:DB01567]
p7959
sg18
Vdrug-target interaction Fludiazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01567_423]
p7960
sa(dp7961
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7962
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01588
p7963
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7964
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01588_423
p7965
sg16
VPrazepam [drugbank:DB01588]
p7966
sg18
Vdrug-target interaction Prazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01588_423]
p7967
sa(dp7968
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7969
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01205
p7970
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7971
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01205_423
p7972
sg16
VFlumazenil [drugbank:DB01205]
p7973
sg18
Vdrug-target interaction Flumazenil and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01205_423]
p7974
sa(dp7975
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7976
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01215
p7977
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7978
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01215_423
p7979
sg16
VEstazolam [drugbank:DB01215]
p7980
sg18
Vdrug-target interaction Estazolam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01215_423]
p7981
sa(dp7982
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7983
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01559
p7984
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7985
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01559_423
p7986
sg16
VClotiazepam [drugbank:DB01559]
p7987
sg18
Vdrug-target interaction Clotiazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01559_423]
p7988
sa(dp7989
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7990
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01589
p7991
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7992
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01589_423
p7993
sg16
VQuazepam [drugbank:DB01589]
p7994
sg18
Vdrug-target interaction Quazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01589_423]
p7995
sa(dp7996
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p7997
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01594
p7998
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p7999
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01594_423
p8000
sg16
VCinolazepam [drugbank:DB01594]
p8001
sg18
Vdrug-target interaction Cinolazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01594_423]
p8002
sa(dp8003
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p8004
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01595
p8005
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p8006
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01595_423
p8007
sg16
VNitrazepam [drugbank:DB01595]
p8008
sg18
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01595_423]
p8009
sa(dp8010
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p8011
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01198
p8012
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p8013
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01198_423
p8014
sg16
VZopiclone [drugbank:DB01198]
p8015
sg18
Vdrug-target interaction Zopiclone and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01198_423]
p8016
sa(dp8017
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p8018
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01351
p8019
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p8020
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01351_423
p8021
sg16
VAmobarbital [drugbank:DB01351]
p8022
sg18
Vdrug-target interaction Amobarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01351_423]
p8023
sa(dp8024
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p8025
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01353
p8026
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p8027
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01353_423
p8028
sg16
VButethal [drugbank:DB01353]
p8029
sg18
Vdrug-target interaction Butethal and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01353_423]
p8030
sa(dp8031
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p8032
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01354
p8033
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p8034
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01354_423
p8035
sg16
VHeptabarbital [drugbank:DB01354]
p8036
sg18
Vdrug-target interaction Heptabarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01354_423]
p8037
sa(dp8038
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p8039
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01355
p8040
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p8041
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01355_423
p8042
sg16
VHexobarbital [drugbank:DB01355]
p8043
sg18
Vdrug-target interaction Hexobarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01355_423]
p8044
sa(dp8045
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:423
p8046
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01496
p8047
sg11
g7721
sg12
S'gamma-aminobutyric acid (GABA) A receptor, alpha 2'
p8048
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01496_423
p8049
sg16
VBarbituric acid derivative [drugbank:DB01496]
p8050
sg18
Vdrug-target interaction Barbituric acid derivative and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01496_423]
p8051
sasS'ENPEP'
p8052
(lp8053
(dp8054
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4020
p8055
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p8056
sg11
g8052
sg12
S'glutamyl aminopeptidase (aminopeptidase A)'
p8057
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_4020
p8058
sg16
VL-Glutamic Acid [drugbank:DB00142]
p8059
sg18
Vdrug-target interaction L-Glutamic Acid and Glutamyl aminopeptidase [drugbank_resource:DB00142_4020]
p8060
sasS'FCER1G'
p8061
(lp8062
(dp8063
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:55
p8064
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00895
p8065
sg11
g8061
sg12
S'Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide'
p8066
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00895_55
p8067
sg16
VBenzylpenicilloyl Polylysine [drugbank:DB00895]
p8068
sg18
Vdrug-target interaction Benzylpenicilloyl Polylysine and High affinity immunoglobulin epsilon receptor gamma-subunit [drugbank_resource:DB00895_55]
p8069
sasS'NCOA1'
p8070
(lp8071
(dp8072
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8073
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01645
p8074
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8075
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01645_6228
p8076
sg16
VGenistein [drugbank:DB01645]
p8077
sg18
Vdrug-target interaction Genistein and Nuclear receptor coactivator 1 [drugbank_resource:DB01645_6228]
p8078
sa(dp8079
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8080
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06875
p8081
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8082
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06875_6228
p8083
sg16
V3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE [drugbank:DB06875]
p8084
sg18
Vdrug-target interaction 3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE and Nuclear receptor coactivator 1 [drugbank_resource:DB06875_6228]
p8085
sa(dp8086
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8087
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07009
p8088
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8089
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07009_6228
p8090
sg16
V2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL [drugbank:DB07009]
p8091
sg18
Vdrug-target interaction 2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL and Nuclear receptor coactivator 1 [drugbank_resource:DB07009_6228]
p8092
sa(dp8093
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8094
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07119
p8095
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8096
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07119_6228
p8097
sg16
V1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL [drugbank:DB07119]
p8098
sg18
Vdrug-target interaction 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL and Nuclear receptor coactivator 1 [drugbank_resource:DB07119_6228]
p8099
sa(dp8100
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8101
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07150
p8102
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8103
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07150_6228
p8104
sg16
V4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME [drugbank:DB07150]
p8105
sg18
Vdrug-target interaction 4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME and Nuclear receptor coactivator 1 [drugbank_resource:DB07150_6228]
p8106
sa(dp8107
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8108
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07230
p8109
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8110
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07230_6228
p8111
sg16
V3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE [drugbank:DB07230]
p8112
sg18
Vdrug-target interaction 3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE and Nuclear receptor coactivator 1 [drugbank_resource:DB07230_6228]
p8113
sa(dp8114
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8115
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06832
p8116
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8117
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06832_6228
p8118
sg16
V2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL [drugbank:DB06832]
p8119
sg18
Vdrug-target interaction 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL and Nuclear receptor coactivator 1 [drugbank_resource:DB06832_6228]
p8120
sa(dp8121
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8122
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06908
p8123
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8124
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06908_6228
p8125
sg16
V(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID [drugbank:DB06908]
p8126
sg18
Vdrug-target interaction (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID and Nuclear receptor coactivator 1 [drugbank_resource:DB06908_6228]
p8127
sa(dp8128
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8129
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07215
p8130
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8131
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07215_6228
p8132
sg16
V2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID [drugbank:DB07215]
p8133
sg18
Vdrug-target interaction 2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID and Nuclear receptor coactivator 1 [drugbank_resource:DB07215_6228]
p8134
sa(dp8135
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8136
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07236
p8137
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8138
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07236_6228
p8139
sg16
V3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL [drugbank:DB07236]
p8140
sg18
Vdrug-target interaction 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL and Nuclear receptor coactivator 1 [drugbank_resource:DB07236_6228]
p8141
sa(dp8142
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8143
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04652
p8144
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8145
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04652_6228
p8146
sg16
V(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE [drugbank:DB04652]
p8147
sg18
Vdrug-target interaction (11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE and Nuclear receptor coactivator 1 [drugbank_resource:DB04652_6228]
p8148
sa(dp8149
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8150
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06927
p8151
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06927_6228
p8153
sg16
V[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE [drugbank:DB06927]
p8154
sg18
Vdrug-target interaction [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE and Nuclear receptor coactivator 1 [drugbank_resource:DB06927_6228]
p8155
sa(dp8156
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8157
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07080
p8158
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8159
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07080_6228
p8160
sg16
VN-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE [drugbank:DB07080]
p8161
sg18
Vdrug-target interaction N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE and Nuclear receptor coactivator 1 [drugbank_resource:DB07080_6228]
p8162
sa(dp8163
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8164
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07198
p8165
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8166
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07198_6228
p8167
sg16
V5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE [drugbank:DB07198]
p8168
sg18
Vdrug-target interaction 5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE and Nuclear receptor coactivator 1 [drugbank_resource:DB07198_6228]
p8169
sa(dp8170
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8171
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07530
p8172
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8173
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07530_6228
p8174
sg16
V(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol [drugbank:DB07530]
p8175
sg18
Vdrug-target interaction (1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol and Nuclear receptor coactivator 1 [drugbank_resource:DB07530_6228]
p8176
sa(dp8177
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8178
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08231
p8179
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8180
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08231_6228
p8181
sg16
VMYRISTIC ACID [drugbank:DB08231]
p8182
sg18
Vdrug-target interaction MYRISTIC ACID and Nuclear receptor coactivator 1 [drugbank_resource:DB08231_6228]
p8183
sa(dp8184
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8185
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07557
p8186
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8187
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07557_6228
p8188
sg16
V(5BETA)-PREGNANE-3,20-DIONE [drugbank:DB07557]
p8189
sg18
Vdrug-target interaction (5BETA)-PREGNANE-3,20-DIONE and Nuclear receptor coactivator 1 [drugbank_resource:DB07557_6228]
p8190
sa(dp8191
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8192
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07724
p8193
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8194
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07724_6228
p8195
sg16
V3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid [drugbank:DB07724]
p8196
sg18
Vdrug-target interaction 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid and Nuclear receptor coactivator 1 [drugbank_resource:DB07724_6228]
p8197
sa(dp8198
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8199
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08220
p8200
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8201
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08220_6228
p8202
sg16
V(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid [drugbank:DB08220]
p8203
sg18
Vdrug-target interaction (8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid and Nuclear receptor coactivator 1 [drugbank_resource:DB08220_6228]
p8204
sa(dp8205
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8206
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08483
p8207
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08483_6228
p8209
sg16
V(2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid [drugbank:DB08483]
p8210
sg18
Vdrug-target interaction (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid and Nuclear receptor coactivator 1 [drugbank_resource:DB08483_6228]
p8211
sa(dp8212
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6228
p8213
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08742
p8214
sg11
g8070
sg12
S'nuclear receptor coactivator 1'
p8215
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08742_6228
p8216
sg16
V1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z) [drugbank:DB08742]
p8217
sg18
Vdrug-target interaction 1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z) and Nuclear receptor coactivator 1 [drugbank_resource:DB08742_6228]
p8218
sasS'SKP1'
p8219
(lp8220
(dp8221
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6269
p8222
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01750
p8223
sg11
g8219
sg12
S'S-phase kinase-associated protein 1'
p8224
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01750_6269
p8225
sg16
VNaphthalen-1-Yl-Acetic Acid [drugbank:DB01750]
p8226
sg18
Vdrug-target interaction Naphthalen-1-Yl-Acetic Acid and S-phase kinase-associated protein 1 [drugbank_resource:DB01750_6269]
p8227
sa(dp8228
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6269
p8229
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06980
p8230
sg11
g8219
sg12
S'S-phase kinase-associated protein 1'
p8231
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06980_6269
p8232
sg16
V(2S)-2-(1H-indol-3-yl)hexanoic acid [drugbank:DB06980]
p8233
sg18
Vdrug-target interaction (2S)-2-(1H-indol-3-yl)hexanoic acid and S-phase kinase-associated protein 1 [drugbank_resource:DB06980_6269]
p8234
sa(dp8235
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6269
p8236
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06981
p8237
sg11
g8219
sg12
S'S-phase kinase-associated protein 1'
p8238
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06981_6269
p8239
sg16
V(2S)-2-(1H-indol-3-yl)pentanoic acid [drugbank:DB06981]
p8240
sg18
Vdrug-target interaction (2S)-2-(1H-indol-3-yl)pentanoic acid and S-phase kinase-associated protein 1 [drugbank_resource:DB06981_6269]
p8241
sa(dp8242
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6269
p8243
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06982
p8244
sg11
g8219
sg12
S'S-phase kinase-associated protein 1'
p8245
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06982_6269
p8246
sg16
V(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid [drugbank:DB06982]
p8247
sg18
Vdrug-target interaction (2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid and S-phase kinase-associated protein 1 [drugbank_resource:DB06982_6269]
p8248
sa(dp8249
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6269
p8250
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07950
p8251
sg11
g8219
sg12
S'S-phase kinase-associated protein 1'
p8252
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07950_6269
p8253
sg16
V1H-INDOL-3-YLACETIC ACID [drugbank:DB07950]
p8254
sg18
Vdrug-target interaction 1H-INDOL-3-YLACETIC ACID and S-phase kinase-associated protein 1 [drugbank_resource:DB07950_6269]
p8255
sasS'CACNB3'
p8256
(lp8257
(dp8258
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4114
p8259
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00393
p8260
sg11
g8256
sg12
S'calcium channel, voltage-dependent, beta 3 subunit'
p8261
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00393_4114
p8262
sg16
VNimodipine [drugbank:DB00393]
p8263
sg18
Vdrug-target interaction Nimodipine and Voltage-dependent L-type calcium channel subunit beta-3 [drugbank_resource:DB00393_4114]
p8264
sa(dp8265
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4114
p8266
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00661
p8267
sg11
g8256
sg12
S'calcium channel, voltage-dependent, beta 3 subunit'
p8268
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00661_4114
p8269
sg16
VVerapamil [drugbank:DB00661]
p8270
sg18
Vdrug-target interaction Verapamil and Voltage-dependent L-type calcium channel subunit beta-3 [drugbank_resource:DB00661_4114]
p8271
sa(dp8272
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4114
p8273
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01388
p8274
sg11
g8256
sg12
S'calcium channel, voltage-dependent, beta 3 subunit'
p8275
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01388_4114
p8276
sg16
VMibefradil [drugbank:DB01388]
p8277
sg18
Vdrug-target interaction Mibefradil and Voltage-dependent L-type calcium channel subunit beta-3 [drugbank_resource:DB01388_4114]
p8278
sasS'CACNB2'
p8279
(lp8280
(dp8281
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4110
p8282
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00270
p8283
sg11
g8279
sg12
S'calcium channel, voltage-dependent, beta 2 subunit'
p8284
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00270_4110
p8285
sg16
VIsradipine [drugbank:DB00270]
p8286
sg18
Vdrug-target interaction Isradipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB00270_4110]
p8287
sa(dp8288
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4110
p8289
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00393
p8290
sg11
g8279
sg12
S'calcium channel, voltage-dependent, beta 2 subunit'
p8291
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00393_4110
p8292
sg16
VNimodipine [drugbank:DB00393]
p8293
sg18
Vdrug-target interaction Nimodipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB00393_4110]
p8294
sa(dp8295
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4110
p8296
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00381
p8297
sg11
g8279
sg12
S'calcium channel, voltage-dependent, beta 2 subunit'
p8298
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00381_4110
p8299
sg16
VAmlodipine [drugbank:DB00381]
p8300
sg18
Vdrug-target interaction Amlodipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB00381_4110]
p8301
sa(dp8302
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4110
p8303
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00401
p8304
sg11
g8279
sg12
S'calcium channel, voltage-dependent, beta 2 subunit'
p8305
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00401_4110
p8306
sg16
VNisoldipine [drugbank:DB00401]
p8307
sg18
Vdrug-target interaction Nisoldipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB00401_4110]
p8308
sa(dp8309
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4110
p8310
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00622
p8311
sg11
g8279
sg12
S'calcium channel, voltage-dependent, beta 2 subunit'
p8312
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00622_4110
p8313
sg16
VNicardipine [drugbank:DB00622]
p8314
sg18
Vdrug-target interaction Nicardipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB00622_4110]
p8315
sa(dp8316
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4110
p8317
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00661
p8318
sg11
g8279
sg12
S'calcium channel, voltage-dependent, beta 2 subunit'
p8319
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00661_4110
p8320
sg16
VVerapamil [drugbank:DB00661]
p8321
sg18
Vdrug-target interaction Verapamil and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB00661_4110]
p8322
sa(dp8323
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4110
p8324
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00653
p8325
sg11
g8279
sg12
S'calcium channel, voltage-dependent, beta 2 subunit'
p8326
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00653_4110
p8327
sg16
VMagnesium Sulfate [drugbank:DB00653]
p8328
sg18
Vdrug-target interaction Magnesium Sulfate and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB00653_4110]
p8329
sa(dp8330
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4110
p8331
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01023
p8332
sg11
g8279
sg12
S'calcium channel, voltage-dependent, beta 2 subunit'
p8333
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01023_4110
p8334
sg16
VFelodipine [drugbank:DB01023]
p8335
sg18
Vdrug-target interaction Felodipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB01023_4110]
p8336
sa(dp8337
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4110
p8338
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01054
p8339
sg11
g8279
sg12
S'calcium channel, voltage-dependent, beta 2 subunit'
p8340
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01054_4110
p8341
sg16
VNitrendipine [drugbank:DB01054]
p8342
sg18
Vdrug-target interaction Nitrendipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB01054_4110]
p8343
sa(dp8344
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4110
p8345
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01115
p8346
sg11
g8279
sg12
S'calcium channel, voltage-dependent, beta 2 subunit'
p8347
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01115_4110
p8348
sg16
VNifedipine [drugbank:DB01115]
p8349
sg18
Vdrug-target interaction Nifedipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB01115_4110]
p8350
sa(dp8351
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4110
p8352
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01388
p8353
sg11
g8279
sg12
S'calcium channel, voltage-dependent, beta 2 subunit'
p8354
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01388_4110
p8355
sg16
VMibefradil [drugbank:DB01388]
p8356
sg18
Vdrug-target interaction Mibefradil and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB01388_4110]
p8357
sa(dp8358
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4110
p8359
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06712
p8360
sg11
g8279
sg12
S'calcium channel, voltage-dependent, beta 2 subunit'
p8361
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06712_4110
p8362
sg16
VNilvadipine [drugbank:DB06712]
p8363
sg18
Vdrug-target interaction Nilvadipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB06712_4110]
p8364
sasS'HPRT1'
p8365
(lp8366
(dp8367
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:87
p8368
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00993
p8369
sg11
g8365
sg12
S'hypoxanthine phosphoribosyltransferase 1'
p8370
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00993_87
p8371
sg16
VAzathioprine [drugbank:DB00993]
p8372
sg18
Vdrug-target interaction Azathioprine and Hypoxanthine-guanine phosphoribosyltransferase [drugbank_resource:DB00993_87]
p8373
sa(dp8374
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:87
p8375
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01033
p8376
sg11
g8365
sg12
S'hypoxanthine phosphoribosyltransferase 1'
p8377
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01033_87
p8378
sg16
VMercaptopurine [drugbank:DB01033]
p8379
sg18
Vdrug-target interaction Mercaptopurine and Hypoxanthine-guanine phosphoribosyltransferase [drugbank_resource:DB01033_87]
p8380
sa(dp8381
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:87
p8382
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01632
p8383
sg11
g8365
sg12
S'hypoxanthine phosphoribosyltransferase 1'
p8384
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01632_87
p8385
sg16
VAlpha-Phosphoribosylpyrophosphoric Acid [drugbank:DB01632]
p8386
sg18
Vdrug-target interaction Alpha-Phosphoribosylpyrophosphoric Acid and Hypoxanthine-guanine phosphoribosyltransferase [drugbank_resource:DB01632_87]
p8387
sa(dp8388
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:87
p8389
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02212
p8390
sg11
g8365
sg12
S'hypoxanthine phosphoribosyltransferase 1'
p8391
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02212_87
p8392
sg16
VPyrophosphate 2- [drugbank:DB02212]
p8393
sg18
Vdrug-target interaction Pyrophosphate 2- and Hypoxanthine-guanine phosphoribosyltransferase [drugbank_resource:DB02212_87]
p8394
sa(dp8395
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:87
p8396
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02309
p8397
sg11
g8365
sg12
S'hypoxanthine phosphoribosyltransferase 1'
p8398
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02309_87
p8399
sg16
V5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine [drugbank:DB02309]
p8400
sg18
Vdrug-target interaction 5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine and Hypoxanthine-guanine phosphoribosyltransferase [drugbank_resource:DB02309_87]
p8401
sa(dp8402
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:87
p8403
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03153
p8404
sg11
g8365
sg12
S'hypoxanthine phosphoribosyltransferase 1'
p8405
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03153_87
p8406
sg16
V3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol [drugbank:DB03153]
p8407
sg18
Vdrug-target interaction 3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol and Hypoxanthine-guanine phosphoribosyltransferase [drugbank_resource:DB03153_87]
p8408
sa(dp8409
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:87
p8410
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04356
p8411
sg11
g8365
sg12
S'hypoxanthine phosphoribosyltransferase 1'
p8412
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04356_87
p8413
sg16
V9-Deazaguanine [drugbank:DB04356]
p8414
sg18
Vdrug-target interaction 9-Deazaguanine and Hypoxanthine-guanine phosphoribosyltransferase [drugbank_resource:DB04356_87]
p8415
sasS'CACNA2D3'
p8416
(lp8417
(dp8418
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6045
p8419
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00381
p8420
sg11
g8416
sg12
S'calcium channel, voltage-dependent, alpha 2/delta subunit 3'
p8421
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00381_6045
p8422
sg16
VAmlodipine [drugbank:DB00381]
p8423
sg18
Vdrug-target interaction Amlodipine and Voltage-dependent calcium channel subunit alpha-2/delta-3 [drugbank_resource:DB00381_6045]
p8424
sa(dp8425
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6045
p8426
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06712
p8427
sg11
g8416
sg12
S'calcium channel, voltage-dependent, alpha 2/delta subunit 3'
p8428
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06712_6045
p8429
sg16
VNilvadipine [drugbank:DB06712]
p8430
sg18
Vdrug-target interaction Nilvadipine and Voltage-dependent calcium channel subunit alpha-2/delta-3 [drugbank_resource:DB06712_6045]
p8431
sasS'CD86'
p8432
(lp8433
(dp8434
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:942
p8435
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00098
p8436
sg11
g8432
sg12
S'CD86 molecule'
p8437
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00098_942
p8438
sg16
VAntithymocyte globulin [drugbank:DB00098]
p8439
sg18
Vdrug-target interaction Antithymocyte globulin and T-lymphocyte activation antigen CD86 [drugbank_resource:DB00098_942]
p8440
sa(dp8441
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:942
p8442
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01281
p8443
sg11
g8432
sg12
S'CD86 molecule'
p8444
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01281_942
p8445
sg16
VAbatacept [drugbank:DB01281]
p8446
sg18
Vdrug-target interaction Abatacept and T-lymphocyte activation antigen CD86 [drugbank_resource:DB01281_942]
p8447
sasS'MAPK3'
p8448
(lp8449
(dp8450
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1714
p8451
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00605
p8452
sg11
g8448
sg12
S'mitogen-activated protein kinase 3'
p8453
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00605_1714
p8454
sg16
VSulindac [drugbank:DB00605]
p8455
sg18
Vdrug-target interaction Sulindac and Mitogen-activated protein kinase 3 [drugbank_resource:DB00605_1714]
p8456
sa(dp8457
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1714
p8458
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01169
p8459
sg11
g8448
sg12
S'mitogen-activated protein kinase 3'
p8460
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01169_1714
p8461
sg16
VArsenic trioxide [drugbank:DB01169]
p8462
sg18
Vdrug-target interaction Arsenic trioxide and Mitogen-activated protein kinase 3 [drugbank_resource:DB01169_1714]
p8463
sa(dp8464
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1714
p8465
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02733
p8466
sg11
g8448
sg12
S'mitogen-activated protein kinase 3'
p8467
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02733_1714
p8468
sg16
VPurvalanol [drugbank:DB02733]
p8469
sg18
Vdrug-target interaction Purvalanol and Mitogen-activated protein kinase 3 [drugbank_resource:DB02733_1714]
p8470
sa(dp8471
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1714
p8472
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04604
p8473
sg11
g8448
sg12
S'mitogen-activated protein kinase 3'
p8474
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04604_1714
p8475
sg16
V5-iodotubercidin [drugbank:DB04604]
p8476
sg18
Vdrug-target interaction 5-iodotubercidin and Mitogen-activated protein kinase 3 [drugbank_resource:DB04604_1714]
p8477
sasS'MAPK1'
p8478
(lp8479
(dp8480
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p8481
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01064
p8482
sg11
g8478
sg12
S'mitogen-activated protein kinase 1'
p8483
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01064_1176
p8484
sg16
VIsoproterenol [drugbank:DB01064]
p8485
sg18
Vdrug-target interaction Isoproterenol and Mitogen-activated protein kinase 1 [drugbank_resource:DB01064_1176]
p8486
sa(dp8487
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p8488
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02116
p8489
sg11
g8478
sg12
S'mitogen-activated protein kinase 1'
p8490
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02116_1176
p8491
sg16
VOlomoucine [drugbank:DB02116]
p8492
sg18
Vdrug-target interaction Olomoucine and Mitogen-activated protein kinase 1 [drugbank_resource:DB02116_1176]
p8493
sa(dp8494
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p8495
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01169
p8496
sg11
g8478
sg12
S'mitogen-activated protein kinase 1'
p8497
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01169_1176
p8498
sg16
VArsenic trioxide [drugbank:DB01169]
p8499
sg18
Vdrug-target interaction Arsenic trioxide and Mitogen-activated protein kinase 1 [drugbank_resource:DB01169_1176]
p8500
sa(dp8501
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p8502
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02482
p8503
sg11
g8478
sg12
S'mitogen-activated protein kinase 1'
p8504
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02482_1176
p8505
sg16
VPhosphonothreonine [drugbank:DB02482]
p8506
sg18
Vdrug-target interaction Phosphonothreonine and Mitogen-activated protein kinase 1 [drugbank_resource:DB02482_1176]
p8507
sa(dp8508
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p8509
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02733
p8510
sg11
g8478
sg12
S'mitogen-activated protein kinase 1'
p8511
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02733_1176
p8512
sg16
VPurvalanol [drugbank:DB02733]
p8513
sg18
Vdrug-target interaction Purvalanol and Mitogen-activated protein kinase 1 [drugbank_resource:DB02733_1176]
p8514
sa(dp8515
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p8516
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04338
p8517
sg11
g8478
sg12
S'mitogen-activated protein kinase 1'
p8518
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04338_1176
p8519
sg16
VSB220025 [drugbank:DB04338]
p8520
sg18
Vdrug-target interaction SB220025 and Mitogen-activated protein kinase 1 [drugbank_resource:DB04338_1176]
p8521
sa(dp8522
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p8523
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06877
p8524
sg11
g8478
sg12
S'mitogen-activated protein kinase 1'
p8525
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06877_1176
p8526
sg16
VN,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE [drugbank:DB06877]
p8527
sg18
Vdrug-target interaction N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE and Mitogen-activated protein kinase 1 [drugbank_resource:DB06877_1176]
p8528
sa(dp8529
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p8530
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07010
p8531
sg11
g8478
sg12
S'mitogen-activated protein kinase 1'
p8532
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07010_1176
p8533
sg16
VN-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE [drugbank:DB07010]
p8534
sg18
Vdrug-target interaction N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE and Mitogen-activated protein kinase 1 [drugbank_resource:DB07010_1176]
p8535
sa(dp8536
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p8537
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07264
p8538
sg11
g8478
sg12
S'mitogen-activated protein kinase 1'
p8539
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07264_1176
p8540
sg16
V(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE [drugbank:DB07264]
p8541
sg18
Vdrug-target interaction (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE and Mitogen-activated protein kinase 1 [drugbank_resource:DB07264_1176]
p8542
sa(dp8543
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p8544
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07788
p8545
sg11
g8478
sg12
S'mitogen-activated protein kinase 1'
p8546
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07788_1176
p8547
sg16
V(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE [drugbank:DB07788]
p8548
sg18
Vdrug-target interaction (3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE and Mitogen-activated protein kinase 1 [drugbank_resource:DB07788_1176]
p8549
sa(dp8550
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p8551
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07794
p8552
sg11
g8478
sg12
S'mitogen-activated protein kinase 1'
p8553
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07794_1176
p8554
sg16
V5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE [drugbank:DB07794]
p8555
sg18
Vdrug-target interaction 5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE and Mitogen-activated protein kinase 1 [drugbank_resource:DB07794_1176]
p8556
sa(dp8557
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p8558
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08513
p8559
sg11
g8478
sg12
S'mitogen-activated protein kinase 1'
p8560
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08513_1176
p8561
sg16
V[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID [drugbank:DB08513]
p8562
sg18
Vdrug-target interaction [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID and Mitogen-activated protein kinase 1 [drugbank_resource:DB08513_1176]
p8563
sa(dp8564
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p8565
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07905
p8566
sg11
g8478
sg12
S'mitogen-activated protein kinase 1'
p8567
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07905_1176
p8568
sg16
V(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione [drugbank:DB07905]
p8569
sg18
Vdrug-target interaction (1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione and Mitogen-activated protein kinase 1 [drugbank_resource:DB07905_1176]
p8570
sa(dp8571
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1176
p8572
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08521
p8573
sg11
g8478
sg12
S'mitogen-activated protein kinase 1'
p8574
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08521_1176
p8575
sg16
V4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE [drugbank:DB08521]
p8576
sg18
Vdrug-target interaction 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE and Mitogen-activated protein kinase 1 [drugbank_resource:DB08521_1176]
p8577
sasS'PLAUR'
p8578
(lp8579
(dp8580
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:791
p8581
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00031
p8582
sg11
g8578
sg12
S'plasminogen activator, urokinase receptor'
p8583
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00031_791
p8584
sg16
VTenecteplase [drugbank:DB00031]
p8585
sg18
Vdrug-target interaction Tenecteplase and Urokinase plasminogen activator surface receptor [drugbank_resource:DB00031_791]
p8586
sa(dp8587
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:791
p8588
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00009
p8589
sg11
g8578
sg12
S'plasminogen activator, urokinase receptor'
p8590
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00009_791
p8591
sg16
VAlteplase [drugbank:DB00009]
p8592
sg18
Vdrug-target interaction Alteplase and Urokinase plasminogen activator surface receptor [drugbank_resource:DB00009_791]
p8593
sa(dp8594
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:791
p8595
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00013
p8596
sg11
g8578
sg12
S'plasminogen activator, urokinase receptor'
p8597
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00013_791
p8598
sg16
VUrokinase [drugbank:DB00013]
p8599
sg18
Vdrug-target interaction Urokinase and Urokinase plasminogen activator surface receptor [drugbank_resource:DB00013_791]
p8600
sa(dp8601
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:791
p8602
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00015
p8603
sg11
g8578
sg12
S'plasminogen activator, urokinase receptor'
p8604
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00015_791
p8605
sg16
VReteplase [drugbank:DB00015]
p8606
sg18
Vdrug-target interaction Reteplase and Urokinase plasminogen activator surface receptor [drugbank_resource:DB00015_791]
p8607
sa(dp8608
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:791
p8609
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00029
p8610
sg11
g8578
sg12
S'plasminogen activator, urokinase receptor'
p8611
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00029_791
p8612
sg16
VAnistreplase [drugbank:DB00029]
p8613
sg18
Vdrug-target interaction Anistreplase and Urokinase plasminogen activator surface receptor [drugbank_resource:DB00029_791]
p8614
sasS'C3'
p8615
(lp8616
(dp8617
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2683
p8618
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01907
p8619
sg11
g8615
sg12
S'complement component 3'
p8620
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01907_2683
p8621
sg16
VNicotinamide-Adenine-Dinucleotide [drugbank:DB01907]
p8622
sg18
Vdrug-target interaction Nicotinamide-Adenine-Dinucleotide and Mono-ADP-ribosyltransferase C3 [drugbank_resource:DB01907_2683]
p8623
sa(dp8624
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2683
p8625
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02147
p8626
sg11
g8615
sg12
S'complement component 3'
p8627
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02147_2683
p8628
sg16
VCyclo-Tetrametavanadate [drugbank:DB02147]
p8629
sg18
Vdrug-target interaction Cyclo-Tetrametavanadate and Mono-ADP-ribosyltransferase C3 [drugbank_resource:DB02147_2683]
p8630
sa(dp8631
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2683
p8632
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p8633
sg11
g8615
sg12
S'complement component 3'
p8634
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_2683
p8635
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p8636
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Mono-ADP-ribosyltransferase C3 [drugbank_resource:DB03431_2683]
p8637
sa(dp8638
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5898
p8639
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00028
p8640
sg11
g8615
sg12
S'complement component 3'
p8641
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00028_5898
p8642
sg16
VIntravenous Immunoglobulin [drugbank:DB00028]
p8643
sg18
Vdrug-target interaction Intravenous Immunoglobulin and Complement C3 [drugbank_resource:DB00028_5898]
p8644
sa(dp8645
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5898
p8646
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01915
p8647
sg11
g8615
sg12
S'complement component 3'
p8648
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01915_5898
p8649
sg16
VS-Hydroxycysteine [drugbank:DB01915]
p8650
sg18
Vdrug-target interaction S-Hydroxycysteine and Complement C3 [drugbank_resource:DB01915_5898]
p8651
sasS'NFKB1'
p8652
(lp8653
(dp8654
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1787
p8655
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01041
p8656
sg11
g8652
sg12
S'nuclear factor of kappa light polypeptide gene enhancer in B-cells 1'
p8657
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01041_1787
p8658
sg16
VThalidomide [drugbank:DB01041]
p8659
sg18
Vdrug-target interaction Thalidomide and Nuclear factor NF-kappa-B p105 subunit [drugbank_resource:DB01041_1787]
p8660
sa(dp8661
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1787
p8662
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01411
p8663
sg11
g8652
sg12
S'nuclear factor of kappa light polypeptide gene enhancer in B-cells 1'
p8664
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01411_1787
p8665
sg16
VPranlukast [drugbank:DB01411]
p8666
sg18
Vdrug-target interaction Pranlukast and Nuclear factor NF-kappa-B p105 subunit [drugbank_resource:DB01411_1787]
p8667
sa(dp8668
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1787
p8669
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08814
p8670
sg11
g8652
sg12
S'nuclear factor of kappa light polypeptide gene enhancer in B-cells 1'
p8671
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08814_1787
p8672
sg16
VTriflusal [drugbank:DB08814]
p8673
sg18
Vdrug-target interaction Triflusal and Nuclear factor NF-kappa-B p105 subunit [drugbank_resource:DB08814_1787]
p8674
sasS'NFKB2'
p8675
(lp8676
(dp8677
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4149
p8678
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01296
p8679
sg11
g8675
sg12
S'nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)'
p8680
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01296_4149
p8681
sg16
VGlucosamine [drugbank:DB01296]
p8682
sg18
Vdrug-target interaction Glucosamine and Nuclear factor NF-kappa-B p100 subunit [drugbank_resource:DB01296_4149]
p8683
sasS'KDR'
p8684
(lp8685
(dp8686
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:407
p8687
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00398
p8688
sg11
g8684
sg12
S'kinase insert domain receptor (a type III receptor tyrosine kinase)'
p8689
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00398_407
p8690
sg16
VSorafenib [drugbank:DB00398]
p8691
sg18
Vdrug-target interaction Sorafenib and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB00398_407]
p8692
sa(dp8693
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:407
p8694
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01268
p8695
sg11
g8684
sg12
S'kinase insert domain receptor (a type III receptor tyrosine kinase)'
p8696
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01268_407
p8697
sg16
VSunitinib [drugbank:DB01268]
p8698
sg18
Vdrug-target interaction Sunitinib and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB01268_407]
p8699
sa(dp8700
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:407
p8701
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06938
p8702
sg11
g8684
sg12
S'kinase insert domain receptor (a type III receptor tyrosine kinase)'
p8703
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06938_407
p8704
sg16
V4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide [drugbank:DB06938]
p8705
sg18
Vdrug-target interaction 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB06938_407]
p8706
sa(dp8707
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:407
p8708
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07183
p8709
sg11
g8684
sg12
S'kinase insert domain receptor (a type III receptor tyrosine kinase)'
p8710
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07183_407
p8711
sg16
VN-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide [drugbank:DB07183]
p8712
sg18
Vdrug-target interaction N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07183_407]
p8713
sa(dp8714
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:407
p8715
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07274
p8716
sg11
g8684
sg12
S'kinase insert domain receptor (a type III receptor tyrosine kinase)'
p8717
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07274_407
p8718
sg16
VN-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide [drugbank:DB07274]
p8719
sg18
Vdrug-target interaction N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07274_407]
p8720
sa(dp8721
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:407
p8722
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07326
p8723
sg11
g8684
sg12
S'kinase insert domain receptor (a type III receptor tyrosine kinase)'
p8724
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07326_407
p8725
sg16
V6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide [drugbank:DB07326]
p8726
sg18
Vdrug-target interaction 6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07326_407]
p8727
sa(dp8728
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:407
p8729
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04727
p8730
sg11
g8684
sg12
S'kinase insert domain receptor (a type III receptor tyrosine kinase)'
p8731
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04727_407
p8732
sg16
VN-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA [drugbank:DB04727]
p8733
sg18
Vdrug-target interaction N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB04727_407]
p8734
sa(dp8735
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:407
p8736
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07333
p8737
sg11
g8684
sg12
S'kinase insert domain receptor (a type III receptor tyrosine kinase)'
p8738
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07333_407
p8739
sg16
VN-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE [drugbank:DB07333]
p8740
sg18
Vdrug-target interaction N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07333_407]
p8741
sa(dp8742
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:407
p8743
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07334
p8744
sg11
g8684
sg12
S'kinase insert domain receptor (a type III receptor tyrosine kinase)'
p8745
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07334_407
p8746
sg16
VN-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE [drugbank:DB07334]
p8747
sg18
Vdrug-target interaction N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07334_407]
p8748
sa(dp8749
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:407
p8750
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07514
p8751
sg11
g8684
sg12
S'kinase insert domain receptor (a type III receptor tyrosine kinase)'
p8752
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07514_407
p8753
sg16
V3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one [drugbank:DB07514]
p8754
sg18
Vdrug-target interaction 3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07514_407]
p8755
sa(dp8756
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:407
p8757
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07528
p8758
sg11
g8684
sg12
S'kinase insert domain receptor (a type III receptor tyrosine kinase)'
p8759
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07528_407
p8760
sg16
V3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one [drugbank:DB07528]
p8761
sg18
Vdrug-target interaction 3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07528_407]
p8762
sa(dp8763
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:407
p8764
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07537
p8765
sg11
g8684
sg12
S'kinase insert domain receptor (a type III receptor tyrosine kinase)'
p8766
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07537_407
p8767
sg16
VN'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide [drugbank:DB07537]
p8768
sg18
Vdrug-target interaction N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07537_407]
p8769
sa(dp8770
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:407
p8771
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08042
p8772
sg11
g8684
sg12
S'kinase insert domain receptor (a type III receptor tyrosine kinase)'
p8773
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08042_407
p8774
sg16
VN~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine [drugbank:DB08042]
p8775
sg18
Vdrug-target interaction N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB08042_407]
p8776
sa(dp8777
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:407
p8778
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08519
p8779
sg11
g8684
sg12
S'kinase insert domain receptor (a type III receptor tyrosine kinase)'
p8780
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08519_407
p8781
sg16
VN~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine [drugbank:DB08519]
p8782
sg18
Vdrug-target interaction N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB08519_407]
p8783
sasS'SRC'
p8784
(lp8785
(dp8786
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8787
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01678
p8788
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8789
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01678_933
p8790
sg16
VRU84687 [drugbank:DB01678]
p8791
sg18
Vdrug-target interaction RU84687 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB01678_933]
p8792
sa(dp8793
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8794
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01908
p8795
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8796
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01908_933
p8797
sg16
VRU85493 [drugbank:DB01908]
p8798
sg18
Vdrug-target interaction RU85493 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB01908_933]
p8799
sa(dp8800
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8801
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01962
p8802
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8803
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01962_933
p8804
sg16
VPhosphonotyrosine [drugbank:DB01962]
p8805
sg18
Vdrug-target interaction Phosphonotyrosine and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB01962_933]
p8806
sa(dp8807
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8808
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01254
p8809
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8810
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01254_933
p8811
sg16
VDasatinib [drugbank:DB01254]
p8812
sg18
Vdrug-target interaction Dasatinib and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB01254_933]
p8813
sa(dp8814
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8815
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01866
p8816
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8817
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01866_933
p8818
sg16
VRU79256 [drugbank:DB01866]
p8819
sg18
Vdrug-target interaction RU79256 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB01866_933]
p8820
sa(dp8821
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8822
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01893
p8823
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8824
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01893_933
p8825
sg16
VN6-Benzyl Adenosine-5'-Diphosphate [drugbank:DB01893]
p8826
sg18
Vdrug-target interaction N6-Benzyl Adenosine-5'-Diphosphate and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB01893_933]
p8827
sa(dp8828
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8829
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01947
p8830
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8831
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01947_933
p8832
sg16
VRU78262 [drugbank:DB01947]
p8833
sg18
Vdrug-target interaction RU78262 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB01947_933]
p8834
sa(dp8835
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8836
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02336
p8837
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8838
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02336_933
p8839
sg16
VRU83876 [drugbank:DB02336]
p8840
sg18
Vdrug-target interaction RU83876 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB02336_933]
p8841
sa(dp8842
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8843
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02175
p8844
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8845
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02175_933
p8846
sg16
VMalonic acid [drugbank:DB02175]
p8847
sg18
Vdrug-target interaction Malonic acid and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB02175_933]
p8848
sa(dp8849
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8850
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02432
p8851
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8852
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02432_933
p8853
sg16
VRU90395 [drugbank:DB02432]
p8854
sg18
Vdrug-target interaction RU90395 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB02432_933]
p8855
sa(dp8856
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8857
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02762
p8858
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8859
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02762_933
p8860
sg16
VRU79072 [drugbank:DB02762]
p8861
sg18
Vdrug-target interaction RU79072 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB02762_933]
p8862
sa(dp8863
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8864
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03268
p8865
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8866
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03268_933
p8867
sg16
VRU82197 [drugbank:DB03268]
p8868
sg18
Vdrug-target interaction RU82197 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03268_933]
p8869
sa(dp8870
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8871
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03023
p8872
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8873
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03023_933
p8874
sg16
V1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine [drugbank:DB03023]
p8875
sg18
Vdrug-target interaction 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03023_933]
p8876
sa(dp8877
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8878
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03114
p8879
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8880
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03114_933
p8881
sg16
VPAS219 [drugbank:DB03114]
p8882
sg18
Vdrug-target interaction PAS219 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03114_933]
p8883
sa(dp8884
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8885
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03217
p8886
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8887
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03217_933
p8888
sg16
VDPI59 [drugbank:DB03217]
p8889
sg18
Vdrug-target interaction DPI59 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03217_933]
p8890
sa(dp8891
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8892
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02908
p8893
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8894
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02908_933
p8895
sg16
VRU78783 [drugbank:DB02908]
p8896
sg18
Vdrug-target interaction RU78783 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB02908_933]
p8897
sa(dp8898
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8899
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03078
p8900
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8901
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03078_933
p8902
sg16
VPASBN [drugbank:DB03078]
p8903
sg18
Vdrug-target interaction PASBN and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03078_933]
p8904
sa(dp8905
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8906
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03104
p8907
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8908
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03104_933
p8909
sg16
VRU82129 [drugbank:DB03104]
p8910
sg18
Vdrug-target interaction RU82129 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03104_933]
p8911
sa(dp8912
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8913
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03298
p8914
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8915
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03298_933
p8916
sg16
VPhenylphosphate [drugbank:DB03298]
p8917
sg18
Vdrug-target interaction Phenylphosphate and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03298_933]
p8918
sa(dp8919
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8920
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03306
p8921
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8922
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03306_933
p8923
sg16
VRU78300 [drugbank:DB03306]
p8924
sg18
Vdrug-target interaction RU78300 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03306_933]
p8925
sa(dp8926
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8927
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03525
p8928
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8929
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03525_933
p8930
sg16
VRU79073 [drugbank:DB03525]
p8931
sg18
Vdrug-target interaction RU79073 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03525_933]
p8932
sa(dp8933
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8934
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03712
p8935
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8936
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03712_933
p8937
sg16
VRU85053 [drugbank:DB03712]
p8938
sg18
Vdrug-target interaction RU85053 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03712_933]
p8939
sa(dp8940
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8941
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03591
p8942
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8943
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03591_933
p8944
sg16
VRU82209 [drugbank:DB03591]
p8945
sg18
Vdrug-target interaction RU82209 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03591_933]
p8946
sa(dp8947
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8948
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03628
p8949
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8950
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03628_933
p8951
sg16
VISO24 [drugbank:DB03628]
p8952
sg18
Vdrug-target interaction ISO24 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03628_933]
p8953
sa(dp8954
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8955
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03902
p8956
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8957
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03902_933
p8958
sg16
VOxalic Acid [drugbank:DB03902]
p8959
sg18
Vdrug-target interaction Oxalic Acid and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03902_933]
p8960
sa(dp8961
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8962
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03828
p8963
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8964
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03828_933
p8965
sg16
VRU78299 [drugbank:DB03828]
p8966
sg18
Vdrug-target interaction RU78299 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03828_933]
p8967
sa(dp8968
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8969
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04495
p8970
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8971
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04495_933
p8972
sg16
VRU81843 [drugbank:DB04495]
p8973
sg18
Vdrug-target interaction RU81843 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB04495_933]
p8974
sa(dp8975
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8976
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04080
p8977
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8978
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04080_933
p8979
sg16
VRU78191 [drugbank:DB04080]
p8980
sg18
Vdrug-target interaction RU78191 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB04080_933]
p8981
sa(dp8982
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8983
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04272
p8984
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8985
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04272_933
p8986
sg16
VCitric Acid [drugbank:DB04272]
p8987
sg18
Vdrug-target interaction Citric Acid and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB04272_933]
p8988
sa(dp8989
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8990
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04739
p8991
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8992
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04739_933
p8993
sg16
V4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE [drugbank:DB04739]
p8994
sg18
Vdrug-target interaction 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB04739_933]
p8995
sa(dp8996
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p8997
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04751
p8998
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p8999
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04751_933
p9000
sg16
VPurvalanol A [drugbank:DB04751]
p9001
sg18
Vdrug-target interaction Purvalanol A and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB04751_933]
p9002
sa(dp9003
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p9004
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07335
p9005
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p9006
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07335_933
p9007
sg16
V3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL [drugbank:DB07335]
p9008
sg18
Vdrug-target interaction 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB07335_933]
p9009
sa(dp9010
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p9011
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06882
p9012
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p9013
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06882_933
p9014
sg16
V1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea [drugbank:DB06882]
p9015
sg18
Vdrug-target interaction 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB06882_933]
p9016
sa(dp9017
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p9018
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06883
p9019
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p9020
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06883_933
p9021
sg16
V1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea [drugbank:DB06883]
p9022
sg18
Vdrug-target interaction 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB06883_933]
p9023
sa(dp9024
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p9025
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08462
p9026
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p9027
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08462_933
p9028
sg16
VN-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE [drugbank:DB08462]
p9029
sg18
Vdrug-target interaction N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB08462_933]
p9030
sa(dp9031
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p9032
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08564
p9033
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p9034
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08564_933
p9035
sg16
V(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide [drugbank:DB08564]
p9036
sg18
Vdrug-target interaction (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB08564_933]
p9037
sa(dp9038
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p9039
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07662
p9040
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p9041
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07662_933
p9042
sg16
VN-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE [drugbank:DB07662]
p9043
sg18
Vdrug-target interaction N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB07662_933]
p9044
sa(dp9045
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p9046
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07966
p9047
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p9048
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07966_933
p9049
sg16
V[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile [drugbank:DB07966]
p9050
sg18
Vdrug-target interaction [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB07966_933]
p9051
sa(dp9052
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p9053
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08054
p9054
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p9055
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08054_933
p9056
sg16
V1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine [drugbank:DB08054]
p9057
sg18
Vdrug-target interaction 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB08054_933]
p9058
sa(dp9059
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p9060
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08052
p9061
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p9062
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08052_933
p9063
sg16
V1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine [drugbank:DB08052]
p9064
sg18
Vdrug-target interaction 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB08052_933]
p9065
sa(dp9066
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p9067
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08053
p9068
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p9069
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08053_933
p9070
sg16
V1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine [drugbank:DB08053]
p9071
sg18
Vdrug-target interaction 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB08053_933]
p9072
sa(dp9073
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:933
p9074
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08192
p9075
sg11
g8784
sg12
S'v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)'
p9076
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08192_933
p9077
sg16
V2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE [drugbank:DB08192]
p9078
sg18
Vdrug-target interaction 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB08192_933]
p9079
sasS'TGFBR1'
p9080
(lp9081
(dp9082
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6284
p9083
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03921
p9084
sg11
g9080
sg12
S'transforming growth factor, beta receptor 1'
p9085
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03921_6284
p9086
sg16
V4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline [drugbank:DB03921]
p9087
sg18
Vdrug-target interaction 4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline and TGF-beta receptor type-1 [drugbank_resource:DB03921_6284]
p9088
sa(dp9089
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6284
p9090
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04434
p9091
sg11
g9080
sg12
S'transforming growth factor, beta receptor 1'
p9092
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04434_6284
p9093
sg16
VNaphthyridine Inhibitor [drugbank:DB04434]
p9094
sg18
Vdrug-target interaction Naphthyridine Inhibitor and TGF-beta receptor type-1 [drugbank_resource:DB04434_6284]
p9095
sa(dp9096
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6284
p9097
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04480
p9098
sg11
g9080
sg12
S'transforming growth factor, beta receptor 1'
p9099
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04480_6284
p9100
sg16
V3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole [drugbank:DB04480]
p9101
sg18
Vdrug-target interaction 3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole and TGF-beta receptor type-1 [drugbank_resource:DB04480_6284]
p9102
sa(dp9103
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6284
p9104
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07152
p9105
sg11
g9080
sg12
S'transforming growth factor, beta receptor 1'
p9106
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07152_6284
p9107
sg16
VN-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide [drugbank:DB07152]
p9108
sg18
Vdrug-target interaction N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide and TGF-beta receptor type-1 [drugbank_resource:DB07152_6284]
p9109
sa(dp9110
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6284
p9111
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07267
p9112
sg11
g9080
sg12
S'transforming growth factor, beta receptor 1'
p9113
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07267_6284
p9114
sg16
V2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine [drugbank:DB07267]
p9115
sg18
Vdrug-target interaction 2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine and TGF-beta receptor type-1 [drugbank_resource:DB07267_6284]
p9116
sa(dp9117
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6284
p9118
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08450
p9119
sg11
g9080
sg12
S'transforming growth factor, beta receptor 1'
p9120
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08450_6284
p9121
sg16
VN-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine [drugbank:DB08450]
p9122
sg18
Vdrug-target interaction N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine and TGF-beta receptor type-1 [drugbank_resource:DB08450_6284]
p9123
sasS'NTSR2'
p9124
(lp9125
(dp9126
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:516
p9127
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01106
p9128
sg11
g9124
sg12
S'neurotensin receptor 2'
p9129
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01106_516
p9130
sg16
VLevocabastine [drugbank:DB01106]
p9131
sg18
Vdrug-target interaction Levocabastine and Neurotensin receptor type 2 [drugbank_resource:DB01106_516]
p9132
sasS'MAPK8'
p9133
(lp9134
(dp9135
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6292
p9136
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01782
p9137
sg11
g9133
sg12
S'mitogen-activated protein kinase 8'
p9138
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01782_6292
p9139
sg16
V2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One [drugbank:DB01782]
p9140
sg18
Vdrug-target interaction 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One and Mitogen-activated protein kinase 8 [drugbank_resource:DB01782_6292]
p9141
sa(dp9142
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6292
p9143
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07268
p9144
sg11
g9133
sg12
S'mitogen-activated protein kinase 8'
p9145
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07268_6292
p9146
sg16
V2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE [drugbank:DB07268]
p9147
sg18
Vdrug-target interaction 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE and Mitogen-activated protein kinase 8 [drugbank_resource:DB07268_6292]
p9148
sa(dp9149
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6292
p9150
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07218
p9151
sg11
g9133
sg12
S'mitogen-activated protein kinase 8'
p9152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07218_6292
p9153
sg16
V6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE [drugbank:DB07218]
p9154
sg18
Vdrug-target interaction 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE and Mitogen-activated protein kinase 8 [drugbank_resource:DB07218_6292]
p9155
sa(dp9156
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6292
p9157
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07272
p9158
sg11
g9133
sg12
S'mitogen-activated protein kinase 8'
p9159
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07272_6292
p9160
sg16
VN-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE [drugbank:DB07272]
p9161
sg18
Vdrug-target interaction N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE and Mitogen-activated protein kinase 8 [drugbank_resource:DB07272_6292]
p9162
sa(dp9163
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6292
p9164
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07276
p9165
sg11
g9133
sg12
S'mitogen-activated protein kinase 8'
p9166
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07276_6292
p9167
sg16
V5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE [drugbank:DB07276]
p9168
sg18
Vdrug-target interaction 5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE and Mitogen-activated protein kinase 8 [drugbank_resource:DB07276_6292]
p9169
sa(dp9170
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6292
p9171
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07845
p9172
sg11
g9133
sg12
S'mitogen-activated protein kinase 8'
p9173
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07845_6292
p9174
sg16
V2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide [drugbank:DB07845]
p9175
sg18
Vdrug-target interaction 2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide and Mitogen-activated protein kinase 8 [drugbank_resource:DB07845_6292]
p9176
sasS'RXRA'
p9177
(lp9178
(dp9179
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:459
p9180
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00210
p9181
sg11
g9177
sg12
S'retinoid X receptor, alpha'
p9182
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00210_459
p9183
sg16
VAdapalene [drugbank:DB00210]
p9184
sg18
Vdrug-target interaction Adapalene and Retinoic acid receptor RXR-alpha [drugbank_resource:DB00210_459]
p9185
sa(dp9186
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:459
p9187
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00459
p9188
sg11
g9177
sg12
S'retinoid X receptor, alpha'
p9189
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00459_459
p9190
sg16
VAcitretin [drugbank:DB00459]
p9191
sg18
Vdrug-target interaction Acitretin and Retinoic acid receptor RXR-alpha [drugbank_resource:DB00459_459]
p9192
sa(dp9193
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:459
p9194
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00523
p9195
sg11
g9177
sg12
S'retinoid X receptor, alpha'
p9196
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00523_459
p9197
sg16
VAlitretinoin [drugbank:DB00523]
p9198
sg18
Vdrug-target interaction Alitretinoin and Retinoic acid receptor RXR-alpha [drugbank_resource:DB00523_459]
p9199
sa(dp9200
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:459
p9201
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00307
p9202
sg11
g9177
sg12
S'retinoid X receptor, alpha'
p9203
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00307_459
p9204
sg16
VBexarotene [drugbank:DB00307]
p9205
sg18
Vdrug-target interaction Bexarotene and Retinoic acid receptor RXR-alpha [drugbank_resource:DB00307_459]
p9206
sa(dp9207
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:459
p9208
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00926
p9209
sg11
g9177
sg12
S'retinoid X receptor, alpha'
p9210
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00926_459
p9211
sg16
VEtretinate [drugbank:DB00926]
p9212
sg18
Vdrug-target interaction Etretinate and Retinoic acid receptor RXR-alpha [drugbank_resource:DB00926_459]
p9213
sa(dp9214
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:459
p9215
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00749
p9216
sg11
g9177
sg12
S'retinoid X receptor, alpha'
p9217
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00749_459
p9218
sg16
VEtodolac [drugbank:DB00749]
p9219
sg18
Vdrug-target interaction Etodolac and Retinoic acid receptor RXR-alpha [drugbank_resource:DB00749_459]
p9220
sa(dp9221
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:459
p9222
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07863
p9223
sg11
g9177
sg12
S'retinoid X receptor, alpha'
p9224
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07863_459
p9225
sg16
V2-chloro-5-nitro-N-phenylbenzamide [drugbank:DB07863]
p9226
sg18
Vdrug-target interaction 2-chloro-5-nitro-N-phenylbenzamide and Retinoic acid receptor RXR-alpha [drugbank_resource:DB07863_459]
p9227
sa(dp9228
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:459
p9229
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08063
p9230
sg11
g9177
sg12
S'retinoid X receptor, alpha'
p9231
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08063_459
p9232
sg16
V1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE [drugbank:DB08063]
p9233
sg18
Vdrug-target interaction 1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE and Retinoic acid receptor RXR-alpha [drugbank_resource:DB08063_459]
p9234
sa(dp9235
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:459
p9236
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07557
p9237
sg11
g9177
sg12
S'retinoid X receptor, alpha'
p9238
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07557_459
p9239
sg16
V(5BETA)-PREGNANE-3,20-DIONE [drugbank:DB07557]
p9240
sg18
Vdrug-target interaction (5BETA)-PREGNANE-3,20-DIONE and Retinoic acid receptor RXR-alpha [drugbank_resource:DB07557_459]
p9241
sa(dp9242
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:459
p9243
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08402
p9244
sg11
g9177
sg12
S'retinoid X receptor, alpha'
p9245
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08402_459
p9246
sg16
V2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID [drugbank:DB08402]
p9247
sg18
Vdrug-target interaction 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID and Retinoic acid receptor RXR-alpha [drugbank_resource:DB08402_459]
p9248
sa(dp9249
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:459
p9250
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08601
p9251
sg11
g9177
sg12
S'retinoid X receptor, alpha'
p9252
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08601_459
p9253
sg16
Vtributylstannanyl [drugbank:DB08601]
p9254
sg18
Vdrug-target interaction tributylstannanyl and Retinoic acid receptor RXR-alpha [drugbank_resource:DB08601_459]
p9255
sasS'KAT2B'
p9256
(lp9257
(dp9258
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4573
p9259
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01992
p9260
sg11
g9256
sg12
S'K(lysine) acetyltransferase 2B'
p9261
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01992_4573
p9262
sg16
VCoenzyme A [drugbank:DB01992]
p9263
sg18
Vdrug-target interaction Coenzyme A and Histone acetyltransferase PCAF [drugbank_resource:DB01992_4573]
p9264
sa(dp9265
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4573
p9266
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08186
p9267
sg11
g9256
sg12
S'K(lysine) acetyltransferase 2B'
p9268
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08186_4573
p9269
sg16
V(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE [drugbank:DB08186]
p9270
sg18
Vdrug-target interaction (3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE and Histone acetyltransferase PCAF [drugbank_resource:DB08186_4573]
p9271
sa(dp9272
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4573
p9273
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08291
p9274
sg11
g9256
sg12
S'K(lysine) acetyltransferase 2B'
p9275
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08291_4573
p9276
sg16
VN-(3-AMINOPROPYL)-2-NITROBENZENAMINE [drugbank:DB08291]
p9277
sg18
Vdrug-target interaction N-(3-AMINOPROPYL)-2-NITROBENZENAMINE and Histone acetyltransferase PCAF [drugbank_resource:DB08291_4573]
p9278
sasS'MTOR'
p9279
(lp9280
(dp9281
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4148
p9282
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00337
p9283
sg11
g9279
sg12
S'mechanistic target of rapamycin (serine/threonine kinase)'
p9284
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00337_4148
p9285
sg16
VPimecrolimus [drugbank:DB00337]
p9286
sg18
Vdrug-target interaction Pimecrolimus and Serine/threonine-protein kinase mTOR [drugbank_resource:DB00337_4148]
p9287
sa(dp9288
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4148
p9289
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00877
p9290
sg11
g9279
sg12
S'mechanistic target of rapamycin (serine/threonine kinase)'
p9291
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00877_4148
p9292
sg16
VSirolimus [drugbank:DB00877]
p9293
sg18
Vdrug-target interaction Sirolimus and Serine/threonine-protein kinase mTOR [drugbank_resource:DB00877_4148]
p9294
sa(dp9295
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4148
p9296
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01590
p9297
sg11
g9279
sg12
S'mechanistic target of rapamycin (serine/threonine kinase)'
p9298
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01590_4148
p9299
sg16
VEverolimus [drugbank:DB01590]
p9300
sg18
Vdrug-target interaction Everolimus and Serine/threonine-protein kinase mTOR [drugbank_resource:DB01590_4148]
p9301
sa(dp9302
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4148
p9303
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06287
p9304
sg11
g9279
sg12
S'mechanistic target of rapamycin (serine/threonine kinase)'
p9305
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06287_4148
p9306
sg16
VTemsirolimus [drugbank:DB06287]
p9307
sg18
Vdrug-target interaction Temsirolimus and Serine/threonine-protein kinase mTOR [drugbank_resource:DB06287_4148]
p9308
sasS'LTF'
p9309
(lp9310
(dp9311
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1439
p9312
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01811
p9313
sg11
g9309
sg12
S'lactotransferrin'
p9314
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01811_1439
p9315
sg16
V3h-Indole-5,6-Diol [drugbank:DB01811]
p9316
sg18
Vdrug-target interaction 3h-Indole-5,6-Diol and Lactotransferrin [drugbank_resource:DB01811_1439]
p9317
sa(dp9318
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1439
p9319
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02944
p9320
sg11
g9309
sg12
S'lactotransferrin'
p9321
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02944_1439
p9322
sg16
VAlpha-D-Mannose [drugbank:DB02944]
p9323
sg18
Vdrug-target interaction Alpha-D-Mannose and Lactotransferrin [drugbank_resource:DB02944_1439]
p9324
sa(dp9325
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1439
p9326
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03040
p9327
sg11
g9309
sg12
S'lactotransferrin'
p9328
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03040_1439
p9329
sg16
VNitrilotriacetic Acid [drugbank:DB03040]
p9330
sg18
Vdrug-target interaction Nitrilotriacetic Acid and Lactotransferrin [drugbank_resource:DB03040_1439]
p9331
sa(dp9332
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1439
p9333
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03485
p9334
sg11
g9309
sg12
S'lactotransferrin'
p9335
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03485_1439
p9336
sg16
VAlpha-D-Fucose [drugbank:DB03485]
p9337
sg18
Vdrug-target interaction Alpha-D-Fucose and Lactotransferrin [drugbank_resource:DB03485_1439]
p9338
sa(dp9339
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1439
p9340
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04743
p9341
sg11
g9309
sg12
S'lactotransferrin'
p9342
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04743_1439
p9343
sg16
VNimesulide [drugbank:DB04743]
p9344
sg18
Vdrug-target interaction Nimesulide and Lactotransferrin [drugbank_resource:DB04743_1439]
p9345
sa(dp9346
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1439
p9347
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06987
p9348
sg11
g9309
sg12
S'lactotransferrin'
p9349
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06987_1439
p9350
sg16
V2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE [drugbank:DB06987]
p9351
sg18
Vdrug-target interaction 2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE and Lactotransferrin [drugbank_resource:DB06987_1439]
p9352
sa(dp9353
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1439
p9354
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08439
p9355
sg11
g9309
sg12
S'lactotransferrin'
p9356
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08439_1439
p9357
sg16
Vparecoxib [drugbank:DB08439]
p9358
sg18
Vdrug-target interaction parecoxib and Lactotransferrin [drugbank_resource:DB08439_1439]
p9359
sasS'S100A4'
p9360
(lp9361
(dp9362
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6859
p9363
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00831
p9364
sg11
g9360
sg12
S'S100 calcium binding protein A4'
p9365
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00831_6859
p9366
sg16
VTrifluoperazine [drugbank:DB00831]
p9367
sg18
Vdrug-target interaction Trifluoperazine and Protein S100-A4 [drugbank_resource:DB00831_6859]
p9368
sasS'LGALS3'
p9369
(lp9370
(dp9371
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2467
p9372
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01827
p9373
sg11
g9369
sg12
S'lectin, galactoside-binding, soluble, 3'
p9374
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01827_2467
p9375
sg16
V2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide [drugbank:DB01827]
p9376
sg18
Vdrug-target interaction 2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide and Galectin-3 [drugbank_resource:DB01827_2467]
p9377
sasS'ESR2'
p9378
(lp9379
(dp9380
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9381
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00255
p9382
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9383
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00255_869
p9384
sg16
VDiethylstilbestrol [drugbank:DB00255]
p9385
sg18
Vdrug-target interaction Diethylstilbestrol and Estrogen receptor beta [drugbank_resource:DB00255_869]
p9386
sa(dp9387
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9388
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00481
p9389
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9390
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00481_869
p9391
sg16
VRaloxifene [drugbank:DB00481]
p9392
sg18
Vdrug-target interaction Raloxifene and Estrogen receptor beta [drugbank_resource:DB00481_869]
p9393
sa(dp9394
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9395
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00675
p9396
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9397
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00675_869
p9398
sg16
VTamoxifen [drugbank:DB00675]
p9399
sg18
Vdrug-target interaction Tamoxifen and Estrogen receptor beta [drugbank_resource:DB00675_869]
p9400
sa(dp9401
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9402
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01108
p9403
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9404
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01108_869
p9405
sg16
VTrilostane [drugbank:DB01108]
p9406
sg18
Vdrug-target interaction Trilostane and Estrogen receptor beta [drugbank_resource:DB01108_869]
p9407
sa(dp9408
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9409
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00783
p9410
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9411
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00783_869
p9412
sg16
VEstradiol [drugbank:DB00783]
p9413
sg18
Vdrug-target interaction Estradiol and Estrogen receptor beta [drugbank_resource:DB00783_869]
p9414
sa(dp9415
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9416
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01196
p9417
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9418
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01196_869
p9419
sg16
VEstramustine [drugbank:DB01196]
p9420
sg18
Vdrug-target interaction Estramustine and Estrogen receptor beta [drugbank_resource:DB01196_869]
p9421
sa(dp9422
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9423
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01645
p9424
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9425
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01645_869
p9426
sg16
VGenistein [drugbank:DB01645]
p9427
sg18
Vdrug-target interaction Genistein and Estrogen receptor beta [drugbank_resource:DB01645_869]
p9428
sa(dp9429
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9430
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02983
p9431
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9432
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02983_869
p9433
sg16
VPara-Mercury-Benzenesulfonic Acid [drugbank:DB02983]
p9434
sg18
Vdrug-target interaction Para-Mercury-Benzenesulfonic Acid and Estrogen receptor beta [drugbank_resource:DB02983_869]
p9435
sa(dp9436
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9437
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03860
p9438
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9439
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03860_869
p9440
sg16
VN-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide [drugbank:DB03860]
p9441
sg18
Vdrug-target interaction N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide and Estrogen receptor beta [drugbank_resource:DB03860_869]
p9442
sa(dp9443
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9444
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03882
p9445
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9446
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03882_869
p9447
sg16
V5-Alpha-Androstane-3-Beta,17beta-Diol [drugbank:DB03882]
p9448
sg18
Vdrug-target interaction 5-Alpha-Androstane-3-Beta,17beta-Diol and Estrogen receptor beta [drugbank_resource:DB03882_869]
p9449
sa(dp9450
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9451
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04020
p9452
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9453
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04020_869
p9454
sg16
V4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol [drugbank:DB04020]
p9455
sg18
Vdrug-target interaction 4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol and Estrogen receptor beta [drugbank_resource:DB04020_869]
p9456
sa(dp9457
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9458
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06832
p9459
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9460
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06832_869
p9461
sg16
V2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL [drugbank:DB06832]
p9462
sg18
Vdrug-target interaction 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL and Estrogen receptor beta [drugbank_resource:DB06832_869]
p9463
sa(dp9464
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9465
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07009
p9466
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9467
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07009_869
p9468
sg16
V2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL [drugbank:DB07009]
p9469
sg18
Vdrug-target interaction 2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL and Estrogen receptor beta [drugbank_resource:DB07009_869]
p9470
sa(dp9471
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9472
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07036
p9473
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9474
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07036_869
p9475
sg16
V(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol [drugbank:DB07036]
p9476
sg18
Vdrug-target interaction (3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol and Estrogen receptor beta [drugbank_resource:DB07036_869]
p9477
sa(dp9478
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9479
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07150
p9480
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9481
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07150_869
p9482
sg16
V4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME [drugbank:DB07150]
p9483
sg18
Vdrug-target interaction 4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME and Estrogen receptor beta [drugbank_resource:DB07150_869]
p9484
sa(dp9485
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9486
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07230
p9487
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9488
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07230_869
p9489
sg16
V3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE [drugbank:DB07230]
p9490
sg18
Vdrug-target interaction 3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE and Estrogen receptor beta [drugbank_resource:DB07230_869]
p9491
sa(dp9492
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9493
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04573
p9494
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9495
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04573_869
p9496
sg16
VEstriol [drugbank:DB04573]
p9497
sg18
Vdrug-target interaction Estriol and Estrogen receptor beta [drugbank_resource:DB04573_869]
p9498
sa(dp9499
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9500
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04574
p9501
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9502
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04574_869
p9503
sg16
VEstropipate [drugbank:DB04574]
p9504
sg18
Vdrug-target interaction Estropipate and Estrogen receptor beta [drugbank_resource:DB04574_869]
p9505
sa(dp9506
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9507
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06875
p9508
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9509
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06875_869
p9510
sg16
V3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE [drugbank:DB06875]
p9511
sg18
Vdrug-target interaction 3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE and Estrogen receptor beta [drugbank_resource:DB06875_869]
p9512
sa(dp9513
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9514
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06927
p9515
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9516
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06927_869
p9517
sg16
V[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE [drugbank:DB06927]
p9518
sg18
Vdrug-target interaction [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE and Estrogen receptor beta [drugbank_resource:DB06927_869]
p9519
sa(dp9520
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9521
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06937
p9522
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9523
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06937_869
p9524
sg16
V4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL [drugbank:DB06937]
p9525
sg18
Vdrug-target interaction 4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL and Estrogen receptor beta [drugbank_resource:DB06937_869]
p9526
sa(dp9527
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9528
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07032
p9529
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9530
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07032_869
p9531
sg16
V2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL [drugbank:DB07032]
p9532
sg18
Vdrug-target interaction 2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL and Estrogen receptor beta [drugbank_resource:DB07032_869]
p9533
sa(dp9534
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9535
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07119
p9536
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9537
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07119_869
p9538
sg16
V1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL [drugbank:DB07119]
p9539
sg18
Vdrug-target interaction 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL and Estrogen receptor beta [drugbank_resource:DB07119_869]
p9540
sa(dp9541
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9542
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07198
p9543
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9544
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07198_869
p9545
sg16
V5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE [drugbank:DB07198]
p9546
sg18
Vdrug-target interaction 5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE and Estrogen receptor beta [drugbank_resource:DB07198_869]
p9547
sa(dp9548
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9549
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07236
p9550
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9551
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07236_869
p9552
sg16
V3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL [drugbank:DB07236]
p9553
sg18
Vdrug-target interaction 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL and Estrogen receptor beta [drugbank_resource:DB07236_869]
p9554
sa(dp9555
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9556
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08020
p9557
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9558
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08020_869
p9559
sg16
V(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB08020]
p9560
sg18
Vdrug-target interaction (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor beta [drugbank_resource:DB08020_869]
p9561
sa(dp9562
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9563
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07757
p9564
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9565
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07757_869
p9566
sg16
V(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one [drugbank:DB07757]
p9567
sg18
Vdrug-target interaction (9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one and Estrogen receptor beta [drugbank_resource:DB07757_869]
p9568
sa(dp9569
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9570
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07933
p9571
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9572
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07933_869
p9573
sg16
V(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB07933]
p9574
sg18
Vdrug-target interaction (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor beta [drugbank_resource:DB07933_869]
p9575
sa(dp9576
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9577
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07638
p9578
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9579
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07638_869
p9580
sg16
V(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB07638]
p9581
sg18
Vdrug-target interaction (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor beta [drugbank_resource:DB07638_869]
p9582
sa(dp9583
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:869
p9584
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07702
p9585
sg11
g9378
sg12
S'estrogen receptor 2 (ER beta)'
p9586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07702_869
p9587
sg16
V(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL [drugbank:DB07702]
p9588
sg18
Vdrug-target interaction (16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL and Estrogen receptor beta [drugbank_resource:DB07702_869]
p9589
sasS'GABRB3'
p9590
(lp9591
(dp9592
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9593
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00231
p9594
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9595
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00231_4099
p9596
sg16
VTemazepam [drugbank:DB00231]
p9597
sg18
Vdrug-target interaction Temazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00231_4099]
p9598
sa(dp9599
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9600
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00189
p9601
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9602
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00189_4099
p9603
sg16
VEthchlorvynol [drugbank:DB00189]
p9604
sg18
Vdrug-target interaction Ethchlorvynol and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00189_4099]
p9605
sa(dp9606
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9607
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00186
p9608
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00186_4099
p9610
sg16
VLorazepam [drugbank:DB00186]
p9611
sg18
Vdrug-target interaction Lorazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00186_4099]
p9612
sa(dp9613
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9614
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00546
p9615
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9616
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00546_4099
p9617
sg16
VAdinazolam [drugbank:DB00546]
p9618
sg18
Vdrug-target interaction Adinazolam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00546_4099]
p9619
sa(dp9620
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9621
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00592
p9622
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9623
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00592_4099
p9624
sg16
VPiperazine [drugbank:DB00592]
p9625
sg18
Vdrug-target interaction Piperazine and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00592_4099]
p9626
sa(dp9627
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9628
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00349
p9629
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9630
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00349_4099
p9631
sg16
VClobazam [drugbank:DB00349]
p9632
sg18
Vdrug-target interaction Clobazam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00349_4099]
p9633
sa(dp9634
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9635
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00404
p9636
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9637
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00404_4099
p9638
sg16
VAlprazolam [drugbank:DB00404]
p9639
sg18
Vdrug-target interaction Alprazolam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00404_4099]
p9640
sa(dp9641
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9642
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00475
p9643
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9644
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00475_4099
p9645
sg16
VChlordiazepoxide [drugbank:DB00475]
p9646
sg18
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00475_4099]
p9647
sa(dp9648
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9649
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00602
p9650
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9651
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00602_4099
p9652
sg16
VIvermectin [drugbank:DB00602]
p9653
sg18
Vdrug-target interaction Ivermectin and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00602_4099]
p9654
sa(dp9655
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9656
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00628
p9657
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9658
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00628_4099
p9659
sg16
VClorazepate [drugbank:DB00628]
p9660
sg18
Vdrug-target interaction Clorazepate and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00628_4099]
p9661
sa(dp9662
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9663
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00683
p9664
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9665
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00683_4099
p9666
sg16
VMidazolam [drugbank:DB00683]
p9667
sg18
Vdrug-target interaction Midazolam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00683_4099]
p9668
sa(dp9669
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9670
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00690
p9671
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9672
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00690_4099
p9673
sg16
VFlurazepam [drugbank:DB00690]
p9674
sg18
Vdrug-target interaction Flurazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00690_4099]
p9675
sa(dp9676
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9677
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00801
p9678
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9679
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00801_4099
p9680
sg16
VHalazepam [drugbank:DB00801]
p9681
sg18
Vdrug-target interaction Halazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00801_4099]
p9682
sa(dp9683
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9684
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00818
p9685
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9686
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00818_4099
p9687
sg16
VPropofol [drugbank:DB00818]
p9688
sg18
Vdrug-target interaction Propofol and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00818_4099]
p9689
sa(dp9690
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9691
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00897
p9692
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9693
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00897_4099
p9694
sg16
VTriazolam [drugbank:DB00897]
p9695
sg18
Vdrug-target interaction Triazolam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00897_4099]
p9696
sa(dp9697
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9698
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00829
p9699
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9700
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00829_4099
p9701
sg16
VDiazepam [drugbank:DB00829]
p9702
sg18
Vdrug-target interaction Diazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00829_4099]
p9703
sa(dp9704
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9705
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00842
p9706
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9707
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00842_4099
p9708
sg16
VOxazepam [drugbank:DB00842]
p9709
sg18
Vdrug-target interaction Oxazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00842_4099]
p9710
sa(dp9711
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9712
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01068
p9713
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9714
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01068_4099
p9715
sg16
VClonazepam [drugbank:DB01068]
p9716
sg18
Vdrug-target interaction Clonazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01068_4099]
p9717
sa(dp9718
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9719
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01215
p9720
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9721
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01215_4099
p9722
sg16
VEstazolam [drugbank:DB01215]
p9723
sg18
Vdrug-target interaction Estazolam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01215_4099]
p9724
sa(dp9725
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9726
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01559
p9727
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9728
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01559_4099
p9729
sg16
VClotiazepam [drugbank:DB01559]
p9730
sg18
Vdrug-target interaction Clotiazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01559_4099]
p9731
sa(dp9732
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9733
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01567
p9734
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9735
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01567_4099
p9736
sg16
VFludiazepam [drugbank:DB01567]
p9737
sg18
Vdrug-target interaction Fludiazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01567_4099]
p9738
sa(dp9739
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9740
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01594
p9741
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9742
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01594_4099
p9743
sg16
VCinolazepam [drugbank:DB01594]
p9744
sg18
Vdrug-target interaction Cinolazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01594_4099]
p9745
sa(dp9746
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9747
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01558
p9748
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9749
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01558_4099
p9750
sg16
VBromazepam [drugbank:DB01558]
p9751
sg18
Vdrug-target interaction Bromazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01558_4099]
p9752
sa(dp9753
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9754
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01588
p9755
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9756
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01588_4099
p9757
sg16
VPrazepam [drugbank:DB01588]
p9758
sg18
Vdrug-target interaction Prazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01588_4099]
p9759
sa(dp9760
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9761
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01589
p9762
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9763
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01589_4099
p9764
sg16
VQuazepam [drugbank:DB01589]
p9765
sg18
Vdrug-target interaction Quazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01589_4099]
p9766
sa(dp9767
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9768
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01595
p9769
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9770
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01595_4099
p9771
sg16
VNitrazepam [drugbank:DB01595]
p9772
sg18
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01595_4099]
p9773
sa(dp9774
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4099
p9775
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06716
p9776
sg11
g9590
sg12
S'gamma-aminobutyric acid (GABA) A receptor, beta 3'
p9777
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06716_4099
p9778
sg16
VFospropofol [drugbank:DB06716]
p9779
sg18
Vdrug-target interaction Fospropofol and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB06716_4099]
p9780
sasS'WAS'
p9781
(lp9782
(dp9783
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4304
p9784
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01731
p9785
sg11
g9781
sg12
S'Wiskott-Aldrich syndrome'
p9786
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01731_4304
p9787
sg16
V(S)-Wiskostatin [drugbank:DB01731]
p9788
sg18
Vdrug-target interaction (S)-Wiskostatin and Wiskott-Aldrich syndrome protein [drugbank_resource:DB01731_4304]
p9789
sasS'WEE1'
p9790
(lp9791
(dp9792
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5717
p9793
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07226
p9794
sg11
g9790
sg12
S'WEE1 homolog (S. pombe)'
p9795
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07226_5717
p9796
sg16
VN-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE [drugbank:DB07226]
p9797
sg18
Vdrug-target interaction N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE and Wee1-like protein kinase [drugbank_resource:DB07226_5717]
p9798
sa(dp9799
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5717
p9800
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07257
p9801
sg11
g9790
sg12
S'WEE1 homolog (S. pombe)'
p9802
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07257_5717
p9803
sg16
V4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione [drugbank:DB07257]
p9804
sg18
Vdrug-target interaction 4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione and Wee1-like protein kinase [drugbank_resource:DB07257_5717]
p9805
sa(dp9806
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5717
p9807
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07265
p9808
sg11
g9790
sg12
S'WEE1 homolog (S. pombe)'
p9809
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07265_5717
p9810
sg16
V3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID [drugbank:DB07265]
p9811
sg18
Vdrug-target interaction 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID and Wee1-like protein kinase [drugbank_resource:DB07265_5717]
p9812
sa(dp9813
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5717
p9814
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04608
p9815
sg11
g9790
sg12
S'WEE1 homolog (S. pombe)'
p9816
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04608_5717
p9817
sg16
V9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE [drugbank:DB04608]
p9818
sg18
Vdrug-target interaction 9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE and Wee1-like protein kinase [drugbank_resource:DB04608_5717]
p9819
sa(dp9820
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5717
p9821
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07006
p9822
sg11
g9790
sg12
S'WEE1 homolog (S. pombe)'
p9823
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07006_5717
p9824
sg16
V9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE [drugbank:DB07006]
p9825
sg18
Vdrug-target interaction 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE and Wee1-like protein kinase [drugbank_resource:DB07006_5717]
p9826
sa(dp9827
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5717
p9828
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08365
p9829
sg11
g9790
sg12
S'WEE1 homolog (S. pombe)'
p9830
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08365_5717
p9831
sg16
V8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide [drugbank:DB08365]
p9832
sg18
Vdrug-target interaction 8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide and Wee1-like protein kinase [drugbank_resource:DB08365_5717]
p9833
sasS'KCNJ3'
p9834
(lp9835
(dp9836
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1571
p9837
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01159
p9838
sg11
g9834
sg12
S'potassium inwardly-rectifying channel, subfamily J, member 3'
p9839
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01159_1571
p9840
sg16
VHalothane [drugbank:DB01159]
p9841
sg18
Vdrug-target interaction Halothane and G protein-activated inward rectifier potassium channel 1 [drugbank_resource:DB01159_1571]
p9842
sasS'CTNNB1'
p9843
(lp9844
(dp9845
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1392
p9846
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03904
p9847
sg11
g9843
sg12
S'catenin (cadherin-associated protein), beta 1, 88kDa'
p9848
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03904_1392
p9849
sg16
VUrea [drugbank:DB03904]
p9850
sg18
Vdrug-target interaction Urea and Catenin beta-1 [drugbank_resource:DB03904_1392]
p9851
sasS'HSP90AA1'
p9852
(lp9853
(dp9854
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9855
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00615
p9856
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9857
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00615_1939
p9858
sg16
VRifabutin [drugbank:DB00615]
p9859
sg18
Vdrug-target interaction Rifabutin and Heat shock protein HSP 90-alpha [drugbank_resource:DB00615_1939]
p9860
sa(dp9861
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9862
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00716
p9863
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9864
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00716_1939
p9865
sg16
VNedocromil [drugbank:DB00716]
p9866
sg18
Vdrug-target interaction Nedocromil and Heat shock protein HSP 90-alpha [drugbank_resource:DB00716_1939]
p9867
sa(dp9868
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9869
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02359
p9870
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9871
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02359_1939
p9872
sg16
V9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine [drugbank:DB02359]
p9873
sg18
Vdrug-target interaction 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB02359_1939]
p9874
sa(dp9875
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9876
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02754
p9877
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9878
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02754_1939
p9879
sg16
V9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine [drugbank:DB02754]
p9880
sg18
Vdrug-target interaction 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB02754_1939]
p9881
sa(dp9882
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9883
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02424
p9884
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9885
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02424_1939
p9886
sg16
VGeldanamycin [drugbank:DB02424]
p9887
sg18
Vdrug-target interaction Geldanamycin and Heat shock protein HSP 90-alpha [drugbank_resource:DB02424_1939]
p9888
sa(dp9889
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9890
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02550
p9891
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9892
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02550_1939
p9893
sg16
V8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine [drugbank:DB02550]
p9894
sg18
Vdrug-target interaction 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB02550_1939]
p9895
sa(dp9896
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9897
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02840
p9898
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9899
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02840_1939
p9900
sg16
V4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid [drugbank:DB02840]
p9901
sg18
Vdrug-target interaction 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid and Heat shock protein HSP 90-alpha [drugbank_resource:DB02840_1939]
p9902
sa(dp9903
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9904
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03137
p9905
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9906
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03137_1939
p9907
sg16
V8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine [drugbank:DB03137]
p9908
sg18
Vdrug-target interaction 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03137_1939]
p9909
sa(dp9910
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9911
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03080
p9912
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9913
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03080_1939
p9914
sg16
V17-Dmag [drugbank:DB03080]
p9915
sg18
Vdrug-target interaction 17-Dmag and Heat shock protein HSP 90-alpha [drugbank_resource:DB03080_1939]
p9916
sa(dp9917
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9918
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03093
p9919
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9920
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03093_1939
p9921
sg16
V8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine [drugbank:DB03093]
p9922
sg18
Vdrug-target interaction 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03093_1939]
p9923
sa(dp9924
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9925
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03504
p9926
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9927
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03504_1939
p9928
sg16
V9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine [drugbank:DB03504]
p9929
sg18
Vdrug-target interaction 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03504_1939]
p9930
sa(dp9931
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9932
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03749
p9933
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9934
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03749_1939
p9935
sg16
V4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole [drugbank:DB03749]
p9936
sg18
Vdrug-target interaction 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole and Heat shock protein HSP 90-alpha [drugbank_resource:DB03749_1939]
p9937
sa(dp9938
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9939
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03809
p9940
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9941
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03809_1939
p9942
sg16
V9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine [drugbank:DB03809]
p9943
sg18
Vdrug-target interaction 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03809_1939]
p9944
sa(dp9945
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9946
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03899
p9947
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9948
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03899_1939
p9949
sg16
V9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine [drugbank:DB03899]
p9950
sg18
Vdrug-target interaction 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03899_1939]
p9951
sa(dp9952
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9953
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04054
p9954
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9955
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04054_1939
p9956
sg16
V9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine [drugbank:DB04054]
p9957
sg18
Vdrug-target interaction 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB04054_1939]
p9958
sa(dp9959
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9960
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p9961
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9962
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_1939
p9963
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p9964
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Heat shock protein HSP 90-alpha [drugbank_resource:DB03431_1939]
p9965
sa(dp9966
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9967
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04254
p9968
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9969
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04254_1939
p9970
sg16
V8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine [drugbank:DB04254]
p9971
sg18
Vdrug-target interaction 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB04254_1939]
p9972
sa(dp9973
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9974
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04588
p9975
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9976
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04588_1939
p9977
sg16
VN-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE [drugbank:DB04588]
p9978
sg18
Vdrug-target interaction N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB04588_1939]
p9979
sa(dp9980
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9981
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06956
p9982
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9983
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06956_1939
p9984
sg16
VN-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE [drugbank:DB06956]
p9985
sg18
Vdrug-target interaction N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB06956_1939]
p9986
sa(dp9987
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9988
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06958
p9989
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9990
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06958_1939
p9991
sg16
V5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE [drugbank:DB06958]
p9992
sg18
Vdrug-target interaction 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB06958_1939]
p9993
sa(dp9994
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p9995
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06961
p9996
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p9997
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06961_1939
p9998
sg16
V5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide [drugbank:DB06961]
p9999
sg18
Vdrug-target interaction 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide and Heat shock protein HSP 90-alpha [drugbank_resource:DB06961_1939]
p10000
sa(dp10001
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10002
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06969
p10003
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10004
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06969_1939
p10005
sg16
V2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide [drugbank:DB06969]
p10006
sg18
Vdrug-target interaction 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide and Heat shock protein HSP 90-alpha [drugbank_resource:DB06969_1939]
p10007
sa(dp10008
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10009
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04505
p10010
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10011
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04505_1939
p10012
sg16
V8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine [drugbank:DB04505]
p10013
sg18
Vdrug-target interaction 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB04505_1939]
p10014
sa(dp10015
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10016
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07324
p10017
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10018
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07324_1939
p10019
sg16
V3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE [drugbank:DB07324]
p10020
sg18
Vdrug-target interaction 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07324_1939]
p10021
sa(dp10022
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10023
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07325
p10024
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10025
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07325_1939
p10026
sg16
VN-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE [drugbank:DB07325]
p10027
sg18
Vdrug-target interaction N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07325_1939]
p10028
sa(dp10029
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10030
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06957
p10031
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10032
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06957_1939
p10033
sg16
V4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL [drugbank:DB06957]
p10034
sg18
Vdrug-target interaction 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL and Heat shock protein HSP 90-alpha [drugbank_resource:DB06957_1939]
p10035
sa(dp10036
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10037
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06964
p10038
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10039
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06964_1939
p10040
sg16
V5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE [drugbank:DB06964]
p10041
sg18
Vdrug-target interaction 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB06964_1939]
p10042
sa(dp10043
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10044
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07100
p10045
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10046
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07100_1939
p10047
sg16
V4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL [drugbank:DB07100]
p10048
sg18
Vdrug-target interaction 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL and Heat shock protein HSP 90-alpha [drugbank_resource:DB07100_1939]
p10049
sa(dp10050
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10051
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07317
p10052
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10053
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07317_1939
p10054
sg16
V(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one [drugbank:DB07317]
p10055
sg18
Vdrug-target interaction (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one and Heat shock protein HSP 90-alpha [drugbank_resource:DB07317_1939]
p10056
sa(dp10057
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10058
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07319
p10059
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10060
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07319_1939
p10061
sg16
V6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE [drugbank:DB07319]
p10062
sg18
Vdrug-target interaction 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07319_1939]
p10063
sa(dp10064
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10065
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07495
p10066
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10067
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07495_1939
p10068
sg16
V5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE [drugbank:DB07495]
p10069
sg18
Vdrug-target interaction 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07495_1939]
p10070
sa(dp10071
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10072
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07502
p10073
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10074
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07502_1939
p10075
sg16
V4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol [drugbank:DB07502]
p10076
sg18
Vdrug-target interaction 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol and Heat shock protein HSP 90-alpha [drugbank_resource:DB07502_1939]
p10077
sa(dp10078
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10079
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08197
p10080
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10081
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08197_1939
p10082
sg16
V(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime [drugbank:DB08197]
p10083
sg18
Vdrug-target interaction (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime and Heat shock protein HSP 90-alpha [drugbank_resource:DB08197_1939]
p10084
sa(dp10085
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10086
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08442
p10087
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10088
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08442_1939
p10089
sg16
V4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol [drugbank:DB08442]
p10090
sg18
Vdrug-target interaction 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol and Heat shock protein HSP 90-alpha [drugbank_resource:DB08442_1939]
p10091
sa(dp10092
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10093
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07594
p10094
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10095
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07594_1939
p10096
sg16
V4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL [drugbank:DB07594]
p10097
sg18
Vdrug-target interaction 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL and Heat shock protein HSP 90-alpha [drugbank_resource:DB07594_1939]
p10098
sa(dp10099
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10100
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07877
p10101
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10102
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07877_1939
p10103
sg16
V8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE [drugbank:DB07877]
p10104
sg18
Vdrug-target interaction 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07877_1939]
p10105
sa(dp10106
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10107
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08194
p10108
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10109
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08194_1939
p10110
sg16
V4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine [drugbank:DB08194]
p10111
sg18
Vdrug-target interaction 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB08194_1939]
p10112
sa(dp10113
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10114
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08436
p10115
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10116
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08436_1939
p10117
sg16
V8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H- [drugbank:DB08436]
p10118
sg18
Vdrug-target interaction 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H- and Heat shock protein HSP 90-alpha [drugbank_resource:DB08436_1939]
p10119
sa(dp10120
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10121
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08443
p10122
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10123
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08443_1939
p10124
sg16
V2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol [drugbank:DB08443]
p10125
sg18
Vdrug-target interaction 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol and Heat shock protein HSP 90-alpha [drugbank_resource:DB08443_1939]
p10126
sa(dp10127
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10128
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08786
p10129
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10130
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08786_1939
p10131
sg16
V4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine [drugbank:DB08786]
p10132
sg18
Vdrug-target interaction 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB08786_1939]
p10133
sa(dp10134
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10135
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08787
p10136
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10137
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08787_1939
p10138
sg16
V4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine [drugbank:DB08787]
p10139
sg18
Vdrug-target interaction 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB08787_1939]
p10140
sa(dp10141
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10142
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08789
p10143
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10144
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08789_1939
p10145
sg16
V2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE [drugbank:DB08789]
p10146
sg18
Vdrug-target interaction 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB08789_1939]
p10147
sa(dp10148
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10149
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07601
p10150
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10151
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07601_1939
p10152
sg16
V4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol [drugbank:DB07601]
p10153
sg18
Vdrug-target interaction 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol and Heat shock protein HSP 90-alpha [drugbank_resource:DB07601_1939]
p10154
sa(dp10155
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10156
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08557
p10157
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10158
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08557_1939
p10159
sg16
V2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide [drugbank:DB08557]
p10160
sg18
Vdrug-target interaction 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide and Heat shock protein HSP 90-alpha [drugbank_resource:DB08557_1939]
p10161
sa(dp10162
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1939
p10163
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08788
p10164
sg11
g9852
sg12
S'heat shock protein 90kDa alpha (cytosolic), class A member 1'
p10165
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08788_1939
p10166
sg16
V3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE [drugbank:DB08788]
p10167
sg18
Vdrug-target interaction 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB08788_1939]
p10168
sasS'F5'
p10169
(lp10170
(dp10171
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:46
p10172
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00055
p10173
sg11
g10169
sg12
S'coagulation factor V (proaccelerin, labile factor)'
p10174
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00055_46
p10175
sg16
VDrotrecogin alfa [drugbank:DB00055]
p10176
sg18
Vdrug-target interaction Drotrecogin alfa and Coagulation factor V [drugbank_resource:DB00055_46]
p10177
sa(dp10178
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:46
p10179
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04558
p10180
sg11
g10169
sg12
S'coagulation factor V (proaccelerin, labile factor)'
p10181
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04558_46
p10182
sg16
VPhenylmercury [drugbank:DB04558]
p10183
sg18
Vdrug-target interaction Phenylmercury and Coagulation factor V [drugbank_resource:DB04558_46]
p10184
sasS'TRPA1'
p10185
(lp10186
(dp10187
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1944
p10188
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00825
p10189
sg11
g10185
sg12
S'transient receptor potential cation channel, subfamily A, member 1'
p10190
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00825_1944
p10191
sg16
VMenthol [drugbank:DB00825]
p10192
sg18
Vdrug-target interaction Menthol and Transient receptor potential cation channel subfamily A member 1 [drugbank_resource:DB00825_1944]
p10193
sasS'ESR1'
p10194
(lp10195
(dp10196
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10197
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00255
p10198
sg11
g10194
sg12
S'estrogen receptor 1'
p10199
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00255_136
p10200
sg16
VDiethylstilbestrol [drugbank:DB00255]
p10201
sg18
Vdrug-target interaction Diethylstilbestrol and Estrogen receptor [drugbank_resource:DB00255_136]
p10202
sa(dp10203
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10204
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00269
p10205
sg11
g10194
sg12
S'estrogen receptor 1'
p10206
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00269_136
p10207
sg16
VChlorotrianisene [drugbank:DB00269]
p10208
sg18
Vdrug-target interaction Chlorotrianisene and Estrogen receptor [drugbank_resource:DB00269_136]
p10209
sa(dp10210
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10211
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00304
p10212
sg11
g10194
sg12
S'estrogen receptor 1'
p10213
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00304_136
p10214
sg16
VDesogestrel [drugbank:DB00304]
p10215
sg18
Vdrug-target interaction Desogestrel and Estrogen receptor [drugbank_resource:DB00304_136]
p10216
sa(dp10217
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10218
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00286
p10219
sg11
g10194
sg12
S'estrogen receptor 1'
p10220
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00286_136
p10221
sg16
VConjugated Estrogens [drugbank:DB00286]
p10222
sg18
Vdrug-target interaction Conjugated Estrogens and Estrogen receptor [drugbank_resource:DB00286_136]
p10223
sa(dp10224
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10225
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00294
p10226
sg11
g10194
sg12
S'estrogen receptor 1'
p10227
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00294_136
p10228
sg16
VEtonogestrel [drugbank:DB00294]
p10229
sg18
Vdrug-target interaction Etonogestrel and Estrogen receptor [drugbank_resource:DB00294_136]
p10230
sa(dp10231
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10232
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00396
p10233
sg11
g10194
sg12
S'estrogen receptor 1'
p10234
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00396_136
p10235
sg16
VProgesterone [drugbank:DB00396]
p10236
sg18
Vdrug-target interaction Progesterone and Estrogen receptor [drugbank_resource:DB00396_136]
p10237
sa(dp10238
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10239
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00481
p10240
sg11
g10194
sg12
S'estrogen receptor 1'
p10241
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00481_136
p10242
sg16
VRaloxifene [drugbank:DB00481]
p10243
sg18
Vdrug-target interaction Raloxifene and Estrogen receptor [drugbank_resource:DB00481_136]
p10244
sa(dp10245
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10246
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00539
p10247
sg11
g10194
sg12
S'estrogen receptor 1'
p10248
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00539_136
p10249
sg16
VToremifene [drugbank:DB00539]
p10250
sg18
Vdrug-target interaction Toremifene and Estrogen receptor [drugbank_resource:DB00539_136]
p10251
sa(dp10252
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10253
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00603
p10254
sg11
g10194
sg12
S'estrogen receptor 1'
p10255
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00603_136
p10256
sg16
VMedroxyprogesterone [drugbank:DB00603]
p10257
sg18
Vdrug-target interaction Medroxyprogesterone and Estrogen receptor [drugbank_resource:DB00603_136]
p10258
sa(dp10259
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10260
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00367
p10261
sg11
g10194
sg12
S'estrogen receptor 1'
p10262
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00367_136
p10263
sg16
VLevonorgestrel [drugbank:DB00367]
p10264
sg18
Vdrug-target interaction Levonorgestrel and Estrogen receptor [drugbank_resource:DB00367_136]
p10265
sa(dp10266
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10267
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00655
p10268
sg11
g10194
sg12
S'estrogen receptor 1'
p10269
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00655_136
p10270
sg16
VEstrone [drugbank:DB00655]
p10271
sg18
Vdrug-target interaction Estrone and Estrogen receptor [drugbank_resource:DB00655_136]
p10272
sa(dp10273
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10274
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00783
p10275
sg11
g10194
sg12
S'estrogen receptor 1'
p10276
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00783_136
p10277
sg16
VEstradiol [drugbank:DB00783]
p10278
sg18
Vdrug-target interaction Estradiol and Estrogen receptor [drugbank_resource:DB00783_136]
p10279
sa(dp10280
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10281
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00823
p10282
sg11
g10194
sg12
S'estrogen receptor 1'
p10283
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00823_136
p10284
sg16
VEthynodiol Diacetate [drugbank:DB00823]
p10285
sg18
Vdrug-target interaction Ethynodiol Diacetate and Estrogen receptor [drugbank_resource:DB00823_136]
p10286
sa(dp10287
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10288
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00957
p10289
sg11
g10194
sg12
S'estrogen receptor 1'
p10290
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00957_136
p10291
sg16
VNorgestimate [drugbank:DB00957]
p10292
sg18
Vdrug-target interaction Norgestimate and Estrogen receptor [drugbank_resource:DB00957_136]
p10293
sa(dp10294
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10295
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00675
p10296
sg11
g10194
sg12
S'estrogen receptor 1'
p10297
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00675_136
p10298
sg16
VTamoxifen [drugbank:DB00675]
p10299
sg18
Vdrug-target interaction Tamoxifen and Estrogen receptor [drugbank_resource:DB00675_136]
p10300
sa(dp10301
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10302
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00882
p10303
sg11
g10194
sg12
S'estrogen receptor 1'
p10304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00882_136
p10305
sg16
VClomifene [drugbank:DB00882]
p10306
sg18
Vdrug-target interaction Clomifene and Estrogen receptor [drugbank_resource:DB00882_136]
p10307
sa(dp10308
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10309
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00947
p10310
sg11
g10194
sg12
S'estrogen receptor 1'
p10311
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00947_136
p10312
sg16
VFulvestrant [drugbank:DB00947]
p10313
sg18
Vdrug-target interaction Fulvestrant and Estrogen receptor [drugbank_resource:DB00947_136]
p10314
sa(dp10315
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10316
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00890
p10317
sg11
g10194
sg12
S'estrogen receptor 1'
p10318
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00890_136
p10319
sg16
VDienestrol [drugbank:DB00890]
p10320
sg18
Vdrug-target interaction Dienestrol and Estrogen receptor [drugbank_resource:DB00890_136]
p10321
sa(dp10322
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10323
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00977
p10324
sg11
g10194
sg12
S'estrogen receptor 1'
p10325
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00977_136
p10326
sg16
VEthinyl Estradiol [drugbank:DB00977]
p10327
sg18
Vdrug-target interaction Ethinyl Estradiol and Estrogen receptor [drugbank_resource:DB00977_136]
p10328
sa(dp10329
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10330
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01065
p10331
sg11
g10194
sg12
S'estrogen receptor 1'
p10332
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01065_136
p10333
sg16
VMelatonin [drugbank:DB01065]
p10334
sg18
Vdrug-target interaction Melatonin and Estrogen receptor [drugbank_resource:DB01065_136]
p10335
sa(dp10336
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10337
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01108
p10338
sg11
g10194
sg12
S'estrogen receptor 1'
p10339
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01108_136
p10340
sg16
VTrilostane [drugbank:DB01108]
p10341
sg18
Vdrug-target interaction Trilostane and Estrogen receptor [drugbank_resource:DB01108_136]
p10342
sa(dp10343
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10344
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01431
p10345
sg11
g10194
sg12
S'estrogen receptor 1'
p10346
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01431_136
p10347
sg16
VAllylestrenol [drugbank:DB01431]
p10348
sg18
Vdrug-target interaction Allylestrenol and Estrogen receptor [drugbank_resource:DB01431_136]
p10349
sa(dp10350
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10351
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01645
p10352
sg11
g10194
sg12
S'estrogen receptor 1'
p10353
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01645_136
p10354
sg16
VGenistein [drugbank:DB01645]
p10355
sg18
Vdrug-target interaction Genistein and Estrogen receptor [drugbank_resource:DB01645_136]
p10356
sa(dp10357
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10358
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01196
p10359
sg11
g10194
sg12
S'estrogen receptor 1'
p10360
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01196_136
p10361
sg16
VEstramustine [drugbank:DB01196]
p10362
sg18
Vdrug-target interaction Estramustine and Estrogen receptor [drugbank_resource:DB01196_136]
p10363
sa(dp10364
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10365
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01406
p10366
sg11
g10194
sg12
S'estrogen receptor 1'
p10367
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01406_136
p10368
sg16
VDanazol [drugbank:DB01406]
p10369
sg18
Vdrug-target interaction Danazol and Estrogen receptor [drugbank_resource:DB01406_136]
p10370
sa(dp10371
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10372
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01183
p10373
sg11
g10194
sg12
S'estrogen receptor 1'
p10374
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01183_136
p10375
sg16
VNaloxone [drugbank:DB01183]
p10376
sg18
Vdrug-target interaction Naloxone and Estrogen receptor [drugbank_resource:DB01183_136]
p10377
sa(dp10378
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10379
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01185
p10380
sg11
g10194
sg12
S'estrogen receptor 1'
p10381
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01185_136
p10382
sg16
VFluoxymesterone [drugbank:DB01185]
p10383
sg18
Vdrug-target interaction Fluoxymesterone and Estrogen receptor [drugbank_resource:DB01185_136]
p10384
sa(dp10385
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10386
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01357
p10387
sg11
g10194
sg12
S'estrogen receptor 1'
p10388
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01357_136
p10389
sg16
VMestranol [drugbank:DB01357]
p10390
sg18
Vdrug-target interaction Mestranol and Estrogen receptor [drugbank_resource:DB01357_136]
p10391
sa(dp10392
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10393
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02715
p10394
sg11
g10194
sg12
S'estrogen receptor 1'
p10395
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02715_136
p10396
sg16
VCompound 18 [drugbank:DB02715]
p10397
sg18
Vdrug-target interaction Compound 18 and Estrogen receptor [drugbank_resource:DB02715_136]
p10398
sa(dp10399
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10400
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02615
p10401
sg11
g10194
sg12
S'estrogen receptor 1'
p10402
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02615_136
p10403
sg16
VCompound 19 [drugbank:DB02615]
p10404
sg18
Vdrug-target interaction Compound 19 and Estrogen receptor [drugbank_resource:DB02615_136]
p10405
sa(dp10406
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10407
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03742
p10408
sg11
g10194
sg12
S'estrogen receptor 1'
p10409
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03742_136
p10410
sg16
VCompound 4-D [drugbank:DB03742]
p10411
sg18
Vdrug-target interaction Compound 4-D and Estrogen receptor [drugbank_resource:DB03742_136]
p10412
sa(dp10413
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10414
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03802
p10415
sg11
g10194
sg12
S'estrogen receptor 1'
p10416
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03802_136
p10417
sg16
V1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol [drugbank:DB03802]
p10418
sg18
Vdrug-target interaction 1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol and Estrogen receptor [drugbank_resource:DB03802_136]
p10419
sa(dp10420
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10421
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04471
p10422
sg11
g10194
sg12
S'estrogen receptor 1'
p10423
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04471_136
p10424
sg16
V2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol [drugbank:DB04471]
p10425
sg18
Vdrug-target interaction 2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol and Estrogen receptor [drugbank_resource:DB04471_136]
p10426
sa(dp10427
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10428
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04574
p10429
sg11
g10194
sg12
S'estrogen receptor 1'
p10430
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04574_136
p10431
sg16
VEstropipate [drugbank:DB04574]
p10432
sg18
Vdrug-target interaction Estropipate and Estrogen receptor [drugbank_resource:DB04574_136]
p10433
sa(dp10434
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10435
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06713
p10436
sg11
g10194
sg12
S'estrogen receptor 1'
p10437
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06713_136
p10438
sg16
VNorelgestromin [drugbank:DB06713]
p10439
sg18
Vdrug-target interaction Norelgestromin and Estrogen receptor [drugbank_resource:DB06713_136]
p10440
sa(dp10441
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10442
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06927
p10443
sg11
g10194
sg12
S'estrogen receptor 1'
p10444
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06927_136
p10445
sg16
V[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE [drugbank:DB06927]
p10446
sg18
Vdrug-target interaction [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE and Estrogen receptor [drugbank_resource:DB06927_136]
p10447
sa(dp10448
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10449
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07087
p10450
sg11
g10194
sg12
S'estrogen receptor 1'
p10451
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07087_136
p10452
sg16
V4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07087]
p10453
sg18
Vdrug-target interaction 4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Estrogen receptor [drugbank_resource:DB07087_136]
p10454
sa(dp10455
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10456
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07195
p10457
sg11
g10194
sg12
S'estrogen receptor 1'
p10458
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07195_136
p10459
sg16
V4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07195]
p10460
sg18
Vdrug-target interaction 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Estrogen receptor [drugbank_resource:DB07195_136]
p10461
sa(dp10462
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10463
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04573
p10464
sg11
g10194
sg12
S'estrogen receptor 1'
p10465
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04573_136
p10466
sg16
VEstriol [drugbank:DB04573]
p10467
sg18
Vdrug-target interaction Estriol and Estrogen receptor [drugbank_resource:DB04573_136]
p10468
sa(dp10469
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10470
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04575
p10471
sg11
g10194
sg12
S'estrogen receptor 1'
p10472
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04575_136
p10473
sg16
VQuinestrol [drugbank:DB04575]
p10474
sg18
Vdrug-target interaction Quinestrol and Estrogen receptor [drugbank_resource:DB04575_136]
p10475
sa(dp10476
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10477
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06898
p10478
sg11
g10194
sg12
S'estrogen receptor 1'
p10479
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06898_136
p10480
sg16
V4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol [drugbank:DB06898]
p10481
sg18
Vdrug-target interaction 4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol and Estrogen receptor [drugbank_resource:DB06898_136]
p10482
sa(dp10483
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10484
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06871
p10485
sg11
g10194
sg12
S'estrogen receptor 1'
p10486
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06871_136
p10487
sg16
V17-METHYL-17-ALPHA-DIHYDROEQUILENIN [drugbank:DB06871]
p10488
sg18
Vdrug-target interaction 17-METHYL-17-ALPHA-DIHYDROEQUILENIN and Estrogen receptor [drugbank_resource:DB06871_136]
p10489
sa(dp10490
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10491
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07086
p10492
sg11
g10194
sg12
S'estrogen receptor 1'
p10493
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07086_136
p10494
sg16
V4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07086]
p10495
sg18
Vdrug-target interaction 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Estrogen receptor [drugbank_resource:DB07086_136]
p10496
sa(dp10497
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10498
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07567
p10499
sg11
g10194
sg12
S'estrogen receptor 1'
p10500
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07567_136
p10501
sg16
V(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL [drugbank:DB07567]
p10502
sg18
Vdrug-target interaction (2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL and Estrogen receptor [drugbank_resource:DB07567_136]
p10503
sa(dp10504
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10505
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07638
p10506
sg11
g10194
sg12
S'estrogen receptor 1'
p10507
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07638_136
p10508
sg16
V(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB07638]
p10509
sg18
Vdrug-target interaction (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor [drugbank_resource:DB07638_136]
p10510
sa(dp10511
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10512
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07712
p10513
sg11
g10194
sg12
S'estrogen receptor 1'
p10514
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07712_136
p10515
sg16
V3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL [drugbank:DB07712]
p10516
sg18
Vdrug-target interaction 3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL and Estrogen receptor [drugbank_resource:DB07712_136]
p10517
sa(dp10518
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10519
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07991
p10520
sg11
g10194
sg12
S'estrogen receptor 1'
p10521
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07991_136
p10522
sg16
VN-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE [drugbank:DB07991]
p10523
sg18
Vdrug-target interaction N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE and Estrogen receptor [drugbank_resource:DB07991_136]
p10524
sa(dp10525
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10526
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08020
p10527
sg11
g10194
sg12
S'estrogen receptor 1'
p10528
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08020_136
p10529
sg16
V(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB08020]
p10530
sg18
Vdrug-target interaction (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor [drugbank_resource:DB08020_136]
p10531
sa(dp10532
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10533
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08048
p10534
sg11
g10194
sg12
S'estrogen receptor 1'
p10535
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08048_136
p10536
sg16
V4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL [drugbank:DB08048]
p10537
sg18
Vdrug-target interaction 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL and Estrogen receptor [drugbank_resource:DB08048_136]
p10538
sa(dp10539
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10540
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07678
p10541
sg11
g10194
sg12
S'estrogen receptor 1'
p10542
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07678_136
p10543
sg16
V(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL [drugbank:DB07678]
p10544
sg18
Vdrug-target interaction (9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL and Estrogen receptor [drugbank_resource:DB07678_136]
p10545
sa(dp10546
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10547
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07708
p10548
sg11
g10194
sg12
S'estrogen receptor 1'
p10549
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07708_136
p10550
sg16
V3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL [drugbank:DB07708]
p10551
sg18
Vdrug-target interaction 3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL and Estrogen receptor [drugbank_resource:DB07708_136]
p10552
sa(dp10553
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10554
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07707
p10555
sg11
g10194
sg12
S'estrogen receptor 1'
p10556
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07707_136
p10557
sg16
V(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL [drugbank:DB07707]
p10558
sg18
Vdrug-target interaction (9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL and Estrogen receptor [drugbank_resource:DB07707_136]
p10559
sa(dp10560
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10561
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07932
p10562
sg11
g10194
sg12
S'estrogen receptor 1'
p10563
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07932_136
p10564
sg16
Vdimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate [drugbank:DB07932]
p10565
sg18
Vdrug-target interaction dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate and Estrogen receptor [drugbank_resource:DB07932_136]
p10566
sa(dp10567
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10568
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07933
p10569
sg11
g10194
sg12
S'estrogen receptor 1'
p10570
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07933_136
p10571
sg16
V(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB07933]
p10572
sg18
Vdrug-target interaction (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor [drugbank_resource:DB07933_136]
p10573
sa(dp10574
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10575
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08047
p10576
sg11
g10194
sg12
S'estrogen receptor 1'
p10577
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08047_136
p10578
sg16
V4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol [drugbank:DB08047]
p10579
sg18
Vdrug-target interaction 4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol and Estrogen receptor [drugbank_resource:DB08047_136]
p10580
sa(dp10581
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10582
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08320
p10583
sg11
g10194
sg12
S'estrogen receptor 1'
p10584
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08320_136
p10585
sg16
VDIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE [drugbank:DB08320]
p10586
sg18
Vdrug-target interaction DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE and Estrogen receptor [drugbank_resource:DB08320_136]
p10587
sa(dp10588
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10589
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08398
p10590
sg11
g10194
sg12
S'estrogen receptor 1'
p10591
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08398_136
p10592
sg16
V2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE [drugbank:DB08398]
p10593
sg18
Vdrug-target interaction 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE and Estrogen receptor [drugbank_resource:DB08398_136]
p10594
sa(dp10595
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10596
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08595
p10597
sg11
g10194
sg12
S'estrogen receptor 1'
p10598
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08595_136
p10599
sg16
V4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB08595]
p10600
sg18
Vdrug-target interaction 4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Estrogen receptor [drugbank_resource:DB08595_136]
p10601
sa(dp10602
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10603
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08737
p10604
sg11
g10194
sg12
S'estrogen receptor 1'
p10605
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08737_136
p10606
sg16
V(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL [drugbank:DB08737]
p10607
sg18
Vdrug-target interaction (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL and Estrogen receptor [drugbank_resource:DB08737_136]
p10608
sa(dp10609
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:136
p10610
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08773
p10611
sg11
g10194
sg12
S'estrogen receptor 1'
p10612
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08773_136
p10613
sg16
VRALOXIFENE CORE [drugbank:DB08773]
p10614
sg18
Vdrug-target interaction RALOXIFENE CORE and Estrogen receptor [drugbank_resource:DB08773_136]
p10615
sasS'IRS1'
p10616
(lp10617
(dp10618
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1372
p10619
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08513
p10620
sg11
g10616
sg12
S'insulin receptor substrate 1'
p10621
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08513_1372
p10622
sg16
V[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID [drugbank:DB08513]
p10623
sg18
Vdrug-target interaction [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID and Insulin receptor substrate 1 [drugbank_resource:DB08513_1372]
p10624
sasS'IL6'
p10625
(lp10626
(dp10627
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1159
p10628
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01404
p10629
sg11
g10625
sg12
S'interleukin 6 (interferon, beta 2)'
p10630
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01404_1159
p10631
sg16
VGinseng [drugbank:DB01404]
p10632
sg18
Vdrug-target interaction Ginseng and Interleukin-6 [drugbank_resource:DB01404_1159]
p10633
sasS'MET'
p10634
(lp10635
(dp10636
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p10637
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02152
p10638
sg11
g10634
sg12
S'met proto-oncogene (hepatocyte growth factor receptor)'
p10639
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02152_1144
p10640
sg16
VK-252a [drugbank:DB02152]
p10641
sg18
Vdrug-target interaction K-252a and Hepatocyte growth factor receptor [drugbank_resource:DB02152_1144]
p10642
sa(dp10643
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p10644
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06896
p10645
sg11
g10634
sg12
S'met proto-oncogene (hepatocyte growth factor receptor)'
p10646
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06896_1144
p10647
sg16
V1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide [drugbank:DB06896]
p10648
sg18
Vdrug-target interaction 1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide and Hepatocyte growth factor receptor [drugbank_resource:DB06896_1144]
p10649
sa(dp10650
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p10651
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06995
p10652
sg11
g10634
sg12
S'met proto-oncogene (hepatocyte growth factor receptor)'
p10653
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06995_1144
p10654
sg16
VN-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide [drugbank:DB06995]
p10655
sg18
Vdrug-target interaction N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide and Hepatocyte growth factor receptor [drugbank_resource:DB06995_1144]
p10656
sa(dp10657
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p10658
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06997
p10659
sg11
g10634
sg12
S'met proto-oncogene (hepatocyte growth factor receptor)'
p10660
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06997_1144
p10661
sg16
V2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide [drugbank:DB06997]
p10662
sg18
Vdrug-target interaction 2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide and Hepatocyte growth factor receptor [drugbank_resource:DB06997_1144]
p10663
sa(dp10664
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p10665
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07369
p10666
sg11
g10634
sg12
S'met proto-oncogene (hepatocyte growth factor receptor)'
p10667
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07369_1144
p10668
sg16
VN-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide [drugbank:DB07369]
p10669
sg18
Vdrug-target interaction N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide and Hepatocyte growth factor receptor [drugbank_resource:DB07369_1144]
p10670
sa(dp10671
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p10672
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07969
p10673
sg11
g10634
sg12
S'met proto-oncogene (hepatocyte growth factor receptor)'
p10674
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07969_1144
p10675
sg16
V3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol [drugbank:DB07969]
p10676
sg18
Vdrug-target interaction 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol and Hepatocyte growth factor receptor [drugbank_resource:DB07969_1144]
p10677
sa(dp10678
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p10679
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08584
p10680
sg11
g10634
sg12
S'met proto-oncogene (hepatocyte growth factor receptor)'
p10681
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08584_1144
p10682
sg16
V6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline [drugbank:DB08584]
p10683
sg18
Vdrug-target interaction 6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline and Hepatocyte growth factor receptor [drugbank_resource:DB08584_1144]
p10684
sa(dp10685
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p10686
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08700
p10687
sg11
g10634
sg12
S'met proto-oncogene (hepatocyte growth factor receptor)'
p10688
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08700_1144
p10689
sg16
V3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine [drugbank:DB08700]
p10690
sg18
Vdrug-target interaction 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine and Hepatocyte growth factor receptor [drugbank_resource:DB08700_1144]
p10691
sa(dp10692
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1144
p10693
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08791
p10694
sg11
g10634
sg12
S'met proto-oncogene (hepatocyte growth factor receptor)'
p10695
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08791_1144
p10696
sg16
V1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE [drugbank:DB08791]
p10697
sg18
Vdrug-target interaction 1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE and Hepatocyte growth factor receptor [drugbank_resource:DB08791_1144]
p10698
sasS'CDK2'
p10699
(lp10700
(dp10701
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10702
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01769
p10703
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10704
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01769_2240
p10705
sg16
VDouble Oxidized Cysteine [drugbank:DB01769]
p10706
sg18
Vdrug-target interaction Double Oxidized Cysteine and Cell division protein kinase 2 [drugbank_resource:DB01769_2240]
p10707
sa(dp10708
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10709
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01888
p10710
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10711
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01888_2240
p10712
sg16
V4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide [drugbank:DB01888]
p10713
sg18
Vdrug-target interaction 4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB01888_2240]
p10714
sa(dp10715
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10716
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02091
p10717
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10718
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02091_2240
p10719
sg16
V4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine [drugbank:DB02091]
p10720
sg18
Vdrug-target interaction 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine and Cell division protein kinase 2 [drugbank_resource:DB02091_2240]
p10721
sa(dp10722
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10723
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02116
p10724
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10725
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02116_2240
p10726
sg16
VOlomoucine [drugbank:DB02116]
p10727
sg18
Vdrug-target interaction Olomoucine and Cell division protein kinase 2 [drugbank_resource:DB02116_2240]
p10728
sa(dp10729
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10730
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02197
p10731
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10732
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02197_2240
p10733
sg16
V4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide [drugbank:DB02197]
p10734
sg18
Vdrug-target interaction 4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB02197_2240]
p10735
sa(dp10736
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10737
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02010
p10738
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10739
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02010_2240
p10740
sg16
VStaurosporine [drugbank:DB02010]
p10741
sg18
Vdrug-target interaction Staurosporine and Cell division protein kinase 2 [drugbank_resource:DB02010_2240]
p10742
sa(dp10743
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10744
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02052
p10745
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10746
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02052_2240
p10747
sg16
VIndirubin-3'-Monoxime [drugbank:DB02052]
p10748
sg18
Vdrug-target interaction Indirubin-3'-Monoxime and Cell division protein kinase 2 [drugbank_resource:DB02052_2240]
p10749
sa(dp10750
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10751
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02538
p10752
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10753
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02538_2240
p10754
sg16
VN-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide [drugbank:DB02538]
p10755
sg18
Vdrug-target interaction N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide and Cell division protein kinase 2 [drugbank_resource:DB02538_2240]
p10756
sa(dp10757
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10758
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02297
p10759
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10760
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02297_2240
p10761
sg16
V2-Amino-6-Chloropyrazine [drugbank:DB02297]
p10762
sg18
Vdrug-target interaction 2-Amino-6-Chloropyrazine and Cell division protein kinase 2 [drugbank_resource:DB02297_2240]
p10763
sa(dp10764
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10765
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02407
p10766
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10767
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02407_2240
p10768
sg16
V6-O-Cyclohexylmethyl Guanine [drugbank:DB02407]
p10769
sg18
Vdrug-target interaction 6-O-Cyclohexylmethyl Guanine and Cell division protein kinase 2 [drugbank_resource:DB02407_2240]
p10770
sa(dp10771
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10772
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02833
p10773
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10774
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02833_2240
p10775
sg16
V[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine [drugbank:DB02833]
p10776
sg18
Vdrug-target interaction [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine and Cell division protein kinase 2 [drugbank_resource:DB02833_2240]
p10777
sa(dp10778
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10779
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02898
p10780
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10781
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02898_2240
p10782
sg16
V5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone [drugbank:DB02898]
p10783
sg18
Vdrug-target interaction 5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone and Cell division protein kinase 2 [drugbank_resource:DB02898_2240]
p10784
sa(dp10785
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10786
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02915
p10787
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10788
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02915_2240
p10789
sg16
V4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine [drugbank:DB02915]
p10790
sg18
Vdrug-target interaction 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine and Cell division protein kinase 2 [drugbank_resource:DB02915_2240]
p10791
sa(dp10792
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10793
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02950
p10794
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10795
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02950_2240
p10796
sg16
VHymenialdisine [drugbank:DB02950]
p10797
sg18
Vdrug-target interaction Hymenialdisine and Cell division protein kinase 2 [drugbank_resource:DB02950_2240]
p10798
sa(dp10799
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10800
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03019
p10801
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10802
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03019_2240
p10803
sg16
V4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine [drugbank:DB03019]
p10804
sg18
Vdrug-target interaction 4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine and Cell division protein kinase 2 [drugbank_resource:DB03019_2240]
p10805
sa(dp10806
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10807
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02603
p10808
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10809
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02603_2240
p10810
sg16
V1-Amino-6-Cyclohex-3-Enylmethyloxypurine [drugbank:DB02603]
p10811
sg18
Vdrug-target interaction 1-Amino-6-Cyclohex-3-Enylmethyloxypurine and Cell division protein kinase 2 [drugbank_resource:DB02603_2240]
p10812
sa(dp10813
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10814
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02647
p10815
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10816
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02647_2240
p10817
sg16
VN-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide [drugbank:DB02647]
p10818
sg18
Vdrug-target interaction N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide and Cell division protein kinase 2 [drugbank_resource:DB02647_2240]
p10819
sa(dp10820
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10821
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02733
p10822
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10823
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02733_2240
p10824
sg16
VPurvalanol [drugbank:DB02733]
p10825
sg18
Vdrug-target interaction Purvalanol and Cell division protein kinase 2 [drugbank_resource:DB02733_2240]
p10826
sa(dp10827
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10828
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03307
p10829
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10830
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03307_2240
p10831
sg16
V4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide [drugbank:DB03307]
p10832
sg18
Vdrug-target interaction 4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB03307_2240]
p10833
sa(dp10834
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10835
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02963
p10836
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10837
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02963_2240
p10838
sg16
V(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine [drugbank:DB02963]
p10839
sg18
Vdrug-target interaction (5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine and Cell division protein kinase 2 [drugbank_resource:DB02963_2240]
p10840
sa(dp10841
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10842
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02973
p10843
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10844
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02973_2240
p10845
sg16
V4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide [drugbank:DB02973]
p10846
sg18
Vdrug-target interaction 4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB02973_2240]
p10847
sa(dp10848
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10849
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03428
p10850
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10851
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03428_2240
p10852
sg16
VSU9516 [drugbank:DB03428]
p10853
sg18
Vdrug-target interaction SU9516 and Cell division protein kinase 2 [drugbank_resource:DB03428_2240]
p10854
sa(dp10855
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10856
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03737
p10857
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10858
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03737_2240
p10859
sg16
V4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One [drugbank:DB03737]
p10860
sg18
Vdrug-target interaction 4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One and Cell division protein kinase 2 [drugbank_resource:DB03737_2240]
p10861
sa(dp10862
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10863
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03365
p10864
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10865
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03365_2240
p10866
sg16
V4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline [drugbank:DB03365]
p10867
sg18
Vdrug-target interaction 4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline and Cell division protein kinase 2 [drugbank_resource:DB03365_2240]
p10868
sa(dp10869
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10870
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p10871
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10872
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_2240
p10873
sg16
VFlavopiridol [drugbank:DB03496]
p10874
sg18
Vdrug-target interaction Flavopiridol and Cell division protein kinase 2 [drugbank_resource:DB03496_2240]
p10875
sa(dp10876
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10877
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03583
p10878
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10879
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03583_2240
p10880
sg16
V(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One [drugbank:DB03583]
p10881
sg18
Vdrug-target interaction (2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One and Cell division protein kinase 2 [drugbank_resource:DB03583_2240]
p10882
sa(dp10883
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10884
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03801
p10885
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10886
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03801_2240
p10887
sg16
VLysine Nz-Carboxylic Acid [drugbank:DB03801]
p10888
sg18
Vdrug-target interaction Lysine Nz-Carboxylic Acid and Cell division protein kinase 2 [drugbank_resource:DB03801_2240]
p10889
sa(dp10890
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10891
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04006
p10892
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10893
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04006_2240
p10894
sg16
V[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone [drugbank:DB04006]
p10895
sg18
Vdrug-target interaction [2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone and Cell division protein kinase 2 [drugbank_resource:DB04006_2240]
p10896
sa(dp10897
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10898
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03490
p10899
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10900
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03490_2240
p10901
sg16
V3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole [drugbank:DB03490]
p10902
sg18
Vdrug-target interaction 3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole and Cell division protein kinase 2 [drugbank_resource:DB03490_2240]
p10903
sa(dp10904
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10905
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03663
p10906
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10907
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03663_2240
p10908
sg16
V1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol [drugbank:DB03663]
p10909
sg18
Vdrug-target interaction 1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol and Cell division protein kinase 2 [drugbank_resource:DB03663_2240]
p10910
sa(dp10911
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10912
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04186
p10913
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10914
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04186_2240
p10915
sg16
VN'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea [drugbank:DB04186]
p10916
sg18
Vdrug-target interaction N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea and Cell division protein kinase 2 [drugbank_resource:DB04186_2240]
p10917
sa(dp10918
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10919
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04288
p10920
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10921
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04288_2240
p10922
sg16
V2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine [drugbank:DB04288]
p10923
sg18
Vdrug-target interaction 2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine and Cell division protein kinase 2 [drugbank_resource:DB04288_2240]
p10924
sa(dp10925
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10926
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04407
p10927
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10928
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04407_2240
p10929
sg16
V4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol [drugbank:DB04407]
p10930
sg18
Vdrug-target interaction 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol and Cell division protein kinase 2 [drugbank_resource:DB04407_2240]
p10931
sa(dp10932
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10933
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04101
p10934
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10935
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04101_2240
p10936
sg16
VN-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide [drugbank:DB04101]
p10937
sg18
Vdrug-target interaction N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide and Cell division protein kinase 2 [drugbank_resource:DB04101_2240]
p10938
sa(dp10939
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10940
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04662
p10941
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10942
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04662_2240
p10943
sg16
VOLOMOUCINE II [drugbank:DB04662]
p10944
sg18
Vdrug-target interaction OLOMOUCINE II and Cell division protein kinase 2 [drugbank_resource:DB04662_2240]
p10945
sa(dp10946
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10947
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04669
p10948
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10949
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04669_2240
p10950
sg16
VTRIAZOLOPYRIMIDINE [drugbank:DB04669]
p10951
sg18
Vdrug-target interaction TRIAZOLOPYRIMIDINE and Cell division protein kinase 2 [drugbank_resource:DB04669_2240]
p10952
sa(dp10953
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10954
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06844
p10955
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10956
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06844_2240
p10957
sg16
V4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE [drugbank:DB06844]
p10958
sg18
Vdrug-target interaction 4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB06844_2240]
p10959
sa(dp10960
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10961
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06976
p10962
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10963
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06976_2240
p10964
sg16
V1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA [drugbank:DB06976]
p10965
sg18
Vdrug-target interaction 1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA and Cell division protein kinase 2 [drugbank_resource:DB06976_2240]
p10966
sa(dp10967
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10968
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06983
p10969
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10970
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06983_2240
p10971
sg16
V(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol [drugbank:DB06983]
p10972
sg18
Vdrug-target interaction (5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol and Cell division protein kinase 2 [drugbank_resource:DB06983_2240]
p10973
sa(dp10974
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10975
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07065
p10976
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10977
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07065_2240
p10978
sg16
V5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB07065]
p10979
sg18
Vdrug-target interaction 5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB07065_2240]
p10980
sa(dp10981
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10982
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07203
p10983
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10984
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07203_2240
p10985
sg16
V6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE [drugbank:DB07203]
p10986
sg18
Vdrug-target interaction 6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE and Cell division protein kinase 2 [drugbank_resource:DB07203_2240]
p10987
sa(dp10988
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10989
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04518
p10990
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10991
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04518_2240
p10992
sg16
V3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol [drugbank:DB04518]
p10993
sg18
Vdrug-target interaction 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol and Cell division protein kinase 2 [drugbank_resource:DB04518_2240]
p10994
sa(dp10995
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p10996
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04607
p10997
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p10998
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04607_2240
p10999
sg16
VPHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE [drugbank:DB04607]
p11000
sg18
Vdrug-target interaction PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE and Cell division protein kinase 2 [drugbank_resource:DB04607_2240]
p11001
sa(dp11002
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11003
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06888
p11004
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11005
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06888_2240
p11006
sg16
V(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE [drugbank:DB06888]
p11007
sg18
Vdrug-target interaction (13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE and Cell division protein kinase 2 [drugbank_resource:DB06888_2240]
p11008
sa(dp11009
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11010
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07024
p11011
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11012
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07024_2240
p11013
sg16
V2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE [drugbank:DB07024]
p11014
sg18
Vdrug-target interaction 2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE and Cell division protein kinase 2 [drugbank_resource:DB07024_2240]
p11015
sa(dp11016
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11017
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07054
p11018
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11019
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07054_2240
p11020
sg16
V(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL [drugbank:DB07054]
p11021
sg18
Vdrug-target interaction (2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07054_2240]
p11022
sa(dp11023
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11024
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07137
p11025
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11026
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07137_2240
p11027
sg16
V(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE [drugbank:DB07137]
p11028
sg18
Vdrug-target interaction (2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07137_2240]
p11029
sa(dp11030
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11031
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07163
p11032
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11033
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07163_2240
p11034
sg16
V5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE [drugbank:DB07163]
p11035
sg18
Vdrug-target interaction 5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE and Cell division protein kinase 2 [drugbank_resource:DB07163_2240]
p11036
sa(dp11037
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11038
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07164
p11039
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11040
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07164_2240
p11041
sg16
VN-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine [drugbank:DB07164]
p11042
sg18
Vdrug-target interaction N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine and Cell division protein kinase 2 [drugbank_resource:DB07164_2240]
p11043
sa(dp11044
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11045
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07179
p11046
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11047
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07179_2240
p11048
sg16
V3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide [drugbank:DB07179]
p11049
sg18
Vdrug-target interaction 3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide and Cell division protein kinase 2 [drugbank_resource:DB07179_2240]
p11050
sa(dp11051
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11052
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07210
p11053
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11054
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07210_2240
p11055
sg16
V3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB07210]
p11056
sg18
Vdrug-target interaction 3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB07210_2240]
p11057
sa(dp11058
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11059
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07220
p11060
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11061
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07220_2240
p11062
sg16
VN-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE [drugbank:DB07220]
p11063
sg18
Vdrug-target interaction N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07220_2240]
p11064
sa(dp11065
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11066
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07431
p11067
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11068
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07431_2240
p11069
sg16
V(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one [drugbank:DB07431]
p11070
sg18
Vdrug-target interaction (3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one and Cell division protein kinase 2 [drugbank_resource:DB07431_2240]
p11071
sa(dp11072
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11073
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06944
p11074
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11075
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06944_2240
p11076
sg16
VN-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE [drugbank:DB06944]
p11077
sg18
Vdrug-target interaction N-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE and Cell division protein kinase 2 [drugbank_resource:DB06944_2240]
p11078
sa(dp11079
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11080
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06948
p11081
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11082
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06948_2240
p11083
sg16
V2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE [drugbank:DB06948]
p11084
sg18
Vdrug-target interaction 2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE and Cell division protein kinase 2 [drugbank_resource:DB06948_2240]
p11085
sa(dp11086
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11087
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07126
p11088
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11089
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07126_2240
p11090
sg16
VO6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE [drugbank:DB07126]
p11091
sg18
Vdrug-target interaction O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE and Cell division protein kinase 2 [drugbank_resource:DB07126_2240]
p11092
sa(dp11093
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11094
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07493
p11095
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11096
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07493_2240
p11097
sg16
V(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE [drugbank:DB07493]
p11098
sg18
Vdrug-target interaction (2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE and Cell division protein kinase 2 [drugbank_resource:DB07493_2240]
p11099
sa(dp11100
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11101
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07504
p11102
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11103
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07504_2240
p11104
sg16
V(2R)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07504]
p11105
sg18
Vdrug-target interaction (2R)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07504_2240]
p11106
sa(dp11107
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11108
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07529
p11109
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11110
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07529_2240
p11111
sg16
V2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE [drugbank:DB07529]
p11112
sg18
Vdrug-target interaction 2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE and Cell division protein kinase 2 [drugbank_resource:DB07529_2240]
p11113
sa(dp11114
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11115
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07471
p11116
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11117
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07471_2240
p11118
sg16
V5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE [drugbank:DB07471]
p11119
sg18
Vdrug-target interaction 5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07471_2240]
p11120
sa(dp11121
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11122
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07501
p11123
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11124
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07501_2240
p11125
sg16
V(2S)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07501]
p11126
sg18
Vdrug-target interaction (2S)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07501_2240]
p11127
sa(dp11128
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11129
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07531
p11130
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11131
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07531_2240
p11132
sg16
V4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE [drugbank:DB07531]
p11133
sg18
Vdrug-target interaction 4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07531_2240]
p11134
sa(dp11135
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11136
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07538
p11137
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11138
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07538_2240
p11139
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE [drugbank:DB07538]
p11140
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07538_2240]
p11141
sa(dp11142
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11143
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07540
p11144
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11145
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07540_2240
p11146
sg16
V4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE [drugbank:DB07540]
p11147
sg18
Vdrug-target interaction 4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07540_2240]
p11148
sa(dp11149
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11150
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07562
p11151
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11152
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07562_2240
p11153
sg16
VN-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE [drugbank:DB07562]
p11154
sg18
Vdrug-target interaction N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE and Cell division protein kinase 2 [drugbank_resource:DB07562_2240]
p11155
sa(dp11156
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11157
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07612
p11158
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11159
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07612_2240
p11160
sg16
V6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE [drugbank:DB07612]
p11161
sg18
Vdrug-target interaction 6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE and Cell division protein kinase 2 [drugbank_resource:DB07612_2240]
p11162
sa(dp11163
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11164
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07618
p11165
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11166
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07618_2240
p11167
sg16
V2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE [drugbank:DB07618]
p11168
sg18
Vdrug-target interaction 2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07618_2240]
p11169
sa(dp11170
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11171
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07685
p11172
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11173
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07685_2240
p11174
sg16
V4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE [drugbank:DB07685]
p11175
sg18
Vdrug-target interaction 4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07685_2240]
p11176
sa(dp11177
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11178
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07687
p11179
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11180
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07687_2240
p11181
sg16
V4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE [drugbank:DB07687]
p11182
sg18
Vdrug-target interaction 4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07687_2240]
p11183
sa(dp11184
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11185
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07688
p11186
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11187
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07688_2240
p11188
sg16
V4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE [drugbank:DB07688]
p11189
sg18
Vdrug-target interaction 4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07688_2240]
p11190
sa(dp11191
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11192
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07750
p11193
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11194
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07750_2240
p11195
sg16
V(2R)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07750]
p11196
sg18
Vdrug-target interaction (2R)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07750_2240]
p11197
sa(dp11198
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11199
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07755
p11200
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11201
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07755_2240
p11202
sg16
V(2S)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07755]
p11203
sg18
Vdrug-target interaction (2S)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07755_2240]
p11204
sa(dp11205
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11206
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07761
p11207
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07761_2240
p11209
sg16
V(2R)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07761]
p11210
sg18
Vdrug-target interaction (2R)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07761_2240]
p11211
sa(dp11212
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11213
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07790
p11214
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11215
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07790_2240
p11216
sg16
VN-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE [drugbank:DB07790]
p11217
sg18
Vdrug-target interaction N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07790_2240]
p11218
sa(dp11219
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11220
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08132
p11221
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11222
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08132_2240
p11223
sg16
V5-hydroxynaphthalene-1-sulfonamide [drugbank:DB08132]
p11224
sg18
Vdrug-target interaction 5-hydroxynaphthalene-1-sulfonamide and Cell division protein kinase 2 [drugbank_resource:DB08132_2240]
p11225
sa(dp11226
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11227
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08133
p11228
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11229
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08133_2240
p11230
sg16
VN-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide [drugbank:DB08133]
p11231
sg18
Vdrug-target interaction N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08133_2240]
p11232
sa(dp11233
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11234
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08139
p11235
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11236
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08139_2240
p11237
sg16
V5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile [drugbank:DB08139]
p11238
sg18
Vdrug-target interaction 5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile and Cell division protein kinase 2 [drugbank_resource:DB08139_2240]
p11239
sa(dp11240
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11241
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08141
p11242
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11243
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08141_2240
p11244
sg16
V4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide [drugbank:DB08141]
p11245
sg18
Vdrug-target interaction 4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08141_2240]
p11246
sa(dp11247
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11248
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08247
p11249
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11250
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08247_2240
p11251
sg16
V6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE [drugbank:DB08247]
p11252
sg18
Vdrug-target interaction 6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE and Cell division protein kinase 2 [drugbank_resource:DB08247_2240]
p11253
sa(dp11254
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11255
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08248
p11256
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11257
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08248_2240
p11258
sg16
V3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE [drugbank:DB08248]
p11259
sg18
Vdrug-target interaction 3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08248_2240]
p11260
sa(dp11261
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11262
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08312
p11263
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11264
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08312_2240
p11265
sg16
V6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE [drugbank:DB08312]
p11266
sg18
Vdrug-target interaction 6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE and Cell division protein kinase 2 [drugbank_resource:DB08312_2240]
p11267
sa(dp11268
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11269
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08355
p11270
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11271
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08355_2240
p11272
sg16
V1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid [drugbank:DB08355]
p11273
sg18
Vdrug-target interaction 1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid and Cell division protein kinase 2 [drugbank_resource:DB08355_2240]
p11274
sa(dp11275
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11276
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08533
p11277
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11278
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08533_2240
p11279
sg16
V3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine [drugbank:DB08533]
p11280
sg18
Vdrug-target interaction 3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine and Cell division protein kinase 2 [drugbank_resource:DB08533_2240]
p11281
sa(dp11282
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11283
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08534
p11284
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11285
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08534_2240
p11286
sg16
V5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08534]
p11287
sg18
Vdrug-target interaction 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08534_2240]
p11288
sa(dp11289
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11290
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08539
p11291
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11292
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08539_2240
p11293
sg16
V3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08539]
p11294
sg18
Vdrug-target interaction 3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08539_2240]
p11295
sa(dp11296
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11297
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08572
p11298
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11299
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08572_2240
p11300
sg16
V4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE [drugbank:DB08572]
p11301
sg18
Vdrug-target interaction 4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08572_2240]
p11302
sa(dp11303
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11304
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08673
p11305
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11306
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08673_2240
p11307
sg16
V4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE [drugbank:DB08673]
p11308
sg18
Vdrug-target interaction 4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08673_2240]
p11309
sa(dp11310
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11311
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08677
p11312
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11313
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08677_2240
p11314
sg16
VN-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE [drugbank:DB08677]
p11315
sg18
Vdrug-target interaction N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08677_2240]
p11316
sa(dp11317
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11318
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08694
p11319
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11320
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08694_2240
p11321
sg16
V9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol [drugbank:DB08694]
p11322
sg18
Vdrug-target interaction 9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol and Cell division protein kinase 2 [drugbank_resource:DB08694_2240]
p11323
sa(dp11324
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11325
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07533
p11326
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11327
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07533_2240
p11328
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE [drugbank:DB07533]
p11329
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07533_2240]
p11330
sa(dp11331
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11332
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07534
p11333
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11334
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07534_2240
p11335
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE [drugbank:DB07534]
p11336
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07534_2240]
p11337
sa(dp11338
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11339
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07539
p11340
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11341
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07539_2240
p11342
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID [drugbank:DB07539]
p11343
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID and Cell division protein kinase 2 [drugbank_resource:DB07539_2240]
p11344
sa(dp11345
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11346
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07606
p11347
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11348
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07606_2240
p11349
sg16
V6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE [drugbank:DB07606]
p11350
sg18
Vdrug-target interaction 6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE and Cell division protein kinase 2 [drugbank_resource:DB07606_2240]
p11351
sa(dp11352
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11353
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07622
p11354
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11355
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07622_2240
p11356
sg16
V1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA [drugbank:DB07622]
p11357
sg18
Vdrug-target interaction 1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA and Cell division protein kinase 2 [drugbank_resource:DB07622_2240]
p11358
sa(dp11359
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11360
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07751
p11361
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11362
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07751_2240
p11363
sg16
V(2S)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07751]
p11364
sg18
Vdrug-target interaction (2S)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07751_2240]
p11365
sa(dp11366
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11367
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07791
p11368
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11369
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07791_2240
p11370
sg16
V4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE [drugbank:DB07791]
p11371
sg18
Vdrug-target interaction 4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07791_2240]
p11372
sa(dp11373
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11374
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07852
p11375
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11376
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07852_2240
p11377
sg16
V1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID [drugbank:DB07852]
p11378
sg18
Vdrug-target interaction 1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID and Cell division protein kinase 2 [drugbank_resource:DB07852_2240]
p11379
sa(dp11380
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11381
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07982
p11382
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11383
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07982_2240
p11384
sg16
V2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol [drugbank:DB07982]
p11385
sg18
Vdrug-target interaction 2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol and Cell division protein kinase 2 [drugbank_resource:DB07982_2240]
p11386
sa(dp11387
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11388
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08094
p11389
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11390
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08094_2240
p11391
sg16
V(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE [drugbank:DB08094]
p11392
sg18
Vdrug-target interaction (4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE and Cell division protein kinase 2 [drugbank_resource:DB08094_2240]
p11393
sa(dp11394
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11395
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08122
p11396
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11397
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08122_2240
p11398
sg16
VN-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE [drugbank:DB08122]
p11399
sg18
Vdrug-target interaction N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08122_2240]
p11400
sa(dp11401
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11402
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08123
p11403
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11404
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08123_2240
p11405
sg16
VN-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE [drugbank:DB08123]
p11406
sg18
Vdrug-target interaction N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08123_2240]
p11407
sa(dp11408
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11409
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08125
p11410
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11411
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08125_2240
p11412
sg16
V4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE [drugbank:DB08125]
p11413
sg18
Vdrug-target interaction 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08125_2240]
p11414
sa(dp11415
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11416
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08126
p11417
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11418
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08126_2240
p11419
sg16
V3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE [drugbank:DB08126]
p11420
sg18
Vdrug-target interaction 3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE and Cell division protein kinase 2 [drugbank_resource:DB08126_2240]
p11421
sa(dp11422
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11423
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08134
p11424
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11425
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08134_2240
p11426
sg16
V4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide [drugbank:DB08134]
p11427
sg18
Vdrug-target interaction 4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB08134_2240]
p11428
sa(dp11429
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11430
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08135
p11431
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11432
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08135_2240
p11433
sg16
VN-phenyl-1H-pyrazole-3-carboxamide [drugbank:DB08135]
p11434
sg18
Vdrug-target interaction N-phenyl-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08135_2240]
p11435
sa(dp11436
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11437
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08137
p11438
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11439
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08137_2240
p11440
sg16
V(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide [drugbank:DB08137]
p11441
sg18
Vdrug-target interaction (4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08137_2240]
p11442
sa(dp11443
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11444
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08178
p11445
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11446
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08178_2240
p11447
sg16
V4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine [drugbank:DB08178]
p11448
sg18
Vdrug-target interaction 4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine and Cell division protein kinase 2 [drugbank_resource:DB08178_2240]
p11449
sa(dp11450
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11451
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08309
p11452
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11453
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08309_2240
p11454
sg16
V3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL [drugbank:DB08309]
p11455
sg18
Vdrug-target interaction 3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL and Cell division protein kinase 2 [drugbank_resource:DB08309_2240]
p11456
sa(dp11457
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11458
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08441
p11459
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11460
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08441_2240
p11461
sg16
V6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE [drugbank:DB08441]
p11462
sg18
Vdrug-target interaction 6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE and Cell division protein kinase 2 [drugbank_resource:DB08441_2240]
p11463
sa(dp11464
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11465
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08532
p11466
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11467
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08532_2240
p11468
sg16
V6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine [drugbank:DB08532]
p11469
sg18
Vdrug-target interaction 6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine and Cell division protein kinase 2 [drugbank_resource:DB08532_2240]
p11470
sa(dp11471
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11472
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08536
p11473
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11474
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08536_2240
p11475
sg16
V3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine [drugbank:DB08536]
p11476
sg18
Vdrug-target interaction 3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08536_2240]
p11477
sa(dp11478
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11479
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08537
p11480
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11481
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08537_2240
p11482
sg16
V3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine [drugbank:DB08537]
p11483
sg18
Vdrug-target interaction 3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine and Cell division protein kinase 2 [drugbank_resource:DB08537_2240]
p11484
sa(dp11485
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11486
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08768
p11487
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11488
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08768_2240
p11489
sg16
VN-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE [drugbank:DB08768]
p11490
sg18
Vdrug-target interaction N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE and Cell division protein kinase 2 [drugbank_resource:DB08768_2240]
p11491
sa(dp11492
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11493
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07595
p11494
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11495
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07595_2240
p11496
sg16
V(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE [drugbank:DB07595]
p11497
sg18
Vdrug-target interaction (5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE and Cell division protein kinase 2 [drugbank_resource:DB07595_2240]
p11498
sa(dp11499
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11500
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07686
p11501
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11502
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07686_2240
p11503
sg16
V4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE [drugbank:DB07686]
p11504
sg18
Vdrug-target interaction 4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07686_2240]
p11505
sa(dp11506
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11507
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07731
p11508
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11509
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07731_2240
p11510
sg16
V4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL [drugbank:DB07731]
p11511
sg18
Vdrug-target interaction 4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL and Cell division protein kinase 2 [drugbank_resource:DB07731_2240]
p11512
sa(dp11513
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11514
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07889
p11515
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11516
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07889_2240
p11517
sg16
V1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN-2-OL [drugbank:DB07889]
p11518
sg18
Vdrug-target interaction 1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07889_2240]
p11519
sa(dp11520
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11521
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07936
p11522
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11523
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07936_2240
p11524
sg16
VN-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine [drugbank:DB07936]
p11525
sg18
Vdrug-target interaction N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine and Cell division protein kinase 2 [drugbank_resource:DB07936_2240]
p11526
sa(dp11527
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11528
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08066
p11529
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11530
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08066_2240
p11531
sg16
VN-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE [drugbank:DB08066]
p11532
sg18
Vdrug-target interaction N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08066_2240]
p11533
sa(dp11534
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11535
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08124
p11536
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11537
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08124_2240
p11538
sg16
V3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE [drugbank:DB08124]
p11539
sg18
Vdrug-target interaction 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE and Cell division protein kinase 2 [drugbank_resource:DB08124_2240]
p11540
sa(dp11541
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11542
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08136
p11543
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11544
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08136_2240
p11545
sg16
V4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide [drugbank:DB08136]
p11546
sg18
Vdrug-target interaction 4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08136_2240]
p11547
sa(dp11548
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11549
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08138
p11550
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11551
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08138_2240
p11552
sg16
V{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide [drugbank:DB08138]
p11553
sg18
Vdrug-target interaction {[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08138_2240]
p11554
sa(dp11555
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11556
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08140
p11557
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11558
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08140_2240
p11559
sg16
V5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE [drugbank:DB08140]
p11560
sg18
Vdrug-target interaction 5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE and Cell division protein kinase 2 [drugbank_resource:DB08140_2240]
p11561
sa(dp11562
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11563
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08142
p11564
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11565
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08142_2240
p11566
sg16
V4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide [drugbank:DB08142]
p11567
sg18
Vdrug-target interaction 4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08142_2240]
p11568
sa(dp11569
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11570
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08182
p11571
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11572
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08182_2240
p11573
sg16
V4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine [drugbank:DB08182]
p11574
sg18
Vdrug-target interaction 4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine and Cell division protein kinase 2 [drugbank_resource:DB08182_2240]
p11575
sa(dp11576
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11577
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08218
p11578
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11579
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08218_2240
p11580
sg16
VHYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM [drugbank:DB08218]
p11581
sg18
Vdrug-target interaction HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM and Cell division protein kinase 2 [drugbank_resource:DB08218_2240]
p11582
sa(dp11583
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11584
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08219
p11585
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11586
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08219_2240
p11587
sg16
V4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE [drugbank:DB08219]
p11588
sg18
Vdrug-target interaction 4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE and Cell division protein kinase 2 [drugbank_resource:DB08219_2240]
p11589
sa(dp11590
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11591
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08233
p11592
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11593
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08233_2240
p11594
sg16
V6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE [drugbank:DB08233]
p11595
sg18
Vdrug-target interaction 6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE and Cell division protein kinase 2 [drugbank_resource:DB08233_2240]
p11596
sa(dp11597
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11598
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08241
p11599
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11600
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08241_2240
p11601
sg16
V4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE [drugbank:DB08241]
p11602
sg18
Vdrug-target interaction 4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08241_2240]
p11603
sa(dp11604
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11605
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08285
p11606
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11607
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08285_2240
p11608
sg16
V(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol [drugbank:DB08285]
p11609
sg18
Vdrug-target interaction (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol and Cell division protein kinase 2 [drugbank_resource:DB08285_2240]
p11610
sa(dp11611
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11612
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08463
p11613
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11614
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08463_2240
p11615
sg16
V(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol [drugbank:DB08463]
p11616
sg18
Vdrug-target interaction (2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol and Cell division protein kinase 2 [drugbank_resource:DB08463_2240]
p11617
sa(dp11618
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11619
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08527
p11620
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11621
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08527_2240
p11622
sg16
V1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE [drugbank:DB08527]
p11623
sg18
Vdrug-target interaction 1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08527_2240]
p11624
sa(dp11625
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11626
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08531
p11627
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11628
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08531_2240
p11629
sg16
V5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08531]
p11630
sg18
Vdrug-target interaction 5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08531_2240]
p11631
sa(dp11632
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11633
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08535
p11634
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11635
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08535_2240
p11636
sg16
V3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08535]
p11637
sg18
Vdrug-target interaction 3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08535_2240]
p11638
sa(dp11639
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2240
p11640
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08538
p11641
sg11
g10699
sg12
S'cyclin-dependent kinase 2'
p11642
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08538_2240
p11643
sg16
VN-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08538]
p11644
sg18
Vdrug-target interaction N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08538_2240]
p11645
sasS'SSTR2'
p11646
(lp11647
(dp11648
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6008
p11649
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00104
p11650
sg11
g11646
sg12
S'somatostatin receptor 2'
p11651
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00104_6008
p11652
sg16
VOctreotide [drugbank:DB00104]
p11653
sg18
Vdrug-target interaction Octreotide and Somatostatin receptor type 2 [drugbank_resource:DB00104_6008]
p11654
sa(dp11655
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6008
p11656
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04894
p11657
sg11
g11646
sg12
S'somatostatin receptor 2'
p11658
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04894_6008
p11659
sg16
VVapreotide [drugbank:DB04894]
p11660
sg18
Vdrug-target interaction Vapreotide and Somatostatin receptor type 2 [drugbank_resource:DB04894_6008]
p11661
sasS'PRKACA'
p11662
(lp11663
(dp11664
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11665
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01940
p11666
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11667
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01940_6263
p11668
sg16
VBalanol Analog 2 [drugbank:DB01940]
p11669
sg18
Vdrug-target interaction Balanol Analog 2 and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB01940_6263]
p11670
sa(dp11671
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11672
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01919
p11673
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11674
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01919_6263
p11675
sg16
VPentanal [drugbank:DB01919]
p11676
sg18
Vdrug-target interaction Pentanal and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB01919_6263]
p11677
sa(dp11678
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11679
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02440
p11680
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11681
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02440_6263
p11682
sg16
VN-Octane [drugbank:DB02440]
p11683
sg18
Vdrug-target interaction N-Octane and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB02440_6263]
p11684
sa(dp11685
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11686
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02155
p11687
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11688
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02155_6263
p11689
sg16
VBalanol Analog 8 [drugbank:DB02155]
p11690
sg18
Vdrug-target interaction Balanol Analog 8 and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB02155_6263]
p11691
sa(dp11692
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11693
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02482
p11694
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11695
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02482_6263
p11696
sg16
VPhosphonothreonine [drugbank:DB02482]
p11697
sg18
Vdrug-target interaction Phosphonothreonine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB02482_6263]
p11698
sa(dp11699
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11700
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02611
p11701
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11702
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02611_6263
p11703
sg16
VBalanol Analog 1 [drugbank:DB02611]
p11704
sg18
Vdrug-target interaction Balanol Analog 1 and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB02611_6263]
p11705
sa(dp11706
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11707
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03374
p11708
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11709
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03374_6263
p11710
sg16
V3,5-Diiodotyrosine [drugbank:DB03374]
p11711
sg18
Vdrug-target interaction 3,5-Diiodotyrosine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB03374_6263]
p11712
sa(dp11713
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11714
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04098
p11715
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11716
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04098_6263
p11717
sg16
VBalanol [drugbank:DB04098]
p11718
sg18
Vdrug-target interaction Balanol and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB04098_6263]
p11719
sa(dp11720
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11721
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04707
p11722
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11723
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04707_6263
p11724
sg16
VHYDROXYFASUDIL [drugbank:DB04707]
p11725
sg18
Vdrug-target interaction HYDROXYFASUDIL and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB04707_6263]
p11726
sa(dp11727
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11728
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06959
p11729
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11730
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06959_6263
p11731
sg16
V(1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE [drugbank:DB06959]
p11732
sg18
Vdrug-target interaction (1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB06959_6263]
p11733
sa(dp11734
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11735
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06977
p11736
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11737
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06977_6263
p11738
sg16
V(2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE [drugbank:DB06977]
p11739
sg18
Vdrug-target interaction (2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB06977_6263]
p11740
sa(dp11741
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11742
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07124
p11743
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11744
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07124_6263
p11745
sg16
V(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE [drugbank:DB07124]
p11746
sg18
Vdrug-target interaction (2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07124_6263]
p11747
sa(dp11748
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11749
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04522
p11750
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11751
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04522_6263
p11752
sg16
VPhosphonoserine [drugbank:DB04522]
p11753
sg18
Vdrug-target interaction Phosphonoserine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB04522_6263]
p11754
sa(dp11755
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11756
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07107
p11757
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11758
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07107_6263
p11759
sg16
V(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE [drugbank:DB07107]
p11760
sg18
Vdrug-target interaction (1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07107_6263]
p11761
sa(dp11762
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11763
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07458
p11764
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11765
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07458_6263
p11766
sg16
V3-(1H-INDOL-3-YL)-4-{1-[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]-1H-INDOL-3-YL}-1H-PYRROLE-2,5-DIONE [drugbank:DB07458]
p11767
sg18
Vdrug-target interaction 3-(1H-INDOL-3-YL)-4-{1-[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]-1H-INDOL-3-YL}-1H-PYRROLE-2,5-DIONE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07458_6263]
p11768
sa(dp11769
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11770
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04530
p11771
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11772
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04530_6263
p11773
sg16
VS,S-(2-Hydroxyethyl)Thiocysteine [drugbank:DB04530]
p11774
sg18
Vdrug-target interaction S,S-(2-Hydroxyethyl)Thiocysteine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB04530_6263]
p11775
sa(dp11776
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11777
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07204
p11778
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11779
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07204_6263
p11780
sg16
V(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE [drugbank:DB07204]
p11781
sg18
Vdrug-target interaction (1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07204_6263]
p11782
sa(dp11783
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11784
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07235
p11785
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11786
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07235_6263
p11787
sg16
VN-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE [drugbank:DB07235]
p11788
sg18
Vdrug-target interaction N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07235_6263]
p11789
sa(dp11790
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11791
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07857
p11792
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11793
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07857_6263
p11794
sg16
V(2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE [drugbank:DB07857]
p11795
sg18
Vdrug-target interaction (2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07857_6263]
p11796
sa(dp11797
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11798
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07858
p11799
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11800
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07858_6263
p11801
sg16
V(2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE [drugbank:DB07858]
p11802
sg18
Vdrug-target interaction (2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07858_6263]
p11803
sa(dp11804
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11805
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07947
p11806
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11807
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07947_6263
p11808
sg16
VISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE [drugbank:DB07947]
p11809
sg18
Vdrug-target interaction ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07947_6263]
p11810
sa(dp11811
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11812
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08070
p11813
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11814
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08070_6263
p11815
sg16
V2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE [drugbank:DB08070]
p11816
sg18
Vdrug-target interaction 2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08070_6263]
p11817
sa(dp11818
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11819
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08162
p11820
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11821
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08162_6263
p11822
sg16
V5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE [drugbank:DB08162]
p11823
sg18
Vdrug-target interaction 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08162_6263]
p11824
sa(dp11825
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11826
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08568
p11827
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11828
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08568_6263
p11829
sg16
V(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE [drugbank:DB08568]
p11830
sg18
Vdrug-target interaction (2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08568_6263]
p11831
sa(dp11832
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11833
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07855
p11834
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11835
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07855_6263
p11836
sg16
V(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE [drugbank:DB07855]
p11837
sg18
Vdrug-target interaction (S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07855_6263]
p11838
sa(dp11839
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11840
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07996
p11841
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11842
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07996_6263
p11843
sg16
V1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE [drugbank:DB07996]
p11844
sg18
Vdrug-target interaction 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07996_6263]
p11845
sa(dp11846
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11847
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08073
p11848
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11849
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08073_6263
p11850
sg16
V(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE [drugbank:DB08073]
p11851
sg18
Vdrug-target interaction (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08073_6263]
p11852
sa(dp11853
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11854
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08114
p11855
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11856
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08114_6263
p11857
sg16
V5-benzyl-1,3-thiazol-2-amine [drugbank:DB08114]
p11858
sg18
Vdrug-target interaction 5-benzyl-1,3-thiazol-2-amine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08114_6263]
p11859
sa(dp11860
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11861
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08149
p11862
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11863
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08149_6263
p11864
sg16
V1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine [drugbank:DB08149]
p11865
sg18
Vdrug-target interaction 1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08149_6263]
p11866
sa(dp11867
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11868
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08150
p11869
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11870
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08150_6263
p11871
sg16
V4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium [drugbank:DB08150]
p11872
sg18
Vdrug-target interaction 4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08150_6263]
p11873
sa(dp11874
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11875
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08569
p11876
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11877
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08569_6263
p11878
sg16
V3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE [drugbank:DB08569]
p11879
sg18
Vdrug-target interaction 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08569_6263]
p11880
sa(dp11881
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11882
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07583
p11883
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11884
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07583_6263
p11885
sg16
V(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE [drugbank:DB07583]
p11886
sg18
Vdrug-target interaction (4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07583_6263]
p11887
sa(dp11888
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11889
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07854
p11890
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11891
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07854_6263
p11892
sg16
VN-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE [drugbank:DB07854]
p11893
sg18
Vdrug-target interaction N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07854_6263]
p11894
sa(dp11895
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11896
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07856
p11897
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11898
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07856_6263
p11899
sg16
V6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE [drugbank:DB07856]
p11900
sg18
Vdrug-target interaction 6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07856_6263]
p11901
sa(dp11902
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11903
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07859
p11904
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11905
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07859_6263
p11906
sg16
V4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE [drugbank:DB07859]
p11907
sg18
Vdrug-target interaction 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07859_6263]
p11908
sa(dp11909
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11910
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07860
p11911
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11912
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07860_6263
p11913
sg16
V(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE [drugbank:DB07860]
p11914
sg18
Vdrug-target interaction (2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07860_6263]
p11915
sa(dp11916
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11917
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07876
p11918
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11919
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07876_6263
p11920
sg16
V(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE [drugbank:DB07876]
p11921
sg18
Vdrug-target interaction (S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07876_6263]
p11922
sa(dp11923
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11924
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07995
p11925
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11926
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07995_6263
p11927
sg16
VN-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE [drugbank:DB07995]
p11928
sg18
Vdrug-target interaction N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07995_6263]
p11929
sa(dp11930
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11931
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07997
p11932
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11933
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07997_6263
p11934
sg16
VN-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE [drugbank:DB07997]
p11935
sg18
Vdrug-target interaction N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07997_6263]
p11936
sa(dp11937
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11938
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08113
p11939
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11940
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08113_6263
p11941
sg16
V3-pyridin-4-yl-1H-indazole [drugbank:DB08113]
p11942
sg18
Vdrug-target interaction 3-pyridin-4-yl-1H-indazole and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08113_6263]
p11943
sa(dp11944
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11945
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08148
p11946
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11947
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08148_6263
p11948
sg16
V1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine [drugbank:DB08148]
p11949
sg18
Vdrug-target interaction 1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08148_6263]
p11950
sa(dp11951
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11952
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08231
p11953
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11954
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08231_6263
p11955
sg16
VMYRISTIC ACID [drugbank:DB08231]
p11956
sg18
Vdrug-target interaction MYRISTIC ACID and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08231_6263]
p11957
sa(dp11958
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6263
p11959
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08756
p11960
sg11
g11662
sg12
S'protein kinase, cAMP-dependent, catalytic, alpha'
p11961
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08756_6263
p11962
sg16
V(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE [drugbank:DB08756]
p11963
sg18
Vdrug-target interaction (R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08756_6263]
p11964
sasS'CDK5'
p11965
(lp11966
(dp11967
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1058
p11968
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02052
p11969
sg11
g11965
sg12
S'cyclin-dependent kinase 5'
p11970
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02052_1058
p11971
sg16
VIndirubin-3'-Monoxime [drugbank:DB02052]
p11972
sg18
Vdrug-target interaction Indirubin-3'-Monoxime and Cell division protein kinase 5 [drugbank_resource:DB02052_1058]
p11973
sa(dp11974
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1058
p11975
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02116
p11976
sg11
g11965
sg12
S'cyclin-dependent kinase 5'
p11977
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02116_1058
p11978
sg16
VOlomoucine [drugbank:DB02116]
p11979
sg18
Vdrug-target interaction Olomoucine and Cell division protein kinase 5 [drugbank_resource:DB02116_1058]
p11980
sa(dp11981
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1058
p11982
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02950
p11983
sg11
g11965
sg12
S'cyclin-dependent kinase 5'
p11984
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02950_1058
p11985
sg16
VHymenialdisine [drugbank:DB02950]
p11986
sg18
Vdrug-target interaction Hymenialdisine and Cell division protein kinase 5 [drugbank_resource:DB02950_1058]
p11987
sa(dp11988
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1058
p11989
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03428
p11990
sg11
g11965
sg12
S'cyclin-dependent kinase 5'
p11991
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03428_1058
p11992
sg16
VSU9516 [drugbank:DB03428]
p11993
sg18
Vdrug-target interaction SU9516 and Cell division protein kinase 5 [drugbank_resource:DB03428_1058]
p11994
sa(dp11995
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1058
p11996
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p11997
sg11
g11965
sg12
S'cyclin-dependent kinase 5'
p11998
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_1058
p11999
sg16
VFlavopiridol [drugbank:DB03496]
p12000
sg18
Vdrug-target interaction Flavopiridol and Cell division protein kinase 5 [drugbank_resource:DB03496_1058]
p12001
sa(dp12002
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1058
p12003
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04014
p12004
sg11
g11965
sg12
S'cyclin-dependent kinase 5'
p12005
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04014_1058
p12006
sg16
VAlsterpaullone [drugbank:DB04014]
p12007
sg18
Vdrug-target interaction Alsterpaullone and Cell division protein kinase 5 [drugbank_resource:DB04014_1058]
p12008
sa(dp12009
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1058
p12010
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07364
p12011
sg11
g11965
sg12
S'cyclin-dependent kinase 5'
p12012
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07364_1058
p12013
sg16
V6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE [drugbank:DB07364]
p12014
sg18
Vdrug-target interaction 6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE and Cell division protein kinase 5 [drugbank_resource:DB07364_1058]
p12015
sasS'COL1A1'
p12016
(lp12017
(dp12018
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:28
p12019
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00048
p12020
sg11
g12016
sg12
S'collagen, type I, alpha 1'
p12021
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00048_28
p12022
sg16
VCollagenase [drugbank:DB00048]
p12023
sg18
Vdrug-target interaction Collagenase and Collagen alpha-1(I) chain [drugbank_resource:DB00048_28]
p12024
sasS'CDK8'
p12025
(lp12026
(dp12027
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3968
p12028
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p12029
sg11
g12025
sg12
S'cyclin-dependent kinase 8'
p12030
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_3968
p12031
sg16
VFlavopiridol [drugbank:DB03496]
p12032
sg18
Vdrug-target interaction Flavopiridol and Cell division protein kinase 8 [drugbank_resource:DB03496_3968]
p12033
sasS'CDK9'
p12034
(lp12035
(dp12036
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3950
p12037
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p12038
sg11
g12034
sg12
S'cyclin-dependent kinase 9'
p12039
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_3950
p12040
sg16
VFlavopiridol [drugbank:DB03496]
p12041
sg18
Vdrug-target interaction Flavopiridol and Cell division protein kinase 9 [drugbank_resource:DB03496_3950]
p12042
sasS'PPIC'
p12043
(lp12044
(dp12045
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4085
p12046
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00172
p12047
sg11
g12043
sg12
S'peptidylprolyl isomerase C (cyclophilin C)'
p12048
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00172_4085
p12049
sg16
VL-Proline [drugbank:DB00172]
p12050
sg18
Vdrug-target interaction L-Proline and Peptidyl-prolyl cis-trans isomerase C [drugbank_resource:DB00172_4085]
p12051
sasS'CALR'
p12052
(lp12053
(dp12054
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3830
p12055
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00025
p12056
sg11
g12052
sg12
S'calreticulin'
p12057
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00025_3830
p12058
sg16
VAntihemophilic Factor [drugbank:DB00025]
p12059
sg18
Vdrug-target interaction Antihemophilic Factor and Calreticulin [drugbank_resource:DB00025_3830]
p12060
sa(dp12061
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3830
p12062
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00031
p12063
sg11
g12052
sg12
S'calreticulin'
p12064
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00031_3830
p12065
sg16
VTenecteplase [drugbank:DB00031]
p12066
sg18
Vdrug-target interaction Tenecteplase and Calreticulin [drugbank_resource:DB00031_3830]
p12067
sa(dp12068
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3830
p12069
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01065
p12070
sg11
g12052
sg12
S'calreticulin'
p12071
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01065_3830
p12072
sg16
VMelatonin [drugbank:DB01065]
p12073
sg18
Vdrug-target interaction Melatonin and Calreticulin [drugbank_resource:DB01065_3830]
p12074
sasS'GLS2'
p12075
(lp12076
(dp12077
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5
p12078
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p12079
sg11
g12075
sg12
S'glutaminase 2 (liver, mitochondrial)'
p12080
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_5
p12081
sg16
VL-Glutamic Acid [drugbank:DB00142]
p12082
sg18
Vdrug-target interaction L-Glutamic Acid and Glutaminase liver isoform, mitochondrial [drugbank_resource:DB00142_5]
p12083
sasS'CDC42'
p12084
(lp12085
(dp12086
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7128
p12087
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02623
p12088
sg11
g12084
sg12
S'cell division cycle 42'
p12089
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02623_7128
p12090
sg16
VAminophosphonic Acid-Guanylate Ester [drugbank:DB02623]
p12091
sg18
Vdrug-target interaction Aminophosphonic Acid-Guanylate Ester and Cell division control protein 42 homolog [drugbank_resource:DB02623_7128]
p12092
sa(dp12093
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7128
p12094
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04315
p12095
sg11
g12084
sg12
S'cell division cycle 42'
p12096
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04315_7128
p12097
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p12098
sg18
Vdrug-target interaction Guanosine-5'-Diphosphate and Cell division control protein 42 homolog [drugbank_resource:DB04315_7128]
p12099
sasS'SAT1'
p12100
(lp12101
(dp12102
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:123
p12103
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04633
p12104
sg11
g12100
sg12
S'spermidine/spermine N1-acetyltransferase 1'
p12105
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04633_123
p12106
sg16
VN-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine [drugbank:DB04633]
p12107
sg18
Vdrug-target interaction N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine and Diamine acetyltransferase 1 [drugbank_resource:DB04633_123]
p12108
sasS'POLA1'
p12109
(lp12110
(dp12111
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:603
p12112
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00242
p12113
sg11
g12109
sg12
S'polymerase (DNA directed), alpha 1, catalytic subunit'
p12114
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00242_603
p12115
sg16
VCladribine [drugbank:DB00242]
p12116
sg18
Vdrug-target interaction Cladribine and DNA polymerase alpha catalytic subunit [drugbank_resource:DB00242_603]
p12117
sa(dp12118
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:603
p12119
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00631
p12120
sg11
g12109
sg12
S'polymerase (DNA directed), alpha 1, catalytic subunit'
p12121
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00631_603
p12122
sg16
VClofarabine [drugbank:DB00631]
p12123
sg18
Vdrug-target interaction Clofarabine and DNA polymerase alpha catalytic subunit [drugbank_resource:DB00631_603]
p12124
sa(dp12125
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:603
p12126
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01073
p12127
sg11
g12109
sg12
S'polymerase (DNA directed), alpha 1, catalytic subunit'
p12128
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01073_603
p12129
sg16
VFludarabine [drugbank:DB01073]
p12130
sg18
Vdrug-target interaction Fludarabine and DNA polymerase alpha catalytic subunit [drugbank_resource:DB01073_603]
p12131
sa(dp12132
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:603
p12133
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01280
p12134
sg11
g12109
sg12
S'polymerase (DNA directed), alpha 1, catalytic subunit'
p12135
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01280_603
p12136
sg16
VNelarabine [drugbank:DB01280]
p12137
sg18
Vdrug-target interaction Nelarabine and DNA polymerase alpha catalytic subunit [drugbank_resource:DB01280_603]
p12138
sasS'CAMK1D'
p12139
(lp12140
(dp12141
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6833
p12142
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08454
p12143
sg11
g12139
sg12
S'calcium/calmodulin-dependent protein kinase ID'
p12144
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08454_6833
p12145
sg16
VN-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE [drugbank:DB08454]
p12146
sg18
Vdrug-target interaction N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE and Calcium/calmodulin-dependent protein kinase type 1D [drugbank_resource:DB08454_6833]
p12147
sasS'HLA-B'
p12148
(lp12149
(dp12150
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6585
p12151
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04464
p12152
sg11
g12148
sg12
S'major histocompatibility complex, class I, B'
p12153
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04464_6585
p12154
sg16
VN-Formylmethionine [drugbank:DB04464]
p12155
sg18
Vdrug-target interaction N-Formylmethionine and HLA class I histocompatibility antigen, B-27 alpha chain [drugbank_resource:DB04464_6585]
p12156
sasS'EEF1A1'
p12157
(lp12158
(dp12159
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7038
p12160
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04315
p12161
sg11
g12157
sg12
S'eukaryotic translation elongation factor 1 alpha 1'
p12162
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04315_7038
p12163
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p12164
sg18
Vdrug-target interaction Guanosine-5'-Diphosphate and Elongation factor 1-alpha 1 [drugbank_resource:DB04315_7038]
p12165
sasS'EGFR'
p12166
(lp12167
(dp12168
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p12169
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00072
p12170
sg11
g12166
sg12
S'epidermal growth factor receptor'
p12171
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00072_844
p12172
sg16
VTrastuzumab [drugbank:DB00072]
p12173
sg18
Vdrug-target interaction Trastuzumab and Epidermal growth factor receptor [drugbank_resource:DB00072_844]
p12174
sa(dp12175
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p12176
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00002
p12177
sg11
g12166
sg12
S'epidermal growth factor receptor'
p12178
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00002_844
p12179
sg16
VCetuximab [drugbank:DB00002]
p12180
sg18
Vdrug-target interaction Cetuximab and Epidermal growth factor receptor [drugbank_resource:DB00002_844]
p12181
sa(dp12182
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p12183
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00281
p12184
sg11
g12166
sg12
S'epidermal growth factor receptor'
p12185
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00281_844
p12186
sg16
VLidocaine [drugbank:DB00281]
p12187
sg18
Vdrug-target interaction Lidocaine and Epidermal growth factor receptor [drugbank_resource:DB00281_844]
p12188
sa(dp12189
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p12190
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00317
p12191
sg11
g12166
sg12
S'epidermal growth factor receptor'
p12192
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00317_844
p12193
sg16
VGefitinib [drugbank:DB00317]
p12194
sg18
Vdrug-target interaction Gefitinib and Epidermal growth factor receptor [drugbank_resource:DB00317_844]
p12195
sa(dp12196
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p12197
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00530
p12198
sg11
g12166
sg12
S'epidermal growth factor receptor'
p12199
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00530_844
p12200
sg16
VErlotinib [drugbank:DB00530]
p12201
sg18
Vdrug-target interaction Erlotinib and Epidermal growth factor receptor [drugbank_resource:DB00530_844]
p12202
sa(dp12203
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p12204
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01259
p12205
sg11
g12166
sg12
S'epidermal growth factor receptor'
p12206
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01259_844
p12207
sg16
VLapatinib [drugbank:DB01259]
p12208
sg18
Vdrug-target interaction Lapatinib and Epidermal growth factor receptor [drugbank_resource:DB01259_844]
p12209
sa(dp12210
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p12211
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01269
p12212
sg11
g12166
sg12
S'epidermal growth factor receptor'
p12213
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01269_844
p12214
sg16
VPanitumumab [drugbank:DB01269]
p12215
sg18
Vdrug-target interaction Panitumumab and Epidermal growth factor receptor [drugbank_resource:DB01269_844]
p12216
sa(dp12217
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p12218
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03496
p12219
sg11
g12166
sg12
S'epidermal growth factor receptor'
p12220
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03496_844
p12221
sg16
VFlavopiridol [drugbank:DB03496]
p12222
sg18
Vdrug-target interaction Flavopiridol and Epidermal growth factor receptor [drugbank_resource:DB03496_844]
p12223
sa(dp12224
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p12225
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07602
p12226
sg11
g12166
sg12
S'epidermal growth factor receptor'
p12227
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07602_844
p12228
sg16
VS-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE [drugbank:DB07602]
p12229
sg18
Vdrug-target interaction S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE and Epidermal growth factor receptor [drugbank_resource:DB07602_844]
p12230
sa(dp12231
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:844
p12232
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07662
p12233
sg11
g12166
sg12
S'epidermal growth factor receptor'
p12234
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07662_844
p12235
sg16
VN-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE [drugbank:DB07662]
p12236
sg18
Vdrug-target interaction N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE and Epidermal growth factor receptor [drugbank_resource:DB07662_844]
p12237
sasS'PRKAA1'
p12238
(lp12239
(dp12240
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:748
p12241
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00131
p12242
sg11
g12238
sg12
S'protein kinase, AMP-activated, alpha 1 catalytic subunit'
p12243
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00131_748
p12244
sg16
VAdenosine monophosphate [drugbank:DB00131]
p12245
sg18
Vdrug-target interaction Adenosine monophosphate and 5'-AMP-activated protein kinase catalytic subunit alpha-1 [drugbank_resource:DB00131_748]
p12246
sa(dp12247
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:748
p12248
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00171
p12249
sg11
g12238
sg12
S'protein kinase, AMP-activated, alpha 1 catalytic subunit'
p12250
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00171_748
p12251
sg16
VAdenosine triphosphate [drugbank:DB00171]
p12252
sg18
Vdrug-target interaction Adenosine triphosphate and 5'-AMP-activated protein kinase catalytic subunit alpha-1 [drugbank_resource:DB00171_748]
p12253
sa(dp12254
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:748
p12255
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00914
p12256
sg11
g12238
sg12
S'protein kinase, AMP-activated, alpha 1 catalytic subunit'
p12257
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00914_748
p12258
sg16
VPhenformin [drugbank:DB00914]
p12259
sg18
Vdrug-target interaction Phenformin and 5'-AMP-activated protein kinase catalytic subunit alpha-1 [drugbank_resource:DB00914_748]
p12260
sasS'F13A1'
p12261
(lp12262
(dp12263
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6
p12264
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01839
p12265
sg11
g12261
sg12
S'coagulation factor XIII, A1 polypeptide'
p12266
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01839_6
p12267
sg16
V1,2-Propanediol [drugbank:DB01839]
p12268
sg18
Vdrug-target interaction 1,2-Propanediol and Coagulation factor XIII A chain [drugbank_resource:DB01839_6]
p12269
sa(dp12270
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6
p12271
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02340
p12272
sg11
g12261
sg12
S'coagulation factor XIII, A1 polypeptide'
p12273
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02340_6
p12274
sg16
VN-Acetyl-Serine [drugbank:DB02340]
p12275
sg18
Vdrug-target interaction N-Acetyl-Serine and Coagulation factor XIII A chain [drugbank_resource:DB02340_6]
p12276
sasS'PRSS3'
p12277
(lp12278
(dp12279
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2886
p12280
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02541
p12281
sg11
g12277
sg12
S'protease, serine, 3'
p12282
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02541_2886
p12283
sg16
V4-Hydroxybutan-1-Aminium [drugbank:DB02541]
p12284
sg18
Vdrug-target interaction 4-Hydroxybutan-1-Aminium and Trypsin-3 [drugbank_resource:DB02541_2886]
p12285
sa(dp12286
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2886
p12287
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02585
p12288
sg11
g12277
sg12
S'protease, serine, 3'
p12289
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02585_2886
p12290
sg16
V4-(Hydroxymethyl)Benzamidine [drugbank:DB02585]
p12291
sg18
Vdrug-target interaction 4-(Hydroxymethyl)Benzamidine and Trypsin-3 [drugbank_resource:DB02585_2886]
p12292
sa(dp12293
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2886
p12294
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03127
p12295
sg11
g12277
sg12
S'protease, serine, 3'
p12296
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03127_2886
p12297
sg16
VBenzamidine [drugbank:DB03127]
p12298
sg18
Vdrug-target interaction Benzamidine and Trypsin-3 [drugbank_resource:DB03127_2886]
p12299
sa(dp12300
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2886
p12301
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02308
p12302
sg11
g12277
sg12
S'protease, serine, 3'
p12303
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02308_2886
p12304
sg16
V4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium [drugbank:DB02308]
p12305
sg18
Vdrug-target interaction 4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium and Trypsin-3 [drugbank_resource:DB02308_2886]
p12306
sa(dp12307
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2886
p12308
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03129
p12309
sg11
g12277
sg12
S'protease, serine, 3'
p12310
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03129_2886
p12311
sg16
V[3-(1,3,2-Dioxaborolan-2-Yloxy)Propyl]Guanidine [drugbank:DB03129]
p12312
sg18
Vdrug-target interaction [3-(1,3,2-Dioxaborolan-2-Yloxy)Propyl]Guanidine and Trypsin-3 [drugbank_resource:DB03129_2886]
p12313
sa(dp12314
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2886
p12315
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03637
p12316
sg11
g12277
sg12
S'protease, serine, 3'
p12317
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03637_2886
p12318
sg16
VGuanidine-3-Propanol [drugbank:DB03637]
p12319
sg18
Vdrug-target interaction Guanidine-3-Propanol and Trypsin-3 [drugbank_resource:DB03637_2886]
p12320
sa(dp12321
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2886
p12322
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04109
p12323
sg11
g12277
sg12
S'protease, serine, 3'
p12324
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04109_2886
p12325
sg16
V[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine [drugbank:DB04109]
p12326
sg18
Vdrug-target interaction [4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine and Trypsin-3 [drugbank_resource:DB04109_2886]
p12327
sa(dp12328
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2886
p12329
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04369
p12330
sg11
g12277
sg12
S'protease, serine, 3'
p12331
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04369_2886
p12332
sg16
V1,3,2-Dioxaborolan-2-Ol [drugbank:DB04369]
p12333
sg18
Vdrug-target interaction 1,3,2-Dioxaborolan-2-Ol and Trypsin-3 [drugbank_resource:DB04369_2886]
p12334
sasS'RNASE2'
p12335
(lp12336
(dp12337
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2390
p12338
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02098
p12339
sg11
g12335
sg12
S'ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)'
p12340
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02098_2390
p12341
sg16
VAdenosine-2'-5'-Diphosphate [drugbank:DB02098]
p12342
sg18
Vdrug-target interaction Adenosine-2'-5'-Diphosphate and Nonsecretory ribonuclease [drugbank_resource:DB02098_2390]
p12343
sa(dp12344
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2390
p12345
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01812
p12346
sg11
g12335
sg12
S'ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)'
p12347
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01812_2390
p12348
sg16
VAdenosine-3'-5'-Diphosphate [drugbank:DB01812]
p12349
sg18
Vdrug-target interaction Adenosine-3'-5'-Diphosphate and Nonsecretory ribonuclease [drugbank_resource:DB01812_2390]
p12350
sa(dp12351
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2390
p12352
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p12353
sg11
g12335
sg12
S'ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)'
p12354
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_2390
p12355
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p12356
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Nonsecretory ribonuclease [drugbank_resource:DB03431_2390]
p12357
sasS'RRM2'
p12358
(lp12359
(dp12360
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4218
p12361
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00242
p12362
sg11
g12358
sg12
S'ribonucleotide reductase M2'
p12363
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00242_4218
p12364
sg16
VCladribine [drugbank:DB00242]
p12365
sg18
Vdrug-target interaction Cladribine and Ribonucleoside-diphosphate reductase M2 subunit [drugbank_resource:DB00242_4218]
p12366
sa(dp12367
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4218
p12368
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB05260
p12369
sg11
g12358
sg12
S'ribonucleotide reductase M2'
p12370
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB05260_4218
p12371
sg16
VGallium nitrate [drugbank:DB05260]
p12372
sg18
Vdrug-target interaction Gallium nitrate and Ribonucleoside-diphosphate reductase M2 subunit [drugbank_resource:DB05260_4218]
p12373
sasS'COL3A1'
p12374
(lp12375
(dp12376
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3853
p12377
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00048
p12378
sg11
g12374
sg12
S'collagen, type III, alpha 1'
p12379
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00048_3853
p12380
sg16
VCollagenase [drugbank:DB00048]
p12381
sg18
Vdrug-target interaction Collagenase and Collagen alpha-1(III) chain [drugbank_resource:DB00048_3853]
p12382
sasS'SYK'
p12383
(lp12384
(dp12385
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2408
p12386
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02010
p12387
sg11
g12383
sg12
S'spleen tyrosine kinase'
p12388
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02010_2408
p12389
sg16
VStaurosporine [drugbank:DB02010]
p12390
sg18
Vdrug-target interaction Staurosporine and Tyrosine-protein kinase SYK [drugbank_resource:DB02010_2408]
p12391
sa(dp12392
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2408
p12393
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06834
p12394
sg11
g12383
sg12
S'spleen tyrosine kinase'
p12395
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06834_2408
p12396
sg16
VN-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide [drugbank:DB06834]
p12397
sg18
Vdrug-target interaction N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide and Tyrosine-protein kinase SYK [drugbank_resource:DB06834_2408]
p12398
sa(dp12399
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2408
p12400
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07194
p12401
sg11
g12383
sg12
S'spleen tyrosine kinase'
p12402
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07194_2408
p12403
sg16
V2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide [drugbank:DB07194]
p12404
sg18
Vdrug-target interaction 2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide and Tyrosine-protein kinase SYK [drugbank_resource:DB07194_2408]
p12405
sa(dp12406
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2408
p12407
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07159
p12408
sg11
g12383
sg12
S'spleen tyrosine kinase'
p12409
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07159_2408
p12410
sg16
V6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one [drugbank:DB07159]
p12411
sg18
Vdrug-target interaction 6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one and Tyrosine-protein kinase SYK [drugbank_resource:DB07159_2408]
p12412
sa(dp12413
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2408
p12414
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08361
p12415
sg11
g12383
sg12
S'spleen tyrosine kinase'
p12416
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08361_2408
p12417
sg16
V2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide [drugbank:DB08361]
p12418
sg18
Vdrug-target interaction 2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide and Tyrosine-protein kinase SYK [drugbank_resource:DB08361_2408]
p12419
sasS'PIN1'
p12420
(lp12421
(dp12422
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6240
p12423
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01766
p12424
sg11
g12420
sg12
S'peptidylprolyl cis/trans isomerase, NIMA-interacting 1'
p12425
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01766_6240
p12426
sg16
VBeta-(2-Naphthyl)-Alanine [drugbank:DB01766]
p12427
sg18
Vdrug-target interaction Beta-(2-Naphthyl)-Alanine and Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 [drugbank_resource:DB01766_6240]
p12428
sa(dp12429
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6240
p12430
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06867
p12431
sg11
g12420
sg12
S'peptidylprolyl cis/trans isomerase, NIMA-interacting 1'
p12432
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06867_6240
p12433
sg16
V3,6,9,12,15,18-HEXAOXAICOSANE [drugbank:DB06867]
p12434
sg18
Vdrug-target interaction 3,6,9,12,15,18-HEXAOXAICOSANE and Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 [drugbank_resource:DB06867_6240]
p12435
sasS'CA4'
p12436
(lp12437
(dp12438
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12439
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00232
p12440
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12441
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00232_592
p12442
sg16
VMethyclothiazide [drugbank:DB00232]
p12443
sg18
Vdrug-target interaction Methyclothiazide and Carbonic anhydrase 4 [drugbank_resource:DB00232_592]
p12444
sa(dp12445
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12446
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00273
p12447
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12448
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00273_592
p12449
sg16
VTopiramate [drugbank:DB00273]
p12450
sg18
Vdrug-target interaction Topiramate and Carbonic anhydrase 4 [drugbank_resource:DB00273_592]
p12451
sa(dp12452
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12453
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00436
p12454
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12455
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00436_592
p12456
sg16
VBendroflumethiazide [drugbank:DB00436]
p12457
sg18
Vdrug-target interaction Bendroflumethiazide and Carbonic anhydrase 4 [drugbank_resource:DB00436_592]
p12458
sa(dp12459
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12460
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00606
p12461
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12462
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00606_592
p12463
sg16
VCyclothiazide [drugbank:DB00606]
p12464
sg18
Vdrug-target interaction Cyclothiazide and Carbonic anhydrase 4 [drugbank_resource:DB00606_592]
p12465
sa(dp12466
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12467
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00311
p12468
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12469
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00311_592
p12470
sg16
VEthoxzolamide [drugbank:DB00311]
p12471
sg18
Vdrug-target interaction Ethoxzolamide and Carbonic anhydrase 4 [drugbank_resource:DB00311_592]
p12472
sa(dp12473
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12474
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00562
p12475
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12476
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00562_592
p12477
sg16
VBenzthiazide [drugbank:DB00562]
p12478
sg18
Vdrug-target interaction Benzthiazide and Carbonic anhydrase 4 [drugbank_resource:DB00562_592]
p12479
sa(dp12480
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12481
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00703
p12482
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12483
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00703_592
p12484
sg16
VMethazolamide [drugbank:DB00703]
p12485
sg18
Vdrug-target interaction Methazolamide and Carbonic anhydrase 4 [drugbank_resource:DB00703_592]
p12486
sa(dp12487
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12488
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00819
p12489
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12490
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00819_592
p12491
sg16
VAcetazolamide [drugbank:DB00819]
p12492
sg18
Vdrug-target interaction Acetazolamide and Carbonic anhydrase 4 [drugbank_resource:DB00819_592]
p12493
sa(dp12494
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12495
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00880
p12496
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12497
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00880_592
p12498
sg16
VChlorothiazide [drugbank:DB00880]
p12499
sg18
Vdrug-target interaction Chlorothiazide and Carbonic anhydrase 4 [drugbank_resource:DB00880_592]
p12500
sa(dp12501
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12502
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00909
p12503
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12504
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00909_592
p12505
sg16
VZonisamide [drugbank:DB00909]
p12506
sg18
Vdrug-target interaction Zonisamide and Carbonic anhydrase 4 [drugbank_resource:DB00909_592]
p12507
sa(dp12508
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12509
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00999
p12510
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12511
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00999_592
p12512
sg16
VHydrochlorothiazide [drugbank:DB00999]
p12513
sg18
Vdrug-target interaction Hydrochlorothiazide and Carbonic anhydrase 4 [drugbank_resource:DB00999_592]
p12514
sa(dp12515
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12516
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00869
p12517
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12518
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00869_592
p12519
sg16
VDorzolamide [drugbank:DB00869]
p12520
sg18
Vdrug-target interaction Dorzolamide and Carbonic anhydrase 4 [drugbank_resource:DB00869_592]
p12521
sa(dp12522
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12523
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00774
p12524
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12525
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00774_592
p12526
sg16
VHydroflumethiazide [drugbank:DB00774]
p12527
sg18
Vdrug-target interaction Hydroflumethiazide and Carbonic anhydrase 4 [drugbank_resource:DB00774_592]
p12528
sa(dp12529
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12530
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01021
p12531
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12532
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01021_592
p12533
sg16
VTrichlormethiazide [drugbank:DB01021]
p12534
sg18
Vdrug-target interaction Trichlormethiazide and Carbonic anhydrase 4 [drugbank_resource:DB01021_592]
p12535
sa(dp12536
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12537
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01144
p12538
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12539
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01144_592
p12540
sg16
VDichlorphenamide [drugbank:DB01144]
p12541
sg18
Vdrug-target interaction Dichlorphenamide and Carbonic anhydrase 4 [drugbank_resource:DB01144_592]
p12542
sa(dp12543
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:592
p12544
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01194
p12545
sg11
g12436
sg12
S'carbonic anhydrase IV'
p12546
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01194_592
p12547
sg16
VBrinzolamide [drugbank:DB01194]
p12548
sg18
Vdrug-target interaction Brinzolamide and Carbonic anhydrase 4 [drugbank_resource:DB01194_592]
p12549
sasS'CRH'
p12550
(lp12551
(dp12552
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1566
p12553
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01285
p12554
sg11
g12550
sg12
S'corticotropin releasing hormone'
p12555
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01285_1566
p12556
sg16
VCorticotropin [drugbank:DB01285]
p12557
sg18
Vdrug-target interaction Corticotropin and Corticoliberin [drugbank_resource:DB01285_1566]
p12558
sa(dp12559
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1566
p12560
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02556
p12561
sg11
g12550
sg12
S'corticotropin releasing hormone'
p12562
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02556_1566
p12563
sg16
VD-Phenylalanine [drugbank:DB02556]
p12564
sg18
Vdrug-target interaction D-Phenylalanine and Corticoliberin [drugbank_resource:DB02556_1566]
p12565
sa(dp12566
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1566
p12567
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02952
p12568
sg11
g12550
sg12
S'corticotropin releasing hormone'
p12569
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02952_1566
p12570
sg16
VAlpha-Aminoisobutyric Acid [drugbank:DB02952]
p12571
sg18
Vdrug-target interaction Alpha-Aminoisobutyric Acid and Corticoliberin [drugbank_resource:DB02952_1566]
p12572
sasS'TNFRSF1A'
p12573
(lp12574
(dp12575
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1984
p12576
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03507
p12577
sg11
g12573
sg12
S'tumor necrosis factor receptor superfamily, member 1A'
p12578
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03507_1984
p12579
sg16
V6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One [drugbank:DB03507]
p12580
sg18
Vdrug-target interaction 6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One and Tumor necrosis factor receptor superfamily member 1A [drugbank_resource:DB03507_1984]
p12581
sasS'HDAC3'
p12582
(lp12583
(dp12584
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4123
p12585
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02546
p12586
sg11
g12582
sg12
S'histone deacetylase 3'
p12587
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02546_4123
p12588
sg16
VVorinostat [drugbank:DB02546]
p12589
sg18
Vdrug-target interaction Vorinostat and Histone deacetylase 3 [drugbank_resource:DB02546_4123]
p12590
sasS'CCNA2'
p12591
(lp12592
(dp12593
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12594
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02091
p12595
sg11
g12591
sg12
S'cyclin A2'
p12596
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02091_6235
p12597
sg16
V4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine [drugbank:DB02091]
p12598
sg18
Vdrug-target interaction 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine and Cyclin-A2 [drugbank_resource:DB02091_6235]
p12599
sa(dp12600
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12601
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02407
p12602
sg11
g12591
sg12
S'cyclin A2'
p12603
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02407_6235
p12604
sg16
V6-O-Cyclohexylmethyl Guanine [drugbank:DB02407]
p12605
sg18
Vdrug-target interaction 6-O-Cyclohexylmethyl Guanine and Cyclin-A2 [drugbank_resource:DB02407_6235]
p12606
sa(dp12607
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12608
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02915
p12609
sg11
g12591
sg12
S'cyclin A2'
p12610
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02915_6235
p12611
sg16
V4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine [drugbank:DB02915]
p12612
sg18
Vdrug-target interaction 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine and Cyclin-A2 [drugbank_resource:DB02915_6235]
p12613
sa(dp12614
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12615
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02833
p12616
sg11
g12591
sg12
S'cyclin A2'
p12617
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02833_6235
p12618
sg16
V[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine [drugbank:DB02833]
p12619
sg18
Vdrug-target interaction [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine and Cyclin-A2 [drugbank_resource:DB02833_6235]
p12620
sa(dp12621
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12622
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06844
p12623
sg11
g12591
sg12
S'cyclin A2'
p12624
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06844_6235
p12625
sg16
V4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE [drugbank:DB06844]
p12626
sg18
Vdrug-target interaction 4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB06844_6235]
p12627
sa(dp12628
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12629
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06944
p12630
sg11
g12591
sg12
S'cyclin A2'
p12631
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06944_6235
p12632
sg16
VN-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE [drugbank:DB06944]
p12633
sg18
Vdrug-target interaction N-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE and Cyclin-A2 [drugbank_resource:DB06944_6235]
p12634
sa(dp12635
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12636
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07126
p12637
sg11
g12591
sg12
S'cyclin A2'
p12638
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07126_6235
p12639
sg16
VO6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE [drugbank:DB07126]
p12640
sg18
Vdrug-target interaction O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE and Cyclin-A2 [drugbank_resource:DB07126_6235]
p12641
sa(dp12642
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12643
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07137
p12644
sg11
g12591
sg12
S'cyclin A2'
p12645
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07137_6235
p12646
sg16
V(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE [drugbank:DB07137]
p12647
sg18
Vdrug-target interaction (2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE and Cyclin-A2 [drugbank_resource:DB07137_6235]
p12648
sa(dp12649
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12650
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07164
p12651
sg11
g12591
sg12
S'cyclin A2'
p12652
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07164_6235
p12653
sg16
VN-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine [drugbank:DB07164]
p12654
sg18
Vdrug-target interaction N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine and Cyclin-A2 [drugbank_resource:DB07164_6235]
p12655
sa(dp12656
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12657
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07203
p12658
sg11
g12591
sg12
S'cyclin A2'
p12659
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07203_6235
p12660
sg16
V6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE [drugbank:DB07203]
p12661
sg18
Vdrug-target interaction 6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE and Cyclin-A2 [drugbank_resource:DB07203_6235]
p12662
sa(dp12663
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12664
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06948
p12665
sg11
g12591
sg12
S'cyclin A2'
p12666
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06948_6235
p12667
sg16
V2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE [drugbank:DB06948]
p12668
sg18
Vdrug-target interaction 2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE and Cyclin-A2 [drugbank_resource:DB06948_6235]
p12669
sa(dp12670
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12671
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07538
p12672
sg11
g12591
sg12
S'cyclin A2'
p12673
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07538_6235
p12674
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE [drugbank:DB07538]
p12675
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB07538_6235]
p12676
sa(dp12677
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12678
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07471
p12679
sg11
g12591
sg12
S'cyclin A2'
p12680
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07471_6235
p12681
sg16
V5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE [drugbank:DB07471]
p12682
sg18
Vdrug-target interaction 5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE and Cyclin-A2 [drugbank_resource:DB07471_6235]
p12683
sa(dp12684
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12685
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07533
p12686
sg11
g12591
sg12
S'cyclin A2'
p12687
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07533_6235
p12688
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE [drugbank:DB07533]
p12689
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB07533_6235]
p12690
sa(dp12691
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12692
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07534
p12693
sg11
g12591
sg12
S'cyclin A2'
p12694
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07534_6235
p12695
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE [drugbank:DB07534]
p12696
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB07534_6235]
p12697
sa(dp12698
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12699
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07539
p12700
sg11
g12591
sg12
S'cyclin A2'
p12701
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07539_6235
p12702
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID [drugbank:DB07539]
p12703
sg18
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID and Cyclin-A2 [drugbank_resource:DB07539_6235]
p12704
sa(dp12705
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12706
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07688
p12707
sg11
g12591
sg12
S'cyclin A2'
p12708
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07688_6235
p12709
sg16
V4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE [drugbank:DB07688]
p12710
sg18
Vdrug-target interaction 4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB07688_6235]
p12711
sa(dp12712
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12713
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07852
p12714
sg11
g12591
sg12
S'cyclin A2'
p12715
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07852_6235
p12716
sg16
V1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID [drugbank:DB07852]
p12717
sg18
Vdrug-target interaction 1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID and Cyclin-A2 [drugbank_resource:DB07852_6235]
p12718
sa(dp12719
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12720
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08182
p12721
sg11
g12591
sg12
S'cyclin A2'
p12722
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08182_6235
p12723
sg16
V4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine [drugbank:DB08182]
p12724
sg18
Vdrug-target interaction 4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine and Cyclin-A2 [drugbank_resource:DB08182_6235]
p12725
sa(dp12726
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12727
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08241
p12728
sg11
g12591
sg12
S'cyclin A2'
p12729
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08241_6235
p12730
sg16
V4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE [drugbank:DB08241]
p12731
sg18
Vdrug-target interaction 4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE and Cyclin-A2 [drugbank_resource:DB08241_6235]
p12732
sa(dp12733
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12734
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08248
p12735
sg11
g12591
sg12
S'cyclin A2'
p12736
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08248_6235
p12737
sg16
V3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE [drugbank:DB08248]
p12738
sg18
Vdrug-target interaction 3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB08248_6235]
p12739
sa(dp12740
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12741
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08285
p12742
sg11
g12591
sg12
S'cyclin A2'
p12743
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08285_6235
p12744
sg16
V(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol [drugbank:DB08285]
p12745
sg18
Vdrug-target interaction (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol and Cyclin-A2 [drugbank_resource:DB08285_6235]
p12746
sa(dp12747
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12748
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08463
p12749
sg11
g12591
sg12
S'cyclin A2'
p12750
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08463_6235
p12751
sg16
V(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol [drugbank:DB08463]
p12752
sg18
Vdrug-target interaction (2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol and Cyclin-A2 [drugbank_resource:DB08463_6235]
p12753
sa(dp12754
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12755
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08218
p12756
sg11
g12591
sg12
S'cyclin A2'
p12757
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08218_6235
p12758
sg16
VHYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM [drugbank:DB08218]
p12759
sg18
Vdrug-target interaction HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM and Cyclin-A2 [drugbank_resource:DB08218_6235]
p12760
sa(dp12761
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12762
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08219
p12763
sg11
g12591
sg12
S'cyclin A2'
p12764
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08219_6235
p12765
sg16
V4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE [drugbank:DB08219]
p12766
sg18
Vdrug-target interaction 4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE and Cyclin-A2 [drugbank_resource:DB08219_6235]
p12767
sa(dp12768
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12769
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08233
p12770
sg11
g12591
sg12
S'cyclin A2'
p12771
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08233_6235
p12772
sg16
V6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE [drugbank:DB08233]
p12773
sg18
Vdrug-target interaction 6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE and Cyclin-A2 [drugbank_resource:DB08233_6235]
p12774
sa(dp12775
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12776
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07562
p12777
sg11
g12591
sg12
S'cyclin A2'
p12778
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07562_6235
p12779
sg16
VN-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE [drugbank:DB07562]
p12780
sg18
Vdrug-target interaction N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE and Cyclin-A2 [drugbank_resource:DB07562_6235]
p12781
sa(dp12782
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12783
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08178
p12784
sg11
g12591
sg12
S'cyclin A2'
p12785
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08178_6235
p12786
sg16
V4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine [drugbank:DB08178]
p12787
sg18
Vdrug-target interaction 4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine and Cyclin-A2 [drugbank_resource:DB08178_6235]
p12788
sa(dp12789
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12790
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08309
p12791
sg11
g12591
sg12
S'cyclin A2'
p12792
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08309_6235
p12793
sg16
V3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL [drugbank:DB08309]
p12794
sg18
Vdrug-target interaction 3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL and Cyclin-A2 [drugbank_resource:DB08309_6235]
p12795
sa(dp12796
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12797
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08355
p12798
sg11
g12591
sg12
S'cyclin A2'
p12799
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08355_6235
p12800
sg16
V1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid [drugbank:DB08355]
p12801
sg18
Vdrug-target interaction 1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid and Cyclin-A2 [drugbank_resource:DB08355_6235]
p12802
sa(dp12803
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12804
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08527
p12805
sg11
g12591
sg12
S'cyclin A2'
p12806
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08527_6235
p12807
sg16
V1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE [drugbank:DB08527]
p12808
sg18
Vdrug-target interaction 1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE and Cyclin-A2 [drugbank_resource:DB08527_6235]
p12809
sa(dp12810
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12811
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08572
p12812
sg11
g12591
sg12
S'cyclin A2'
p12813
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08572_6235
p12814
sg16
V4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE [drugbank:DB08572]
p12815
sg18
Vdrug-target interaction 4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE and Cyclin-A2 [drugbank_resource:DB08572_6235]
p12816
sa(dp12817
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6235
p12818
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08694
p12819
sg11
g12591
sg12
S'cyclin A2'
p12820
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08694_6235
p12821
sg16
V9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol [drugbank:DB08694]
p12822
sg18
Vdrug-target interaction 9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol and Cyclin-A2 [drugbank_resource:DB08694_6235]
p12823
sasS'DPYD'
p12824
(lp12825
(dp12826
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1302
p12827
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02303
p12828
sg11
g12824
sg12
S'dihydropyrimidine dehydrogenase'
p12829
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02303_1302
p12830
sg16
V(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione [drugbank:DB02303]
p12831
sg18
Vdrug-target interaction (5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione and Dihydropyrimidine dehydrogenase [NADP+] [drugbank_resource:DB02303_1302]
p12832
sa(dp12833
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1302
p12834
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03147
p12835
sg11
g12824
sg12
S'dihydropyrimidine dehydrogenase'
p12836
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03147_1302
p12837
sg16
VFlavin-Adenine Dinucleotide [drugbank:DB03147]
p12838
sg18
Vdrug-target interaction Flavin-Adenine Dinucleotide and Dihydropyrimidine dehydrogenase [NADP+] [drugbank_resource:DB03147_1302]
p12839
sa(dp12840
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1302
p12841
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02338
p12842
sg11
g12824
sg12
S'dihydropyrimidine dehydrogenase'
p12843
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02338_1302
p12844
sg16
VNadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate [drugbank:DB02338]
p12845
sg18
Vdrug-target interaction Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate and Dihydropyrimidine dehydrogenase [NADP+] [drugbank_resource:DB02338_1302]
p12846
sa(dp12847
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1302
p12848
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03247
p12849
sg11
g12824
sg12
S'dihydropyrimidine dehydrogenase'
p12850
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03247_1302
p12851
sg16
VRiboflavin Monophosphate [drugbank:DB03247]
p12852
sg18
Vdrug-target interaction Riboflavin Monophosphate and Dihydropyrimidine dehydrogenase [NADP+] [drugbank_resource:DB03247_1302]
p12853
sa(dp12854
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1302
p12855
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03048
p12856
sg11
g12824
sg12
S'dihydropyrimidine dehydrogenase'
p12857
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03048_1302
p12858
sg16
V6-Carboxymethyluracil [drugbank:DB03048]
p12859
sg18
Vdrug-target interaction 6-Carboxymethyluracil and Dihydropyrimidine dehydrogenase [NADP+] [drugbank_resource:DB03048_1302]
p12860
sa(dp12861
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1302
p12862
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03554
p12863
sg11
g12824
sg12
S'dihydropyrimidine dehydrogenase'
p12864
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03554_1302
p12865
sg16
V5-Iodouracil [drugbank:DB03554]
p12866
sg18
Vdrug-target interaction 5-Iodouracil and Dihydropyrimidine dehydrogenase [NADP+] [drugbank_resource:DB03554_1302]
p12867
sa(dp12868
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1302
p12869
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03419
p12870
sg11
g12824
sg12
S'dihydropyrimidine dehydrogenase'
p12871
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03419_1302
p12872
sg16
VUracil [drugbank:DB03419]
p12873
sg18
Vdrug-target interaction Uracil and Dihydropyrimidine dehydrogenase [NADP+] [drugbank_resource:DB03419_1302]
p12874
sasS'PLOD2'
p12875
(lp12876
(dp12877
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3935
p12878
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00126
p12879
sg11
g12875
sg12
S'procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2'
p12880
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00126_3935
p12881
sg16
VVitamin C [drugbank:DB00126]
p12882
sg18
Vdrug-target interaction Vitamin C and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 [drugbank_resource:DB00126_3935]
p12883
sasS'PLOD3'
p12884
(lp12885
(dp12886
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3938
p12887
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00126
p12888
sg11
g12884
sg12
S'procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3'
p12889
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00126_3938
p12890
sg16
VVitamin C [drugbank:DB00126]
p12891
sg18
Vdrug-target interaction Vitamin C and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 [drugbank_resource:DB00126_3938]
p12892
sa(dp12893
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3938
p12894
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00139
p12895
sg11
g12884
sg12
S'procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3'
p12896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00139_3938
p12897
sg16
VSuccinic acid [drugbank:DB00139]
p12898
sg18
Vdrug-target interaction Succinic acid and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 [drugbank_resource:DB00139_3938]
p12899
sasS'PDE1A'
p12900
(lp12901
(dp12902
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6047
p12903
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00622
p12904
sg11
g12900
sg12
S'phosphodiesterase 1A, calmodulin-dependent'
p12905
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00622_6047
p12906
sg16
VNicardipine [drugbank:DB00622]
p12907
sg18
Vdrug-target interaction Nicardipine and Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A [drugbank_resource:DB00622_6047]
p12908
sa(dp12909
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6047
p12910
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01023
p12911
sg11
g12900
sg12
S'phosphodiesterase 1A, calmodulin-dependent'
p12912
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01023_6047
p12913
sg16
VFelodipine [drugbank:DB01023]
p12914
sg18
Vdrug-target interaction Felodipine and Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A [drugbank_resource:DB01023_6047]
p12915
sa(dp12916
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6047
p12917
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01244
p12918
sg11
g12900
sg12
S'phosphodiesterase 1A, calmodulin-dependent'
p12919
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01244_6047
p12920
sg16
VBepridil [drugbank:DB01244]
p12921
sg18
Vdrug-target interaction Bepridil and Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A [drugbank_resource:DB01244_6047]
p12922
sasS'PLOD1'
p12923
(lp12924
(dp12925
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:97
p12926
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00126
p12927
sg11
g12923
sg12
S'procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1'
p12928
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00126_97
p12929
sg16
VVitamin C [drugbank:DB00126]
p12930
sg18
Vdrug-target interaction Vitamin C and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 [drugbank_resource:DB00126_97]
p12931
sa(dp12932
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:97
p12933
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00139
p12934
sg11
g12923
sg12
S'procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1'
p12935
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00139_97
p12936
sg16
VSuccinic acid [drugbank:DB00139]
p12937
sg18
Vdrug-target interaction Succinic acid and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 [drugbank_resource:DB00139_97]
p12938
sasS'KCNK1'
p12939
(lp12940
(dp12941
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:172
p12942
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00308
p12943
sg11
g12939
sg12
S'potassium channel, subfamily K, member 1'
p12944
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00308_172
p12945
sg16
VIbutilide [drugbank:DB00308]
p12946
sg18
Vdrug-target interaction Ibutilide and Potassium channel subfamily K member 1 [drugbank_resource:DB00308_172]
p12947
sa(dp12948
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:172
p12949
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00908
p12950
sg11
g12939
sg12
S'potassium channel, subfamily K, member 1'
p12951
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00908_172
p12952
sg16
VQuinidine [drugbank:DB00908]
p12953
sg18
Vdrug-target interaction Quinidine and Potassium channel subfamily K member 1 [drugbank_resource:DB00908_172]
p12954
sa(dp12955
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:172
p12956
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01346
p12957
sg11
g12939
sg12
S'potassium channel, subfamily K, member 1'
p12958
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01346_172
p12959
sg16
VQuinidine barbiturate [drugbank:DB01346]
p12960
sg18
Vdrug-target interaction Quinidine barbiturate and Potassium channel subfamily K member 1 [drugbank_resource:DB01346_172]
p12961
sasS'NSF'
p12962
(lp12963
(dp12964
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7018
p12965
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01902
p12966
sg11
g12962
sg12
S'N-ethylmaleimide-sensitive factor'
p12967
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01902_7018
p12968
sg16
V1-Ethyl-Pyrrolidine-2,5-Dione [drugbank:DB01902]
p12969
sg18
Vdrug-target interaction 1-Ethyl-Pyrrolidine-2,5-Dione and Vesicle-fusing ATPase [drugbank_resource:DB01902_7018]
p12970
sasS'SCN2A'
p12971
(lp12972
(dp12973
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3802
p12974
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00555
p12975
sg11
g12971
sg12
S'sodium channel, voltage-gated, type II, alpha subunit'
p12976
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00555_3802
p12977
sg16
VLamotrigine [drugbank:DB00555]
p12978
sg18
Vdrug-target interaction Lamotrigine and Sodium channel protein type 2 subunit alpha [drugbank_resource:DB00555_3802]
p12979
sa(dp12980
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3802
p12981
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00818
p12982
sg11
g12971
sg12
S'sodium channel, voltage-gated, type II, alpha subunit'
p12983
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00818_3802
p12984
sg16
VPropofol [drugbank:DB00818]
p12985
sg18
Vdrug-target interaction Propofol and Sodium channel protein type 2 subunit alpha [drugbank_resource:DB00818_3802]
p12986
sa(dp12987
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3802
p12988
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00909
p12989
sg11
g12971
sg12
S'sodium channel, voltage-gated, type II, alpha subunit'
p12990
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00909_3802
p12991
sg16
VZonisamide [drugbank:DB00909]
p12992
sg18
Vdrug-target interaction Zonisamide and Sodium channel protein type 2 subunit alpha [drugbank_resource:DB00909_3802]
p12993
sa(dp12994
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3802
p12995
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06716
p12996
sg11
g12971
sg12
S'sodium channel, voltage-gated, type II, alpha subunit'
p12997
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06716_3802
p12998
sg16
VFospropofol [drugbank:DB06716]
p12999
sg18
Vdrug-target interaction Fospropofol and Sodium channel protein type 2 subunit alpha [drugbank_resource:DB06716_3802]
p13000
sasS'PGR'
p13001
(lp13002
(dp13003
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13004
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00294
p13005
sg11
g13001
sg12
S'progesterone receptor'
p13006
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00294_614
p13007
sg16
VEtonogestrel [drugbank:DB00294]
p13008
sg18
Vdrug-target interaction Etonogestrel and Progesterone receptor [drugbank_resource:DB00294_614]
p13009
sa(dp13010
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13011
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00351
p13012
sg11
g13001
sg12
S'progesterone receptor'
p13013
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00351_614
p13014
sg16
VMegestrol [drugbank:DB00351]
p13015
sg18
Vdrug-target interaction Megestrol and Progesterone receptor [drugbank_resource:DB00351_614]
p13016
sa(dp13017
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13018
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00378
p13019
sg11
g13001
sg12
S'progesterone receptor'
p13020
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00378_614
p13021
sg16
VDydrogesterone [drugbank:DB00378]
p13022
sg18
Vdrug-target interaction Dydrogesterone and Progesterone receptor [drugbank_resource:DB00378_614]
p13023
sa(dp13024
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13025
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00304
p13026
sg11
g13001
sg12
S'progesterone receptor'
p13027
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00304_614
p13028
sg16
VDesogestrel [drugbank:DB00304]
p13029
sg18
Vdrug-target interaction Desogestrel and Progesterone receptor [drugbank_resource:DB00304_614]
p13030
sa(dp13031
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13032
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00588
p13033
sg11
g13001
sg12
S'progesterone receptor'
p13034
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00588_614
p13035
sg16
VFluticasone Propionate [drugbank:DB00588]
p13036
sg18
Vdrug-target interaction Fluticasone Propionate and Progesterone receptor [drugbank_resource:DB00588_614]
p13037
sa(dp13038
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13039
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00367
p13040
sg11
g13001
sg12
S'progesterone receptor'
p13041
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00367_614
p13042
sg16
VLevonorgestrel [drugbank:DB00367]
p13043
sg18
Vdrug-target interaction Levonorgestrel and Progesterone receptor [drugbank_resource:DB00367_614]
p13044
sa(dp13045
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13046
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00396
p13047
sg11
g13001
sg12
S'progesterone receptor'
p13048
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00396_614
p13049
sg16
VProgesterone [drugbank:DB00396]
p13050
sg18
Vdrug-target interaction Progesterone and Progesterone receptor [drugbank_resource:DB00396_614]
p13051
sa(dp13052
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13053
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00603
p13054
sg11
g13001
sg12
S'progesterone receptor'
p13055
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00603_614
p13056
sg16
VMedroxyprogesterone [drugbank:DB00603]
p13057
sg18
Vdrug-target interaction Medroxyprogesterone and Progesterone receptor [drugbank_resource:DB00603_614]
p13058
sa(dp13059
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13060
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00823
p13061
sg11
g13001
sg12
S'progesterone receptor'
p13062
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00823_614
p13063
sg16
VEthynodiol Diacetate [drugbank:DB00823]
p13064
sg18
Vdrug-target interaction Ethynodiol Diacetate and Progesterone receptor [drugbank_resource:DB00823_614]
p13065
sa(dp13066
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13067
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00717
p13068
sg11
g13001
sg12
S'progesterone receptor'
p13069
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00717_614
p13070
sg16
VNorethindrone [drugbank:DB00717]
p13071
sg18
Vdrug-target interaction Norethindrone and Progesterone receptor [drugbank_resource:DB00717_614]
p13072
sa(dp13073
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13074
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00834
p13075
sg11
g13001
sg12
S'progesterone receptor'
p13076
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00834_614
p13077
sg16
VMifepristone [drugbank:DB00834]
p13078
sg18
Vdrug-target interaction Mifepristone and Progesterone receptor [drugbank_resource:DB00834_614]
p13079
sa(dp13080
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13081
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00957
p13082
sg11
g13001
sg12
S'progesterone receptor'
p13083
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00957_614
p13084
sg16
VNorgestimate [drugbank:DB00957]
p13085
sg18
Vdrug-target interaction Norgestimate and Progesterone receptor [drugbank_resource:DB00957_614]
p13086
sa(dp13087
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13088
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01406
p13089
sg11
g13001
sg12
S'progesterone receptor'
p13090
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01406_614
p13091
sg16
VDanazol [drugbank:DB01406]
p13092
sg18
Vdrug-target interaction Danazol and Progesterone receptor [drugbank_resource:DB01406_614]
p13093
sa(dp13094
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13095
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01431
p13096
sg11
g13001
sg12
S'progesterone receptor'
p13097
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01431_614
p13098
sg16
VAllylestrenol [drugbank:DB01431]
p13099
sg18
Vdrug-target interaction Allylestrenol and Progesterone receptor [drugbank_resource:DB01431_614]
p13100
sa(dp13101
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13102
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01395
p13103
sg11
g13001
sg12
S'progesterone receptor'
p13104
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01395_614
p13105
sg16
VDrospirenone [drugbank:DB01395]
p13106
sg18
Vdrug-target interaction Drospirenone and Progesterone receptor [drugbank_resource:DB01395_614]
p13107
sa(dp13108
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13109
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02998
p13110
sg11
g13001
sg12
S'progesterone receptor'
p13111
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02998_614
p13112
sg16
VMethyltrienolone [drugbank:DB02998]
p13113
sg18
Vdrug-target interaction Methyltrienolone and Progesterone receptor [drugbank_resource:DB02998_614]
p13114
sa(dp13115
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13116
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04787
p13117
sg11
g13001
sg12
S'progesterone receptor'
p13118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04787_614
p13119
sg16
VTanaproget [drugbank:DB04787]
p13120
sg18
Vdrug-target interaction Tanaproget and Progesterone receptor [drugbank_resource:DB04787_614]
p13121
sa(dp13122
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:614
p13123
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06713
p13124
sg11
g13001
sg12
S'progesterone receptor'
p13125
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06713_614
p13126
sg16
VNorelgestromin [drugbank:DB06713]
p13127
sg18
Vdrug-target interaction Norelgestromin and Progesterone receptor [drugbank_resource:DB06713_614]
p13128
sasS'ZAP70'
p13129
(lp13130
(dp13131
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2398
p13132
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02010
p13133
sg11
g13129
sg12
S'zeta-chain (TCR) associated protein kinase 70kDa'
p13134
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02010_2398
p13135
sg16
VStaurosporine [drugbank:DB02010]
p13136
sg18
Vdrug-target interaction Staurosporine and Tyrosine-protein kinase ZAP-70 [drugbank_resource:DB02010_2398]
p13137
sasS'AURKB'
p13138
(lp13139
(dp13140
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5817
p13141
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07340
p13142
sg11
g13138
sg12
S'aurora kinase B'
p13143
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07340_5817
p13144
sg16
VN~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine [drugbank:DB07340]
p13145
sg18
Vdrug-target interaction N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine and Serine/threonine-protein kinase 12 [drugbank_resource:DB07340_5817]
p13146
sa(dp13147
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5817
p13148
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04703
p13149
sg11
g13138
sg12
S'aurora kinase B'
p13150
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04703_5817
p13151
sg16
VHESPERIDIN [drugbank:DB04703]
p13152
sg18
Vdrug-target interaction HESPERIDIN and Serine/threonine-protein kinase 12 [drugbank_resource:DB04703_5817]
p13153
sasS'CXCR4'
p13154
(lp13155
(dp13156
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1162
p13157
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00452
p13158
sg11
g13154
sg12
S'chemokine (C-X-C motif) receptor 4'
p13159
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00452_1162
p13160
sg16
VFramycetin [drugbank:DB00452]
p13161
sg18
Vdrug-target interaction Framycetin and C-X-C chemokine receptor type 4 [drugbank_resource:DB00452_1162]
p13162
sa(dp13163
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1162
p13164
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06809
p13165
sg11
g13154
sg12
S'chemokine (C-X-C motif) receptor 4'
p13166
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06809_1162
p13167
sg16
VPlerixafor [drugbank:DB06809]
p13168
sg18
Vdrug-target interaction Plerixafor and C-X-C chemokine receptor type 4 [drugbank_resource:DB06809_1162]
p13169
sasS'ATP6V1B2'
p13170
(lp13171
(dp13172
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6315
p13173
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB05260
p13174
sg11
g13170
sg12
S'ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2'
p13175
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB05260_6315
p13176
sg16
VGallium nitrate [drugbank:DB05260]
p13177
sg18
Vdrug-target interaction Gallium nitrate and V-type proton ATPase subunit B, brain isoform [drugbank_resource:DB05260_6315]
p13178
sa(dp13179
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6315
p13180
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07347
p13181
sg11
g13170
sg12
S'ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2'
p13182
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07347_6315
p13183
sg16
V4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE [drugbank:DB07347]
p13184
sg18
Vdrug-target interaction 4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE and V-type proton ATPase subunit B, brain isoform [drugbank_resource:DB07347_6315]
p13185
sasS'MBP'
p13186
(lp13187
(dp13188
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3836
p13189
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00020
p13190
sg11
S'PRG2'
p13191
sg12
S'proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)'
p13192
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00020_3836
p13193
sg16
VSargramostim [drugbank:DB00020]
p13194
sg18
Vdrug-target interaction Sargramostim and Bone-marrow proteoglycan [drugbank_resource:DB00020_3836]
p13195
sasS'KCND2'
p13196
(lp13197
(dp13198
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6098
p13199
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00280
p13200
sg11
g13196
sg12
S'potassium voltage-gated channel, Shal-related subfamily, member 2'
p13201
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00280_6098
p13202
sg16
VDisopyramide [drugbank:DB00280]
p13203
sg18
Vdrug-target interaction Disopyramide and Potassium voltage-gated channel subfamily D member 2 [drugbank_resource:DB00280_6098]
p13204
sa(dp13205
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6098
p13206
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00321
p13207
sg11
g13196
sg12
S'potassium voltage-gated channel, Shal-related subfamily, member 2'
p13208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00321_6098
p13209
sg16
VAmitriptyline [drugbank:DB00321]
p13210
sg18
Vdrug-target interaction Amitriptyline and Potassium voltage-gated channel subfamily D member 2 [drugbank_resource:DB00321_6098]
p13211
sa(dp13212
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6098
p13213
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00458
p13214
sg11
g13196
sg12
S'potassium voltage-gated channel, Shal-related subfamily, member 2'
p13215
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00458_6098
p13216
sg16
VImipramine [drugbank:DB00458]
p13217
sg18
Vdrug-target interaction Imipramine and Potassium voltage-gated channel subfamily D member 2 [drugbank_resource:DB00458_6098]
p13218
sasS'YWHAE'
p13219
(lp13220
(dp13221
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7080
p13222
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01780
p13223
sg11
g13219
sg12
S'tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide'
p13224
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01780_7080
p13225
sg16
VFusicoccin [drugbank:DB01780]
p13226
sg18
Vdrug-target interaction Fusicoccin and 14-3-3 protein epsilon [drugbank_resource:DB01780_7080]
p13227
sasS'ANXA1'
p13228
(lp13229
(dp13230
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:469
p13231
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00288
p13232
sg11
g13228
sg12
S'annexin A1'
p13233
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00288_469
p13234
sg16
VAmcinonide [drugbank:DB00288]
p13235
sg18
Vdrug-target interaction Amcinonide and Annexin A1 [drugbank_resource:DB00288_469]
p13236
sa(dp13237
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:469
p13238
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00741
p13239
sg11
g13228
sg12
S'annexin A1'
p13240
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00741_469
p13241
sg16
VHydrocortisone [drugbank:DB00741]
p13242
sg18
Vdrug-target interaction Hydrocortisone and Annexin A1 [drugbank_resource:DB00741_469]
p13243
sa(dp13244
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:469
p13245
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01234
p13246
sg11
g13228
sg12
S'annexin A1'
p13247
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01234_469
p13248
sg16
VDexamethasone [drugbank:DB01234]
p13249
sg18
Vdrug-target interaction Dexamethasone and Annexin A1 [drugbank_resource:DB01234_469]
p13250
sasS'CCKBR'
p13251
(lp13252
(dp13253
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2049
p13254
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00183
p13255
sg11
g13251
sg12
S'cholecystokinin B receptor'
p13256
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00183_2049
p13257
sg16
VPentagastrin [drugbank:DB00183]
p13258
sg18
Vdrug-target interaction Pentagastrin and Gastrin/cholecystokinin type B receptor [drugbank_resource:DB00183_2049]
p13259
sasS'ANXA3'
p13260
(lp13261
(dp13262
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5483
p13263
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03994
p13264
sg11
g13260
sg12
S'annexin A3'
p13265
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03994_5483
p13266
sg16
VEthanolamine [drugbank:DB03994]
p13267
sg18
Vdrug-target interaction Ethanolamine and Annexin A3 [drugbank_resource:DB03994_5483]
p13268
sasS'ANXA2'
p13269
(lp13270
(dp13271
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2111
p13272
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00031
p13273
sg11
g13269
sg12
S'annexin A2'
p13274
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00031_2111
p13275
sg16
VTenecteplase [drugbank:DB00031]
p13276
sg18
Vdrug-target interaction Tenecteplase and Annexin A2 [drugbank_resource:DB00031_2111]
p13277
sasS'ANXA5'
p13278
(lp13279
(dp13280
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6654
p13281
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02929
p13282
sg11
g13278
sg12
S'annexin A5'
p13283
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02929_6654
p13284
sg16
VK201 [drugbank:DB02929]
p13285
sg18
Vdrug-target interaction K201 and Annexin A5 [drugbank_resource:DB02929_6654]
p13286
sa(dp13287
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6654
p13288
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02497
p13289
sg11
g13278
sg12
S'annexin A5'
p13290
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02497_6654
p13291
sg16
VL-Alpha-Glycerophosphorylserine [drugbank:DB02497]
p13292
sg18
Vdrug-target interaction L-Alpha-Glycerophosphorylserine and Annexin A5 [drugbank_resource:DB02497_6654]
p13293
sa(dp13294
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6654
p13295
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02846
p13296
sg11
g13278
sg12
S'annexin A5'
p13297
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02846_6654
p13298
sg16
VThioproline [drugbank:DB02846]
p13299
sg18
Vdrug-target interaction Thioproline and Annexin A5 [drugbank_resource:DB02846_6654]
p13300
sa(dp13301
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6654
p13302
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03935
p13303
sg11
g13278
sg12
S'annexin A5'
p13304
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03935_6654
p13305
sg16
V1,4-Dideoxy-O2-Sulfo-Glucuronic Acid [drugbank:DB03935]
p13306
sg18
Vdrug-target interaction 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid and Annexin A5 [drugbank_resource:DB03935_6654]
p13307
sa(dp13308
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6654
p13309
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03959
p13310
sg11
g13278
sg12
S'annexin A5'
p13311
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03959_6654
p13312
sg16
VN,O6-Disulfo-Glucosamine [drugbank:DB03959]
p13313
sg18
Vdrug-target interaction N,O6-Disulfo-Glucosamine and Annexin A5 [drugbank_resource:DB03959_6654]
p13314
sa(dp13315
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6654
p13316
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03484
p13317
sg11
g13278
sg12
S'annexin A5'
p13318
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03484_6654
p13319
sg16
VL-Alpha-Glycerophosphorylethanolamine [drugbank:DB03484]
p13320
sg18
Vdrug-target interaction L-Alpha-Glycerophosphorylethanolamine and Annexin A5 [drugbank_resource:DB03484_6654]
p13321
sa(dp13322
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6654
p13323
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03981
p13324
sg11
g13278
sg12
S'annexin A5'
p13325
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03981_6654
p13326
sg16
V1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid [drugbank:DB03981]
p13327
sg18
Vdrug-target interaction 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid and Annexin A5 [drugbank_resource:DB03981_6654]
p13328
sasS'RAC1'
p13329
(lp13330
(dp13331
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1882
p13332
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04315
p13333
sg11
g13329
sg12
S'ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)'
p13334
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04315_1882
p13335
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p13336
sg18
Vdrug-target interaction Guanosine-5'-Diphosphate and Ras-related C3 botulinum toxin substrate 1 [drugbank_resource:DB04315_1882]
p13337
sasS'PRKCA'
p13338
(lp13339
(dp13340
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1970
p13341
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00144
p13342
sg11
g13338
sg12
S'protein kinase C, alpha'
p13343
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00144_1970
p13344
sg16
VPhosphatidylserine [drugbank:DB00144]
p13345
sg18
Vdrug-target interaction Phosphatidylserine and Protein kinase C alpha type [drugbank_resource:DB00144_1970]
p13346
sa(dp13347
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1970
p13348
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00163
p13349
sg11
g13338
sg12
S'protein kinase C, alpha'
p13350
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00163_1970
p13351
sg16
VVitamin E [drugbank:DB00163]
p13352
sg18
Vdrug-target interaction Vitamin E and Protein kinase C alpha type [drugbank_resource:DB00163_1970]
p13353
sasS'CD44'
p13354
(lp13355
(dp13356
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1901
p13357
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08818
p13358
sg11
g13354
sg12
S'CD44 molecule (Indian blood group)'
p13359
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08818_1901
p13360
sg16
VHyaluronan [drugbank:DB08818]
p13361
sg18
Vdrug-target interaction Hyaluronan and CD44 antigen [drugbank_resource:DB08818_1901]
p13362
sasS'FCGR2B'
p13363
(lp13364
(dp13365
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13366
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00002
p13367
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13368
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00002_3820
p13369
sg16
VCetuximab [drugbank:DB00002]
p13370
sg18
Vdrug-target interaction Cetuximab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00002_3820]
p13371
sa(dp13372
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13373
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00028
p13374
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13375
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00028_3820
p13376
sg16
VIntravenous Immunoglobulin [drugbank:DB00028]
p13377
sg18
Vdrug-target interaction Intravenous Immunoglobulin and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00028_3820]
p13378
sa(dp13379
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13380
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00054
p13381
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13382
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00054_3820
p13383
sg16
VAbciximab [drugbank:DB00054]
p13384
sg18
Vdrug-target interaction Abciximab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00054_3820]
p13385
sa(dp13386
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13387
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00078
p13388
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13389
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00078_3820
p13390
sg16
VIbritumomab [drugbank:DB00078]
p13391
sg18
Vdrug-target interaction Ibritumomab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00078_3820]
p13392
sa(dp13393
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13394
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00081
p13395
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13396
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00081_3820
p13397
sg16
VTositumomab [drugbank:DB00081]
p13398
sg18
Vdrug-target interaction Tositumomab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00081_3820]
p13399
sa(dp13400
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13401
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00051
p13402
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13403
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00051_3820
p13404
sg16
VAdalimumab [drugbank:DB00051]
p13405
sg18
Vdrug-target interaction Adalimumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00051_3820]
p13406
sa(dp13407
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13408
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00073
p13409
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13410
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00073_3820
p13411
sg16
VRituximab [drugbank:DB00073]
p13412
sg18
Vdrug-target interaction Rituximab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00073_3820]
p13413
sa(dp13414
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13415
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00074
p13416
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13417
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00074_3820
p13418
sg16
VBasiliximab [drugbank:DB00074]
p13419
sg18
Vdrug-target interaction Basiliximab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00074_3820]
p13420
sa(dp13421
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13422
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00110
p13423
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13424
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00110_3820
p13425
sg16
VPalivizumab [drugbank:DB00110]
p13426
sg18
Vdrug-target interaction Palivizumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00110_3820]
p13427
sa(dp13428
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13429
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00112
p13430
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13431
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00112_3820
p13432
sg16
VBevacizumab [drugbank:DB00112]
p13433
sg18
Vdrug-target interaction Bevacizumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00112_3820]
p13434
sa(dp13435
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13436
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00005
p13437
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13438
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00005_3820
p13439
sg16
VEtanercept [drugbank:DB00005]
p13440
sg18
Vdrug-target interaction Etanercept and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00005_3820]
p13441
sa(dp13442
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13443
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00056
p13444
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13445
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00056_3820
p13446
sg16
VGemtuzumab ozogamicin [drugbank:DB00056]
p13447
sg18
Vdrug-target interaction Gemtuzumab ozogamicin and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00056_3820]
p13448
sa(dp13449
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13450
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00072
p13451
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13452
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00072_3820
p13453
sg16
VTrastuzumab [drugbank:DB00072]
p13454
sg18
Vdrug-target interaction Trastuzumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00072_3820]
p13455
sa(dp13456
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13457
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00075
p13458
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13459
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00075_3820
p13460
sg16
VMuromonab [drugbank:DB00075]
p13461
sg18
Vdrug-target interaction Muromonab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00075_3820]
p13462
sa(dp13463
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13464
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00087
p13465
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13466
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00087_3820
p13467
sg16
VAlemtuzumab [drugbank:DB00087]
p13468
sg18
Vdrug-target interaction Alemtuzumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00087_3820]
p13469
sa(dp13470
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13471
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00092
p13472
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13473
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00092_3820
p13474
sg16
VAlefacept [drugbank:DB00092]
p13475
sg18
Vdrug-target interaction Alefacept and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00092_3820]
p13476
sa(dp13477
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13478
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00095
p13479
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13480
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00095_3820
p13481
sg16
VEfalizumab [drugbank:DB00095]
p13482
sg18
Vdrug-target interaction Efalizumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00095_3820]
p13483
sa(dp13484
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13485
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00098
p13486
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13487
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00098_3820
p13488
sg16
VAntithymocyte globulin [drugbank:DB00098]
p13489
sg18
Vdrug-target interaction Antithymocyte globulin and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00098_3820]
p13490
sa(dp13491
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13492
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00108
p13493
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13494
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00108_3820
p13495
sg16
VNatalizumab [drugbank:DB00108]
p13496
sg18
Vdrug-target interaction Natalizumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00108_3820]
p13497
sa(dp13498
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3820
p13499
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00111
p13500
sg11
g13363
sg12
S'Fc fragment of IgG, low affinity IIb, receptor (CD32)'
p13501
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00111_3820
p13502
sg16
VDaclizumab [drugbank:DB00111]
p13503
sg18
Vdrug-target interaction Daclizumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00111_3820]
p13504
sasS'PRKCD'
p13505
(lp13506
(dp13507
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:4184
p13508
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04376
p13509
sg11
g13505
sg12
S'protein kinase C, delta'
p13510
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04376_4184
p13511
sg16
V13-Acetylphorbol [drugbank:DB04376]
p13512
sg18
Vdrug-target interaction 13-Acetylphorbol and Protein kinase C delta type [drugbank_resource:DB04376_4184]
p13513
sasS'CD4'
p13514
(lp13515
(dp13516
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:5955
p13517
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00098
p13518
sg11
g13514
sg12
S'CD4 molecule'
p13519
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00098_5955
p13520
sg16
VAntithymocyte globulin [drugbank:DB00098]
p13521
sg18
Vdrug-target interaction Antithymocyte globulin and T-cell surface glycoprotein CD4 [drugbank_resource:DB00098_5955]
p13522
sasS'PLAT'
p13523
(lp13524
(dp13525
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1792
p13526
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00013
p13527
sg11
g13523
sg12
S'plasminogen activator, tissue'
p13528
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00013_1792
p13529
sg16
VUrokinase [drugbank:DB00013]
p13530
sg18
Vdrug-target interaction Urokinase and Tissue-type plasminogen activator [drugbank_resource:DB00013_1792]
p13531
sa(dp13532
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1792
p13533
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00513
p13534
sg11
g13523
sg12
S'plasminogen activator, tissue'
p13535
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00513_1792
p13536
sg16
VAminocaproic Acid [drugbank:DB00513]
p13537
sg18
Vdrug-target interaction Aminocaproic Acid and Tissue-type plasminogen activator [drugbank_resource:DB00513_1792]
p13538
sa(dp13539
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1792
p13540
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01088
p13541
sg11
g13523
sg12
S'plasminogen activator, tissue'
p13542
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01088_1792
p13543
sg16
VIloprost [drugbank:DB01088]
p13544
sg18
Vdrug-target interaction Iloprost and Tissue-type plasminogen activator [drugbank_resource:DB01088_1792]
p13545
sa(dp13546
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1792
p13547
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04134
p13548
sg11
g13523
sg12
S'plasminogen activator, tissue'
p13549
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04134_1792
p13550
sg16
V6-Amino Hexanoic Acid [drugbank:DB04134]
p13551
sg18
Vdrug-target interaction 6-Amino Hexanoic Acid and Tissue-type plasminogen activator [drugbank_resource:DB04134_1792]
p13552
sa(dp13553
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1792
p13554
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07684
p13555
sg11
g13523
sg12
S'plasminogen activator, tissue'
p13556
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07684_1792
p13557
sg16
V5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID [drugbank:DB07684]
p13558
sg18
Vdrug-target interaction 5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID and Tissue-type plasminogen activator [drugbank_resource:DB07684_1792]
p13559
sasS'VCP'
p13560
(lp13561
(dp13562
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7082
p13563
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03431
p13564
sg11
g13560
sg12
S'valosin containing protein'
p13565
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03431_7082
p13566
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p13567
sg18
Vdrug-target interaction Adenosine-5'-Diphosphate and Transitional endoplasmic reticulum ATPase [drugbank_resource:DB03431_7082]
p13568
sa(dp13569
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:7082
p13570
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04395
p13571
sg11
g13560
sg12
S'valosin containing protein'
p13572
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04395_7082
p13573
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p13574
sg18
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Transitional endoplasmic reticulum ATPase [drugbank_resource:DB04395_7082]
p13575
sasS'HTR2A'
p13576
(lp13577
(dp13578
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13579
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00248
p13580
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13581
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00248_502
p13582
sg16
VCabergoline [drugbank:DB00248]
p13583
sg18
Vdrug-target interaction Cabergoline and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00248_502]
p13584
sa(dp13585
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13586
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00246
p13587
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13588
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00246_502
p13589
sg16
VZiprasidone [drugbank:DB00246]
p13590
sg18
Vdrug-target interaction Ziprasidone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00246_502]
p13591
sa(dp13592
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13593
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00247
p13594
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13595
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00247_502
p13596
sg16
VMethysergide [drugbank:DB00247]
p13597
sg18
Vdrug-target interaction Methysergide and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00247_502]
p13598
sa(dp13599
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13600
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00268
p13601
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13602
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00268_502
p13603
sg16
VRopinirole [drugbank:DB00268]
p13604
sg18
Vdrug-target interaction Ropinirole and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00268_502]
p13605
sa(dp13606
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13607
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00363
p13608
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13609
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00363_502
p13610
sg16
VClozapine [drugbank:DB00363]
p13611
sg18
Vdrug-target interaction Clozapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00363_502]
p13612
sa(dp13613
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13614
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00413
p13615
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13616
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00413_502
p13617
sg16
VPramipexole [drugbank:DB00413]
p13618
sg18
Vdrug-target interaction Pramipexole and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00413_502]
p13619
sa(dp13620
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13621
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00420
p13622
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13623
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00420_502
p13624
sg16
VPromazine [drugbank:DB00420]
p13625
sg18
Vdrug-target interaction Promazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00420_502]
p13626
sa(dp13627
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13628
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00477
p13629
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13630
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00477_502
p13631
sg16
VChlorpromazine [drugbank:DB00477]
p13632
sg18
Vdrug-target interaction Chlorpromazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00477_502]
p13633
sa(dp13634
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13635
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00321
p13636
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13637
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00321_502
p13638
sg16
VAmitriptyline [drugbank:DB00321]
p13639
sg18
Vdrug-target interaction Amitriptyline and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00321_502]
p13640
sa(dp13641
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13642
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00334
p13643
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13644
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00334_502
p13645
sg16
VOlanzapine [drugbank:DB00334]
p13646
sg18
Vdrug-target interaction Olanzapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00334_502]
p13647
sa(dp13648
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13649
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00370
p13650
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13651
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00370_502
p13652
sg16
VMirtazapine [drugbank:DB00370]
p13653
sg18
Vdrug-target interaction Mirtazapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00370_502]
p13654
sa(dp13655
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13656
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00408
p13657
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13658
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00408_502
p13659
sg16
VLoxapine [drugbank:DB00408]
p13660
sg18
Vdrug-target interaction Loxapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00408_502]
p13661
sa(dp13662
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13663
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00409
p13664
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13665
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00409_502
p13666
sg16
VRemoxipride [drugbank:DB00409]
p13667
sg18
Vdrug-target interaction Remoxipride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00409_502]
p13668
sa(dp13669
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13670
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00458
p13671
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13672
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00458_502
p13673
sg16
VImipramine [drugbank:DB00458]
p13674
sg18
Vdrug-target interaction Imipramine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00458_502]
p13675
sa(dp13676
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13677
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00472
p13678
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13679
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00472_502
p13680
sg16
VFluoxetine [drugbank:DB00472]
p13681
sg18
Vdrug-target interaction Fluoxetine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00472_502]
p13682
sa(dp13683
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13684
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00540
p13685
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13686
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00540_502
p13687
sg16
VNortriptyline [drugbank:DB00540]
p13688
sg18
Vdrug-target interaction Nortriptyline and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00540_502]
p13689
sa(dp13690
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13691
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00589
p13692
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13693
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00589_502
p13694
sg16
VLisuride [drugbank:DB00589]
p13695
sg18
Vdrug-target interaction Lisuride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00589_502]
p13696
sa(dp13697
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13698
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00604
p13699
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13700
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00604_502
p13701
sg16
VCisapride [drugbank:DB00604]
p13702
sg18
Vdrug-target interaction Cisapride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00604_502]
p13703
sa(dp13704
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13705
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00656
p13706
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13707
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00656_502
p13708
sg16
VTrazodone [drugbank:DB00656]
p13709
sg18
Vdrug-target interaction Trazodone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00656_502]
p13710
sa(dp13711
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13712
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00434
p13713
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13714
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00434_502
p13715
sg16
VCyproheptadine [drugbank:DB00434]
p13716
sg18
Vdrug-target interaction Cyproheptadine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00434_502]
p13717
sa(dp13718
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13719
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00502
p13720
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13721
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00502_502
p13722
sg16
VHaloperidol [drugbank:DB00502]
p13723
sg18
Vdrug-target interaction Haloperidol and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00502_502]
p13724
sa(dp13725
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13726
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00679
p13727
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13728
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00679_502
p13729
sg16
VThioridazine [drugbank:DB00679]
p13730
sg18
Vdrug-target interaction Thioridazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00679_502]
p13731
sa(dp13732
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13733
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00696
p13734
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13735
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00696_502
p13736
sg16
VErgotamine [drugbank:DB00696]
p13737
sg18
Vdrug-target interaction Ergotamine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00696_502]
p13738
sa(dp13739
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13740
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00714
p13741
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13742
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00714_502
p13743
sg16
VApomorphine [drugbank:DB00714]
p13744
sg18
Vdrug-target interaction Apomorphine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00714_502]
p13745
sa(dp13746
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13747
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00715
p13748
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13749
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00715_502
p13750
sg16
VParoxetine [drugbank:DB00715]
p13751
sg18
Vdrug-target interaction Paroxetine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00715_502]
p13752
sa(dp13753
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13754
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00726
p13755
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13756
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00726_502
p13757
sg16
VTrimipramine [drugbank:DB00726]
p13758
sg18
Vdrug-target interaction Trimipramine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00726_502]
p13759
sa(dp13760
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13761
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00751
p13762
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13763
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00751_502
p13764
sg16
VEpinastine [drugbank:DB00751]
p13765
sg18
Vdrug-target interaction Epinastine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00751_502]
p13766
sa(dp13767
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13768
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00805
p13769
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13770
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00805_502
p13771
sg16
VMinaprine [drugbank:DB00805]
p13772
sg18
Vdrug-target interaction Minaprine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00805_502]
p13773
sa(dp13774
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13775
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00875
p13776
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13777
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00875_502
p13778
sg16
VFlupenthixol [drugbank:DB00875]
p13779
sg18
Vdrug-target interaction Flupenthixol and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00875_502]
p13780
sa(dp13781
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13782
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00924
p13783
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13784
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00924_502
p13785
sg16
VCyclobenzaprine [drugbank:DB00924]
p13786
sg18
Vdrug-target interaction Cyclobenzaprine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00924_502]
p13787
sa(dp13788
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13789
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00933
p13790
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13791
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00933_502
p13792
sg16
VMesoridazine [drugbank:DB00933]
p13793
sg18
Vdrug-target interaction Mesoridazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00933_502]
p13794
sa(dp13795
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13796
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00734
p13797
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13798
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00734_502
p13799
sg16
VRisperidone [drugbank:DB00734]
p13800
sg18
Vdrug-target interaction Risperidone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00734_502]
p13801
sa(dp13802
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13803
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00843
p13804
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13805
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00843_502
p13806
sg16
VDonepezil [drugbank:DB00843]
p13807
sg18
Vdrug-target interaction Donepezil and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00843_502]
p13808
sa(dp13809
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13810
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01069
p13811
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13812
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01069_502
p13813
sg16
VPromethazine [drugbank:DB01069]
p13814
sg18
Vdrug-target interaction Promethazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01069_502]
p13815
sa(dp13816
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13817
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01079
p13818
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13819
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01079_502
p13820
sg16
VTegaserod [drugbank:DB01079]
p13821
sg18
Vdrug-target interaction Tegaserod and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01079_502]
p13822
sa(dp13823
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13824
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00777
p13825
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13826
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00777_502
p13827
sg16
VPropiomazine [drugbank:DB00777]
p13828
sg18
Vdrug-target interaction Propiomazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00777_502]
p13829
sa(dp13830
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13831
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01149
p13832
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13833
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01149_502
p13834
sg16
VNefazodone [drugbank:DB01149]
p13835
sg18
Vdrug-target interaction Nefazodone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01149_502]
p13836
sa(dp13837
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13838
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01151
p13839
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13840
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01151_502
p13841
sg16
VDesipramine [drugbank:DB01151]
p13842
sg18
Vdrug-target interaction Desipramine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01151_502]
p13843
sa(dp13844
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13845
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01142
p13846
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13847
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01142_502
p13848
sg16
VDoxepin [drugbank:DB01142]
p13849
sg18
Vdrug-target interaction Doxepin and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01142_502]
p13850
sa(dp13851
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13852
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01614
p13853
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13854
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01614_502
p13855
sg16
VAcepromazine [drugbank:DB01614]
p13856
sg18
Vdrug-target interaction Acepromazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01614_502]
p13857
sa(dp13858
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13859
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01618
p13860
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13861
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01618_502
p13862
sg16
VMolindone [drugbank:DB01618]
p13863
sg18
Vdrug-target interaction Molindone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01618_502]
p13864
sa(dp13865
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13866
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01287
p13867
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13868
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01287_502
p13869
sg16
VDihydroergotoxine [drugbank:DB01287]
p13870
sg18
Vdrug-target interaction Dihydroergotoxine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01287_502]
p13871
sa(dp13872
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13873
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01403
p13874
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13875
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01403_502
p13876
sg16
VMethotrimeprazine [drugbank:DB01403]
p13877
sg18
Vdrug-target interaction Methotrimeprazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01403_502]
p13878
sa(dp13879
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13880
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01454
p13881
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13882
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01454_502
p13883
sg16
V3,4-Methylenedioxymethamphetamine [drugbank:DB01454]
p13884
sg18
Vdrug-target interaction 3,4-Methylenedioxymethamphetamine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01454_502]
p13885
sa(dp13886
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13887
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01621
p13888
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13889
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01621_502
p13890
sg16
VPipotiazine [drugbank:DB01621]
p13891
sg18
Vdrug-target interaction Pipotiazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01621_502]
p13892
sa(dp13893
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13894
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01623
p13895
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13896
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01623_502
p13897
sg16
VThiothixene [drugbank:DB01623]
p13898
sg18
Vdrug-target interaction Thiothixene and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01623_502]
p13899
sa(dp13900
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13901
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01186
p13902
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13903
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01186_502
p13904
sg16
VPergolide [drugbank:DB01186]
p13905
sg18
Vdrug-target interaction Pergolide and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01186_502]
p13906
sa(dp13907
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13908
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01200
p13909
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13910
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01200_502
p13911
sg16
VBromocriptine [drugbank:DB01200]
p13912
sg18
Vdrug-target interaction Bromocriptine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01200_502]
p13913
sa(dp13914
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13915
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01224
p13916
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13917
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01224_502
p13918
sg16
VQuetiapine [drugbank:DB01224]
p13919
sg18
Vdrug-target interaction Quetiapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01224_502]
p13920
sa(dp13921
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13922
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01238
p13923
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13924
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01238_502
p13925
sg16
VAripiprazole [drugbank:DB01238]
p13926
sg18
Vdrug-target interaction Aripiprazole and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01238_502]
p13927
sa(dp13928
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13929
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01239
p13930
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13931
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01239_502
p13932
sg16
VChlorprothixene [drugbank:DB01239]
p13933
sg18
Vdrug-target interaction Chlorprothixene and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01239_502]
p13934
sa(dp13935
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13936
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01242
p13937
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13938
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01242_502
p13939
sg16
VClomipramine [drugbank:DB01242]
p13940
sg18
Vdrug-target interaction Clomipramine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01242_502]
p13941
sa(dp13942
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13943
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01267
p13944
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13945
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01267_502
p13946
sg16
VPaliperidone [drugbank:DB01267]
p13947
sg18
Vdrug-target interaction Paliperidone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01267_502]
p13948
sa(dp13949
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13950
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01392
p13951
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13952
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01392_502
p13953
sg16
VYohimbine [drugbank:DB01392]
p13954
sg18
Vdrug-target interaction Yohimbine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01392_502]
p13955
sa(dp13956
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13957
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01442
p13958
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13959
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01442_502
p13960
sg16
VMMDA [drugbank:DB01442]
p13961
sg18
Vdrug-target interaction MMDA and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01442_502]
p13962
sa(dp13963
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13964
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01488
p13965
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13966
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01488_502
p13967
sg16
VDimethyltryptamine [drugbank:DB01488]
p13968
sg18
Vdrug-target interaction Dimethyltryptamine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01488_502]
p13969
sa(dp13970
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13971
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01622
p13972
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13973
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01622_502
p13974
sg16
VThioproperazine [drugbank:DB01622]
p13975
sg18
Vdrug-target interaction Thioproperazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01622_502]
p13976
sa(dp13977
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13978
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01624
p13979
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13980
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01624_502
p13981
sg16
VZuclopenthixol [drugbank:DB01624]
p13982
sg18
Vdrug-target interaction Zuclopenthixol and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01624_502]
p13983
sa(dp13984
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13985
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04842
p13986
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13987
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04842_502
p13988
sg16
VFluspirilene [drugbank:DB04842]
p13989
sg18
Vdrug-target interaction Fluspirilene and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB04842_502]
p13990
sa(dp13991
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13992
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06288
p13993
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p13994
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06288_502
p13995
sg16
VAmisulpride [drugbank:DB06288]
p13996
sg18
Vdrug-target interaction Amisulpride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB06288_502]
p13997
sa(dp13998
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p13999
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06144
p14000
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p14001
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06144_502
p14002
sg16
VSertindole [drugbank:DB06144]
p14003
sg18
Vdrug-target interaction Sertindole and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB06144_502]
p14004
sa(dp14005
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p14006
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04599
p14007
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p14008
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04599_502
p14009
sg16
VAniracetam [drugbank:DB04599]
p14010
sg18
Vdrug-target interaction Aniracetam and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB04599_502]
p14011
sa(dp14012
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p14013
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06148
p14014
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p14015
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06148_502
p14016
sg16
VMianserin [drugbank:DB06148]
p14017
sg18
Vdrug-target interaction Mianserin and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB06148_502]
p14018
sa(dp14019
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:502
p14020
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08810
p14021
sg11
g13576
sg12
S'5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled'
p14022
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08810_502
p14023
sg16
VCinitapride [drugbank:DB08810]
p14024
sg18
Vdrug-target interaction Cinitapride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB08810_502]
p14025
sasS'VDR'
p14026
(lp14027
(dp14028
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p14029
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00136
p14030
sg11
g14026
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p14031
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00136_856
p14032
sg16
VCalcitriol [drugbank:DB00136]
p14033
sg18
Vdrug-target interaction Calcitriol and Vitamin D3 receptor [drugbank_resource:DB00136_856]
p14034
sa(dp14035
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p14036
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00169
p14037
sg11
g14026
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p14038
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00169_856
p14039
sg16
VCholecalciferol [drugbank:DB00169]
p14040
sg18
Vdrug-target interaction Cholecalciferol and Vitamin D3 receptor [drugbank_resource:DB00169_856]
p14041
sa(dp14042
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p14043
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00146
p14044
sg11
g14026
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p14045
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00146_856
p14046
sg16
VCalcidiol [drugbank:DB00146]
p14047
sg18
Vdrug-target interaction Calcidiol and Vitamin D3 receptor [drugbank_resource:DB00146_856]
p14048
sa(dp14049
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p14050
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00153
p14051
sg11
g14026
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p14052
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00153_856
p14053
sg16
VErgocalciferol [drugbank:DB00153]
p14054
sg18
Vdrug-target interaction Ergocalciferol and Vitamin D3 receptor [drugbank_resource:DB00153_856]
p14055
sa(dp14056
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p14057
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01070
p14058
sg11
g14026
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p14059
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01070_856
p14060
sg16
VDihydrotachysterol [drugbank:DB01070]
p14061
sg18
Vdrug-target interaction Dihydrotachysterol and Vitamin D3 receptor [drugbank_resource:DB01070_856]
p14062
sa(dp14063
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p14064
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00910
p14065
sg11
g14026
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p14066
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00910_856
p14067
sg16
VParicalcitol [drugbank:DB00910]
p14068
sg18
Vdrug-target interaction Paricalcitol and Vitamin D3 receptor [drugbank_resource:DB00910_856]
p14069
sa(dp14070
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p14071
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01436
p14072
sg11
g14026
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p14073
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01436_856
p14074
sg16
VAlfacalcidol [drugbank:DB01436]
p14075
sg18
Vdrug-target interaction Alfacalcidol and Vitamin D3 receptor [drugbank_resource:DB01436_856]
p14076
sa(dp14077
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p14078
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02300
p14079
sg11
g14026
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p14080
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02300_856
p14081
sg16
VCalcipotriol [drugbank:DB02300]
p14082
sg18
Vdrug-target interaction Calcipotriol and Vitamin D3 receptor [drugbank_resource:DB02300_856]
p14083
sa(dp14084
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p14085
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03451
p14086
sg11
g14026
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p14087
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03451_856
p14088
sg16
V1alpha,25-Dihydroxyl-20-Epi-22-Oxa-24,26,27-Trihomovitamin D3 [drugbank:DB03451]
p14089
sg18
Vdrug-target interaction 1alpha,25-Dihydroxyl-20-Epi-22-Oxa-24,26,27-Trihomovitamin D3 and Vitamin D3 receptor [drugbank_resource:DB03451_856]
p14090
sa(dp14091
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p14092
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04258
p14093
sg11
g14026
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p14094
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04258_856
p14095
sg16
VSeocalcitol [drugbank:DB04258]
p14096
sg18
Vdrug-target interaction Seocalcitol and Vitamin D3 receptor [drugbank_resource:DB04258_856]
p14097
sa(dp14098
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p14099
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04796
p14100
sg11
g14026
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p14101
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04796_856
p14102
sg16
VInecalcitol [drugbank:DB04796]
p14103
sg18
Vdrug-target interaction Inecalcitol and Vitamin D3 receptor [drugbank_resource:DB04796_856]
p14104
sa(dp14105
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p14106
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07530
p14107
sg11
g14026
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p14108
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07530_856
p14109
sg16
V(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol [drugbank:DB07530]
p14110
sg18
Vdrug-target interaction (1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol and Vitamin D3 receptor [drugbank_resource:DB07530_856]
p14111
sa(dp14112
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p14113
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08696
p14114
sg11
g14026
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p14115
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08696_856
p14116
sg16
V5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL [drugbank:DB08696]
p14117
sg18
Vdrug-target interaction 5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL and Vitamin D3 receptor [drugbank_resource:DB08696_856]
p14118
sa(dp14119
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:856
p14120
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08742
p14121
sg11
g14026
sg12
S'vitamin D (1,25- dihydroxyvitamin D3) receptor'
p14122
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08742_856
p14123
sg16
V1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z) [drugbank:DB08742]
p14124
sg18
Vdrug-target interaction 1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z) and Vitamin D3 receptor [drugbank_resource:DB08742_856]
p14125
sasS'CREB1'
p14126
(lp14127
(dp14128
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1291
p14129
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00131
p14130
sg11
g14126
sg12
S'cAMP responsive element binding protein 1'
p14131
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00131_1291
p14132
sg16
VAdenosine monophosphate [drugbank:DB00131]
p14133
sg18
Vdrug-target interaction Adenosine monophosphate and cAMP response element-binding protein [drugbank_resource:DB00131_1291]
p14134
sa(dp14135
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1291
p14136
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01183
p14137
sg11
g14126
sg12
S'cAMP responsive element binding protein 1'
p14138
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01183_1291
p14139
sg16
VNaloxone [drugbank:DB01183]
p14140
sg18
Vdrug-target interaction Naloxone and cAMP response element-binding protein [drugbank_resource:DB01183_1291]
p14141
sasS'PDPK1'
p14142
(lp14143
(dp14144
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p14145
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00482
p14146
sg11
g14142
sg12
S'3-phosphoinositide dependent protein kinase-1'
p14147
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00482_2180
p14148
sg16
VCelecoxib [drugbank:DB00482]
p14149
sg18
Vdrug-target interaction Celecoxib and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB00482_2180]
p14150
sa(dp14151
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p14152
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02010
p14153
sg11
g14142
sg12
S'3-phosphoinositide dependent protein kinase-1'
p14154
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02010_2180
p14155
sg16
VStaurosporine [drugbank:DB02010]
p14156
sg18
Vdrug-target interaction Staurosporine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB02010_2180]
p14157
sa(dp14158
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p14159
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01933
p14160
sg11
g14142
sg12
S'3-phosphoinositide dependent protein kinase-1'
p14161
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01933_2180
p14162
sg16
V7-Hydroxystaurosporine [drugbank:DB01933]
p14163
sg18
Vdrug-target interaction 7-Hydroxystaurosporine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB01933_2180]
p14164
sa(dp14165
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p14166
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01863
p14167
sg11
g14142
sg12
S'3-phosphoinositide dependent protein kinase-1'
p14168
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01863_2180
p14169
sg16
VInositol 1,3,4,5-Tetrakisphosphate [drugbank:DB01863]
p14170
sg18
Vdrug-target interaction Inositol 1,3,4,5-Tetrakisphosphate and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB01863_2180]
p14171
sa(dp14172
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p14173
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01946
p14174
sg11
g14142
sg12
S'3-phosphoinositide dependent protein kinase-1'
p14175
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01946_2180
p14176
sg16
V3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione [drugbank:DB01946]
p14177
sg18
Vdrug-target interaction 3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB01946_2180]
p14178
sa(dp14179
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p14180
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03777
p14181
sg11
g14142
sg12
S'3-phosphoinositide dependent protein kinase-1'
p14182
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03777_2180
p14183
sg16
VRbt205 Inhibitor [drugbank:DB03777]
p14184
sg18
Vdrug-target interaction Rbt205 Inhibitor and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB03777_2180]
p14185
sa(dp14186
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p14187
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06932
p14188
sg11
g14142
sg12
S'3-phosphoinositide dependent protein kinase-1'
p14189
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06932_2180
p14190
sg16
V10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine [drugbank:DB06932]
p14191
sg18
Vdrug-target interaction 10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB06932_2180]
p14192
sa(dp14193
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p14194
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07033
p14195
sg11
g14142
sg12
S'3-phosphoinositide dependent protein kinase-1'
p14196
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07033_2180
p14197
sg16
V5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE [drugbank:DB07033]
p14198
sg18
Vdrug-target interaction 5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07033_2180]
p14199
sa(dp14200
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p14201
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07132
p14202
sg11
g14142
sg12
S'3-phosphoinositide dependent protein kinase-1'
p14203
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07132_2180
p14204
sg16
V1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA [drugbank:DB07132]
p14205
sg18
Vdrug-target interaction 1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07132_2180]
p14206
sa(dp14207
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p14208
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07457
p14209
sg11
g14142
sg12
S'3-phosphoinositide dependent protein kinase-1'
p14210
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07457_2180
p14211
sg16
V3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE [drugbank:DB07457]
p14212
sg18
Vdrug-target interaction 3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07457_2180]
p14213
sa(dp14214
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p14215
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04522
p14216
sg11
g14142
sg12
S'3-phosphoinositide dependent protein kinase-1'
p14217
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04522_2180
p14218
sg16
VPhosphonoserine [drugbank:DB04522]
p14219
sg18
Vdrug-target interaction Phosphonoserine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB04522_2180]
p14220
sa(dp14221
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p14222
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07300
p14223
sg11
g14142
sg12
S'3-phosphoinositide dependent protein kinase-1'
p14224
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07300_2180
p14225
sg16
V2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine [drugbank:DB07300]
p14226
sg18
Vdrug-target interaction 2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07300_2180]
p14227
sa(dp14228
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2180
p14229
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07456
p14230
sg11
g14142
sg12
S'3-phosphoinositide dependent protein kinase-1'
p14231
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07456_2180
p14232
sg16
V3-(1H-INDOL-3-YL)-4-(1-{2-[(2S)-1-METHYLPYRROLIDINYL]ETHYL}-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE [drugbank:DB07456]
p14233
sg18
Vdrug-target interaction 3-(1H-INDOL-3-YL)-4-(1-{2-[(2S)-1-METHYLPYRROLIDINYL]ETHYL}-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07456_2180]
p14234
sasS'OPRK1'
p14235
(lp14236
(dp14237
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14238
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00193
p14239
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14240
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00193_696
p14241
sg16
VTramadol [drugbank:DB00193]
p14242
sg18
Vdrug-target interaction Tramadol and Kappa-type opioid receptor [drugbank_resource:DB00193_696]
p14243
sa(dp14244
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14245
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00295
p14246
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14247
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00295_696
p14248
sg16
VMorphine [drugbank:DB00295]
p14249
sg18
Vdrug-target interaction Morphine and Kappa-type opioid receptor [drugbank_resource:DB00295_696]
p14250
sa(dp14251
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14252
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00318
p14253
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14254
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00318_696
p14255
sg16
VCodeine [drugbank:DB00318]
p14256
sg18
Vdrug-target interaction Codeine and Kappa-type opioid receptor [drugbank_resource:DB00318_696]
p14257
sa(dp14258
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14259
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00321
p14260
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14261
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00321_696
p14262
sg16
VAmitriptyline [drugbank:DB00321]
p14263
sg18
Vdrug-target interaction Amitriptyline and Kappa-type opioid receptor [drugbank_resource:DB00321_696]
p14264
sa(dp14265
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14266
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00327
p14267
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14268
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00327_696
p14269
sg16
VHydromorphone [drugbank:DB00327]
p14270
sg18
Vdrug-target interaction Hydromorphone and Kappa-type opioid receptor [drugbank_resource:DB00327_696]
p14271
sa(dp14272
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14273
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00370
p14274
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14275
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00370_696
p14276
sg16
VMirtazapine [drugbank:DB00370]
p14277
sg18
Vdrug-target interaction Mirtazapine and Kappa-type opioid receptor [drugbank_resource:DB00370_696]
p14278
sa(dp14279
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14280
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00454
p14281
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14282
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00454_696
p14283
sg16
VMeperidine [drugbank:DB00454]
p14284
sg18
Vdrug-target interaction Meperidine and Kappa-type opioid receptor [drugbank_resource:DB00454_696]
p14285
sa(dp14286
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14287
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00497
p14288
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14289
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00497_696
p14290
sg16
VOxycodone [drugbank:DB00497]
p14291
sg18
Vdrug-target interaction Oxycodone and Kappa-type opioid receptor [drugbank_resource:DB00497_696]
p14292
sa(dp14293
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14294
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00611
p14295
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14296
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00611_696
p14297
sg16
VButorphanol [drugbank:DB00611]
p14298
sg18
Vdrug-target interaction Butorphanol and Kappa-type opioid receptor [drugbank_resource:DB00611_696]
p14299
sa(dp14300
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14301
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00647
p14302
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14303
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00647_696
p14304
sg16
VPropoxyphene [drugbank:DB00647]
p14305
sg18
Vdrug-target interaction Propoxyphene and Kappa-type opioid receptor [drugbank_resource:DB00647_696]
p14306
sa(dp14307
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14308
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00652
p14309
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14310
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00652_696
p14311
sg16
VPentazocine [drugbank:DB00652]
p14312
sg18
Vdrug-target interaction Pentazocine and Kappa-type opioid receptor [drugbank_resource:DB00652_696]
p14313
sa(dp14314
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14315
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00813
p14316
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14317
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00813_696
p14318
sg16
VFentanyl [drugbank:DB00813]
p14319
sg18
Vdrug-target interaction Fentanyl and Kappa-type opioid receptor [drugbank_resource:DB00813_696]
p14320
sa(dp14321
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14322
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00825
p14323
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14324
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00825_696
p14325
sg16
VMenthol [drugbank:DB00825]
p14326
sg18
Vdrug-target interaction Menthol and Kappa-type opioid receptor [drugbank_resource:DB00825_696]
p14327
sa(dp14328
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14329
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00836
p14330
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14331
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00836_696
p14332
sg16
VLoperamide [drugbank:DB00836]
p14333
sg18
Vdrug-target interaction Loperamide and Kappa-type opioid receptor [drugbank_resource:DB00836_696]
p14334
sa(dp14335
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14336
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00844
p14337
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14338
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00844_696
p14339
sg16
VNalbuphine [drugbank:DB00844]
p14340
sg18
Vdrug-target interaction Nalbuphine and Kappa-type opioid receptor [drugbank_resource:DB00844_696]
p14341
sa(dp14342
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14343
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00704
p14344
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14345
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00704_696
p14346
sg16
VNaltrexone [drugbank:DB00704]
p14347
sg18
Vdrug-target interaction Naltrexone and Kappa-type opioid receptor [drugbank_resource:DB00704_696]
p14348
sa(dp14349
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14350
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00708
p14351
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14352
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00708_696
p14353
sg16
VSufentanil [drugbank:DB00708]
p14354
sg18
Vdrug-target interaction Sufentanil and Kappa-type opioid receptor [drugbank_resource:DB00708_696]
p14355
sa(dp14356
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14357
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00854
p14358
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14359
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00854_696
p14360
sg16
VLevorphanol [drugbank:DB00854]
p14361
sg18
Vdrug-target interaction Levorphanol and Kappa-type opioid receptor [drugbank_resource:DB00854_696]
p14362
sa(dp14363
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14364
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00899
p14365
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14366
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00899_696
p14367
sg16
VRemifentanil [drugbank:DB00899]
p14368
sg18
Vdrug-target interaction Remifentanil and Kappa-type opioid receptor [drugbank_resource:DB00899_696]
p14369
sa(dp14370
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14371
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00921
p14372
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14373
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00921_696
p14374
sg16
VBuprenorphine [drugbank:DB00921]
p14375
sg18
Vdrug-target interaction Buprenorphine and Kappa-type opioid receptor [drugbank_resource:DB00921_696]
p14376
sa(dp14377
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14378
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01535
p14379
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14380
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01535_696
p14381
sg16
VCarfentanil [drugbank:DB01535]
p14382
sg18
Vdrug-target interaction Carfentanil and Kappa-type opioid receptor [drugbank_resource:DB01535_696]
p14383
sa(dp14384
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14385
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01548
p14386
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14387
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01548_696
p14388
sg16
VDiprenorphine [drugbank:DB01548]
p14389
sg18
Vdrug-target interaction Diprenorphine and Kappa-type opioid receptor [drugbank_resource:DB01548_696]
p14390
sa(dp14391
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14392
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01439
p14393
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14394
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01439_696
p14395
sg16
V3-Methylthiofentanyl [drugbank:DB01439]
p14396
sg18
Vdrug-target interaction 3-Methylthiofentanyl and Kappa-type opioid receptor [drugbank_resource:DB01439_696]
p14397
sa(dp14398
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14399
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01497
p14400
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14401
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01497_696
p14402
sg16
VEtorphine [drugbank:DB01497]
p14403
sg18
Vdrug-target interaction Etorphine and Kappa-type opioid receptor [drugbank_resource:DB01497_696]
p14404
sa(dp14405
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14406
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01183
p14407
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14408
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01183_696
p14409
sg16
VNaloxone [drugbank:DB01183]
p14410
sg18
Vdrug-target interaction Naloxone and Kappa-type opioid receptor [drugbank_resource:DB01183_696]
p14411
sa(dp14412
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14413
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01209
p14414
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14415
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01209_696
p14416
sg16
VDezocine [drugbank:DB01209]
p14417
sg18
Vdrug-target interaction Dezocine and Kappa-type opioid receptor [drugbank_resource:DB01209_696]
p14418
sa(dp14419
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14420
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01452
p14421
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14422
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01452_696
p14423
sg16
VHeroin [drugbank:DB01452]
p14424
sg18
Vdrug-target interaction Heroin and Kappa-type opioid receptor [drugbank_resource:DB01452_696]
p14425
sa(dp14426
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14427
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01565
p14428
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14429
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01565_696
p14430
sg16
VDihydromorphine [drugbank:DB01565]
p14431
sg18
Vdrug-target interaction Dihydromorphine and Kappa-type opioid receptor [drugbank_resource:DB01565_696]
p14432
sa(dp14433
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14434
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01571
p14435
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14436
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01571_696
p14437
sg16
V3-Methylfentanyl [drugbank:DB01571]
p14438
sg18
Vdrug-target interaction 3-Methylfentanyl and Kappa-type opioid receptor [drugbank_resource:DB01571_696]
p14439
sa(dp14440
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:696
p14441
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06274
p14442
sg11
g14235
sg12
S'opioid receptor, kappa 1'
p14443
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06274_696
p14444
sg16
VAlvimopan [drugbank:DB06274]
p14445
sg18
Vdrug-target interaction Alvimopan and Kappa-type opioid receptor [drugbank_resource:DB06274_696]
p14446
sasS'TUBA4A'
p14447
(lp14448
(dp14449
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2539
p14450
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00541
p14451
sg11
g14447
sg12
S'tubulin, alpha 4a'
p14452
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00541_2539
p14453
sg16
VVincristine [drugbank:DB00541]
p14454
sg18
Vdrug-target interaction Vincristine and Tubulin alpha-1 chain [drugbank_resource:DB00541_2539]
p14455
sa(dp14456
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2539
p14457
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01179
p14458
sg11
g14447
sg12
S'tubulin, alpha 4a'
p14459
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01179_2539
p14460
sg16
VPodofilox [drugbank:DB01179]
p14461
sg18
Vdrug-target interaction Podofilox and Tubulin alpha-1 chain [drugbank_resource:DB01179_2539]
p14462
sa(dp14463
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2539
p14464
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01873
p14465
sg11
g14447
sg12
S'tubulin, alpha 4a'
p14466
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01873_2539
p14467
sg16
VEpothilone D [drugbank:DB01873]
p14468
sg18
Vdrug-target interaction Epothilone D and Tubulin alpha-1 chain [drugbank_resource:DB01873_2539]
p14469
sa(dp14470
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2539
p14471
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03010
p14472
sg11
g14447
sg12
S'tubulin, alpha 4a'
p14473
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03010_2539
p14474
sg16
VEpothilone B [drugbank:DB03010]
p14475
sg18
Vdrug-target interaction Epothilone B and Tubulin alpha-1 chain [drugbank_resource:DB03010_2539]
p14476
sa(dp14477
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2539
p14478
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06772
p14479
sg11
g14447
sg12
S'tubulin, alpha 4a'
p14480
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06772_2539
p14481
sg16
VCabazitaxel [drugbank:DB06772]
p14482
sg18
Vdrug-target interaction Cabazitaxel and Tubulin alpha-1 chain [drugbank_resource:DB06772_2539]
p14483
sasS'TOP2A'
p14484
(lp14485
(dp14486
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14487
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00218
p14488
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14489
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00218_817
p14490
sg16
VMoxifloxacin [drugbank:DB00218]
p14491
sg18
Vdrug-target interaction Moxifloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00218_817]
p14492
sa(dp14493
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14494
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00276
p14495
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14496
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00276_817
p14497
sg16
VAmsacrine [drugbank:DB00276]
p14498
sg18
Vdrug-target interaction Amsacrine and DNA topoisomerase 2-alpha [drugbank_resource:DB00276_817]
p14499
sa(dp14500
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14501
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00467
p14502
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14503
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00467_817
p14504
sg16
VEnoxacin [drugbank:DB00467]
p14505
sg18
Vdrug-target interaction Enoxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00467_817]
p14506
sa(dp14507
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14508
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00487
p14509
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14510
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00487_817
p14511
sg16
VPefloxacin [drugbank:DB00487]
p14512
sg18
Vdrug-target interaction Pefloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00487_817]
p14513
sa(dp14514
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14515
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00380
p14516
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14517
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00380_817
p14518
sg16
VDexrazoxane [drugbank:DB00380]
p14519
sg18
Vdrug-target interaction Dexrazoxane and DNA topoisomerase 2-alpha [drugbank_resource:DB00380_817]
p14520
sa(dp14521
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14522
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00385
p14523
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14524
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00385_817
p14525
sg16
VValrubicin [drugbank:DB00385]
p14526
sg18
Vdrug-target interaction Valrubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB00385_817]
p14527
sa(dp14528
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14529
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00444
p14530
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14531
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00444_817
p14532
sg16
VTeniposide [drugbank:DB00444]
p14533
sg18
Vdrug-target interaction Teniposide and DNA topoisomerase 2-alpha [drugbank_resource:DB00444_817]
p14534
sa(dp14535
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14536
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00445
p14537
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14538
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00445_817
p14539
sg16
VEpirubicin [drugbank:DB00445]
p14540
sg18
Vdrug-target interaction Epirubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB00445_817]
p14541
sa(dp14542
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14543
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00537
p14544
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14545
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00537_817
p14546
sg16
VCiprofloxacin [drugbank:DB00537]
p14547
sg18
Vdrug-target interaction Ciprofloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00537_817]
p14548
sa(dp14549
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14550
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00773
p14551
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14552
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00773_817
p14553
sg16
VEtoposide [drugbank:DB00773]
p14554
sg18
Vdrug-target interaction Etoposide and DNA topoisomerase 2-alpha [drugbank_resource:DB00773_817]
p14555
sa(dp14556
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14557
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00685
p14558
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14559
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00685_817
p14560
sg16
VTrovafloxacin [drugbank:DB00685]
p14561
sg18
Vdrug-target interaction Trovafloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00685_817]
p14562
sa(dp14563
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14564
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00694
p14565
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14566
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00694_817
p14567
sg16
VDaunorubicin [drugbank:DB00694]
p14568
sg18
Vdrug-target interaction Daunorubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB00694_817]
p14569
sa(dp14570
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14571
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00997
p14572
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14573
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00997_817
p14574
sg16
VDoxorubicin [drugbank:DB00997]
p14575
sg18
Vdrug-target interaction Doxorubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB00997_817]
p14576
sa(dp14577
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14578
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01137
p14579
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14580
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01137_817
p14581
sg16
VLevofloxacin [drugbank:DB01137]
p14582
sg18
Vdrug-target interaction Levofloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB01137_817]
p14583
sa(dp14584
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14585
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00978
p14586
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14587
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00978_817
p14588
sg16
VLomefloxacin [drugbank:DB00978]
p14589
sg18
Vdrug-target interaction Lomefloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00978_817]
p14590
sa(dp14591
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14592
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01059
p14593
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14594
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01059_817
p14595
sg16
VNorfloxacin [drugbank:DB01059]
p14596
sg18
Vdrug-target interaction Norfloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB01059_817]
p14597
sa(dp14598
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14599
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01165
p14600
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14601
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01165_817
p14602
sg16
VOfloxacin [drugbank:DB01165]
p14603
sg18
Vdrug-target interaction Ofloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB01165_817]
p14604
sa(dp14605
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14606
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01645
p14607
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14608
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01645_817
p14609
sg16
VGenistein [drugbank:DB01645]
p14610
sg18
Vdrug-target interaction Genistein and DNA topoisomerase 2-alpha [drugbank_resource:DB01645_817]
p14611
sa(dp14612
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14613
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01177
p14614
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14615
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01177_817
p14616
sg16
VIdarubicin [drugbank:DB01177]
p14617
sg18
Vdrug-target interaction Idarubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB01177_817]
p14618
sa(dp14619
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14620
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01179
p14621
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14622
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01179_817
p14623
sg16
VPodofilox [drugbank:DB01179]
p14624
sg18
Vdrug-target interaction Podofilox and DNA topoisomerase 2-alpha [drugbank_resource:DB01179_817]
p14625
sa(dp14626
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14627
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01208
p14628
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14629
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01208_817
p14630
sg16
VSparfloxacin [drugbank:DB01208]
p14631
sg18
Vdrug-target interaction Sparfloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB01208_817]
p14632
sa(dp14633
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14634
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01204
p14635
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14636
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01204_817
p14637
sg16
VMitoxantrone [drugbank:DB01204]
p14638
sg18
Vdrug-target interaction Mitoxantrone and DNA topoisomerase 2-alpha [drugbank_resource:DB01204_817]
p14639
sa(dp14640
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14641
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04576
p14642
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14643
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04576_817
p14644
sg16
VFleroxacin [drugbank:DB04576]
p14645
sg18
Vdrug-target interaction Fleroxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB04576_817]
p14646
sa(dp14647
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:817
p14648
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04967
p14649
sg11
g14484
sg12
S'topoisomerase (DNA) II alpha 170kDa'
p14650
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04967_817
p14651
sg16
VLucanthone [drugbank:DB04967]
p14652
sg18
Vdrug-target interaction Lucanthone and DNA topoisomerase 2-alpha [drugbank_resource:DB04967_817]
p14653
sasS'CASP7'
p14654
(lp14655
(dp14656
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3320
p14657
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03384
p14658
sg11
g14654
sg12
S'caspase 7, apoptosis-related cysteine peptidase'
p14659
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03384_3320
p14660
sg16
VFica [drugbank:DB03384]
p14661
sg18
Vdrug-target interaction Fica and Caspase-7 [drugbank_resource:DB03384_3320]
p14662
sasS'VAMP2'
p14663
(lp14664
(dp14665
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3860
p14666
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00042
p14667
sg11
g14663
sg12
S'vesicle-associated membrane protein 2 (synaptobrevin 2)'
p14668
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00042_3860
p14669
sg16
VBotulinum Toxin Type B [drugbank:DB00042]
p14670
sg18
Vdrug-target interaction Botulinum Toxin Type B and Vesicle-associated membrane protein 2 [drugbank_resource:DB00042_3860]
p14671
sasS'CASP3'
p14672
(lp14673
(dp14674
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2077
p14675
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01017
p14676
sg11
g14672
sg12
S'caspase 3, apoptosis-related cysteine peptidase'
p14677
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01017_2077
p14678
sg16
VMinocycline [drugbank:DB01017]
p14679
sg18
Vdrug-target interaction Minocycline and Caspase-3 [drugbank_resource:DB01017_2077]
p14680
sa(dp14681
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2077
p14682
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03124
p14683
sg11
g14672
sg12
S'caspase 3, apoptosis-related cysteine peptidase'
p14684
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03124_2077
p14685
sg16
V5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid [drugbank:DB03124]
p14686
sg18
Vdrug-target interaction 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid and Caspase-3 [drugbank_resource:DB03124_2077]
p14687
sa(dp14688
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2077
p14689
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB06862
p14690
sg11
g14672
sg12
S'caspase 3, apoptosis-related cysteine peptidase'
p14691
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB06862_2077
p14692
sg16
V2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID [drugbank:DB06862]
p14693
sg18
Vdrug-target interaction 2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID and Caspase-3 [drugbank_resource:DB06862_2077]
p14694
sa(dp14695
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2077
p14696
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08213
p14697
sg11
g14672
sg12
S'caspase 3, apoptosis-related cysteine peptidase'
p14698
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08213_2077
p14699
sg16
V1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE [drugbank:DB08213]
p14700
sg18
Vdrug-target interaction 1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE and Caspase-3 [drugbank_resource:DB08213_2077]
p14701
sa(dp14702
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2077
p14703
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08499
p14704
sg11
g14672
sg12
S'caspase 3, apoptosis-related cysteine peptidase'
p14705
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08499_2077
p14706
sg16
VN-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide [drugbank:DB08499]
p14707
sg18
Vdrug-target interaction N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide and Caspase-3 [drugbank_resource:DB08499_2077]
p14708
sa(dp14709
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2077
p14710
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07696
p14711
sg11
g14672
sg12
S'caspase 3, apoptosis-related cysteine peptidase'
p14712
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07696_2077
p14713
sg16
Vmethyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate [drugbank:DB07696]
p14714
sg18
Vdrug-target interaction methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate and Caspase-3 [drugbank_resource:DB07696_2077]
p14715
sa(dp14716
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2077
p14717
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08229
p14718
sg11
g14672
sg12
S'caspase 3, apoptosis-related cysteine peptidase'
p14719
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08229_2077
p14720
sg16
V[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID [drugbank:DB08229]
p14721
sg18
Vdrug-target interaction [N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID and Caspase-3 [drugbank_resource:DB08229_2077]
p14722
sa(dp14723
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2077
p14724
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08251
p14725
sg11
g14672
sg12
S'caspase 3, apoptosis-related cysteine peptidase'
p14726
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08251_2077
p14727
sg16
V4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID [drugbank:DB08251]
p14728
sg18
Vdrug-target interaction 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID and Caspase-3 [drugbank_resource:DB08251_2077]
p14729
sa(dp14730
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2077
p14731
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08497
p14732
sg11
g14672
sg12
S'caspase 3, apoptosis-related cysteine peptidase'
p14733
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08497_2077
p14734
sg16
V(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate [drugbank:DB08497]
p14735
sg18
Vdrug-target interaction (1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate and Caspase-3 [drugbank_resource:DB08497_2077]
p14736
sa(dp14737
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2077
p14738
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08498
p14739
sg11
g14672
sg12
S'caspase 3, apoptosis-related cysteine peptidase'
p14740
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08498_2077
p14741
sg16
V(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate [drugbank:DB08498]
p14742
sg18
Vdrug-target interaction (1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate and Caspase-3 [drugbank_resource:DB08498_2077]
p14743
sasS'CASP1'
p14744
(lp14745
(dp14746
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:494
p14747
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01017
p14748
sg11
g14744
sg12
S'caspase 1, apoptosis-related cysteine peptidase'
p14749
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01017_494
p14750
sg16
VMinocycline [drugbank:DB01017]
p14751
sg18
Vdrug-target interaction Minocycline and Caspase-1 [drugbank_resource:DB01017_494]
p14752
sa(dp14753
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:494
p14754
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07744
p14755
sg11
g14744
sg12
S'caspase 1, apoptosis-related cysteine peptidase'
p14756
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07744_494
p14757
sg16
V3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID [drugbank:DB07744]
p14758
sg18
Vdrug-target interaction 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID and Caspase-1 [drugbank_resource:DB07744_494]
p14759
sa(dp14760
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:494
p14761
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07733
p14762
sg11
g14744
sg12
S'caspase 1, apoptosis-related cysteine peptidase'
p14763
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07733_494
p14764
sg16
V1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE [drugbank:DB07733]
p14765
sg18
Vdrug-target interaction 1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE and Caspase-1 [drugbank_resource:DB07733_494]
p14766
sa(dp14767
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:494
p14768
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07916
p14769
sg11
g14744
sg12
S'caspase 1, apoptosis-related cysteine peptidase'
p14770
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07916_494
p14771
sg16
V3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID [drugbank:DB07916]
p14772
sg18
Vdrug-target interaction 3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID and Caspase-1 [drugbank_resource:DB07916_494]
p14773
sasS'CFD'
p14774
(lp14775
(dp14776
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3346
p14777
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03058
p14778
sg11
g14774
sg12
S'complement factor D (adipsin)'
p14779
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03058_3346
p14780
sg16
VIsatoic Anhydride [drugbank:DB03058]
p14781
sg18
Vdrug-target interaction Isatoic Anhydride and Complement factor D [drugbank_resource:DB03058_3346]
p14782
sa(dp14783
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3346
p14784
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04459
p14785
sg11
g14774
sg12
S'complement factor D (adipsin)'
p14786
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04459_3346
p14787
sg16
V3,4-Dichloroisocoumarin [drugbank:DB04459]
p14788
sg18
Vdrug-target interaction 3,4-Dichloroisocoumarin and Complement factor D [drugbank_resource:DB04459_3346]
p14789
sasS'DRD5'
p14790
(lp14791
(dp14792
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14793
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00246
p14794
sg11
g14790
sg12
S'dopamine receptor D5'
p14795
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00246_163
p14796
sg16
VZiprasidone [drugbank:DB00246]
p14797
sg18
Vdrug-target interaction Ziprasidone and D(1B) dopamine receptor [drugbank_resource:DB00246_163]
p14798
sa(dp14799
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14800
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00268
p14801
sg11
g14790
sg12
S'dopamine receptor D5'
p14802
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00268_163
p14803
sg16
VRopinirole [drugbank:DB00268]
p14804
sg18
Vdrug-target interaction Ropinirole and D(1B) dopamine receptor [drugbank_resource:DB00268_163]
p14805
sa(dp14806
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14807
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00248
p14808
sg11
g14790
sg12
S'dopamine receptor D5'
p14809
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00248_163
p14810
sg16
VCabergoline [drugbank:DB00248]
p14811
sg18
Vdrug-target interaction Cabergoline and D(1B) dopamine receptor [drugbank_resource:DB00248_163]
p14812
sa(dp14813
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14814
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00334
p14815
sg11
g14790
sg12
S'dopamine receptor D5'
p14816
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00334_163
p14817
sg16
VOlanzapine [drugbank:DB00334]
p14818
sg18
Vdrug-target interaction Olanzapine and D(1B) dopamine receptor [drugbank_resource:DB00334_163]
p14819
sa(dp14820
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14821
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00413
p14822
sg11
g14790
sg12
S'dopamine receptor D5'
p14823
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00413_163
p14824
sg16
VPramipexole [drugbank:DB00413]
p14825
sg18
Vdrug-target interaction Pramipexole and D(1B) dopamine receptor [drugbank_resource:DB00413_163]
p14826
sa(dp14827
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14828
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00589
p14829
sg11
g14790
sg12
S'dopamine receptor D5'
p14830
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00589_163
p14831
sg16
VLisuride [drugbank:DB00589]
p14832
sg18
Vdrug-target interaction Lisuride and D(1B) dopamine receptor [drugbank_resource:DB00589_163]
p14833
sa(dp14834
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14835
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01038
p14836
sg11
g14790
sg12
S'dopamine receptor D5'
p14837
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01038_163
p14838
sg16
VCarphenazine [drugbank:DB01038]
p14839
sg18
Vdrug-target interaction Carphenazine and D(1B) dopamine receptor [drugbank_resource:DB01038_163]
p14840
sa(dp14841
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14842
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00714
p14843
sg11
g14790
sg12
S'dopamine receptor D5'
p14844
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00714_163
p14845
sg16
VApomorphine [drugbank:DB00714]
p14846
sg18
Vdrug-target interaction Apomorphine and D(1B) dopamine receptor [drugbank_resource:DB00714_163]
p14847
sa(dp14848
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14849
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00800
p14850
sg11
g14790
sg12
S'dopamine receptor D5'
p14851
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00800_163
p14852
sg16
VFenoldopam [drugbank:DB00800]
p14853
sg18
Vdrug-target interaction Fenoldopam and D(1B) dopamine receptor [drugbank_resource:DB00800_163]
p14854
sa(dp14855
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14856
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00988
p14857
sg11
g14790
sg12
S'dopamine receptor D5'
p14858
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00988_163
p14859
sg16
VDopamine [drugbank:DB00988]
p14860
sg18
Vdrug-target interaction Dopamine and D(1B) dopamine receptor [drugbank_resource:DB00988_163]
p14861
sa(dp14862
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14863
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01200
p14864
sg11
g14790
sg12
S'dopamine receptor D5'
p14865
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01200_163
p14866
sg16
VBromocriptine [drugbank:DB01200]
p14867
sg18
Vdrug-target interaction Bromocriptine and D(1B) dopamine receptor [drugbank_resource:DB01200_163]
p14868
sa(dp14869
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14870
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01235
p14871
sg11
g14790
sg12
S'dopamine receptor D5'
p14872
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01235_163
p14873
sg16
VLevodopa [drugbank:DB01235]
p14874
sg18
Vdrug-target interaction Levodopa and D(1B) dopamine receptor [drugbank_resource:DB01235_163]
p14875
sa(dp14876
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14877
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01624
p14878
sg11
g14790
sg12
S'dopamine receptor D5'
p14879
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01624_163
p14880
sg16
VZuclopenthixol [drugbank:DB01624]
p14881
sg18
Vdrug-target interaction Zuclopenthixol and D(1B) dopamine receptor [drugbank_resource:DB01624_163]
p14882
sa(dp14883
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14884
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01224
p14885
sg11
g14790
sg12
S'dopamine receptor D5'
p14886
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01224_163
p14887
sg16
VQuetiapine [drugbank:DB01224]
p14888
sg18
Vdrug-target interaction Quetiapine and D(1B) dopamine receptor [drugbank_resource:DB01224_163]
p14889
sa(dp14890
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14891
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01238
p14892
sg11
g14790
sg12
S'dopamine receptor D5'
p14893
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01238_163
p14894
sg16
VAripiprazole [drugbank:DB01238]
p14895
sg18
Vdrug-target interaction Aripiprazole and D(1B) dopamine receptor [drugbank_resource:DB01238_163]
p14896
sa(dp14897
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14898
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01186
p14899
sg11
g14790
sg12
S'dopamine receptor D5'
p14900
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01186_163
p14901
sg16
VPergolide [drugbank:DB01186]
p14902
sg18
Vdrug-target interaction Pergolide and D(1B) dopamine receptor [drugbank_resource:DB01186_163]
p14903
sa(dp14904
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14905
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01403
p14906
sg11
g14790
sg12
S'dopamine receptor D5'
p14907
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01403_163
p14908
sg16
VMethotrimeprazine [drugbank:DB01403]
p14909
sg18
Vdrug-target interaction Methotrimeprazine and D(1B) dopamine receptor [drugbank_resource:DB01403_163]
p14910
sa(dp14911
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:163
p14912
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB05271
p14913
sg11
g14790
sg12
S'dopamine receptor D5'
p14914
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB05271_163
p14915
sg16
VRotigotine [drugbank:DB05271]
p14916
sg18
Vdrug-target interaction Rotigotine and D(1B) dopamine receptor [drugbank_resource:DB05271_163]
p14917
sasS'ROCK1'
p14918
(lp14919
(dp14920
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1531
p14921
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04707
p14922
sg11
g14918
sg12
S'Rho-associated, coiled-coil containing protein kinase 1'
p14923
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04707_1531
p14924
sg16
VHYDROXYFASUDIL [drugbank:DB04707]
p14925
sg18
Vdrug-target interaction HYDROXYFASUDIL and Rho-associated protein kinase 1 [drugbank_resource:DB04707_1531]
p14926
sa(dp14927
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1531
p14928
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07876
p14929
sg11
g14918
sg12
S'Rho-associated, coiled-coil containing protein kinase 1'
p14930
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07876_1531
p14931
sg16
V(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE [drugbank:DB07876]
p14932
sg18
Vdrug-target interaction (S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE and Rho-associated protein kinase 1 [drugbank_resource:DB07876_1531]
p14933
sa(dp14934
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1531
p14935
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08756
p14936
sg11
g14918
sg12
S'Rho-associated, coiled-coil containing protein kinase 1'
p14937
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08756_1531
p14938
sg16
V(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE [drugbank:DB08756]
p14939
sg18
Vdrug-target interaction (R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE and Rho-associated protein kinase 1 [drugbank_resource:DB08756_1531]
p14940
sa(dp14941
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1531
p14942
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08162
p14943
sg11
g14918
sg12
S'Rho-associated, coiled-coil containing protein kinase 1'
p14944
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08162_1531
p14945
sg16
V5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE [drugbank:DB08162]
p14946
sg18
Vdrug-target interaction 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE and Rho-associated protein kinase 1 [drugbank_resource:DB08162_1531]
p14947
sasS'PDE2A'
p14948
(lp14949
(dp14950
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3806
p14951
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02315
p14952
sg11
g14948
sg12
S'phosphodiesterase 2A, cGMP-stimulated'
p14953
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02315_3806
p14954
sg16
VCyclic Guanosine Monophosphate [drugbank:DB02315]
p14955
sg18
Vdrug-target interaction Cyclic Guanosine Monophosphate and cGMP-dependent 3',5'-cyclic phosphodiesterase [drugbank_resource:DB02315_3806]
p14956
sa(dp14957
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3806
p14958
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07954
p14959
sg11
g14948
sg12
S'phosphodiesterase 2A, cGMP-stimulated'
p14960
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07954_3806
p14961
sg16
V3-ISOBUTYL-1-METHYLXANTHINE [drugbank:DB07954]
p14962
sg18
Vdrug-target interaction 3-ISOBUTYL-1-METHYLXANTHINE and cGMP-dependent 3',5'-cyclic phosphodiesterase [drugbank_resource:DB07954_3806]
p14963
sa(dp14964
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:3806
p14965
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08811
p14966
sg11
g14948
sg12
S'phosphodiesterase 2A, cGMP-stimulated'
p14967
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08811_3806
p14968
sg16
VTofisopam [drugbank:DB08811]
p14969
sg18
Vdrug-target interaction Tofisopam and cGMP-dependent 3',5'-cyclic phosphodiesterase [drugbank_resource:DB08811_3806]
p14970
sasS'GRIN2B'
p14971
(lp14972
(dp14973
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:464
p14974
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p14975
sg11
g14971
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 2B'
p14976
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_464
p14977
sg16
VL-Glutamic Acid [drugbank:DB00142]
p14978
sg18
Vdrug-target interaction L-Glutamic Acid and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB00142_464]
p14979
sa(dp14980
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:464
p14981
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00454
p14982
sg11
g14971
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 2B'
p14983
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00454_464
p14984
sg16
VMeperidine [drugbank:DB00454]
p14985
sg18
Vdrug-target interaction Meperidine and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB00454_464]
p14986
sa(dp14987
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:464
p14988
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00502
p14989
sg11
g14971
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 2B'
p14990
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00502_464
p14991
sg16
VHaloperidol [drugbank:DB00502]
p14992
sg18
Vdrug-target interaction Haloperidol and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB00502_464]
p14993
sa(dp14994
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:464
p14995
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00949
p14996
sg11
g14971
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 2B'
p14997
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00949_464
p14998
sg16
VFelbamate [drugbank:DB00949]
p14999
sg18
Vdrug-target interaction Felbamate and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB00949_464]
p15000
sa(dp15001
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:464
p15002
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01043
p15003
sg11
g14971
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 2B'
p15004
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01043_464
p15005
sg16
VMemantine [drugbank:DB01043]
p15006
sg18
Vdrug-target interaction Memantine and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB01043_464]
p15007
sa(dp15008
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:464
p15009
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01520
p15010
sg11
g14971
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 2B'
p15011
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01520_464
p15012
sg16
VTenocyclidine [drugbank:DB01520]
p15013
sg18
Vdrug-target interaction Tenocyclidine and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB01520_464]
p15014
sasS'TYMS'
p15015
(lp15016
(dp15017
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15018
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00293
p15019
sg11
g15015
sg12
S'thymidylate synthetase'
p15020
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00293_359
p15021
sg16
VRaltitrexed [drugbank:DB00293]
p15022
sg18
Vdrug-target interaction Raltitrexed and Thymidylate synthase [drugbank_resource:DB00293_359]
p15023
sa(dp15024
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15025
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00322
p15026
sg11
g15015
sg12
S'thymidylate synthetase'
p15027
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00322_359
p15028
sg16
VFloxuridine [drugbank:DB00322]
p15029
sg18
Vdrug-target interaction Floxuridine and Thymidylate synthase [drugbank_resource:DB00322_359]
p15030
sa(dp15031
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15032
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00441
p15033
sg11
g15015
sg12
S'thymidylate synthetase'
p15034
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00441_359
p15035
sg16
VGemcitabine [drugbank:DB00441]
p15036
sg18
Vdrug-target interaction Gemcitabine and Thymidylate synthase [drugbank_resource:DB00441_359]
p15037
sa(dp15038
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15039
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00642
p15040
sg11
g15015
sg12
S'thymidylate synthetase'
p15041
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00642_359
p15042
sg16
VPemetrexed [drugbank:DB00642]
p15043
sg18
Vdrug-target interaction Pemetrexed and Thymidylate synthase [drugbank_resource:DB00642_359]
p15044
sa(dp15045
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15046
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00544
p15047
sg11
g15015
sg12
S'thymidylate synthetase'
p15048
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00544_359
p15049
sg16
VFluorouracil [drugbank:DB00544]
p15050
sg18
Vdrug-target interaction Fluorouracil and Thymidylate synthase [drugbank_resource:DB00544_359]
p15051
sa(dp15052
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15053
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00544
p15054
sg11
g15015
sg12
S'thymidylate synthetase'
p15055
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00544_359
p15056
sg16
VFluorouracil [drugbank:DB00544]
p15057
sg18
Vdrug-enzyme interaction Fluorouracil and Thymidylate synthase [drugbank_resource:DB00544_359]
p15058
sa(dp15059
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15060
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00432
p15061
sg11
g15015
sg12
S'thymidylate synthetase'
p15062
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00432_359
p15063
sg16
VTrifluridine [drugbank:DB00432]
p15064
sg18
Vdrug-target interaction Trifluridine and Thymidylate synthase [drugbank_resource:DB00432_359]
p15065
sa(dp15066
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15067
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00440
p15068
sg11
g15015
sg12
S'thymidylate synthetase'
p15069
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00440_359
p15070
sg16
VTrimethoprim [drugbank:DB00440]
p15071
sg18
Vdrug-target interaction Trimethoprim and Thymidylate synthase [drugbank_resource:DB00440_359]
p15072
sa(dp15073
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15074
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00650
p15075
sg11
g15015
sg12
S'thymidylate synthetase'
p15076
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00650_359
p15077
sg16
VLeucovorin [drugbank:DB00650]
p15078
sg18
Vdrug-target interaction Leucovorin and Thymidylate synthase [drugbank_resource:DB00650_359]
p15079
sa(dp15080
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15081
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01101
p15082
sg11
g15015
sg12
S'thymidylate synthetase'
p15083
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01101_359
p15084
sg16
VCapecitabine [drugbank:DB01101]
p15085
sg18
Vdrug-target interaction Capecitabine and Thymidylate synthase [drugbank_resource:DB01101_359]
p15086
sa(dp15087
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15088
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01643
p15089
sg11
g15015
sg12
S'thymidylate synthetase'
p15090
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01643_359
p15091
sg16
VThymidine-5'-Phosphate [drugbank:DB01643]
p15092
sg18
Vdrug-target interaction Thymidine-5'-Phosphate and Thymidylate synthase [drugbank_resource:DB01643_359]
p15093
sa(dp15094
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15095
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03541
p15096
sg11
g15015
sg12
S'thymidylate synthetase'
p15097
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03541_359
p15098
sg16
V10-Propargyl-5,8-Dideazafolic Acid [drugbank:DB03541]
p15099
sg18
Vdrug-target interaction 10-Propargyl-5,8-Dideazafolic Acid and Thymidylate synthase [drugbank_resource:DB03541_359]
p15100
sa(dp15101
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15102
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB03800
p15103
sg11
g15015
sg12
S'thymidylate synthetase'
p15104
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB03800_359
p15105
sg16
V2'-deoxyuridylic acid [drugbank:DB03800]
p15106
sg18
Vdrug-target interaction 2'-deoxyuridylic acid and Thymidylate synthase [drugbank_resource:DB03800_359]
p15107
sa(dp15108
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15109
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04530
p15110
sg11
g15015
sg12
S'thymidylate synthetase'
p15111
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04530_359
p15112
sg16
VS,S-(2-Hydroxyethyl)Thiocysteine [drugbank:DB04530]
p15113
sg18
Vdrug-target interaction S,S-(2-Hydroxyethyl)Thiocysteine and Thymidylate synthase [drugbank_resource:DB04530_359]
p15114
sa(dp15115
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15116
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB07577
p15117
sg11
g15015
sg12
S'thymidylate synthetase'
p15118
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB07577_359
p15119
sg16
V6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE [drugbank:DB07577]
p15120
sg18
Vdrug-target interaction 6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE and Thymidylate synthase [drugbank_resource:DB07577_359]
p15121
sa(dp15122
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15123
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08479
p15124
sg11
g15015
sg12
S'thymidylate synthetase'
p15125
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08479_359
p15126
sg16
VN-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide [drugbank:DB08479]
p15127
sg18
Vdrug-target interaction N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide and Thymidylate synthase [drugbank_resource:DB08479_359]
p15128
sa(dp15129
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15130
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08478
p15131
sg11
g15015
sg12
S'thymidylate synthetase'
p15132
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08478_359
p15133
sg16
VN-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide [drugbank:DB08478]
p15134
sg18
Vdrug-target interaction N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide and Thymidylate synthase [drugbank_resource:DB08478_359]
p15135
sa(dp15136
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:359
p15137
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08734
p15138
sg11
g15015
sg12
S'thymidylate synthetase'
p15139
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08734_359
p15140
sg16
V6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE [drugbank:DB08734]
p15141
sg18
Vdrug-target interaction 6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE and Thymidylate synthase [drugbank_resource:DB08734_359]
p15142
sasS'GRIN2A'
p15143
(lp15144
(dp15145
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:837
p15146
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p15147
sg11
g15143
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 2A'
p15148
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_837
p15149
sg16
VL-Glutamic Acid [drugbank:DB00142]
p15150
sg18
Vdrug-target interaction L-Glutamic Acid and Glutamate [NMDA] receptor subunit epsilon-1 [drugbank_resource:DB00142_837]
p15151
sa(dp15152
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:837
p15153
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00145
p15154
sg11
g15143
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 2A'
p15155
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00145_837
p15156
sg16
VGlycine [drugbank:DB00145]
p15157
sg18
Vdrug-target interaction Glycine and Glutamate [NMDA] receptor subunit epsilon-1 [drugbank_resource:DB00145_837]
p15158
sa(dp15159
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:837
p15160
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00454
p15161
sg11
g15143
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 2A'
p15162
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00454_837
p15163
sg16
VMeperidine [drugbank:DB00454]
p15164
sg18
Vdrug-target interaction Meperidine and Glutamate [NMDA] receptor subunit epsilon-1 [drugbank_resource:DB00454_837]
p15165
sa(dp15166
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:837
p15167
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00949
p15168
sg11
g15143
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 2A'
p15169
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00949_837
p15170
sg16
VFelbamate [drugbank:DB00949]
p15171
sg18
Vdrug-target interaction Felbamate and Glutamate [NMDA] receptor subunit epsilon-1 [drugbank_resource:DB00949_837]
p15172
sa(dp15173
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:837
p15174
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01043
p15175
sg11
g15143
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 2A'
p15176
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01043_837
p15177
sg16
VMemantine [drugbank:DB01043]
p15178
sg18
Vdrug-target interaction Memantine and Glutamate [NMDA] receptor subunit epsilon-1 [drugbank_resource:DB01043_837]
p15179
sa(dp15180
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:837
p15181
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01159
p15182
sg11
g15143
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 2A'
p15183
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01159_837
p15184
sg16
VHalothane [drugbank:DB01159]
p15185
sg18
Vdrug-target interaction Halothane and Glutamate [NMDA] receptor subunit epsilon-1 [drugbank_resource:DB01159_837]
p15186
sa(dp15187
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:837
p15188
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01520
p15189
sg11
g15143
sg12
S'glutamate receptor, ionotropic, N-methyl D-aspartate 2A'
p15190
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01520_837
p15191
sg16
VTenocyclidine [drugbank:DB01520]
p15192
sg18
Vdrug-target interaction Tenocyclidine and Glutamate [NMDA] receptor subunit epsilon-1 [drugbank_resource:DB01520_837]
p15193
sasS'CREBBP'
p15194
(lp15195
(dp15196
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6876
p15197
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08655
p15198
sg11
g15194
sg12
S'CREB binding protein'
p15199
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08655_6876
p15200
sg16
V9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE [drugbank:DB08655]
p15201
sg18
Vdrug-target interaction 9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE and CREB-binding protein [drugbank_resource:DB08655_6876]
p15202
sasS'SCN1A'
p15203
(lp15204
(dp15205
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:158
p15206
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00252
p15207
sg11
g15203
sg12
S'sodium channel, voltage-gated, type I, alpha subunit'
p15208
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00252_158
p15209
sg16
VPhenytoin [drugbank:DB00252]
p15210
sg18
Vdrug-target interaction Phenytoin and Sodium channel protein type 1 subunit alpha [drugbank_resource:DB00252_158]
p15211
sa(dp15212
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:158
p15213
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00273
p15214
sg11
g15203
sg12
S'sodium channel, voltage-gated, type I, alpha subunit'
p15215
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00273_158
p15216
sg16
VTopiramate [drugbank:DB00273]
p15217
sg18
Vdrug-target interaction Topiramate and Sodium channel protein type 1 subunit alpha [drugbank_resource:DB00273_158]
p15218
sa(dp15219
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:158
p15220
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00909
p15221
sg11
g15203
sg12
S'sodium channel, voltage-gated, type I, alpha subunit'
p15222
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00909_158
p15223
sg16
VZonisamide [drugbank:DB00909]
p15224
sg18
Vdrug-target interaction Zonisamide and Sodium channel protein type 1 subunit alpha [drugbank_resource:DB00909_158]
p15225
sa(dp15226
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:158
p15227
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01121
p15228
sg11
g15203
sg12
S'sodium channel, voltage-gated, type I, alpha subunit'
p15229
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01121_158
p15230
sg16
VPhenacemide [drugbank:DB01121]
p15231
sg18
Vdrug-target interaction Phenacemide and Sodium channel protein type 1 subunit alpha [drugbank_resource:DB01121_158]
p15232
sa(dp15233
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:158
p15234
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01438
p15235
sg11
g15203
sg12
S'sodium channel, voltage-gated, type I, alpha subunit'
p15236
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01438_158
p15237
sg16
VPhenazopyridine [drugbank:DB01438]
p15238
sg18
Vdrug-target interaction Phenazopyridine and Sodium channel protein type 1 subunit alpha [drugbank_resource:DB01438_158]
p15239
sa(dp15240
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:158
p15241
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01595
p15242
sg11
g15203
sg12
S'sodium channel, voltage-gated, type I, alpha subunit'
p15243
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01595_158
p15244
sg16
VNitrazepam [drugbank:DB01595]
p15245
sg18
Vdrug-target interaction Nitrazepam and Sodium channel protein type 1 subunit alpha [drugbank_resource:DB01595_158]
p15246
sa(dp15247
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:158
p15248
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB04930
p15249
sg11
g15203
sg12
S'sodium channel, voltage-gated, type I, alpha subunit'
p15250
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB04930_158
p15251
sg16
VPermethrin [drugbank:DB04930]
p15252
sg18
Vdrug-target interaction Permethrin and Sodium channel protein type 1 subunit alpha [drugbank_resource:DB04930_158]
p15253
sasS'C1S'
p15254
(lp15255
(dp15256
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p15257
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00054
p15258
sg11
g15254
sg12
S'complement component 1, s subcomponent'
p15259
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00054_2782
p15260
sg16
VAbciximab [drugbank:DB00054]
p15261
sg18
Vdrug-target interaction Abciximab and Complement C1s subcomponent [drugbank_resource:DB00054_2782]
p15262
sa(dp15263
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p15264
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00072
p15265
sg11
g15254
sg12
S'complement component 1, s subcomponent'
p15266
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00072_2782
p15267
sg16
VTrastuzumab [drugbank:DB00072]
p15268
sg18
Vdrug-target interaction Trastuzumab and Complement C1s subcomponent [drugbank_resource:DB00072_2782]
p15269
sa(dp15270
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p15271
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00073
p15272
sg11
g15254
sg12
S'complement component 1, s subcomponent'
p15273
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00073_2782
p15274
sg16
VRituximab [drugbank:DB00073]
p15275
sg18
Vdrug-target interaction Rituximab and Complement C1s subcomponent [drugbank_resource:DB00073_2782]
p15276
sa(dp15277
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p15278
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00075
p15279
sg11
g15254
sg12
S'complement component 1, s subcomponent'
p15280
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00075_2782
p15281
sg16
VMuromonab [drugbank:DB00075]
p15282
sg18
Vdrug-target interaction Muromonab and Complement C1s subcomponent [drugbank_resource:DB00075_2782]
p15283
sa(dp15284
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p15285
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00051
p15286
sg11
g15254
sg12
S'complement component 1, s subcomponent'
p15287
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00051_2782
p15288
sg16
VAdalimumab [drugbank:DB00051]
p15289
sg18
Vdrug-target interaction Adalimumab and Complement C1s subcomponent [drugbank_resource:DB00051_2782]
p15290
sa(dp15291
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p15292
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00056
p15293
sg11
g15254
sg12
S'complement component 1, s subcomponent'
p15294
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00056_2782
p15295
sg16
VGemtuzumab ozogamicin [drugbank:DB00056]
p15296
sg18
Vdrug-target interaction Gemtuzumab ozogamicin and Complement C1s subcomponent [drugbank_resource:DB00056_2782]
p15297
sa(dp15298
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p15299
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00074
p15300
sg11
g15254
sg12
S'complement component 1, s subcomponent'
p15301
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00074_2782
p15302
sg16
VBasiliximab [drugbank:DB00074]
p15303
sg18
Vdrug-target interaction Basiliximab and Complement C1s subcomponent [drugbank_resource:DB00074_2782]
p15304
sa(dp15305
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p15306
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00078
p15307
sg11
g15254
sg12
S'complement component 1, s subcomponent'
p15308
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00078_2782
p15309
sg16
VIbritumomab [drugbank:DB00078]
p15310
sg18
Vdrug-target interaction Ibritumomab and Complement C1s subcomponent [drugbank_resource:DB00078_2782]
p15311
sa(dp15312
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p15313
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00002
p15314
sg11
g15254
sg12
S'complement component 1, s subcomponent'
p15315
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00002_2782
p15316
sg16
VCetuximab [drugbank:DB00002]
p15317
sg18
Vdrug-target interaction Cetuximab and Complement C1s subcomponent [drugbank_resource:DB00002_2782]
p15318
sa(dp15319
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p15320
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00005
p15321
sg11
g15254
sg12
S'complement component 1, s subcomponent'
p15322
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00005_2782
p15323
sg16
VEtanercept [drugbank:DB00005]
p15324
sg18
Vdrug-target interaction Etanercept and Complement C1s subcomponent [drugbank_resource:DB00005_2782]
p15325
sa(dp15326
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:2782
p15327
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB02371
p15328
sg11
g15254
sg12
S'complement component 1, s subcomponent'
p15329
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB02371_2782
p15330
sg16
V2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid [drugbank:DB02371]
p15331
sg18
Vdrug-target interaction 2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid and Complement C1s subcomponent [drugbank_resource:DB02371_2782]
p15332
sasS'PPP3CA'
p15333
(lp15334
(dp15335
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:6746
p15336
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB08231
p15337
sg11
g15333
sg12
S'protein phosphatase 3, catalytic subunit, alpha isozyme'
p15338
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB08231_6746
p15339
sg16
VMYRISTIC ACID [drugbank:DB08231]
p15340
sg18
Vdrug-target interaction MYRISTIC ACID and Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform [drugbank_resource:DB08231_6746]
p15341
sasS'SLC1A2'
p15342
(lp15343
(dp15344
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1047
p15345
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB00142
p15346
sg11
g15342
sg12
S'solute carrier family 1 (glial high affinity glutamate transporter), member 2'
p15347
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB00142_1047
p15348
sg16
VL-Glutamic Acid [drugbank:DB00142]
p15349
sg18
Vdrug-target interaction L-Glutamic Acid and Excitatory amino acid transporter 2 [drugbank_resource:DB00142_1047]
p15350
sasS'VCAM1'
p15351
(lp15352
(dp15353
g4
g5
sg6
Vhttp://bio2rdf.org/drugbank_target:1908
p15354
sg8
Nsg9
Vhttp://bio2rdf.org/drugbank:DB01136
p15355
sg11
g15351
sg12
S'vascular cell adhesion molecule 1'
p15356
sg14
Vhttp://bio2rdf.org/drugbank_resource:DB01136_1908
p15357
sg16
VCarvedilol [drugbank:DB01136]
p15358
sg18
Vdrug-target interaction Carvedilol and Vascular cell adhesion protein 1 [drugbank_resource:DB01136_1908]
p15359
sas.